# RGD-PIPELINE: ftp-file-extracts
# MODULE: annotations-version-1.1.9 (Oct 10, 2019)
# GENERATED-ON: 2025/04/12
# PURPOSE: annotations about active Rat objects extracted from RGD database
# ONTOLOGY: MP: Mammalian Phenotype
# CONTACT: rgd.data@mcw.edu
# FORMAT: tab delimited text
# NOTES: multiple values in a single column are separated by '|'
#
#COLUMN INFORMATION:
#
#1 RGD_ID unique RGD_ID of the annotated object
#2 OBJECT_SYMBOL official symbol of the annotated object
#3 OBJECT_NAME official name of the annotated object
#4 OBJECT_TYPE annotated object data type: one of ['gene','qtl','strain']
#5 TERM_ACC_ID ontology term accession id
#6 TERM_NAME ontology term name
#7 QUALIFIER optional qualifier
#8 EVIDENCE evidence
#9 WITH with info
#10 ASPECT aspect
#11 REFERENCES db references (Reference RGDID|PUBMED ID)
#12 CREATED_DATE created date
#13 ASSIGNED_BY assigned by
#14 MESH_OMIM_ID MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only)
#15 CURATION_NOTES curation notes provided by RGD curators
#16 ORIGINAL_REFERENCE original reference
RGD_ID OBJECT_SYMBOL OBJECT_NAME OBJECT_TYPE TERM_ACC_ID TERM_NAME QUALIFIER EVIDENCE WITH ASPECT REFERENCES CREATED_DATE ASSIGNED_BY MESH_OMIM_ID CURATION_NOTES ORIGINAL_REFERENCE
10000 ACI/N A X C 9935, Irish strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female F344/NHsd
10000 ACI/N A X C 9935, Irish strain MP:0010123 increased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to F344/NHsd female
10002743 DA.E3-(<i>D20Rat42-D20Rat49</i>)/Rhd strain MP:0002936 joint swelling severity IAGP XCO:0000265,XCO:0000281 N RGD:737659|PMID:8972741 20200814 RGD compared to LEW.1AV1/Kini
10002743 DA.E3-(<i>D20Rat42-D20Rat49</i>)/Rhd strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:737659|PMID:8972741 20200814 RGD
10002745 DA.E3-(<i>D20Rat47-AA858870</i>)/Rhd strain MP:0001973 increased thermal nociceptive threshold IAGP N RGD:10002747|PMID:20471989 20201005 RGD
10002745 DA.E3-(<i>D20Rat47-AA858870</i>)/Rhd strain MP:0020955 increased mechanical nociceptive threshold IAGP N RGD:10002747|PMID:20471989 20150423 RGD
10002755 Sbf1<i><sup>m1Ipcv</sup></i> SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20201210 RGD
10002755 Sbf1<i><sup>m1Ipcv</sup></i> SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20201210 RGD
10002755 Sbf1<i><sup>m1Ipcv</sup></i> SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20201210 RGD
10002755 Sbf1<i><sup>m1Ipcv</sup></i> SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20201210 RGD
10002782 SHR-<i>Sbf1<sup>m1Ipcv</i></sup> strain MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type
10002782 SHR-<i>Sbf1<sup>m1Ipcv</i></sup> strain MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type
10002782 SHR-<i>Sbf1<sup>m1Ipcv</i></sup> strain MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type
10002782 SHR-<i>Sbf1<sup>m1Ipcv</i></sup> strain MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type control
10003 BBDR/Rhw strain MP:0001846 increased inflammatory response induced IAGP XCO:0000281 N RGD:61067|PMID:11001927 19990101 RGD compared to BN
10003 BBDR/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20200303 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
10004 BC/CpbU strain MP:0002666 increased circulating aldosterone level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to treated LEW/OlaHsd
10004 BC/CpbU strain MP:0005179 decreased circulating cholesterol level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to control BC/CpbU males
10008 BN/SsNHsd strain MP:0000635 pituitary gland hyperplasia induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD
10008 BN/SsNHsd strain MP:0002891 increased insulin sensitivity IAGP N RGD:6893578|PMID:22947656 20200413 RGD
10008 BN/SsNHsd strain MP:0003026 decreased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd and congenics
10008 BN/SsNHsd strain MP:0003109 short femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female ACI/N
10008 BN/SsNHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD
10008 BN/SsNHsd strain MP:0008938 decreased pituitary gland weight IAGP N RGD:1642526|PMID:17876666 20200327 RGD compared to ACI/SegHsd
10008 BN/SsNHsd strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared to treated ACI/SegHsd
10008 BN/SsNHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared to BN/SsNHsd
10008 BN/SsNHsd strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains
10008 BN/SsNHsd strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains
10008 BN/SsNHsd strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female NAft:HS
10008 BN/SsNHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD in pituitary gland
10008 BN/SsNHsd strain MP:0030794 broad femur neck IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, F344/NHsd, WKY/NHsd
10011 COP/OlaHsd strain MP:0002834 decreased heart weight IAGP N RGD:731241|PMID:11015562 19990101 RGD compared to DA/OlaHsd
10011 COP/OlaHsd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:731241|PMID:11015562 20200629 RGD compared to DA/OlaHsd
10011 COP/OlaHsd strain MP:0003061 decreased aerobic running capacity induced IAGP XCO:0000296 N RGD:731241|PMID:11015562 19990101 RGD compared to DA/OlaHsd
10011 COP/OlaHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD compared to BN/HsdMcwiCrl
10011 COP/OlaHsd strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:1358956|PMID:11713205 20200310 RGD compared to ACI/SegHsd
10015 FHH/Eur strain MP:0002833 increased heart weight IAGP N RGD:724742|PMID:8329672 20201012 RGD compared to WAG/OlaHsd
10015 FHH/Eur strain MP:0002962 increased urine protein level IAGP N RGD:724742|PMID:8329672 20120112 RGD compared to WAG/OlaHsd
10015 FHH/Eur strain MP:0005527 increased renal glomerular filtration rate IAGP N RGD:724742|PMID:8329672 19990101 RGD compared to WAG/OlaHsd
10015 FHH/Eur strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:724742|PMID:8329672 19990101 RGD compared to FHL/Eur
10016 GH/Omr Genetically Hypertensive strain MP:0001260 increased body weight IAGP N RGD:2301936|PMID:18925692 20191125 RGD
10016 GH/Omr Genetically Hypertensive strain MP:0003211 abnormal aorta elastic fiber morphology severity IAGP N RGD:619605|PMID:11526202 20191125 RGD
10016 GH/Omr Genetically Hypertensive strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20191125 RGD
10016 GH/Omr Genetically Hypertensive strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2301936|PMID:18925692 20081114 RGD
10016 GH/Omr Genetically Hypertensive strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:2301936|PMID:18925692 20191125 RGD
10016 GH/Omr Genetically Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2301936|PMID:18925692 20191125 RGD
10017 GK/KyoSwe Goto Kakizaki strain MP:0001260 increased body weight IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl
10017 GK/KyoSwe Goto Kakizaki strain MP:0001559 hyperglycemia IAGP N RGD:61082|PMID:8528247 20191126 RGD compared to F344/DuCrl
10017 GK/KyoSwe Goto Kakizaki strain MP:0005293 impaired glucose tolerance IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl
10017 GK/KyoSwe Goto Kakizaki strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl
10018 IS/Kyo ishibashi rat strain MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:1302444|PMID:6951716 19990101 RGD compared to BN, SHR and other inbreds
10021 LH/Mav strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav
10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav
10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0001548 hyperlipidemia IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav
10021 LH/Mav strain MP:0001559 hyperglycemia induced IAGP XCO:0000103 N RGD:13441562|PMID:18443571 20191126 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0002079 increased circulating insulin level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0002962 increased urine protein level IAGP N RGD:13441562|PMID:18443571 20200220 RGD compared to LL/Mav
10021 LH/Mav strain MP:0002962 increased urine protein level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0002962 increased urine protein level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0003058 increased insulin secretion IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav
10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2290181|PMID:18285521 20200611 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0003917 increased kidney weight treatment IAGP XCO:0000588 N RGD:13441562|PMID:18443571 20191126 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0003980 increased circulating phospholipid level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2290181|PMID:18285521 20200611 RGD
10021 LH/Mav strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav
10021 LH/Mav strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav
10021 LH/Mav strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13441562|PMID:18443571 20191126 RGD compared to LL/Mav
10021 LH/Mav strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0005583 decreased renin activity IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61057|PMID:7981757 20191203 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61058|PMID:9329963 20191202 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13441562|PMID:18443571 20191126 RGD compared to LL/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2316962|PMID:16928787 20191202 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61058|PMID:9329963 20191202 RGD compared to LN/Mav
10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus
10021 LH/Mav strain MP:0006316 increased urine sodium level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
10024 M520/N strain MP:0001262 decreased body weight IAGP N RGD:6893578|PMID:22947656 20131021 RGD
10024 M520/N strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20131021 RGD
10024 M520/N strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains
10024 M520/N strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains
10025 MHS/Gib Milan Hypertensive Strain strain MP:0000208 decreased hematocrit IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0002874 decreased hemoglobin content IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:69692|PMID:11082136 19990101 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:69692|PMID:11082136 19990101 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0010109 abnormal renal sodium reabsorption induces IAGP XCO:0000154 N RGD:126925991|PMID:3759227 20210713 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0012364 decreased erythrocyte sodium level IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0012364 decreased erythrocyte sodium level IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib
10025 MHS/Gib Milan Hypertensive Strain strain MP:0012377 decreased erythrocyte potassium ion content IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib
10028 MNS/Gib Milan Normotensive Strain strain MP:0003917 increased kidney weight IAGP N RGD:127284836|PMID:2838080 20210822 RGD
10028 MNS/Gib Milan Normotensive Strain strain MP:0010111 abnormal renal calcium reabsorption IAGP N RGD:127284836|PMID:2838080 20210822 RGD
10040 SR/Jr Salt Resistant strain MP:0001263 weight loss induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD 8%NaCl diet
10041 SS/Jr Salt Sensitive strain MP:0000274 enlarged heart IAGP N RGD:619631|PMID:10051321 19990101 RGD
10041 SS/Jr Salt Sensitive strain MP:0001260 increased body weight IAGP N RGD:619631|PMID:10051321 19990101 RGD
10041 SS/Jr Salt Sensitive strain MP:0001260 increased body weight IAGP N RGD:634617|PMID:12707388 19990101 RGD compared to SHR/NHsd
10041 SS/Jr Salt Sensitive strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
10041 SS/Jr Salt Sensitive strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20201215 RGD compared to C2S.M21
10041 SS/Jr Salt Sensitive strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to LEW
10041 SS/Jr Salt Sensitive strain MP:0002962 increased urine protein level IAGP N RGD:634617|PMID:12707388 20120112 RGD compared to SHR/NHsd
10041 SS/Jr Salt Sensitive strain MP:0004084 abnormal cardiac muscle relaxation induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD
10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD
10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 20200109 RGD compared to SS.LEW-(D5Rat130-D5Mco10)/Jr; MMO:0000031
10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:69710|PMID:9383281 19990101 RGD
10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:8657072|PMID:21602714 20210108 RGD compared to congenics with Lewis alleles
10041 SS/Jr Salt Sensitive strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to LEW
10041 SS/Jr Salt Sensitive strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61516|PMID:11015598 19990101 RGD compared to SHR/NHsd strain
10043120 BBDP.ACI-(<i>D2Mit8-D2Rat69</i>)/Sunn strain MP:0001823 thymus hypoplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043120 BBDP.ACI-(<i>D2Mit8-D2Rat69</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043120 BBDP.ACI-(<i>D2Mit8-D2Rat69</i>)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen
10043122 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)(<i>D2Rat354-D2Rat69</i>)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn
10043122 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)(<i>D2Rat354-D2Rat69</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043122 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)(<i>D2Rat354-D2Rat69</i>)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen
10043122 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)(<i>D2Rat354-D2Rat69</i>)/Sunn strain MP:0010168 increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043124 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn
10043124 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043124 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)/Sunn strain MP:0003884 decreased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn, spleen
10043124 BBDP.ACI-(<i>D2Mit8-D2Arb16</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043127 BBDP.ACI-(<i>D2Mit8-D2Rat354</i>)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn
10043127 BBDP.ACI-(<i>D2Mit8-D2Rat354</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043127 BBDP.ACI-(<i>D2Mit8-D2Rat354</i>)/Sunn strain MP:0003884 decreased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn, spleen
10043127 BBDP.ACI-(<i>D2Mit8-D2Rat354</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043127 BBDP.ACI-(<i>D2Mit8-D2Rat354</i>)/Sunn strain MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043129 BBDP.ACI-(<i>D2Arb16-D2Rat63</i>)/Sunn strain MP:0001823 thymus hypoplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043129 BBDP.ACI-(<i>D2Arb16-D2Rat63</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043129 BBDP.ACI-(<i>D2Arb16-D2Rat63</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043129 BBDP.ACI-(<i>D2Arb16-D2Rat63</i>)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen
10043129 BBDP.ACI-(<i>D2Arb16-D2Rat63</i>)/Sunn strain MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043132 BBDP.ACI-(<i>D2Rat50-D2Rat63</i>)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn
10043132 BBDP.ACI-(<i>D2Rat50-D2Rat63</i>)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn
10043132 BBDP.ACI-(<i>D2Rat50-D2Rat63</i>)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen
10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 qtl MP:0001759 increased urine glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20150617 RGD
10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 qtl MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20161102 RGD
10043139 Iddm55 Insulin dependent diabetes mellitus QTL 55 qtl MP:0001759 increased urine glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20150617 RGD
10043139 Iddm55 Insulin dependent diabetes mellitus QTL 55 qtl MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20161102 RGD
10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0001559 hyperglycemia IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism
10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0002079 increased circulating insulin level IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism
10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0003564 abnormal insulin secretion IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism
10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170501 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170501 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045592 Dmd<sup>em1Kykn</sup> dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170501 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170501 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045593 WIC-<i>Dmd<sup>em1Kykn</sup></i> strain MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD
10045594 Nfe2l2<sup>em1Kyo</sup> nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045594 Nfe2l2<sup>em1Kyo</sup> nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20201210 RGD
10045594 Nfe2l2<sup>em1Kyo</sup> nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045597 F344-<i>Nfe2l2<sup>em1Kyo</sup></i> strain MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045597 F344-<i>Nfe2l2<sup>em1Kyo</sup></i> strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20190226 RGD
10045597 F344-<i>Nfe2l2<sup>em1Kyo</sup></i> strain MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045598 Nfe2l2<sup>em2Kyo</sup> nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 2, Kyoto University gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045598 Nfe2l2<sup>em2Kyo</sup> nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 2, Kyoto University gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045600 F344-<i>Nfe2l2<sup>em2Kyo</sup></i> strain MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD
10045600 F344-<i>Nfe2l2<sup>em2Kyo</sup></i> strain MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD
10047391 LE/OrlBarth Long-Evans/Cryptorchid strain MP:0002082 postnatal lethality IAGP N RGD:12911229|PMID:26502805 20180504 RGD
10047391 LE/OrlBarth Long-Evans/Cryptorchid strain MP:0002683 delayed fertility IAGP N RGD:12911229|PMID:26502805 20180504 RGD
10053700 Scort23 Serum corticosterone level QTL 23 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10053715 Scort24 Serum corticosterone level QTL 24 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10053718 Scort25 Serum corticosterone level QTL 25 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10053720 Scort26 Serum corticosterone level QTL 26 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10053722 Scort27 Serum corticosterone level QTL 27 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054088 Scort28 Serum corticosterone level QTL 28 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054123 Srcrt6 Stress Responsive Cort QTL 6 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054125 Srcrt7 Stress Responsive Cort QTL 7 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054130 Srcrt8 Stress Responsive Cort QTL 8 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054132 Srcrt9 Stress Responsive Cort QTL 9 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054135 Gmadr2 Adrenal mass QTL 2 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054138 Gmadr3 Adrenal mass QTL 3 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054141 Gmadr4 Adrenal mass QTL 4 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240321 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type females
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type female
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240815 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240321 RGD
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240815 RGD in eyes;compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
10054395 Gla<sup>em2Mcwi</sup> galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240318 RGD
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240318 RGD
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type females
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240812 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type males
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240812 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240318 RGD
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type female
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240813 RGD
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240318 RGD
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240813 RGD in eyes;compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type
10054398 DA-<i>Gla<sup>em2Mcwi</sup></i> strain MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female
10054415 Mmp9<sup>em6Mcwi</sup> matrix metallopeptidase 9; CRISPR/Cas9 system induced mutant 6, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:597805897|PMID:37423509 20250220 RGD
10054415 Mmp9<sup>em6Mcwi</sup> matrix metallopeptidase 9; CRISPR/Cas9 system induced mutant 6, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250220 RGD compared to wild type littermate
10054415 Mmp9<sup>em6Mcwi</sup> matrix metallopeptidase 9; CRISPR/Cas9 system induced mutant 6, Medical College of Wisconsin gene MP:0005554 decreased circulating creatinine level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250220 RGD compared to wild type littermate
10054417 SS-<i>Mmp9<sup>em6Mcwi</sup></i> strain MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:597805897|PMID:37423509 20250218 RGD
10054417 SS-<i>Mmp9<sup>em6Mcwi</sup></i> strain MP:0005540 decreased urine albumin level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250218 RGD compared to wild type littermate
10054417 SS-<i>Mmp9<sup>em6Mcwi</sup></i> strain MP:0005554 decreased circulating creatinine level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250218 RGD compared to wild type littermate
10058949 Gmadr5 Adrenal mass QTL 5 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10058952 Gmadr6 Adrenal mass QTL 6 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10058954 Gmadr7 Adrenal mass QTL 7 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD
10059570 WI;WDB-<i>Kiss1<sup>tm1Nips</i></sup> strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20170815 RGD
10059570 WI;WDB-<i>Kiss1<sup>tm1Nips</i></sup> strain MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20170815 RGD
10059587 Bw173 Body weight QTL 173 qtl MP:0001260 increased body weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059590 Kidm44 Kidney mass QTL 44 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059592 Kidm45 Kidney mass QTL 45 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059594 Kidm46 Kidney mass QTL 46 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059597 Bp377 Blood pressure QTL 377 qtl MP:0003820 increased left ventricle systolic pressure IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059600 Bp378 Blood pressure QTL 378 qtl MP:0003820 increased left ventricle systolic pressure IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059603 Bw174 Body weight QTL 174 qtl MP:0001260 increased body weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10059605 Kidm47 Kidney mass QTL 47 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0001363 increased anxiety-related response IAGP N RGD:40924641|PMID:29107184 20210115 RGD compared to wild type F344/NHsd
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0002229 neurodegeneration IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0003354 astrocytosis IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0004254 cerebral amyloid angiopathy IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008414 abnormal spatial reference memory IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008428 abnormal spatial working memory IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008918 microgliosis IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate;
10401796 Kidm48 Kidney mass QTL 48 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401800 Kidm49 Kidney mass QTL 49 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401803 Kidm50 Kidney mass QTL 50 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401805 Kidm51 Kidney mass QTL 51 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401807 Kidm52 Kidney mass QTL 52 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401810 Kidm53 Kidney mass QTL 53 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401812 Kidm54 Kidney mass QTL 54 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD
10401839 WKY.F344-(<i>D17Rat47-D17Rat51</i>)/Tja strain MP:0004013 decreased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:10401832|PMID:26258299 20200130 RGD compared to WKY/Cruk
10401842 Slc39a12<sup>em77Tja</sup> solute carrier family 39 (zinc transporter), member 12; zinc finger nuclease induced mutant 77, Timothy J. Aitman gene MP:0004013 decreased pulmonary artery pressure IMP N RGD:10401832|PMID:26258299 20200130 RGD
10402051 Gdil2 Gastrointestinal dilation QTL 2 qtl MP:0002926 aganglionic megacolon severity IDA N RGD:10402048|PMID:25790447 20151014 RGD
10402839 LEW.SS-(<i>D10Mgh6-D10Mgh1</i>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:10402053|PMID:25963546 20160114 RGD compared to LEW/Crl
10402852 LEW.SS-(<i>D7Rat27-D7Mgh1</i>)(<i>D17Rat15-D17Rat51</i>)(<i>D10Mgh6-D10Mgh1</i>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:10402053|PMID:25963546 20160114 RGD compared to LEW/Crl
10402855 Bp379 Blood pressure QTL 379 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD
10402857 Bp380 Blood pressure QTL 380 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD
10402859 Bp381 Blood pressure QTL 381 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD
10413846 Abcc6<sup>em2Qlju</sup> ATP-binding cassette, subfamily C (CFTR/MRP), member 6; zinc finger nuclease induced mutant 2, Qiaoli Li gene MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD
10413852 SD-<i>Abcc6<sup>em2Qlju-/-</sup></i> strain MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD
10450493 Bp382 Blood pressure QTL 382 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD
10450495 Bp383 Blood pressure QTL 383 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD
10450498 Bp384 Blood pressure QTL 384 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD
10450500 Bp385 Blood pressure QTL 385 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD
10450503 Bp386 Blood pressure QTL 386 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD
10450794 Scl69 Serum cholesterol level QTL 69 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450804 Scl70 Serum cholesterol level QTL 70 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450806 Scl71 Serum cholesterol level QTL 71 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450808 Scl72 Serum cholesterol level QTL 72 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450811 Scl73 Serum cholesterol level QTL 73 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450813 Scl74 Serum cholesterol level QTL 74 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450816 Scl75 Serum cholesterol level QTL 75 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450818 Scl76 Serum cholesterol level QTL 76 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450821 Scl77 Serum cholesterol level QTL 77 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450825 Scl78 Serum cholesterol level QTL 78 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450828 Scl79 Serum cholesterol level QTL 79 qtl MP:0001556 increased circulating HDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450831 Scl80 Serum cholesterol level QTL 80 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450852 Stl33 Serum triglyceride level QTL 33 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450854 Stl34 Serum triglyceride level QTL 34 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450856 Livw4 Liver weight QTL 4 qtl MP:0002981 increased liver weight IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450862 Kidm55 Kidney mass QTL 55 qtl MP:0003917 increased kidney weight IDA N RGD:10402111|PMID:25296178 20160122 RGD
10450865 Bw175 Body weight QTL 175 qtl MP:0000008 increased white adipose tissue amount IDA N RGD:10402111|PMID:25296178 20160122 RGD
10755350 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0001260 increased body weight IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc;
10755350 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:10755343|PMID:26296322 20160906 RGD
10755350 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0005331 insulin resistance IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc;
10755350 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0011939 increased food intake IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc;
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0001260 increased body weight IAGP N RGD:10755325|PMID:25573024 20160126 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0001552 increased circulating triglyceride level IAGP N RGD:10755325|PMID:25573024 20160126 RGD as compared to LN/MavRrrcAek at 18 wk old
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0002626 increased heart rate IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0002865 increased growth rate IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005178 increased circulating cholesterol level IAGP N RGD:10755325|PMID:25573024 20191202 RGD as compared to LN/MavRrrcAek at 16 wk old
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005560 decreased circulating glucose level IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek at 12 wk old
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005669 increased circulating leptin level IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0014145 increased white adipose tissue mass IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20171204 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0002926 aganglionic megacolon IAGP N RGD:6480215|PMID:22132166 20210218 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20171206 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20171206 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20210218 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20210218 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20210218 RGD
10755424 Ednrb<sup>sl</sup> endothelin receptor type B, spotting lethal gene MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD
10755430 Coatc6 Coat color QTL 6 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755434 Coatc7 Coat color QTL 7 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755436 Coatc8 Coat color QTL 8 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755438 Coatc9 Coat color QTL 9 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755440 Coatc10 Coat color QTL 10 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755451 Coatc11 Coat color QTL 11 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755453 Coatc12 Coat color QTL 12 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755455 Coatc13 Coat color QTL 13 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755457 Coatc14 Coat color QTL 14 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755459 Coatc15 Coat color QTL 15 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755461 Coatc16 Coat color QTL 16 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD
10755495 Bp387 Blood pressure QTL 387 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD
10755497 Bp388 Blood pressure QTL 388 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD
10755499 Bp389 Blood pressure QTL 389 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD
10755501 Bp390 Blood pressure QTL 390 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD
10755503 Bp391 Blood pressure QTL 391 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD
11040521 SHR-<i>Ndufc2<sup>em2Mcwi-/+</sup></i> SHR-<i>Ndufc2<sup>em2Mcwi-</sup></i>/<i>Ndufc2<sup>em2Mcwi+</sup></i> strain MP:0002962 increased urine protein level induced IMP XCO:0000022, XCO:0000032, XCO:0000030 N RGD:11040458|PMID:26888427 20160816 RGD compared to SHR/Bbb
11040521 SHR-<i>Ndufc2<sup>em2Mcwi-/+</sup></i> SHR-<i>Ndufc2<sup>em2Mcwi-</sup></i>/<i>Ndufc2<sup>em2Mcwi+</sup></i> strain MP:0003076 increased susceptibility to ischemic brain injury induced IMP XCO:0000022,XCO:0000032,XCO:0000030 N RGD:11040458|PMID:26888427 20200116 RGD compared to SHR/Bbb
11040521 SHR-<i>Ndufc2<sup>em2Mcwi-/+</sup></i> SHR-<i>Ndufc2<sup>em2Mcwi-</sup></i>/<i>Ndufc2<sup>em2Mcwi+</sup></i> strain MP:0006059 decreased susceptibility to ischemic brain injury induced IMP XCO:0000022,XCO:0000032,XCO:0000030 N RGD:11040458|PMID:26888427 20200116 RGD compared to SHRSP/Bbb
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD
11040962 F344-<i>Bscl2<sup>m1Kyo</sup></i> strain MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
11073608 Mir29b1<sup>em1Mcwi</sup> microRNA 29b-1; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD
11073612 SS-Chr 13<sup>BN</sup>-<i>Mir29b<sup>em1Mcwi</sup></i> strain MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0004805 absent oocytes induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0004856 decreased ovary weight induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0005158 ovary hypoplasia induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0005185 decreased circulating progesterone level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD
11081149 SD-<i>Esr2<sup>em1Soar</sup></i> strain MP:0009819 abnormal circulating androgen level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type
11081177 F344<i><sup>tl</sup></i> toothless (tl) strain MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20180430 RGD
11081177 F344<i><sup>tl</sup></i> toothless (tl) strain MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20180430 RGD
11087551 SD-<i>Il15<sup>em1Soar</sup></i> strain MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD
11087551 SD-<i>Il15<sup>em1Soar</sup></i> strain MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD
11087551 SD-<i>Il15<sup>em1Soar</sup></i> strain MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
11087551 SD-<i>Il15<sup>em1Soar</sup></i> strain MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
11087553 SD-<i>Mmp12<sup>em1Soar</sup></i> strain MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD
11353947 Bp392 Blood pressure QTL 392 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD
11353949 Bp393 Blood pressure QTL 393 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD
11353951 Bp394 Blood pressure QTL 394 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD
11353957 Bmd92 Bone mineral density QTL 92 qtl MP:0000558 abnormal tibia morphology IAGP N RGD:11353859|PMID:27113531 20170424 RGD
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0005333 decreased heart rate IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0006266 decreased pulse pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354901 SS.SHR-(<i>D9Mco110-D9Mco124</i>)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354903 SS.SHR-(<i>D9Mco110-D9Mco121</i>)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354903 SS.SHR-(<i>D9Mco110-D9Mco121</i>)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354903 SS.SHR-(<i>D9Mco110-D9Mco121</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354903 SS.SHR-(<i>D9Mco110-D9Mco121</i>)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0009346 decreased trabecular bone thickness IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0010873 decreased trabecular bone mass IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0010876 decreased bone volume IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0010933 decreased trabecular bone connectivity density IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0010962 decreased compact bone mass IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0010968 decreased compact bone area IAGP N RGD:11353859|PMID:27113531 20160729 RGD
11354924 SS.SHR-(<i>D9Mco113-D9Mco124</i>)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354926 SS.SHR-(<i>D9Mco110-D9Got111</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11354926 SS.SHR-(<i>D9Mco110-D9Got111</i>)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr;
11528588 SHR.LEW-(<i>D4Rat76-D4Mgh11</i>)/Anra strain MP:0001399 hyperactivity IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf
11528588 SHR.LEW-(<i>D4Rat76-D4Mgh11</i>)/Anra strain MP:0004000 impaired passive avoidance behavior IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf
11528588 SHR.LEW-(<i>D4Rat76-D4Mgh11</i>)/Anra strain MP:0012294 enhanced active avoidance behavior IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf
11528620 Bss113 Bone structure and strength QTL 113 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528624 Bss114 Bone structure and strength QTL 114 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528628 Bss116 Bone structure and strength QTL 116 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528631 Bss117 Bone structure and strength QTL 117 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528636 Bss120 Bone structure and strength QTL 120 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528640 Bss121 Bone structure and strength QTL 121 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528644 Bss115 Bone structure and strength QTL 115 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11528648 Bss118 Bone structure and strength QTL 118 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11530002 Bss119 Bone structure and strength QTL 119 qtl MP:0003049 abnormal lumbar vertebrae morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD
11530004 Niddm71 Non-insulin dependent diabetes mellitus QTL 71 qtl MP:0005559 increased circulating glucose level IAGP N RGD:11528530|PMID:27463508 20170424 RGD
11530006 Niddm72 Non-insulin dependent diabetes mellitus QTL 72 qtl MP:0005559 increased circulating glucose level IAGP N RGD:11528530|PMID:27463508 20170424 RGD
11530022 Npy<sup>em6Sage</sup> neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
11530022 Npy<sup>em6Sage</sup> neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
11530022 Npy<sup>em6Sage</sup> neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20160825 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
11531091 SD-<i>F8<sup>em1Sage-/-</sup></i>/Novo strain MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
11531096 F8<i><sup>em1Sage</sup></i> coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20190711 RGD
11531104 iNP-<i>Npy<sup>em6Sage+/-</sup></i>/Iusm strain MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm;
11531104 iNP-<i>Npy<sup>em6Sage+/-</sup></i>/Iusm strain MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm;
11531104 iNP-<i>Npy<sup>em6Sage+/-</sup></i>/Iusm strain MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm;
11531106 iNP-<i>Npy<sup>em6Sage-/-</sup></i>/Iusm strain MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm;
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20201214 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0001262 decreased body weight IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20210218 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0003066 increased liver copper level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0003402 decreased liver weight IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0005344 increased circulating bilirubin level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0006349 decreased circulating copper level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20210218 RGD compared to LEC/Tj;
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0009355 increased liver triglyceride level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0010027 increased liver cholesterol level IAGP N RGD:2292672|PMID:17303181 20170628 RGD
11532742 Atp7b<sup>hts</sup> ATPase copper transporting beta; hepatitis gene MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20201214 RGD
11532753 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D5Rat166-D5Rat90</i>)/Tj strain MP:0001260 increased body weight IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc;
11532753 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D5Rat166-D5Rat90</i>)/Tj strain MP:0003059 decreased insulin secretion IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc;
11532753 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D5Rat166-D5Rat90</i>)/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:11532750|PMID:27523322 20160906 RGD
11532753 F344.ZUC-(<i>Lepr<sup>fa</sup></i>),OLETF-(<i>D5Rat166-D5Rat90</i>)/Tj strain MP:0005331 insulin resistance IAGP N RGD:11532750|PMID:27523322 20160906 RGD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20210211 RGD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 20210211 RGD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
11534996 Anks6<sup>PKD</sup> ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
11553854 Shc1<sup>em1Mcwi</sup> SHC adaptor protein 1; ZFN induced mutant 1, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD
11553862 SS-<i>Shc1<sup>em1Mcwi</sup></i> strain MP:0003025 increased vasoconstriction induced IMP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240307 RGD
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240307 RGD
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240307 RGD
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls
11553872 Fmr1<sup>em2Mcwi</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240321 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240319 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240319 RGD in wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240319 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240319 RGD in wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240319 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240319 RGD compared to wild type controls
11553873 LE-<i>Fmr1<sup>em2Mcwi</sup></i> strain MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated control
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type vehicle-treated control
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to STZ-treated wild type
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control
11553911 Trpc6<sup>em1Mcwi</sup> transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated control
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type vehicle-treated control
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to STZ-treated wild type
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated wild type and control
11553912 SS-<i>Trpc6<sup>em1Mcwi</sup></i> strain MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated wild type and control
11553913 Shc1<sup>em4Mcwi</sup> SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD
11553913 Shc1<sup>em4Mcwi</sup> SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD
11553913 Shc1<sup>em4Mcwi</sup> SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD
11553914 SS-<i>Shc1<sup>em4Mcwi</sup></i> strain MP:0003025 increased vasoconstriction induced IMP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi
11553914 SS-<i>Shc1<sup>em4Mcwi</sup></i> strain MP:0003025 increased vasoconstriction induced IMP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi
11553914 SS-<i>Shc1<sup>em4Mcwi</sup></i> strain MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD compared to SS/JrHsdMcwi
11553914 SS-<i>Shc1<sup>em4Mcwi</sup></i> strain MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi
11553915 Shc1<sup>em5Mcwi</sup> SHC adaptor protein 1; ZFN induced mutant 5, Medical College of Wisconsin gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD
11553916 SS-<i>Shc1<sup>em5Mcwi</sup></i> strain MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS-Chr 2BN/Mcwi,SS-Shc1em1Mcwi, SS-Shc1em4Mcwi
11554327 BDIX.BDIV-<i>D10Mit3-D10Mgh16</i>/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11554205|PMID:26530423 20161026 RGD
11554329 BDIX.BDIV-<i>D10Got1-D10Rat45</i>/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11554205|PMID:26530423 20161026 RGD
11556286 Cm81 Cardiac mass QTL 81 qtl MP:0002834 decreased heart weight susceptibility IAGP N RGD:61054|PMID:9045857 20161102 RGD
11564348 Aspa<sup>em34Kyo</sup> aspartoacylase;TALEN induced mutant 34,Kyo gene MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD
11564348 Aspa<sup>em34Kyo</sup> aspartoacylase;TALEN induced mutant 34,Kyo gene MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD
11564349 F344-<i>Aspa<sup>em34Kyo</sup></i> strain MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD
11564349 F344-<i>Aspa<sup>em34Kyo</sup></i> strain MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD
11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0003983 decreased cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD lens
11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD
11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0010161 decreased brain cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD
11565090 Ccdc85c<sup>em1Kyo</sup> coiled-coil domain containing 85C; TALEN induced mutant1,Kyo gene MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211104 RGD
11565090 Ccdc85c<sup>em1Kyo</sup> coiled-coil domain containing 85C; TALEN induced mutant1,Kyo gene MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211104 RGD
11565091 F344-<i>Ccdc85c<sup>em1Kyo</sup></i> strain MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211028 RGD
11565091 F344-<i>Ccdc85c<sup>em1Kyo</sup></i> strain MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211028 RGD
11565180 Kidm56 Kidney mass QTL 56 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD
11565181 Bw176 Body weight QTL 176 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD
11565451 Bw177 Body weight QTL 177 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD
11565452 Kidm57 Kidney mass QTL 57 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD
11565453 Kidm58 Kidney mass QTL 58 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD
11565454 Kidm59 Kidney mass QTL 59 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD
11565825 Ttn<sup>em1Sage</sup> Titin; zinc finger nuclease induced mutant 1,Sigma Advanced Genetic Engineering Labs gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565825 Ttn<sup>em1Sage</sup> Titin; zinc finger nuclease induced mutant 1,Sigma Advanced Genetic Engineering Labs gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565826 F344-<i>Ttn<sup>em1Sage</sup></i> strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20161129 RGD
11565826 F344-<i>Ttn<sup>em1Sage</sup></i> strain MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20161129 RGD
11565827 Ttn<sup>em2Sage</sup> Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565827 Ttn<sup>em2Sage</sup> Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565827 Ttn<sup>em2Sage</sup> Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565827 Ttn<sup>em2Sage</sup> Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565827 Ttn<sup>em2Sage</sup> Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD
11565829 F344-<i>Ttn<sup>em2Sage</sup></i> strain MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20161128 RGD
11565829 F344-<i>Ttn<sup>em2Sage</sup></i> strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20161129 RGD
11565829 F344-<i>Ttn<sup>em2Sage</sup></i> strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20161129 RGD
11565829 F344-<i>Ttn<sup>em2Sage</sup></i> strain MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20161128 RGD
11565829 F344-<i>Ttn<sup>em2Sage</sup></i> strain MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20161129 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to female heterozygote mutant
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type female
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001513 limb grasping penetrance IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to male SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type female
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210318 RGD
11567272 SD-<i>Mecp2<sup>em1Sage</sup></i> strain MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210318 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to female heterozygote mutant
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001513 limb grasping IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to male SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568035 Mecp2<sup>em1Sage</sup> methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210325 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8:
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240320 RGD compared to wild type controls
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD compared to SD control, DNA:deletion:intron 7, exon 8:
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240319 RGD compared to wild type controls
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240321 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD compared to SD control, DNA:deletion:intron 7, exon 8:
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240321 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240321 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240321 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240320 RGD in juveniles, compared to wild type controls
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240329 RGD compared to wild type
11568040 SD-<i>Fmr1<sup>em1Sage</sup></i> strain MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240321 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8:
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240321 RGD compared to wild type controls
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8:
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240321 RGD compared to wild type controls
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240328 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD DNA:deletion:intron 7, exon 8:
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240328 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240328 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240328 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240321 RGD in juveniles, compared to wild type controls
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240404 RGD compared to wild type
11568041 Fmr1<sup>em1Sage</sup> FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240328 RGD
11568058 SD-<i>Nrxn1<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type littermate
11568058 SD-<i>Nrxn1<sup>em1Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210521 RGD
11568058 SD-<i>Nrxn1<sup>em1Sage</sup></i> strain MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type littermate
11568058 SD-<i>Nrxn1<sup>em1Sage</sup></i> strain MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210521 RGD
11568058 SD-<i>Nrxn1<sup>em1Sage</sup></i> strain MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type male
11568059 Nrxn1<sup>em1</sup> neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate
11568059 Nrxn1<sup>em1</sup> neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210527 RGD
11568059 Nrxn1<sup>em1</sup> neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate
11568059 Nrxn1<sup>em1</sup> neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210527 RGD
11568059 Nrxn1<sup>em1</sup> neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type male
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210422 RGD in males
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210422 RGD
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210422 RGD
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210422 RGD worsens with age
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210422 RGD peak amplitudes and transmission latency
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568646 SD-<i>Cntnap2<sup>em1Sage</sup></i> strain MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210422 RGD in young animals
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210429 RGD in males
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210429 RGD
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210429 RGD
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210429 RGD worsens with age
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210429 RGD peak amplitudes and transmission latency
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20170505 RGD
11568647 Cntnap2<sup>em1Sage</sup> contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210429 RGD in young animals
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210423 RGD
11568700 SD-<i>Nlgn3<sup>em1Sage</sup></i> strain MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD during light cycle
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD during light cycle
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210429 RGD
11568701 Nlgn3<sup>em1Sage</sup> neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210310 RGD compared to wide-type male
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210310 RGD compared to female wild-type
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210310 RGD compared to male wild-type
11568703 SD-<i>Cacna1c<sup>em1Sage</sup></i> strain MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210310 RGD compared to wide-type male
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to female wild-type
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to male wild-type
11568704 Cacna1c<sup>em1Sage</sup> calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male
11570416 Krt71<sup>Rex</sup> keratin 71; autosomal dominant Rex gene MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
11570416 Krt71<sup>Rex</sup> keratin 71; autosomal dominant Rex gene MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
11570416 Krt71<sup>Rex</sup> keratin 71; autosomal dominant Rex gene MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
11570416 Krt71<sup>Rex</sup> keratin 71; autosomal dominant Rex gene MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
11570565 Lepr<sup>cp</sup> leptin receptor;corpulent gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
11570565 Lepr<sup>cp</sup> leptin receptor;corpulent gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0004805 absent oocytes induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0004856 decreased ovary weight induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0005158 ovary hypoplasia induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0005185 decreased circulating progesterone level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type
11667077 SD-<i>Esr2<sup>em2Soar</sup></i> strain MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0000921 demyelination IAGP N RGD:42721980|PMID:29217155 20210226 RGD in axons in striatum; compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0002066 abnormal motor capabilities/coordination/movement IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0002229 neurodegeneration IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0003224 neuron degeneration IAGP N RGD:42722007|PMID:22639889 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0003354 astrocytosis IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0004102 abnormal dorsal striatum morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0004250 tau protein deposits IAGP N RGD:42721980|PMID:29217155 20210226 RGD in brain stem, mesencephalon, olfactory bulb, frontal cortex; compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0004495 decreased synaptic glutamate release induced IAGP XCO:0000521 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0005237 abnormal olfactory tract morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0005366 variegated coat color IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0005366 variegated coat color IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008462 abnormal medium spiny neuron morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:41412185|PMID:27771352 20210301 RGD in striatum, frontal cortex, mesencephalon; compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:42721980|PMID:29217155 20210226 RGD in brain stem, mesencephalon, olfactory bulb, frontal cortex, hippocampus; compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BDIV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008572 abnormal Purkinje cell dendrite morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008657 increased interleukin-1 beta secretion IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0008918 microgliosis IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0009941 abnormal olfactory bulb interneuron morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0010149 abnormal synaptic dopamine release induced IAGP XCO:0000520 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0010956 abnormal mitochondrial ATP synthesis coupled electron transport IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0011270 decreased excitatory postsynaptic current amplitude induced IAGP XCO:0000521 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0011448 decreased dopaminergic neuron number IAGP N RGD:41412185|PMID:27771352 20210301 RGD in substantia nigra pars compacta; compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0013219 abnormal substantia nigra pars compacta morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0013219 abnormal substantia nigra pars compacta morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV
11667081 BDIV-<i>Myo5a</i>/StcRrrc strain MP:0030939 abnormal autophagosome formation IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD
11667088 SD-<i>Esr1<sup>em1Soar</sup></i> strain MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to untreated
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0010769 abnormal survival penetrance IMP XCO:0000014 N RGD:32716373|PMID:32231239 20210323 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats
124713544 W-<i>Cyp27b1<sup>em1Thka</sup></i> strain MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to untreated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0010769 abnormal survival IMP N RGD:32716373|PMID:32231239 20210325 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats
124713545 Cyp27b1<sup>em1Thka</sup> cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated
124713546 W-<i>Vdr<sup>em1Thka</sup></i> strain MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
124713547 Vdr<sup>em1Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD
124713548 W-<i>Vdr<sup>em2Thka</sup></i> strain MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210323 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210325 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD
124713550 Vdr<sup>em2Thka</sup> vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210325 RGD
124715480 Fmr1<sup>em1Mzhe</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20210329 RGD
124715480 Fmr1<sup>em1Mzhe</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20210329 RGD
124715480 Fmr1<sup>em1Mzhe</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20210329 RGD
124715480 Fmr1<sup>em1Mzhe</sup> FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20210329 RGD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD in peripheral blood, compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in spleen, compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in bone marrow and peripheral blood, compared to SD
124715481 Pon1<sup>em1Lizh</sup> paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
125097486 SD-<i>Nr3c1<sup>em1Kuan</sup></i> strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241104 RGD compared to female wild type littermate
125097486 SD-<i>Nr3c1<sup>em1Kuan</sup></i> strain MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241104 RGD compared to male wild type littermate
125097486 SD-<i>Nr3c1<sup>em1Kuan</sup></i> strain MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
125097486 SD-<i>Nr3c1<sup>em1Kuan</sup></i> strain MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
125097486 SD-<i>Nr3c1<sup>em1Kuan</sup></i> strain MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD compared to female wild type littermate
125097487 Nr3c1<sup>em1Kuan</sup> nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate
125097487 Nr3c1<sup>em1Kuan</sup> nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241107 RGD compared to male wild type littermate
125097487 Nr3c1<sup>em1Kuan</sup> nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
125097487 Nr3c1<sup>em1Kuan</sup> nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
125097487 Nr3c1<sup>em1Kuan</sup> nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777684 WI-<i>Mkx<sup>em1Asah</sup></i> strain MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777685 Mkx<sup>em1Asah</sup> mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY and heterozygous
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126777687 WKY-<i>Dnd1<sup>ter</sup></i>/Ztm strain MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY
126779578 LOU/MWsl strain MP:0001262 decreased body weight induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C
126779578 LOU/MWsl strain MP:0002871 albuminuria induced IAGP XCO:0000539 N RGD:45073132|PMID:3456068 20210312 RGD worse in males; doxorubicin XCO:0000539
126779578 LOU/MWsl strain MP:0002962 increased urine protein level induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C
126779578 LOU/MWsl strain MP:0005419 decreased circulating serum albumin level induced IAGP XCO:0000539 N RGD:45073132|PMID:3456068 20210312 RGD worse in males; doxorubicin XCO:0000539
126779578 LOU/MWsl strain MP:0005419 decreased circulating serum albumin level induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779591 SD-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Tset strain MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210413 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210414 RGD
126779592 DA-<i>Csf1r<sup>tm(EGFP)-/-</sup></i>/Hume strain MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210414 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210416 RGD
126781692 Csf1r<sup>tm(EGFP)Tset</sup> colony stimulating factor 1 receptor; target mutant, Tset gene MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210416 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790464 SD-<i>Ube3a<sup>em1Jue</sup></i> strain MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210422 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790465 Ube3a<sup>em1Jue</sup> ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210429 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790496 SD-<i>Shank2<sup>em13Sage</sup></i> strain MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210426 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790499 Shank2<sup>em13Sage</sup> SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210429 RGD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210708 RGD females compared to Hsd:SD females
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD males compared to Hsd:SD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210708 RGD
126790510 Ahr<sup>em2Sage</sup> aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0020969 impaired conditioned taste aversion behavior sexual_dimorphism IMP N RGD:407419883|PMID:30769105 20240912 RGD
126790547 SD-<i>Rin1<sup>em1-/-Hcz</sup></i> strain MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210426 RGD
126790547 SD-<i>Rin1<sup>em1-/-Hcz</sup></i> strain MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210426 RGD
126790548 Rin1<sup>em1Hcz</sup> Ras and Rab interactor 1; TALEN induced mutant 1, Hcz gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210429 RGD
126790548 Rin1<sup>em1Hcz</sup> Ras and Rab interactor 1; TALEN induced mutant 1, Hcz gene MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210429 RGD
126848737 WI-<i> Msh6<sup>m1Hubr</sup></i> strain MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210428 RGD
126848737 WI-<i> Msh6<sup>m1Hubr</sup></i> strain MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210428 RGD
126848738 Msh6<sup>m1Hubr</sup> mutS homolog 6; ENU induced mutant 1, Hubr gene MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210429 RGD
126848738 Msh6<sup>m1Hubr</sup> mutS homolog 6; ENU induced mutant 1, Hubr gene MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210429 RGD
126848739 Lpar1<sup>m1Hubr</sup> lysophosphatidic acid receptor 1; ENU induced mutant 1, Hubr gene MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20210429 RGD
126848739 Lpar1<sup>m1Hubr</sup> lysophosphatidic acid receptor 1; ENU induced mutant 1, Hubr gene MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20210429 RGD
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848793 SS-<i>Gper1<sup>em1Bj-/-</sup></i> strain MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220128 RGD
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848794 SHR-<i>Zbtb16<sup>em1Ipcv+/-</i></sup> strain MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv;
126848804 F344-<i>Trpc4<sup>Tn(sb)1Bni</sup></i> strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210504 RGD
126848804 F344-<i>Trpc4<sup>Tn(sb)1Bni</sup></i> strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210504 RGD
126848808 Trpc4<sup>Tn(sb)Tngen</sup> transient receptor potential cation channel, subfamily C, member 4; sleeping beauty induced mutant, Tngen gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210506 RGD
126848808 Trpc4<sup>Tn(sb)Tngen</sup> transient receptor potential cation channel, subfamily C, member 4; sleeping beauty induced mutant, Tngen gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210506 RGD
126908010 SD-<i>Kcnk3<sup>em1Ang-/-</sup></i> strain MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220127 RGD
126908010 SD-<i>Kcnk3<sup>em1Ang-/-</sup></i> strain MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220127 RGD
126908010 SD-<i>Kcnk3<sup>em1Ang-/-</sup></i> strain MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220127 RGD
126908010 SD-<i>Kcnk3<sup>em1Ang-/-</sup></i> strain MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220127 RGD
126908010 SD-<i>Kcnk3<sup>em1Ang-/-</sup></i> strain MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220127 RGD
126908015 Kcnk3<sup>em1Ang</sup> potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220203 RGD
126908015 Kcnk3<sup>em1Ang</sup> potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220203 RGD
126908015 Kcnk3<sup>em1Ang</sup> potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220203 RGD
126908015 Kcnk3<sup>em1Ang</sup> potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220203 RGD
126908015 Kcnk3<sup>em1Ang</sup> potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220203 RGD
126925134 SD-<i>Il36rn<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD
126925134 SD-<i>Il36rn<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD
126925134 SD-<i>Il36rn<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD
126925134 SD-<i>Il36rn<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD
126925134 SD-<i>Il36rn<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925135 SD-<i>Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup></i> strain MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
126925136 SD-<i>Mstn<sup>em1Cqin</sup></i> strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220121 RGD compared to wild type male
126925138 SD-<i>Ubd<sup>em1</sup></i> strain MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction
126925138 SD-<i>Ubd<sup>em1</sup></i> strain MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction
126925138 SD-<i>Ubd<sup>em1</sup></i> strain MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction
126925138 SD-<i>Ubd<sup>em1</sup></i> strain MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction
126925139 SD-<i>Dnmt1<sup>tm1(Myh6-cre)Cqin</sup></i> strain MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210518 RGD
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925159 Il1rl2<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model
126925161 Il36rn<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210520 RGD
126925161 Il36rn<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210520 RGD
126925161 Il36rn<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210520 RGD
126925161 Il36rn<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210520 RGD
126925161 Il36rn<sup>tm1(Myh6-cre)Mhzh</sup> interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210520 RGD
126925165 Dnmt1<sup>tm1(Myh6-cre)Cqin</sup> DNA methyltransferase 1; tm1(Myh6-cre), Cqin gene MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210520 RGD
126925166 Ubd<sup>em1</sup> ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction
126925166 Ubd<sup>em1</sup> ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction
126925166 Ubd<sup>em1</sup> ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction
126925166 Ubd<sup>em1</sup> ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction
126925212 WI-<i> Drd1<sup>m1Hubr</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type
126925212 WI-<i> Drd1<sup>m1Hubr</sup></i> strain MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type
126925212 WI-<i> Drd1<sup>m1Hubr</sup></i> strain MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type
126925212 WI-<i> Drd1<sup>m1Hubr</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type
126925212 WI-<i> Drd1<sup>m1Hubr</sup></i> strain MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type
126925213 Drd1<sup>m1Hubr</sup> dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
126925213 Drd1<sup>m1Hubr</sup> dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
126925213 Drd1<sup>m1Hubr</sup> dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
126925213 Drd1<sup>m1Hubr</sup> dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
126925213 Drd1<sup>m1Hubr</sup> dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925756 SD-<i>Cryba1<sup>Nuc1Dbsa</sup></i> strain MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210519 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925758 Cryba1<sup>Nuc1Dbsa</sup> crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210520 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925949 SD-<i>Myh7b<sup>em1Blar+/-</sup></i> strain MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD
126925952 SD-<i>Myh7b<sup>em1Blar-/-</sup></i> strain MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210819 RGD
126925953 Myh7b<sup>em1Blar</sup> myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220714 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925978 SD-<i>Ercc6<sup>em1Cgen</sup></i> strain MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210525 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925980 Ercc6<sup>em1Cgen</sup> ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210527 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925992 SD-<i>Cftr<sup>em1Ang</sup></i> strain MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925993 Cftr<sup>em1Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925994 SD-<i>Cftr<sup>em2Ang</sup></i> strain MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD
126925995 Cftr<sup>em2Ang</sup> cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210527 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 4-6 weeks
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 9 weeks
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928146 ACI.Cg.-<i>Cdkn1b<sup>em1Musc</sup></i> strain MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 9 weeks
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928147 Cdkn1b<sup>em1Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 4-6 weeks
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 9 weeks
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928150 ACI.Cg.-<i>Cdkn1b<sup>em4Musc</sup></i> strain MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210607 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 9 weeks
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD
126928151 Cdkn1b<sup>em4Musc</sup> cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD
127284837 GK/Wnsm strain MP:0001262 decreased body weight IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011)
127284837 GK/Wnsm strain MP:0002834 decreased heart weight IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011)
127284837 GK/Wnsm strain MP:0005559 increased circulating glucose level IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011)
127284837 GK/Wnsm strain MP:0006353 increased glycosylated hemoglobin level IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011)
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284870 F344-<i>Nppc<sup>em3Kyo</sup></i> strain MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284871 Nppc<sup>em3Kyo</sup> natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284872 F344-<i>Nppc<sup>em4Kyo</sup></i> strain MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284873 Nppc<sup>em4Kyo</sup> natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
127284883 SD-<i>Aqp4<sup>em1Hrt</sup></i> strain MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220117 RGD
127284884 Aqp4<sup>em1Hrt</sup> aquaporin 4; TALEN induced mutant 1, Hrt gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220120 RGD
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285404 SHR-<i>Cfb<sup>em1Tja</sup></i> strain MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285405 Cfb<sup>em1Tja</sup> complement factor B, ZFN induced mutant 1, Tja gene MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220111 RGD
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type male
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285409 SD-<i>Abcc8<sup>em1Cgen</sup></i> strain MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220113 RGD
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type male
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285598 Abcc8<sup>em1Cgen</sup> ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220113 RGD
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220113 RGD
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220113 RGD
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD
127285617 Pparg<sup>m1Kyo</sup> peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220113 RGD
127285661 SD-<i>Adgrl3<sup>em1Huyc</sup></i> strain MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type
127285661 SD-<i>Adgrl3<sup>em1Huyc</sup></i> strain MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type
127285661 SD-<i>Adgrl3<sup>em1Huyc</sup></i> strain MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type male
127285661 SD-<i>Adgrl3<sup>em1Huyc</sup></i> strain MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type female
127285662 Adgrl3<sup>em1Huyc</sup> adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type
127285662 Adgrl3<sup>em1Huyc</sup> adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type
127285662 Adgrl3<sup>em1Huyc</sup> adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type male
127285662 Adgrl3<sup>em1Huyc</sup> adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type female
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345123 F344-<i>Angptl8<sup>em1Kyo-/-</sup></i> strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345124 F344-<i>Angptl8<sup>em1Kyo+/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345124 F344-<i>Angptl8<sup>em1Kyo+/-</sup></i> strain MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
127345127 Angptl8<sup>em1Kyo</sup> angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
12738218 SD-<i>GEPR-9</i> strain MP:0009358 environmentally induced seizures IAGP XCO:0000048 N RGD:13450925|PMID:21458955 20200622 RGD
12738372 BDIX.BDIV-<i>D6Mit1-D6Mgh2</i>/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain
12738372 BDIX.BDIV-<i>D6Mit1-D6Mgh2</i>/Zte strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain
12743611 SS-<i>Ren<sup>em1Mcwi+/-</sup></i> SS-<i>Ren<sup>em1Mcwi+</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
12743611 SS-<i>Ren<sup>em1Mcwi+/-</sup></i> SS-<i>Ren<sup>em1Mcwi+</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male
12743611 SS-<i>Ren<sup>em1Mcwi+/-</sup></i> SS-<i>Ren<sup>em1Mcwi+</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male
12743611 SS-<i>Ren<sup>em1Mcwi+/-</sup></i> SS-<i>Ren<sup>em1Mcwi+</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male
12790679 PCK-<i>P2rx7<sup>em8Mcwi</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14995937|PMID:31630543 20191105 RGD
12790679 PCK-<i>P2rx7<sup>em8Mcwi</sup></i> strain MP:0005556 abnormal renal filtration rate IMP N RGD:14995937|PMID:31630543 20191105 RGD
12790721 SS.BN-(<i>D13Rat151-D13Rat197)-Serpinc1<sup>em2Mcwi</sup></i> strain MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20170310 RGD
12790722 Serpinc1<sup>em2Mcwi</sup> serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin gene MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20180119 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20201210 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20201210 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20201210 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20201210 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20201210 RGD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD
12790970 Pax6<sup>Sey2</sup> paired box gene 6, small eye mutation 2 gene MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20231005 RGD
12791992 Gja8<sup>m1Cub</sup> gap junction protein, alpha 8; mutant 1 Cub gene MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
12792211 SS.BN-(<i>D13Hmgc1048-D13Hmgc664</i>)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792211 SS.BN-(<i>D13Hmgc1048-D13Hmgc664</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792211 SS.BN-(<i>D13Hmgc1048-D13Hmgc664</i>)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792212 SS.BN-(<i>D13Hmgc1048-D13Hmgc1045</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792212 SS.BN-(<i>D13Hmgc1048-D13Hmgc1045</i>)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792213 SS.BN-(<i>D13Hmgc1048-D13Hmgc1050</i>)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792213 SS.BN-(<i>D13Hmgc1048-D13Hmgc1050</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792213 SS.BN-(<i>D13Hmgc1048-D13Hmgc1050</i>)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792214 SS.BN-(<i>D13Hmgc1041-D13Hmgc664</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD
12792214 SS.BN-(<i>D13Hmgc1041-D13Hmgc664</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD
12792216 SS.BN-(<i>D13Hmgc885-D13Hmgc664</i>)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792216 SS.BN-(<i>D13Hmgc885-D13Hmgc664</i>)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi
12792217 SS.BN-(<i>D13Hmgc1041-D13Hmgc885</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD
12792217 SS.BN-(<i>D13Hmgc1041-D13Hmgc885</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD
12792226 SS.BN-(<i>D13Got45-D13Hmgc664</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792226 SS.BN-(<i>D13Got45-D13Hmgc664</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792283 Scn1a<sup>m1Kyo</sup> sodium voltage-gated channel alpha subunit 1; ENU induced mutant1, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170411 RGD
12792284 Scn1a<sup>m2Kyo</sup> sodium voltage-gated channel alpha subunit 1; ENU induced mutant2, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170411 RGD
12792941 Abcc2<sup>TR-</sup> ATP binding cassette subfamily C member 2;transport deficient mutant , gene MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0001263 weight loss IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005292 improved glucose tolerance IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792942 Dpp4<sup>DPPIV</sup> dipeptidylpeptidase 4; DPPIV mutant gene MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
12792944 SS.BN-(<i>D13Got42-D13Got45</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20191125 RGD
12792944 SS.BN-(<i>D13Got42-D13Got45</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792945 SS.BN-(<i>D13Got42-D13Rat130</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792945 SS.BN-(<i>D13Got42-D13Rat130</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792946 SS.BN-(<i>D13Got42-D13Hmgc354</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792946 SS.BN-(<i>D13Got42-D13Hmgc354</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792947 SS.BN-(<i>D13Got42-D13Hmgc497</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792947 SS.BN-(<i>D13Got42-D13Hmgc497</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792948 SS.BN-(<i>D13Got42-D13Hmgc885</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792948 SS.BN-(<i>D13Got42-D13Hmgc885</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792949 SS.BN-(<i>D13Got42-D13Hmgc664</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792949 SS.BN-(<i>D13Got42-D13Hmgc664</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792950 SS.BN-(<i>D13Mit5-D13Rat32</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792950 SS.BN-(<i>D13Mit5-D13Rat32</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792951 SS.BN-(<i>D13Hmgc5885-D13Rat32</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792951 SS.BN-(<i>D13Hmgc5885-D13Rat32</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD
12792952 SS.BN-(<i>D13Hmgc354-D13Rat32</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792952 SS.BN-(<i>D13Hmgc354-D13Rat32</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792953 SS.BN-(<i>D13Rat130-D13Rat32</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792953 SS.BN-(<i>D13Rat130-D13Rat32</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792954 SS.BN-(<i>D13Got45-D13Rat32</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792954 SS.BN-(<i>D13Got45-D13Rat32</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi
12792962 Sv2a<sup>m1Kyo</sup> synaptic vesicle glycoprotein 2a; ENU induced mutant 1, Kyo, gene MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170410 RGD
12792962 Sv2a<sup>m1Kyo</sup> synaptic vesicle glycoprotein 2a; ENU induced mutant 1, Kyo, gene MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170410 RGD
12792963 Lep<sup>m1Kyo</sup> leptin; ENU induced mutant1, Kyo gene MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170410 RGD
12792963 Lep<sup>m1Kyo</sup> leptin; ENU induced mutant1, Kyo gene MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170410 RGD
12792963 Lep<sup>m1Kyo</sup> leptin; ENU induced mutant1, Kyo gene MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170410 RGD
12792970 Lgi1<sup>m1Kyo</sup> leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20200130 RGD
12792970 Lgi1<sup>m1Kyo</sup> leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170410 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)
12792970 Lgi1<sup>m1Kyo</sup> leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170410 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)
12792972 Tyr<sup>em1Kyo</sup> tyrosinase; TALEN induced mutant1, Kyo gene MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170410 RGD
12798529 SS.BN-(<i>D13Hmgc37-D13Got22</i>)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798529 SS.BN-(<i>D13Hmgc37-D13Got22</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798530 SS.BN-(<i>D13Rat115-D13Got22</i>)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798530 SS.BN-(<i>D13Rat115-D13Got22</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798531 SS.BN-(<i>D13Hmgc86-D13Got22</i>)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798531 SS.BN-(<i>D13Hmgc86-D13Got22</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798532 SS.BN-(<i>D13Hmgc40-D13Got22</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798533 SS.BN-(<i>D13Hmgc85-D13Got22</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798534 SS.BN-(<i>D13Rat77-D13Got22</i>)/Mcwi strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20191213 RGD compared to SS/JrHsdMcwi
12798534 SS.BN-(<i>D13Rat77-D13Got22</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798535 SS.BN-(<i>D13Rat111-D13Rat115</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798536 SS.BN-(<i>D13Rat111-D13Hmgc86</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798537 SS.BN-(<i>D13Rat111-D13Rat20</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD
12798538 SS.BN-(<i>D13Rat111-D13Hmgc85</i>)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12798538 SS.BN-(<i>D13Rat111-D13Hmgc85</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20170411 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001525 impaired balance IAGP N RGD:1581602|PMID:16368876 20170411 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001544 abnormal cardiovascular system physiology IAGP N RGD:1581602|PMID:16368876 20170411 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20200124 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0005211 increased stomach mucosa thickness IAGP N RGD:1581602|PMID:16368876 20170411 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20200124 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20200124 RGD
12802344 Kcnq1<sup>dfk</sup> potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD
12802346 Plp1<i><sup>md</sup></i> proteolipid protein 1; Myelin-deficient gene MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 20170412 RGD
12802346 Plp1<i><sup>md</sup></i> proteolipid protein 1; Myelin-deficient gene MP:0002064 seizures IAGP N RGD:1358781|PMID:2479544 20241206 RGD
12802346 Plp1<i><sup>md</sup></i> proteolipid protein 1; Myelin-deficient gene MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 20241206 RGD
12802353 Unc5c<sup>hob</sup> unc-5 netrin receptor C; hobble mutant gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD
12802355 Unc5c<sup>cvd</sup> unc-5 netrin receptor C; cerebellar vermis defect gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male on 8% NaCl diet
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
12802362 SS.BN-(<i>D13Rat25-RN34_13048990782</i>)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
12802363 SS.BN-(<i>D13Rat25-rs106935835</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD
12802363 SS.BN-(<i>D13Rat25-rs106935835</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD
12802364 SS.BN-(<i>D13Rat25-rs198199323</i>)/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male
12802364 SS.BN-(<i>D13Rat25-rs198199323</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male on 8% NaCl diet
12802364 SS.BN-(<i>D13Rat25-rs198199323</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
12802364 SS.BN-(<i>D13Rat25-rs198199323</i>)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
12802366 SS.BN-(<i>D13Hmgc64-4582</i>)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12802366 SS.BN-(<i>D13Hmgc64-4582</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12802366 SS.BN-(<i>D13Hmgc64-4582</i>)/Mcwi strain MP:0005602 decreased angiogenesis IAGP N RGD:12832723|PMID:21521778 20191122 RGD
12802367 SS.BN-(<i>2340-RN34_13048990782</i>)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12802367 SS.BN-(<i>2340-RN34_13048990782</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001260 increased body weight IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001260 increased body weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001552 increased circulating triglyceride level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001554 increased circulating free fatty acids level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0001860 liver inflammation IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0002079 increased circulating insulin level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0002079 increased circulating insulin level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0002941 increased circulating alanine transaminase level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0002981 increased liver weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0002981 increased liver weight IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0003674 oxidative stress IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005178 increased circulating cholesterol level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005293 impaired glucose tolerance IAGP N RGD:12859275|PMID:25961052 20170414 RGD
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005331 insulin resistance IAGP N RGD:12859275|PMID:25961052 20201006 RGD
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005559 increased circulating glucose level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005559 increased circulating glucose level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0005669 increased circulating leptin level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0009355 increased liver triglyceride level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0011594 decreased catalase activity IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0011603 decreased glutathione peroxidase activity IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859278 Slc:ZUC-<I>Lepr<sup>fa-/-</sup></I> Zucker fatty rats strain MP:0012659 decreased superoxide dismutase level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001258 decreased body length IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001260 increased body weight IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0001559 hyperglycemia IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0002079 increased circulating insulin level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0003334 pancreas fibrosis IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0003980 increased circulating phospholipid level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0005293 impaired glucose tolerance IAGP N RGD:12859275|PMID:25961052 20170414 RGD
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0005331 insulin resistance IAGP N RGD:12859275|PMID:25961052 20201006 RGD
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0005559 increased circulating glucose level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0005669 increased circulating leptin level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0006087 increased body mass index IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0009254 disorganized pancreatic islets IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859279 Ho:ZFDM-<I>Lepr<sup>fa</sup></I> Zucker Fatty Diabetes Mellitus rats strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001260 increased body weight IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001260 increased body weight induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001262 decreased body weight induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002079 increased circulating insulin level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002644 decreased circulating triglyceride level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002727 decreased circulating insulin level IAGP XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0002891 increased insulin sensitivity induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0005455 increased susceptibility to weight gain IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0005455 increased susceptibility to weight gain induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0005668 decreased circulating leptin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0005669 increased circulating leptin level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0005669 increased circulating leptin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0006352 decreased glycosylated hemoglobin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0010182 decreased susceptibility to weight gain induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0011939 increased food intake IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0011939 increased food intake induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0011940 decreased food intake induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0013278 decreased fasting circulating glucose level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0013279 increased fasting circulating glucose level IAGP XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0020088 decreased susceptibility to non-insulin-dependent diabetes induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD
12859287 ZDF-<i>Lepr<sup>fa</sup></i>/Drt Zucker Diabetic Fatty Rat strain MP:0030969 increased circulating adiponectin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed
12879386 W-<i>Ghsr<sup>em1Ottc</sup></i> strain MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD
12879386 W-<i>Ghsr<sup>em1Ottc</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD
12879386 W-<i>Ghsr<sup>em1Ottc</sup></i> strain MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD
12879386 W-<i>Ghsr<sup>em1Ottc</sup></i> strain MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879394 F344-<i>Atm<sup>m1Kyo</sup></i> Atm missense rats strain MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20230119 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879395 Atm<sup>m1Kyo</sup> ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879400 F344-<i>Atm<sup>em1Kyo</sup></i> ZFN-Atm rats strain MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000136 abnormal microglial cell morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20230119 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20230119 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20230119 RGD
12879401 Atm<sup>em1Kyo</sup> ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0020448 increased microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD
12879506 Pur33 Proteinuria QTL 33 qtl MP:0002962 increased urine protein level IAGP N RGD:11353859|PMID:27113531 20170424 RGD
12879830 Bw178 Body weight QTL 178 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879831 Cm82 Cardiac mass QTL 82 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879832 Cm83 Cardiac mass QTL 83 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879833 Cm84 Cardiac mass QTL 84 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD
12879834 Am1 Aortic mass QTL 1 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD
12879837 Am2 Aortic mass QTL 2 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD
12879838 Cm86 Cardiac mass QTL 86 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879839 Cm85 Cardiac mass QTL 85 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879840 Bw179 Body weight QTL 179 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879841 Cm87 Cardiac mass QTL 87 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879842 Cm88 Cardiac mass QTL 88 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879843 Am3 Aortic mass QTL 3 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD
12879845 Cm89 Cardiac mass QTL 89 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879846 Cm90 Cardiac mass QTL 90 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD
12879847 Am4 Aortic mass QTL 4 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD
12879848 Bw181 Body weght QTL 181 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170615 RGD
12879849 Bw180 Body weight QTL 180 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170615 RGD
12879850 Cm91 Cardiac mass QTL 91 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879851 Cm92 Cardiac mass QTL 92 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879852 Cm93 Cardiac mass QTL 93 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879853 Am5 Aortic mass QTL 5 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879854 Kidm63 Kidney mass QTL 63 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20201210 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20201210 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD
12879860 Tg<sup>rdw</sup> thyroglobulin; rdw mutant gene MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes
12879863 Bp402 Blood pressure QTL 402 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879866 Cm94 Cardiac mass QTL 94 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879868 Am6 Aortic mass QTL 6 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879871 Am7 Aortic mass QTL 7 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879872 Cm97 Cardiac mass QTL 97 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879873 Cm96 Cardiac mass QTL 96 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879874 Cm98 Cardiac mass QTL 98 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879875 Kidm64 Kidney mass QTL 64 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12879878 Bw183 Body weight QTL 183 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879879 Cm99 Cardiac mass QTL 99 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879880 Cm100 Cardiac mass QTL 100 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879881 Cm101 Cardiac mass QTL 101 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD
12879882 Am8 Aortic mass QTL 8 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12879883 Kidm65 Kidney mass QTL 65 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880021 SD-<i>Apoe<sup>em1Sage</sup></i> strain MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD
12880021 SD-<i>Apoe<sup>em1Sage</sup></i> strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD
12880022 Apoe<sup>em1Sage</sup> apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211111 RGD
12880022 Apoe<sup>em1Sage</sup> apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211111 RGD
12880023 Bw184 Body weight QTL 184 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880025 Cm102 Cardiac mass QTL 102 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880028 Cm103 Cardiac mass QTL 103 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20080418 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880032 Dmd<sup>em1Ang</sup> dystrophin; TALEN-induced mutant1, Ang gene MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880037 SD-<i>Dmd<sup>em1Ang</sup></i> strain MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD
12880044 Am9 Aortic mass QTL 9 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880050 Am10 Aortic mass QTL 10 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880053 Cm104 Cardiac mass QTL 104 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880055 Am11 Aortic mass QTL 11 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880368 Bw187 Body weight QTL 187 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880370 Cm105 Cardiac mass QTL 105 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880371 Cm106 Cardiac mass QTL 106 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170503 RGD
12880372 Am12 Aortic mass QTL 12 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170503 RGD
12880375 Kidm66 Kidney mass QTL 66 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12880380 Gh1<sup>sdr</sup> gene MP:0005136 decreased growth hormone level IAGP N RGD:1578506|PMID:2152867 20170504 RGD
12880380 Gh1<sup>sdr</sup> gene MP:0005138 decreased prolactin level IAGP N RGD:1578506|PMID:2152867 20170504 RGD
12880382 Cacna1a<sup>gry</sup> calcium voltage-gated channel subunit alpha1 A; groggy mutant gene MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20170504 RGD
12880383 Kcna1<sup>Adms</sup> potassium voltage-gated channel subfamily A member 1;autosomal dominant myokymia and seizures gene MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
12880383 Kcna1<sup>Adms</sup> potassium voltage-gated channel subfamily A member 1;autosomal dominant myokymia and seizures gene MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
12880384 Cm107 Cardiac mass QTL 107 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880385 Cm108 Cardiac mass QTL 108 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880395 Cm109 Cardiac mass QTL 109 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880396 Am13 Aortic mass QTL 13 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880398 Kidm67 Kidney mass QTL 67 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12880435 Ghsr<sup>em1Ottc</sup> growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD
12880435 Ghsr<sup>em1Ottc</sup> growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD
12880435 Ghsr<sup>em1Ottc</sup> growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD
12880435 Ghsr<sup>em1Ottc</sup> growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD
12902614 SS.LEW-(<i>D10M11Mit119-D10Rat27</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS
12902615 Bw185 Body weight QTL 185 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD
12902621 SD-<i>Bdnf<sup>em1Sage+/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20200819 RGD compared to WT
12902621 SD-<i>Bdnf<sup>em1Sage+/-</sup></i> strain MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210216 RGD compared to WT
12902621 SD-<i>Bdnf<sup>em1Sage+/-</sup></i> strain MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20200819 RGD WT compared to heterozygous rats
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20201210 RGD compared to WT
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight severity IMP N RGD:38501054|PMID:23583595 20200820 RGD
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001988 cocaine preference severity IMP N RGD:38501054|PMID:23583595 20200820 RGD
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0002555 addiction severity IMP N RGD:38501054|PMID:23583595 20200820 RGD
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210218 RGD compared to WT
12902622 Bdnf<sup>em1Sage</sup> brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20210225 RGD WT compared to heterozygous rats
12902625 SD-<i>Nr1i2<sup>em1Sage</sup></i> strain MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD
12902625 SD-<i>Nr1i2<sup>em1Sage</sup></i> strain MP:0005319 abnormal enzyme/coenzyme level induced IMP XCO:0000372 N RGD:127285625|PMID:27856527 20210630 RGD Por
12902625 SD-<i>Nr1i2<sup>em1Sage</sup></i> strain MP:0020169 increased thyroid gland weight induced IMP XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD
12902626 Nr1i2<sup>em1Sage</sup> nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD
12902626 Nr1i2<sup>em1Sage</sup> nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0005319 abnormal enzyme/coenzyme level IMP N RGD:127285625|PMID:27856527 20210701 RGD Por
12902626 Nr1i2<sup>em1Sage</sup> nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0020169 increased thyroid gland weight IMP N RGD:38549342|PMID:29548889 20210701 RGD
12903245 Cm110 Cardiac mass QTL 110 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903246 Cm111 Cardiac mass QTL 111 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903247 Cm112 Cardiac mass QTL 112 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903248 Am14 Aortic mass QTL 14 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903249 Kidm68 Kidney mass QTL 68 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903252 Cm113 Cardiac mass QTL 113 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903266 Cm114 Cardiac mass QTL 114 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903267 SD-<i>Nr1i3<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD male rats
12903268 Nr1i3<sup>em1Sage</sup> nuclear receptor subfamily 1, group I, member 3; ZFN induced mutant 1,SAGE gene MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD male rats
12903269 Am15 Aortic mass QTL 15 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903270 SD-<i>Nr1i2<sup>em1Sage</sup></i> <i>Nr1i3<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD male rats
12903278 Am16 Aortic mass QTL 16 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903279 Cm115 Cardiac mass QTL 115 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903281 Cm116 Cardiac mass QTL 116 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD
12903952 Cm117 Cardiac mass QTL 117 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD
12903954 Bw186 Body weight QTL 186 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD
12903955 Kidm69 Kidney mass QTL 69 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD
12903978 Cm118 Cardiac mass QTL 118 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD
12903979 Cm119 Cardiac mass QTL 119 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD
12903980 Cm120 Cardiac mass QTL 120 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD
12903981 Am17 Aortic mass QTL 17 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD
12903982 Kidm70 Kidney mass QTL 70 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD
12904057 SD-<i>Abcb1a<sup>em1Sage -/-</sup></i> SD-<i>Abcb1a<sup>em1</sup>-</sup>/Abcb1a<sup>em1</sup>-</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:45863|CHEBI:6532|CHEBI:51619
12904057 SD-<i>Abcb1a<sup>em1Sage -/-</sup></i> SD-<i>Abcb1a<sup>em1</sup>-</sup>/Abcb1a<sup>em1</sup>-</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210916 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723
12904058 Abcb1a<sup>em1Sage</sup> ATP binding cassette subfamily B member 1A; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:45863|CHEBI:6532|CHEBI:51619
12904058 Abcb1a<sup>em1Sage</sup> ATP binding cassette subfamily B member 1A; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210923 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723
12904063 SD-<i>Abcg2<sup>em1Sage</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619
12904064 Abcg2<sup>em1Sage</sup> ATP-binding cassette, subfamily G (WHITE), member 2; ZFN induced mutatn 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619
12904067 Cm122 Cardiac mass QTL 122 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD
12904069 Cm123 Cardiac mass QTL 123 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD
12904070 Cm124 Cardiac mass QTL 124 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD
12904071 Am18 Aortic mass QTL 18 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD
12904073 Kidm71 Kidney mass QTL 71 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD
12904668 Bw188 Body weight QTL 188 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904669 Cm125 Cardiac mass QTL 125 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904670 Cm126 Cardiac mass QTL 126 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904673 Cm127 Cardiac mass QTL 127 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904675 Am19 Aortic mass QTL 19 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904677 Kidm72 Kidney mass QTL 72 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type and standard diet
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to standard diet
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to standard diet and wild type
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to standard diet
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to standard diet
12904679 WKY-<i>Cyp2j4<sup>em1Sage</sup></i>/Tja strain MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to wild type
12904680 Bw189 Body weight QTL 189 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type and standard diet
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet and wild type
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
12904681 Cyp2j4<i><sup>em1Sage</sup></i> cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
12904685 SD-<i>Abcc2<sup>em1Sage</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:45863|CHEBI:51619
12904687 Abcc2<sup>em1Sage</sup> ATP binding cassette subfamily C member 2; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:9334|CHEBI:45863|CHEBI:51619
12904689 Cm128 Cardiac mass QTL 128 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12904690 Cm129 Cardiac mass QTL 129 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
12904691 Cm130 Cardiac mass QTL 130 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904693 Am20 Aortic mass QTL 20 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904695 Kidm73 Kidney mass QTL 73 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD
12904714 Cm131 Cardiac mass QTL 131 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD
12904715 Cm132 Cardiac mass QTL 132 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD
12904716 Am21 Aortic mass QTL 21 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD
12904736 Cm121 Cardiac mass QTL 121 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170519 RGD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD
12904897 SD-<i>Tp53<sup>em1Sage</sup></i> strain MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210928 RGD seminiferous tubule; compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
12904898 Tp53<sup>em1Sage</sup> tumor protein p53; ZFN induced mutant 1, Sage gene MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210930 RGD seminiferous tubule; compared to SD
12904907 SD-<i>Prkdc<sup>em1Sage</sup></i> strain MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20211111 RGD
12904907 SD-<i>Prkdc<sup>em1Sage</sup></i> strain MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20211111 RGD
12904907 SD-<i>Prkdc<sup>em1Sage</sup></i> strain MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20211111 RGD
12904907 SD-<i>Prkdc<sup>em1Sage</sup></i> strain MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20211111 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904908 SD-<i>Ldlr<sup>em1Sage</sup></i> strain MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904909 Ldlr<sup>em1Sage</sup> low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20170608 RGD
12904912 SD-<i>Lep<sup>em1Sage-/-</sup></i> strain MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904912 SD-<i>Lep<sup>em1Sage-/-</sup></i> strain MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904912 SD-<i>Lep<sup>em1Sage-/-</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904912 SD-<i>Lep<sup>em1Sage-/-</sup></i> strain MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904912 SD-<i>Lep<sup>em1Sage-/-</sup></i> strain MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20201210 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12904927 Lep<sup>em1Sage</sup> leptin; zinc finger nuclease induced mutant1, Sage gene MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20170526 RGD
12907568 WI-<i>Abcb1a<sup>em2Sage</sup></i> strain MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD
12907568 WI-<i>Abcb1a<sup>em2Sage</sup></i> strain MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD
12907569 Abcb1a<sup>em2Sage</sup> ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage gene MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD
12907569 Abcb1a<sup>em2Sage</sup> ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage gene MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD
12910101 SD-<i>Ldlr<sup>em1</sup></i> strain MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD
12910102 Ldlr<sup>em1</sup> low density lipoprotein receptor; ZFN induced mutant 1 gene MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0001258 decreased body length IMP N RGD:625699|PMID:12045256 20170613 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0001262 decreased body weight IMP N RGD:625699|PMID:12045256 20170613 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
12910127 SD-Tg(Th-Ghsros) strain MP:0011940 decreased food intake IMP N RGD:625699|PMID:12045256 20170613 RGD
12910491 Il15<sup>em1Soar</sup> interleukin 15; ZFN induced mutant 1, Soar gene MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD
12910491 Il15<sup>em1Soar</sup> interleukin 15; ZFN induced mutant 1, Soar gene MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD
12910491 Il15<sup>em1Soar</sup> interleukin 15; ZFN induced mutant 1, Soar gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
12910491 Il15<sup>em1Soar</sup> interleukin 15; ZFN induced mutant 1, Soar gene MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
12910493 LEW.1WR1-<i>Ifnar1<sup>em1</sup></i> strain MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD
12910493 LEW.1WR1-<i>Ifnar1<sup>em1</sup></i> strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IMP XCO:0000235 N RGD:12910492|PMID:27999109 20200127 RGD compared to LEW.1WR1/WorBrm
12910493 LEW.1WR1-<i>Ifnar1<sup>em1</sup></i> strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality induced IMP XCO:0000237 N RGD:12910492|PMID:27999109 20200127 RGD encephalomyocarditis virus induced; compared to LEW.1WR1/WorBrm
12910494 LEW.1WR1-<i>Ifnar1<sup>em2</sup></i> strain MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD
12910494 LEW.1WR1-<i>Ifnar1<sup>em2</sup></i> strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IMP XCO:0000235 N RGD:12910492|PMID:27999109 20200127 RGD compared to LEW.1WR1/WorBrm
12910494 LEW.1WR1-<i>Ifnar1<sup>em2</sup></i> strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality induced IMP XCO:0000237 N RGD:12910492|PMID:27999109 20200127 RGD encephalomyocarditis virus induced
12910495 Ifnar1<sup>em1</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD
12910495 Ifnar1<sup>em1</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD
12910495 Ifnar1<sup>em1</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD
12910496 Ifnar1<sup>em2</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD
12910496 Ifnar1<sup>em2</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD
12910496 Ifnar1<sup>em2</sup> interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD
12910500 Mmp12<sup>em1Soar</sup> matrix metallopeptidase 12; TALEN induced mutant 1,Soar gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD
12910505 SD-<i>Mmp12<sup>em2Soar</sup></i> strain MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20170616 RGD
12910505 SD-<i>Mmp12<sup>em2Soar</sup></i> strain MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD
12910506 Mmp12<sup>em2Soar</sup> matrix metallopeptidase 12; TALEN induced mutant 2,Soar gene MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20170616 RGD
12910506 Mmp12<sup>em2Soar</sup> matrix metallopeptidase 12; TALEN induced mutant 2,Soar gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910519 SD-<i>Lepr<sup>em3</sup></i> strain MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910546 Lepr<sup>em3</sup> leptin receptor; TALEN induced mutant 3 gene MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910736 Esr1<sup>em1Soar</sup> estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910762 BN-<i>Kit<sup>Ws</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD
12910763 Kit<sup>Ws</sup> KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD
12910834 Zbtb16<sup>Lx</sup> zinc finger and BTB domain containing 16, Lx mutant gene MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20170626 RGD
12910940 SD-<i>Cdkn1b<sup>we</sup></i> strain MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20180503 RGD
12910940 SD-<i>Cdkn1b<sup>we</sup></i> strain MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20180503 RGD
12910941 Cdkn1b<sup>we</sup> cyclin-dependent kinase inhibitor 1B; white eye mutation gene MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20201210 RGD
12910941 Cdkn1b<sup>we</sup> cyclin-dependent kinase inhibitor 1B; white eye mutation gene MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20201210 RGD
12910954 Csf1<sup>tl</sup> colony stimulating factor 1; tooth less mutant gene MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20180430 RGD
12910954 Csf1<sup>tl</sup> colony stimulating factor 1; tooth less mutant gene MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20180430 RGD
12910954 Csf1<sup>tl</sup> colony stimulating factor 1; tooth less mutant gene MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD
12910954 Csf1<sup>tl</sup> colony stimulating factor 1; tooth less mutant gene MP:0003723 abnormal long bone morphology IAGP N RGD:628338|PMID:12379742 20170629 RGD
12910954 Csf1<sup>tl</sup> colony stimulating factor 1; tooth less mutant gene MP:0030610 absent teeth IAGP N RGD:628338|PMID:12379742 20170629 RGD
1298065 Scl16 Serum cholesterol level QTL 16 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD
1298066 Bp159 Blood pressure QTL 159 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
1298066 Bp159 Blood pressure QTL 159 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD
1298066 Bp159 Blood pressure QTL 159 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD
1298067 Scl15 Serum cholesterol level QTL 15 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD
1298068 Bp167 Blood pressure QTL 167 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61042|PMID:7963489 19990101 RGD
1298069 Bp168 Blood pressure QTL 168 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
1298070 Scl18 Serum cholesterol level QTL 18 qtl MP:0000182 increased circulating LDL cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD
1298071 Edpm12 Estrogen-dependent pituitary mass QTL 12 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:629550|PMID:11003699 19990101 RGD
1298072 Cia26 Collagen induced arthritis QTL 26 qtl MP:0002936 joint swelling QTM N RGD:1285224|PMID:15334486 19990101 RGD
1298073 Cm13 Cardiac mass QTL 13 qtl MP:0002833 increased heart weight QTM N RGD:69705|PMID:9922389 19990101 RGD
1298073 Cm13 Cardiac mass QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69705|PMID:9922389 19990101 RGD
1298074 Bp164 Blood pressure QTL 164 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
1298075 Scl17 Serum cholesterol level QTL 17 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD
1298076 Bp166 Blood pressure QTL 166 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
1298077 Bp157 Blood pressure QTL 157 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:619649|PMID:11875185 19990101 RGD
1298078 Stresp5 Stress response QTL 5 qtl MP:0001745 increased circulating corticosterone level QTM N RGD:737981|PMID:15013833 19990101 RGD
1298079 Activ2 Activity QTL 2 qtl MP:0001415 increased exploration in new environment IDA N RGD:631228|PMID:12660808 19990101 RGD
1298080 Bp163 Blood pressure QTL 163 qtl MP:0002833 increased heart weight IAGP N RGD:68910|PMID:10642295 19990101 RGD
1298080 Bp163 Blood pressure QTL 163 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD
1298081 Cia25 Collagen induced arthritis QTL 25 qtl MP:0002936 joint swelling QTM N RGD:1285224|PMID:15334486 19990101 RGD
1298082 Stresp4 Stress response QTL 4 qtl MP:0001745 increased circulating corticosterone level QTM N RGD:737981|PMID:15013833 19990101 RGD
1298083 Bp158 Blood pressure QTL 158 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61038|PMID:8040284 19990101 RGD
1298084 Thym4 Thymus enlargement QTL 4 qtl MP:0000709 enlarged thymus QTM N RGD:70859|PMID:10792781 19990101 RGD
1298085 Bp165 Blood pressure QTL 165 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
1298086 Bp156 Blood pressure QTL 156 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:619649|PMID:11875185 19990101 RGD
1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 19990101 RGD
1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 19990101 RGD
1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 19990101 RGD
1298088 Edpm11 Estrogen-dependent pituitary mass QTL 11 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:629550|PMID:11003699 19990101 RGD
1298088 Edpm11 Estrogen-dependent pituitary mass QTL 11 qtl MP:0003044 impaired basement membrane formation QTM N RGD:629550|PMID:11003699 19990101 RGD
1298089 Scl14 Serum cholesterol level QTL 14 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD
1298090 Bp155 Blood pressure QTL 155 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:731210|PMID:14678232 20100217 RGD
1298093 LEW/NHsd strain MP:0009752 enhanced behavioral response to nicotine IAGP N RGD:401959299|PMID:21745336 20240118 RGD compared to Fischer344 rats
1298524 Oia8 Oil induced arthritis QTL 8 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD
1298525 Cm1 Cardiac mass QTL 1 qtl MP:0002833 increased heart weight QTM N RGD:69710|PMID:9383281 19990101 RGD
1298526 Arunc3 Aerobic running capacity QTL 3 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD
1298526 Arunc3 Aerobic running capacity QTL 3 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD
1298527 Arunc2 Aerobic running capacity QTL 2 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD
1298527 Arunc2 Aerobic running capacity QTL 2 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD
1298528 Bp169 Blood pressure QTL 169 qtl MP:0006264 decreased systemic arterial systolic blood pressure QTM N RGD:69711|PMID:11247666 19990101 RGD
1298529 Arunc1 Aerobic running capacity QTL 1 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD
1298529 Arunc1 Aerobic running capacity QTL 1 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD
1299868 SS.SR-(<I>D7Uia1-D7Mco7</I>)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr
1299868 SS.SR-(<I>D7Uia1-D7Mco7</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20201030 RGD as compared to SS/Jr on 2% Nacl diet
1299868 SS.SR-(<I>D7Uia1-D7Mco7</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% Nacl diet
1299869 SS.SR-(<I>Cyp11b1</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:69710|PMID:9383281 20191127 RGD compared to SS/Jr
1299869 SS.SR-(<I>Cyp11b1</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:69710|PMID:9383281 20191127 RGD
1299870 SS.LEW-(<I>D5Uia8-D5Rat108</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
1299871 DA.F344-(<I>D20Arb2-D20Arb8</I>)/Arb strain MP:0002933 joint inflammation induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl
1299871 DA.F344-(<I>D20Arb2-D20Arb8</I>)/Arb strain MP:0002936 joint swelling induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl
1299872 DA.F344-(<I>D8Arb15-D8Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD
1299872 DA.F344-(<I>D8Arb15-D8Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
1299872 DA.F344-(<I>D8Arb15-D8Arb22</I>)/Arb strain MP:0008719 impaired neutrophil recruitment induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi
1299873 SS.LEW-(<I>D5Mco34-D5Rat108</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
1299873 SS.LEW-(<I>D5Mco34-D5Rat108</I>)/Jr strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1643012|PMID:17938377 20191127 RGD compared to SS/Jr
1299875 DA.F344-(<i>D7Rat22-D7Mit2</i>)/Nsi strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263|XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
1299875 DA.F344-(<i>D7Rat22-D7Mit2</i>)/Nsi strain MP:0008561 decreased tumor necrosis factor secretion induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi
1299875 DA.F344-(<i>D7Rat22-D7Mit2</i>)/Nsi strain MP:0008719 impaired neutrophil recruitment induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi
1299876 SS.LEW-(<I>D5Rat54-D5Rat108</I>)/Jr strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to LEW/Jr
1299876 SS.LEW-(<I>D5Rat54-D5Rat108</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD
1299877 DA.F344-(<I>D10Rat204-D10Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD
1299877 DA.F344-(<I>D10Rat204-D10Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
1299878 DA.F344-(<I>D4Arb30-D4Arb4</I>)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000281| XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD
1299878 DA.F344-(<I>D4Arb30-D4Arb4</I>)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD
1299878 DA.F344-(<I>D4Arb30-D4Arb4</I>)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
1299879 SS.SR-(<I>D7Mco7-D7Wox19</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20201030 RGD as compared to SS/Jr on 2% Nacl diet
1299880 F344.DA-(<I>D20Arb2-D20Arb8</I>)/Arb strain MP:0002933 joint inflammation induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD
1299880 F344.DA-(<I>D20Arb2-D20Arb8</I>)/Arb strain MP:0002936 joint swelling induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl
1299881 SS.LEW-(<I>D5Wox3-D5Rat108</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
1300075 Glom7 Glomerulus QTL 7 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD
1300076 Glom8 Glomerulus QTL 8 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD
1300107 Rf18 Renal function QTL 18 qtl MP:0001762 polyuria IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300107 Rf18 Renal function QTL 18 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD
1300108 Rf8 Renal function QTL 8 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300108 Rf8 Renal function QTL 8 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300108 Rf8 Renal function QTL 8 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300109 Rf13 Renal function QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300109 Rf13 Renal function QTL 13 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300111 Rf12 Renal function QTL 12 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD
1300111 Rf12 Renal function QTL 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300111 Rf12 Renal function QTL 12 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD
1300111 Rf12 Renal function QTL 12 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300112 Bp183 Blood pressure QTL 183 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300113 Bp176 Blood pressure QTL 176 qtl MP:0002706 abnormal kidney size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300113 Bp176 Blood pressure QTL 176 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300114 Srn2 Serum renin concentration QTL 2 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD
1300115 Hrtrt7 Heart rate QTL 7 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300115 Hrtrt7 Heart rate QTL 7 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300116 Hrtrt5 Heart rate QTL 5 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300116 Hrtrt5 Heart rate QTL 5 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300118 Bp190 Blood pressure QTL 190 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300119 Bp180 Blood pressure QTL 180 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300120 Kidm7 Kidney mass QTL 7 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD
1300120 Kidm7 Kidney mass QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300120 Kidm7 Kidney mass QTL 7 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300121 Hrtrt1 Heart rate QTL 1 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300121 Hrtrt1 Heart rate QTL 1 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300122 Wbc1 White blood cell count QTL 1 qtl MP:0000217 abnormal leukocyte cell number QTM N RGD:727992|PMID:14532335 19990101 RGD
1300122 Wbc1 White blood cell count QTL 1 qtl MP:0000218 increased leukocyte cell number IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300123 Bp194 Blood pressure QTL 194 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300124 Cm4 Cardiac mass QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300124 Cm4 Cardiac mass QTL 4 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300124 Cm4 Cardiac mass QTL 4 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300125 Rf26 Renal function QTL 26 qtl MP:0005618 decreased urine potassium level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300126 Bp175 Blood pressure QTL 175 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD
1300126 Bp175 Blood pressure QTL 175 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300127 Srn1 Serum renin concentration QTL 1 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD
1300128 Rf16 Renal function QTL 16 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300128 Rf16 Renal function QTL 16 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300129 Rf25 Renal function QTL 25 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300129 Rf25 Renal function QTL 25 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300129 Rf25 Renal function QTL 25 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300130 Rf20 Renal function QTL 20 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD
1300130 Rf20 Renal function QTL 20 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300130 Rf20 Renal function QTL 20 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD
1300131 Bp193 Blood pressure QTL 193 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300132 Bp182 Blood pressure QTL 182 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300133 Rf24 Renal function QTL 24 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300133 Rf24 Renal function QTL 24 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300133 Rf24 Renal function QTL 24 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300134 Bp185 Blood pressure QTL 185 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300135 Rf19 Renal function QTL 19 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300135 Rf19 Renal function QTL 19 qtl MP:0002963 decreased urine protein level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300135 Rf19 Renal function QTL 19 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD
1300135 Rf19 Renal function QTL 19 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300136 Rf22 Renal function QTL 22 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300136 Rf22 Renal function QTL 22 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300137 Bp186 Blood pressure QTL 186 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD
1300139 Hrtrt6 Heart rate QTL 6 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300139 Hrtrt6 Heart rate QTL 6 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300140 Srn3 Serum renin concentration QTL 3 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD
1300141 Bp178 Blood pressure QTL 178 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300142 Bp191 Blood pressure QTL 191 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300143 Rf14 Renal function QTL 14 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300143 Rf14 Renal function QTL 14 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300144 Rf23 Renal function QTL 23 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300144 Rf23 Renal function QTL 23 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300145 Rf7 Renal function QTL 7 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300145 Rf7 Renal function QTL 7 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300146 Rf17 Renal function QTL 17 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300146 Rf17 Renal function QTL 17 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300147 Bp187 Blood pressure QTL 187 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300148 Bp192 Blood pressure QTL 192 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300149 Cm6 Cardiac mass QTL 6 qtl MP:0000217 abnormal leukocyte cell number QTM N RGD:727992|PMID:14532335 19990101 RGD
1300149 Cm6 Cardiac mass QTL 6 qtl MP:0002596 abnormal hematocrit QTM N RGD:727992|PMID:14532335 19990101 RGD
1300149 Cm6 Cardiac mass QTL 6 qtl MP:0005294 abnormal heart ventricle morphology QTM N RGD:727992|PMID:14532335 19990101 RGD
1300149 Cm6 Cardiac mass QTL 6 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300150 Cm3 Cardiac mass QTL 3 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300151 Bp181 Blood pressure QTL 181 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300152 Bp195 Blood pressure QTL 195 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300153 Bp171 Blood pressure QTL 171 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300154 Bp189 Blood pressure QTL 189 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300155 Bp174 Blood pressure QTL 174 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300155 Bp174 Blood pressure QTL 174 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD
1300156 Bp179 Blood pressure QTL 179 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300157 Rf21 Renal function QTL 21 qtl MP:0005526 decreased renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300158 Bp173 Blood pressure QTL 173 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300159 Kidm4 Kidney mass QTL 4 qtl MP:0002706 abnormal kidney size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300159 Kidm4 Kidney mass QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300159 Kidm4 Kidney mass QTL 4 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300161 Rf10 Renal function QTL 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300161 Rf10 Renal function QTL 10 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300162 Bp188 Blood pressure QTL 188 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300163 Cardf1 Cardiac cell morphology QTL 1 qtl MP:0000272 abnormal aorta morphology QTM N RGD:727992|PMID:14532335 19990101 RGD
1300164 Rf15 Renal function QTL 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300164 Rf15 Renal function QTL 15 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300165 Rf9 Renal function QTL 9 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD
1300165 Rf9 Renal function QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300165 Rf9 Renal function QTL 9 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD
1300166 Kidm6 Kidney mass QTL 6 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD
1300167 Hrtrt2 Heart rate QTL 2 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300167 Hrtrt2 Heart rate QTL 2 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300168 Bp170 Blood pressure QTL 170 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300169 Bp177 Blood pressure QTL 177 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300170 Rf6 Renal function QTL 6 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300170 Rf6 Renal function QTL 6 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300171 Bp184 Blood pressure QTL 184 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300172 Bp172 Blood pressure QTL 172 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300173 Rf11 Renal function QTL 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300173 Rf11 Renal function QTL 11 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300174 Bw15 Body weight QTL 15 qtl MP:0001259 abnormal body weight QTM N RGD:727992|PMID:14532335 19990101 RGD
1300175 Cm5 Cardiac mass QTL 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300175 Cm5 Cardiac mass QTL 5 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300175 Cm5 Cardiac mass QTL 5 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300176 Hrtrt10 Heart rate QTL 10 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300176 Hrtrt10 Heart rate QTL 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300177 Cm2 Cardiac mass QTL 2 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300177 Cm2 Cardiac mass QTL 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD
1300177 Cm2 Cardiac mass QTL 2 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD
1300178 Hrtrt4 Heart rate QTL 4 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD
1300178 Hrtrt4 Heart rate QTL 4 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300179 Kidm5 Kidney mass QTL 5 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD
1300180 Bw14 Body weight QTL 14 qtl MP:0001259 abnormal body weight QTM N RGD:727992|PMID:14532335 19990101 RGD
1300180 Bw14 Body weight QTL 14 qtl MP:0001260 increased body weight IAGP N RGD:727992|PMID:14532335 19990101 RGD
1300433 LAA/FDSC Hatano Low Avoidance strain MP:0003967 abnormal follicle stimulating hormone level IAGP N RGD:1300227|PMID:12374463 19990101 RGD compared to LAA/FDSC
1300433 LAA/FDSC Hatano Low Avoidance strain MP:0004855 increased ovary weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC
1300433 LAA/FDSC Hatano Low Avoidance strain MP:0004905 decreased uterus weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC
1300433 LAA/FDSC Hatano Low Avoidance strain MP:0008939 increased pituitary gland weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC
1300433 LAA/FDSC Hatano Low Avoidance strain MP:0013308 decreased adrenal gland weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC
1302372 SDDIO/Rrrc strain MP:0000812 abnormal dentate gyrus morphology IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0001260 increased body weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0001260 increased body weight IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0002079 increased circulating insulin level IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0002981 increased liver weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0003674 oxidative stress IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0004981 decreased neuronal precursor cell number IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0005448 abnormal energy homeostasis IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0005559 increased circulating glucose level IAGP XCO:0000069 N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0005658 increased susceptibility to diet-induced obesity IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0005669 increased circulating leptin level IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0008414 abnormal spatial reference memory IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0010951 abnormal lipid oxidation IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0011939 increased food intake IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0014142 increased body fat mass IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain
1302372 SDDIO/Rrrc strain MP:0030772 increased urine noradrenaline level sexual_dimorphism IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain, males only
1302373 SDDR/Rrrc strain MP:0001262 decreased body weight IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDIO/Rrrc strain
1302373 SDDR/Rrrc strain MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDIO/Rrrc strain
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20180816 RGD
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 19990101 RGD
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD
1302377 SPRD-<i>Anks6<sup>PKD</sup></i>/Rrrc strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD
1302404 Cia27 Collagen induced arthritis QTL 27 qtl MP:0002933 joint inflammation IAGP N RGD:61063|PMID:9870869 19990101 RGD
1302404 Cia27 Collagen induced arthritis QTL 27 qtl MP:0002936 joint swelling IAGP N RGD:61063|PMID:9870869 19990101 RGD
1302597 LEXF7C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302604 LEXF4/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302604 LEXF4/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302605 LEXF2A/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302605 LEXF2A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302610 KMI/Tky miniature rat ishikawa strain MP:0000165 abnormal long bone hypertrophic chondrocyte zone IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type
1302610 KMI/Tky miniature rat ishikawa strain MP:0000592 short tail IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0001258 decreased body length IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0001262 decreased body weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0001732 postnatal growth retardation IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type
1302610 KMI/Tky miniature rat ishikawa strain MP:0001732 postnatal growth retardation IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0002999 abnormal bone healing IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type
1302610 KMI/Tky miniature rat ishikawa strain MP:0006398 increased long bone epiphyseal plate size IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type
1302610 KMI/Tky miniature rat ishikawa strain MP:0008272 abnormal endochondral bone ossification IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302610 KMI/Tky miniature rat ishikawa strain MP:0030315 small neurocranium IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates
1302612 LEXF10C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302616 LEXF10B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302618 LEXF9/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302621 LEXF10A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302623 TM/Kyo tester moriyama rat strain MP:0004725 decreased platelet serotonin level IAGP N RGD:1302447|PMID:9250486 20111109 RGD
1302623 TM/Kyo tester moriyama rat strain MP:0005606 increased bleeding time IAGP N RGD:1302447|PMID:9250486 19990101 RGD
1302627 F344/NSlc strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD
1302627 F344/NSlc strain MP:0008911 induced hyperactivity IAGP XCO:0000048 N RGD:14995940|PMID:30813600 20200130 RGD compared to F344-Lgi1m1Kyo
1302630 F344.OLETF-(<I>D10Wox7-D10Wox6</I>)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD
1302631 BN/SsNSlc strain MP:0005012 decreased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20200708 RGD in bone marrow; compared to MES/Slc
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0000231 hypertension susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0002067 abnormal sensory capabilities/reflexes/nociception susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20070306 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0002626 increased heart rate IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20070306 RGD compared to control strain WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 19990101 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0003917 increased kidney weight susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004050 abnormal renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:1578503|PMID:16239369 20070306 RGD compared to control strain WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004183 abnormal sympathetic nervous system physiology IAGP N RGD:2302408|PMID:19047583 20081217 RGD
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to restraint stress
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000307,XCO:0000310 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0005525 increased renal plasma flow rate induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery.
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0005530 decreased renal vascular resistance induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY.SHRSP-(D1Wox29-D1Arb21)/Izm with sham surgery
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0005665 increased circulating noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 19990101 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery.
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0030768 increased urine dopamine level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0030770 increased urine adrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
1302636 WKY.SHRSP-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress
1302638 LEXF11/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302641 LEXF1A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302645 DMY/Kyo demyelination rat strain MP:0006036 abnormal mitochondrial physiology IMP N RGD:12793070|PMID:21253565 20170320 RGD DNA:missense mutation:intron (Mrs2)
1302646 LEXF2C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302648 LEC/Hok Long Evans Cinnamon strain MP:0000611 jaundice IAGP N RGD:1302497|PMID:3429843 19990101 RGD
1302648 LEC/Hok Long Evans Cinnamon strain MP:0000611 jaundice IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0001263 weight loss IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0002083 premature death IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0002628 hepatic steatosis IAGP N RGD:25823147|PMID:2022751 20200501 RGD
1302648 LEC/Hok Long Evans Cinnamon strain MP:0002941 increased circulating alanine transaminase level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP N RGD:15036817|PMID:8291609 20191120 RGD
1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP N RGD:25823154|PMID:1561010 20200501 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0003674 oxidative stress IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0005343 increased circulating aspartate transaminase level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0005344 increased circulating bilirubin level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0006349 decreased circulating copper level IAGP N RGD:25823147|PMID:2022751 20200501 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0012612 decreased ceruloplasmin level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok
1302648 LEC/Hok Long Evans Cinnamon strain MP:0012661 decreased circulating ceruloplasmin level IAGP N RGD:25823154|PMID:1561010 20200501 RGD compared to LEA/Hok
1302649 LEXF7B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302649 LEXF7B/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302652 LEXF7A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302653 LEXF8A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0001262 decreased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0005668 decreased circulating leptin level IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0009299 decreased mesenteric fat pad weight induced IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0009305 decreased retroperitoneal fat pad weight induced IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0011940 decreased food intake IAGP N RGD:1643009|PMID:17710484 20201119 RGD compared to F344/Slc
1302654 F344.OLETF-(<i>D7Mgh16-D7Mgh20</i>)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0001393 ataxia IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type
1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0002880 opisthotonus IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type
1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0003996 clonic seizures IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type
1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type
1302660 RCS/Kyo royal college of surgeons rat strain MP:0005201 abnormal retina pigment epithelium morphology treatment IAGP XCO:0000529 N RGD:69668|PMID:11592982 20200313 RGD
1302660 RCS/Kyo royal college of surgeons rat strain MP:0008450 retina photoreceptor degeneration treatment IAGP XCO:0000529 N RGD:69668|PMID:11592982 20200313 RGD
1302660 RCS/Kyo royal college of surgeons rat strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:69668|PMID:11592982 20190802 RGD
1302661 F344.OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0001260 increased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1302661 F344.OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0001262 decreased body weight IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc;
1302661 F344.OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1302661 F344.OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302661 F344.OLETF-(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1302663 F344.OLETF-(<i>D11Rat4-D11Rat1</i>)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
1302663 F344.OLETF-(<i>D11Rat4-D11Rat1</i>)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
1302666 LEXF1C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302667 F344.OLETF-(<i>D5Mgh5-D5Mgh23</i>)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
1302674 VF/Kyo vacuole formation rat strain MP:0000745 tremors IAGP N RGD:1302449|PMID:12012723 19990101 RGD
1302674 VF/Kyo vacuole formation rat strain MP:0008025 brain vacuoles IAGP N RGD:40818080|PMID:24863653 20201110 RGD
1302674 VF/Kyo vacuole formation rat strain MP:0013438 dysmyelination IAGP N RGD:40818080|PMID:24863653 20201110 RGD
1302675 WKY.SHRSP-(<I>D1Smu13-D1Smu11</I>)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress
1302678 NAR/Slc non albumin rat strain MP:0005419 decreased circulating serum albumin level susceptibility IAGP N RGD:126781840|PMID:451621 20210421 RGD
1302686 F344/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200712 RGD
1302689 WKY.SHRSP-(<I>Ntrk3-D1Smu13</I>)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress
1302695 SER/Kyo spontaneously epileptic rat strain MP:0000745 tremors susceptibility IAGP N RGD:1302445|PMID:3559168 20200923 RGD compared to heterozygous rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0000947 convulsive seizures IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0002064 seizures susceptibility IAGP N RGD:1302445|PMID:3559168 20200923 RGD compared to heterozygous rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0002826 tonic seizures IAGP N RGD:1600256|PMID:17326796 20070306 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0002826 tonic seizures treatment IAGP N RGD:39128157|PMID:16146430 20200923 RGD
1302695 SER/Kyo spontaneously epileptic rat strain MP:0003216 absence seizures IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0003216 absence seizures treatment IAGP N RGD:39128157|PMID:16146430 20200923 RGD
1302695 SER/Kyo spontaneously epileptic rat strain MP:0003471 abnormal summary potential threshold IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0004231 abnormal calcium ion homeostasis IAGP N RGD:1600256|PMID:17326796 20070306 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0011269 increased excitatory postsynaptic current amplitude IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats
1302695 SER/Kyo spontaneously epileptic rat strain MP:0011274 short excitatory postsynaptic current decay time IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats
1302698 SDR/Slc Spontaneous dwarf rat strain MP:0005136 decreased growth hormone level IAGP N RGD:1578505|PMID:2752987 20170504 RGD
1302698 SDR/Slc Spontaneous dwarf rat strain MP:0005138 decreased prolactin level IAGP N RGD:1578505|PMID:2752987 20170504 RGD
1302699 LEXF8D/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302699 LEXF8D/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302700 HOB/Snk hobble rat strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170412 RGD
1302702 TRM/Kyo tremor rat strain MP:0000410 waved hair IAGP N RGD:13602102|PMID:4018151 20180605 RGD
1302702 TRM/Kyo tremor rat strain MP:0000745 tremors susceptibility IAGP N RGD:11060746|PMID:25970616 20200910 RGD compared to TRMR/Kyo and WTC/Kyo
1302702 TRM/Kyo tremor rat strain MP:0001116 small gonad IAGP N RGD:13602102|PMID:4018151 20180605 RGD
1302702 TRM/Kyo tremor rat strain MP:0001274 curly vibrissae IAGP N RGD:13602102|PMID:4018151 20180605 RGD
1302702 TRM/Kyo tremor rat strain MP:0001930 abnormal meiosis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated
1302702 TRM/Kyo tremor rat strain MP:0003216 absence seizures IAGP N RGD:13602101|PMID:3104669 20090209 RGD
1302702 TRM/Kyo tremor rat strain MP:0004852 decreased testis weight treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated
1302702 TRM/Kyo tremor rat strain MP:0008025 brain vacuoles IAGP N RGD:13602102|PMID:4018151 20090209 RGD
1302702 TRM/Kyo tremor rat strain MP:0008279 arrest of spermiogenesis IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated
1302702 TRM/Kyo tremor rat strain MP:0013236 ovary degeneration treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated
1302702 TRM/Kyo tremor rat strain MP:0031396 abnormal aspartoacylase level IAGP N RGD:628404|PMID:10820213 20220531 RGD compared to WTC
1302707 LEXF3/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302707 LEXF3/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302710 LEXF2B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
1302711 ExHC/Seac strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000025 N RGD:2300117|PMID:18753676 20100217 RGD
1302713 F344.OLETF-(<i>D8Rat58-D8Mgh17</i>)/Tj strain MP:0005559 increased circulating glucose level IAGP N RGD:2300331|PMID:18421176 20080912 RGD heterozygous genotype at the Niddm21 locus
1302713 F344.OLETF-(<i>D8Rat58-D8Mgh17</i>)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
1302721 LEC/Tj strain MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20191119 RGD
1302721 LEC/Tj strain MP:0008076 abnormal CD4-positive T cell differentiation IAGP N RGD:15036800|PMID:17434290 20090211 RGD
1302721 LEC/Tj strain MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20191119 RGD
1302723 LEXF5/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
1302727 SHRSR/Ta strain MP:0002833 increased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to WKY
1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction:
1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0005011 increased eosinophil cell number IAGP N RGD:5134988|PMID:21512270 20110711 RGD compared to BN/SsN
1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD
1302786 Kidm8 Kidney mass QTL 8 qtl MP:0003068 enlarged kidney QTM N RGD:629573|PMID:9097967 19990101 RGD
1302786 Kidm8 Kidney mass QTL 8 qtl MP:0005565 increased blood urea nitrogen level QTM N RGD:629573|PMID:9097967 19990101 RGD
1302787 Stl25 Serum triglyceride level QTL 25 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302787 Stl25 Serum triglyceride level QTL 25 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302788 Scl19 Serum cholesterol QTL 19 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302789 Stl26 Serum triglyceride level QTL 26 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302790 Scl20 Serum cholesterol level QTL 20 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302791 Stl29 Serum triglyceride level QTL 29 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:1299960|PMID:14709677 20121002 RGD
1302791 Stl29 Serum triglyceride level QTL 29 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302792 Scl21 Serum cholesterol level QTL 21 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302793 Bw16 Body weight QTL 16 qtl MP:0001260 increased body weight IAGP N RGD:1299960|PMID:14709677 19990101 RGD
1302794 Stl27 Serum triglyceride level QTL 27 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD
1302795 HTG Prague hypertriglyceridemic strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to HTG females, LEW females
1302795 HTG Prague hypertriglyceridemic strain MP:0001262 decreased body weight IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW
1302795 HTG Prague hypertriglyceridemic strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub
1302795 HTG Prague hypertriglyceridemic strain MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub
1302795 HTG Prague hypertriglyceridemic strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to LEW females
1302795 HTG Prague hypertriglyceridemic strain MP:0005292 improved glucose tolerance IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0005331 insulin resistance IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0005662 increased circulating adrenaline level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0005665 increased circulating noradrenaline level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub
1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to HTG females, LEW males
1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to LEW
1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEWCub
1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar
1302795 HTG Prague hypertriglyceridemic strain MP:0006353 increased glycosylated hemoglobin level IAGP N RGD:1342424|PMID:1513201 20200421 RGD compared to Wistar
1302921 F344-Tg(NPHS2-HBEGF)Wig strain MP:0002962 increased urine protein level induced IMP XCO:0000736 N RGD:1556472|PMID:16107576 20200908 RGD
1302921 F344-Tg(NPHS2-HBEGF)Wig strain MP:0011753 decreased podocyte number induced IMP XCO:0000736 N RGD:1556472|PMID:16107576 20200908 RGD
1303024 Krt83 keratin 83 gene MP:0002073 abnormal hair growth IAGP N RGD:2316553|PMID:18420582 20100216 RGD DNA:deletion
1303393 LEC/Ncu strain MP:0003992 increased mortality induced by ionizing radiation IAGP N RGD:69702|PMID:11003700 19990101 RGD compared to BN/Sea
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type and heterozygous
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD
1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type
1304773 Cop1 COP1, E3 ubiquitin ligase gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD
1304773 Cop1 COP1, E3 ubiquitin ligase gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD
1304916 Optc opticin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD
1304916 Optc opticin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD
1305304 Etnk2 ethanolamine kinase 2 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1305304 Etnk2 ethanolamine kinase 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
1305369 Nkx3-1 NK3 homeobox 1 gene MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
1305369 Nkx3-1 NK3 homeobox 1 gene MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0002834 decreased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0002963 decreased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0006317 decreased urine sodium level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0011471 decreased urine creatinine level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD
1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD
1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD
1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0020162 decreased susceptibility to virus induced diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD
1305534 Dop1a DOP1 leucine zipper like protein A gene MP:0008025 brain vacuoles IAGP N RGD:40818080|PMID:24863653 20201110 RGD
1305534 Dop1a DOP1 leucine zipper like protein A gene MP:0013438 dysmyelination IAGP N RGD:40818080|PMID:24863653 20201110 RGD
1305588 Rag2 recombination activating 2 gene MP:0000692 small spleen IMP N RGD:38508903|PMID:30206106 20200821 RGD
1305588 Rag2 recombination activating 2 gene MP:0002021 increased incidence of induced tumors induced IMP N RGD:38508903|PMID:30206106 20200821 RGD XCO:0000709
1305588 Rag2 recombination activating 2 gene MP:0004956 decreased thymus weight IMP N RGD:38508903|PMID:30206106 20200821 RGD
1305588 Rag2 recombination activating 2 gene MP:0005092 decreased double-positive T cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD
1305588 Rag2 recombination activating 2 gene MP:0008044 increased NK cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD
1305588 Rag2 recombination activating 2 gene MP:0008212 absent mature B cells IMP N RGD:38508903|PMID:30206106 20200821 RGD
1305646 Chit1 chitinase 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1305646 Chit1 chitinase 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1305652 Mkx mohawk homeobox gene MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305652 Mkx mohawk homeobox gene MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305652 Mkx mohawk homeobox gene MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305652 Mkx mohawk homeobox gene MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305652 Mkx mohawk homeobox gene MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305652 Mkx mohawk homeobox gene MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar
1305769 Pink1 PTEN induced kinase 1 gene MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
1305769 Pink1 PTEN induced kinase 1 gene MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
1305769 Pink1 PTEN induced kinase 1 gene MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
1305769 Pink1 PTEN induced kinase 1 gene MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
1306212 Tmem163 transmembrane protein 163 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306361 Ube3a ubiquitin protein ligase E3A gene MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210422 RGD
1306374 Eml1 EMAP like 1 gene MP:0000790 abnormal stratification in cerebral cortex IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0000947 convulsive seizures IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0003232 abnormal forebrain development IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0008547 abnormal neocortex morphology IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0008840 abnormal spike wave discharge IAGP N RGD:407985868|PMID:32179177 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0011380 enlarged brain ventricles IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0011724 ectopic cortical neuron IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306374 Eml1 EMAP like 1 gene MP:0020581 abnormal neuron polarity IAGP N RGD:597538480|PMID:9236234 20250213 RGD
1306897 Nek8 NIMA-related kinase 8 gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210304 RGD compared to control Lewis
1307076 Cntnap2 contactin associated protein 2 gene MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210422 RGD in males
1307076 Cntnap2 contactin associated protein 2 gene MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210422 RGD
1307076 Cntnap2 contactin associated protein 2 gene MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20201210 RGD
1307076 Cntnap2 contactin associated protein 2 gene MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210422 RGD
1307076 Cntnap2 contactin associated protein 2 gene MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20201210 RGD
1307076 Cntnap2 contactin associated protein 2 gene MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210422 RGD worsens with age
1307076 Cntnap2 contactin associated protein 2 gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210422 RGD peak amplitudes and transmission latency
1307076 Cntnap2 contactin associated protein 2 gene MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20201210 RGD
1307076 Cntnap2 contactin associated protein 2 gene MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210422 RGD in young animals
1307090 Sbf1 SET binding factor 1 gene MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat)
1307090 Sbf1 SET binding factor 1 gene MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat)
1307090 Sbf1 SET binding factor 1 gene MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat)
1307090 Sbf1 SET binding factor 1 gene MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat)
1307204 Epha2 Eph receptor A2 gene MP:0003711 pathological neovascularization IDA N RGD:1580975|PMID:16359662 20061031 RGD
1307272 Zeb2 zinc finger E-box binding homeobox 2 gene MP:0002183 gliosis IMP N RGD:155882542|PMID:34852714 20230130 RGD
1307272 Zeb2 zinc finger E-box binding homeobox 2 gene MP:0003354 astrocytosis IMP N RGD:155882542|PMID:34852714 20230130 RGD
1307404 Serpinc1 serpin family C member 1 gene MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20180119 RGD
1307427 Rbm20 RNA binding motif protein 20 gene MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210518 RGD
1307488 Cntrob centrobin, centriole duplication and spindle assembly protein gene MP:0000565 oligodactyly IAGP N RGD:150521555|PMID:19710508 20211111 RGD DNA:insertion:intron 10 (rat)
1307511 Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon1:no homozygous knockout embryos found at implantation stage
1307511 Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 gene MP:0002962 increased urine protein level IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon1:heterozygous 107 bp deletion
1307646 Lpin1 lipin 1 gene MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20200909 RGD
1307646 Lpin1 lipin 1 gene MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20200909 RGD
1307646 Lpin1 lipin 1 gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20200909 RGD
1307646 Lpin1 lipin 1 gene MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20200909 RGD
1307646 Lpin1 lipin 1 gene MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20200909 RGD
1307992 Ptpn22 protein tyrosine phosphatase, non-receptor type 22 gene MP:0001559 hyperglycemia IAGP N RGD:9835029|PMID:25505293 20160906 RGD
1307992 Ptpn22 protein tyrosine phosphatase, non-receptor type 22 gene MP:0001759 increased urine glucose level IAGP N RGD:9835029|PMID:25505293 20160906 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD
1307994 Myh7b myosin heavy chain 7B gene MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001262 decreased body weight IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001426 polydipsia IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001759 increased urine glucose level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001762 polyuria IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002871 albuminuria IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002900 abnormal urine phosphate level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002962 increased urine protein level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0003504 thyroid gland inflammation IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0003917 increased kidney weight IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005060 accumulation of giant lysosomes in kidney/renal tubule cells IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005441 increased urine calcium level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005471 decreased thyroxine level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005544 cornea deposits IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005553 increased circulating creatinine level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005558 decreased creatinine clearance IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005565 increased blood urea nitrogen level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0010110 abnormal renal phosphate reabsorption IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0010932 increased trabecular bone connectivity density IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011346 renal tubule atrophy IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011368 increased kidney apoptosis IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011467 decreased urine urea nitrogen level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011471 decreased urine creatinine level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011555 increased urine microglobulin level IMP N RGD:155630629|PMID:35695380 20230221 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20210805 RGD compared to wild type
1308518 Ngly1 N-glycanase 1 gene MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001489 decreased startle reflex IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308518 Ngly1 N-glycanase 1 gene MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20201013 RGD
1308873 Ano3 anoctamin 3 gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:9681745|PMID:23872594 20141208 RGD
1308873 Ano3 anoctamin 3 gene MP:0003998 decreased thermal nociceptive threshold IMP N RGD:9681745|PMID:23872594 20141208 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0000694 spleen hypoplasia IMP N RGD:8696027|PMID:22981234 20170608 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20211111 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001262 decreased body weight IMP N RGD:8696027|PMID:22981234 20170608 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001823 thymus hypoplasia IMP N RGD:8696027|PMID:22981234 20170608 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0002460 decreased immunoglobulin level IMP N RGD:8696027|PMID:22981234 20170608 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20211111 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20211111 RGD
1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20211111 RGD
1309305 Slc39a12 solute carrier family 39 member 12 gene MP:0004013 decreased pulmonary artery pressure IMP N RGD:10401832|PMID:26258299 20200130 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210206 RGD
1309329 Lrp5 LDL receptor related protein 5 gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD
1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:9587793|PMID:22326221 20171101 RGD
1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0020447 decreased NAD(P)H oxidase activity IMP N RGD:9587793|PMID:22326221 20171101 RGD
1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
1309674 Sox13 SRY-box transcription factor 13 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1309674 Sox13 SRY-box transcription factor 13 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20201210 RGD compared to male knockout
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20201210 RGD compared to female knockout
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction sexual_dimorphism IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005333 decreased heart rate sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006265 increased pulse pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
1309912 Fcgr1a Fc gamma receptor 1A gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:127338469|PMID:32510872 20210707 RGD
1309912 Fcgr1a Fc gamma receptor 1A gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:127338469|PMID:32510872 20210707 RGD
1309918 Rnaset2 ribonuclease T2 gene MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD
1309918 Rnaset2 ribonuclease T2 gene MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD
1309927 Wwox WW domain-containing oxidoreductase gene MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202
1309927 Wwox WW domain-containing oxidoreductase gene MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202
1309927 Wwox WW domain-containing oxidoreductase gene MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202
1309927 Wwox WW domain-containing oxidoreductase gene MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309927 Wwox WW domain-containing oxidoreductase gene MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes
1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD
1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD
1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD
1309952 Mthfr methylenetetrahydrofolate reductase gene MP:0002833 increased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1309952 Mthfr methylenetetrahydrofolate reductase gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:2312639|PMID:19423552 20100408 RGD DNA:polymorphism
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD
1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD
1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD
1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD
1310537 Ipo9 importin 9 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1310537 Ipo9 importin 9 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:14985214|PMID:24935944 20191009 RGD
1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14985214|PMID:24935944 20191009 RGD
1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20191105 RGD
1311039 Pde6b phosphodiesterase 6B gene MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311039 Pde6b phosphodiesterase 6B gene MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311039 Pde6b phosphodiesterase 6B gene MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311039 Pde6b phosphodiesterase 6B gene MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311039 Pde6b phosphodiesterase 6B gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311039 Pde6b phosphodiesterase 6B gene MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
1311139 Aire autoimmune regulator gene MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311139 Aire autoimmune regulator gene MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD
1311212 Il36rn interleukin 36 receptor antagonist gene MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD
1311212 Il36rn interleukin 36 receptor antagonist gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD
1311212 Il36rn interleukin 36 receptor antagonist gene MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD
1311212 Il36rn interleukin 36 receptor antagonist gene MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD
1311212 Il36rn interleukin 36 receptor antagonist gene MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210525 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0001698 decreased embryo size treatment IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0008762 embryonic lethality IMP N RGD:11573213|PMID:26873552 20200921 RGD
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD
1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD
1311872 Twf1 twinfilin actin-binding protein 1 gene MP:0020428 abnormal conditioned place aversion behavior IMP N RGD:596938166|PMID:33963280 20250106 RGD
1311872 Twf1 twinfilin actin-binding protein 1 gene MP:0020507 increased dendritic spine density IMP N RGD:596938166|PMID:33963280 20250106 RGD
13204704 W-<i>Myo7a<sup>tnd</sup></i>/Hubr Wistar tornado rat strain MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204704 W-<i>Myo7a<sup>tnd</sup></i>/Hubr Wistar tornado rat strain MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204704 W-<i>Myo7a<sup>tnd</sup></i>/Hubr Wistar tornado rat strain MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204704 W-<i>Myo7a<sup>tnd</sup></i>/Hubr Wistar tornado rat strain MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204704 W-<i>Myo7a<sup>tnd</sup></i>/Hubr Wistar tornado rat strain MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204705 Myo7a<sup>tnd</sup>/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204705 Myo7a<sup>tnd</sup>/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204705 Myo7a<sup>tnd</sup>/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204705 Myo7a<sup>tnd</sup>/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204705 Myo7a<sup>tnd</sup>/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
13204831 Cit<sup>fhJjlo</sup> citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD
13204831 Cit<sup>fhJjlo</sup> citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD
13204831 Cit<sup>fhJjlo</sup> citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20180501 RGD
13208518 SD-<i>Nfe2l2<sup>em1Mcwi-/-</sup></i> SD-<i>Nfe2l2<sup>em1Mcwi-</sup></i>/Nfe2l2<sup>em1Mcwi-</sup></i> strain MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20170913 RGD compared to SD
13209000 Cyba<sup>mesSdi</sup> cytochrome b-245 alpha chain;mutant 1,Sdi gene MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction:
13209000 Cyba<sup>mesSdi</sup> cytochrome b-245 alpha chain;mutant 1,Sdi gene MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction:
1331720 Rf43 Renal function QTL 43 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331721 Bp210 Blood pressure QTL 210 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331721 Bp210 Blood pressure QTL 210 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331722 Thshl1 Thyroid stimulating hormone level QTL 1 qtl MP:0005122 increased circulating thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD
1331723 Bw25 Body weight QTL 25 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331724 Bp223 Blood pressure QTL 223 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331725 Bp212 Blood pressure QTL 212 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331726 Bp208 Blood pressure QTL 208 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331726 Bp208 Blood pressure QTL 208 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331727 Bp237 Blood pressure QTL 237 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331728 Bp214 Blood pressure QTL 214 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331729 Rf42 Renal function QTL 42 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331729 Rf42 Renal function QTL 42 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331730 Scl27 Serum cholesterol level QTL 27 qtl MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331731 Bp216 Blood pressure QTL 216 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331732 Srn4 Serum renin concentration QTL 4 qtl MP:0003352 increased circulating renin level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331733 Bp233 Blood pressure QTL 233 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331734 Bp204 Blood pressure QTL 204 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331735 Rf44 Renal function QTL 44 qtl MP:0002962 increased urine protein level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331736 Bp227 Blood pressure QTL 227 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331737 Uae29 Urinary albumin excretion QTL 29 qtl MP:0002962 increased urine protein level IAGP N RGD:1300043|PMID:15161966 19990101 RGD
1331738 Bp209 Blood pressure QTL 209 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331739 Hrtrt14 Heart rate QTL 14 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331739 Hrtrt14 Heart rate QTL 14 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331740 Bw26 Body weight QTL 26 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331740 Bw26 Body weight QTL 26 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331740 Bw26 Body weight QTL 26 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331741 Bp232 Blood pressure QTL 232 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331742 Bp228 Blood pressure QTL 228 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331743 Uae28 Urinary albumin excretion QTL 28 qtl MP:0002871 albuminuria IAGP N RGD:1300043|PMID:15161966 19990101 RGD
1331743 Uae28 Urinary albumin excretion QTL 28 qtl MP:0002962 increased urine protein level IDA N RGD:1300043|PMID:15161966 20120112 RGD
1331744 Bp217 Blood pressure QTL 217 qtl MP:0002962 increased urine protein level IDA N RGD:70849|PMID:11721057 20120112 RGD
1331744 Bp217 Blood pressure QTL 217 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331745 Bp203 Blood pressure QTL 203 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331745 Bp203 Blood pressure QTL 203 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331746 Kidm9 Kidney mass QTL 9 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331747 Hrtrt16 Heart rate QTL 16 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331748 Bp215 Blood pressure QTL 215 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331749 Hrtrt11 Heart rate QTL 11 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331750 Bp220 Blood pressure QTL 220 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331751 Bp199 Blood pressure QTL 199 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331752 Bw27 Body weight QTL 27 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331753 Bp231 Blood pressure QTL 231 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331754 Bp230 Blood pressure QTL 230 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331755 Bp219 Blood pressure QTL 219 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331756 Rf34 Renal function QTL 34 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331757 Cdexp1 CD45RC expression in CD8 T cells QTL 1 qtl MP:0005010 abnormal CD8-positive, alpha beta T cell morphology IAGP N RGD:1302824|PMID:15322174 19990101 RGD
1331758 Bp207 Blood pressure QTL 207 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331759 Hrtrt13 Heart rate QTL 13 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331759 Hrtrt13 Heart rate QTL 13 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331760 Bp206 Blood pressure QTL 206 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331761 Bp218 Blood pressure QTL 218 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331762 Rf40 Renal function QTL 40 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331763 Wbc2 White blood cell count QTL 2 qtl MP:0000218 increased leukocyte cell number IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331764 Bp205 Blood pressure QTL 205 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331765 Hrtrt15 Heart rate QTL 15 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331765 Hrtrt15 Heart rate QTL 15 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331766 Bp236 Blood pressure QTL 236 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331767 Hrtrt12 Heart rate QTL 12 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331768 Kidm10 Kidney mass QTL 10 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331769 Rf39 Renal function QTL 39 qtl MP:0001762 polyuria IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331770 Bp234 Blood pressure QTL 234 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331771 Rf35 Renal function QTL 35 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331772 Cdexp2 CD45RC expression in CD8 T cells QTL 2 qtl MP:0005010 abnormal CD8-positive, alpha beta T cell morphology IAGP N RGD:1302824|PMID:15322174 19990101 RGD
1331773 Scl26 Serum cholesterol level QTL 26 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331774 Bp226 Blood pressure QTL 226 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331775 Bp235 Blood pressure QTL 235 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331776 Bp225 Blood pressure QTL 225 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331777 Bw24 Body weight QTL 24 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331778 Rf28 Renal function QTL 28 qtl MP:0005619 increased urine potassium level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331779 Rf38 Renal function QTL 38 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331779 Rf38 Renal function QTL 38 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331780 Bp238 Blood pressure QTL 238 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331781 Scl28 Serum cholesterol level QTL 28 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331782 Rf36 Renal function QTL 36 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331783 Bp221 Blood pressure QTL 221 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331783 Bp221 Blood pressure QTL 221 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331784 Bp222 Blood pressure QTL 222 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331786 Kidm11 Kidney mass QTL 11 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331786 Kidm11 Kidney mass QTL 11 qtl MP:0003917 increased kidney weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331787 Rf41 Renal function QTL 41 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331788 Rf45 Renal function QTL 45 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331789 Rf37 Renal function QTL 37 qtl MP:0001761 abnormal urination pattern IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331789 Rf37 Renal function QTL 37 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331790 Bp201 Blood pressure QTL 201 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331791 Cm31 Cardiac mass QTL 31 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331791 Cm31 Cardiac mass QTL 31 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331792 Rf29 Renal function QTL 29 qtl MP:0005619 increased urine potassium level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331793 Bp200 Blood pressure QTL 200 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331794 Bp202 Blood pressure QTL 202 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331795 Rf30 Renal function QTL 30 qtl MP:0002987 abnormal urine osmolality IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331795 Rf30 Renal function QTL 30 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:70849|PMID:11721057 20120112 RGD
1331796 Thshl2 Thyroid stimulating hormone level QTL 2 qtl MP:0005122 increased circulating thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD
1331797 Bp213 Blood pressure QTL 213 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331798 Bp224 Blood pressure QTL 224 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331799 Bp211 Blood pressure QTL 211 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331800 Scl25 Serum cholesterol level QTL 25 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331801 Rf33 Renal function QTL 33 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331801 Rf33 Renal function QTL 33 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331802 Srn5 Serum renin concentration QTL 5 qtl MP:0003349 abnormal circulating renin level IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331803 Rf32 Renal function QTL 32 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331803 Rf32 Renal function QTL 32 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331804 Cm30 Cardiac mass QTL 30 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331804 Cm30 Cardiac mass QTL 30 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331805 Cm29 Cardiac mass QTL 29 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331806 Bp229 Blood pressure QTL 229 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331807 Rf31 Renal function QTL 31 qtl MP:0002987 abnormal urine osmolality IAGP N RGD:70849|PMID:11721057 19990101 RGD
1331807 Rf31 Renal function QTL 31 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:70849|PMID:11721057 20120112 RGD
1331815 LEW/Mol LEW/Mol strain MP:0003917 increased kidney weight sexual_dimorphism IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female
1331816 DA.ACI-(<i>D10Rat2-D10Rat29</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini
1331816 DA.ACI-(<i>D10Rat2-D10Rat29</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302800|PMID:11486278 20200430 RGD compared to DA/ZtmKini
1331824 DA.ACI-(<i>D10Rat219-D10Rat29</i>) strain MP:0009763 increased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini
1331828 DA.ACI-(<i>D10Rat12-D10Rat144</i>) strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini
1331830 F344.BN-(<i>D5Rat1-D5Mit5</i>)/Dlw strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD
1331830 F344.BN-(<i>D5Rat1-D5Mit5</i>)/Dlw strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD
1331833 DA.ACI-(<i>D10Rat15-D10Rat29</i>) strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini
1331833 DA.ACI-(<i>D10Rat15-D10Rat29</i>) strain MP:0009763 increased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini
1331837 Bw23 Body weight QTL 23 qtl MP:0001260 increased body weight IAGP N RGD:1300044|PMID:15164172 19990101 RGD
1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1300044|PMID:15164172 19990101 RGD
1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 qtl MP:0003058 increased insulin secretion IAGP N RGD:1300044|PMID:15164172 19990101 RGD
1331839 Eae18b Experimental allergic encephalomyelitis QTL 18b qtl MP:0000753 paralysis QTM N RGD:1302437|PMID:15240732 19990101 RGD
1332593 Or9r3b olfactory receptor family 9 subfamily R member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332594 Or2f1 olfactory receptor family 2 subfamily F member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332597 Or8g37c olfactory receptor family 8 subfamily G member 37C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332598 Or10a5 olfactory receptor family 10 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332599 Or52n2b olfactory receptor family 52 subfamily N member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332600 Or4c117b olfactory receptor family 4 subfamily C member 117B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332601 Or4d2 olfactory receptor family 4 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332602 Or4f61b olfactory receptor family 4 subfamily F member 61B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332603 Or2t48e olfactory receptor family 2 subfamily T member 48E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332604 Or10ag52b olfactory receptor family 10 subfamily AG member 52B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332606 Or13c7d olfactory receptor family 13 subfamily C member 7D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332608 Or5h27b olfactory receptor family 5 subfamily H member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332610 Or4l1 olfactory receptor family 4 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332612 Or13c3 olfactory receptor family 13 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332615 Or2t48d olfactory receptor family 2 subfamily T member 48D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332619 Or8k31 olfactory receptor family 8 subfamily K member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332620 Or10c1 olfactory receptor family 10 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332621 Or4d10 olfactory receptor family 4 subfamily D member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332623 Or12d2b olfactory receptor family 12 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332626 Or4k45 olfactory receptor family 4 subfamily K member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332628 Or14j3e olfactory receptor family 14 subfamily J member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332629 Or1j12 olfactory receptor family 1 subfamily J member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332630 Or51l4 olfactory receptor family 51 subfamily L member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332631 Or6d12b olfactory receptor family 6 subfamily D member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332632 Or6c216 olfactory receptor family 6 subfamily C member 216 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332633 Or11g27 olfactory receptor family 11 subfamily G member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332634 Or2n1e olfactory receptor family 2 subfamily N member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332635 Or4a71 olfactory receptor family 4 subfamily A member 71 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332636 Or5m10 olfactory receptor family 5 subfamily M member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332637 Or5aq6 olfactory receptor family 5 subfamily AQ member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332638 Or52n2e olfactory receptor family 52 subfamily N member 2E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332639 Or8g51 olfactory receptor family 8 subfamily G member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332640 Or4p20b olfactory receptor family 4 subfamily P member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332641 Or51g2 olfactory receptor family 51 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332642 Or11g26b olfactory receptor family 11 subfamily G member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332643 Or6c66b olfactory receptor family 6 subfamily C member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332644 Or13a27b olfactory receptor family 13 subfamily A member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332645 Or5p56 olfactory receptor family 5 subfamily P member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332647 Or5m9 olfactory receptor family 5 subfamily M member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332648 Or10j27 olfactory receptor family 10 subfamily J member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332650 Or5be3 olfactory receptor family 5 subfamily BE member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332651 Or1o11b olfactory receptor family 1 subfamily O member 11B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332652 Or2n1n olfactory receptor family 2 subfamily N member 1N gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332654 Or5b105 olfactory receptor family 5 subfamily B member 105 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332655 Or4c58 olfactory receptor family 4 subfamily C member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332657 Or10ag59 olfactory receptor family 10 subfamily AG member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332659 Or52ae8b olfactory receptor family 52 subfamily AE member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332662 Or8c13 olfactory receptor family 8 subfamily C member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332664 Or14c43 olfactory receptor family 14 subfamily C member 43 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332666 Or8b44b olfactory receptor family 8 subfamily B member 44B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332669 Or11n2 olfactory receptor family 11 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332670 Or2t47 olfactory receptor family 2 subfamily T member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332671 Or1f19 olfactory receptor family 1 subfamily F member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332672 Or6k4 olfactory receptor family 6 subfamily K member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332673 Olr1102 olfactory receptor 1102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332674 Or8k3 olfactory receptor family 8 subfamily K member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332675 Or5p76b olfactory receptor family 5 subfamily P member 76B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332681 Or8b12c olfactory receptor family 8 subfamily B member 12C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332682 Or1j1 olfactory receptor family 1 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332683 Or6k14b olfactory receptor family 6 subfamily K member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332684 Or13e8 olfactory receptor family 13 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332685 Or1a1 olfactory receptor family 1 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332686 Or5w8b olfactory receptor family 5 subfamily W member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332687 Or56a3b olfactory receptor family 56 subfamily A member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332688 Or2t29 olfactory receptor family 2 subfamily T member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332689 Or8b43 olfactory receptor family 8 subfamily B member 43 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332690 Or2ak4c olfactory receptor family 2 subfamily AK member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332691 Or1o11 olfactory receptor family 1 subfamily O member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332692 Or4p20 olfactory receptor family 4 subfamily P member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332693 Or8g2 olfactory receptor family 8 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332695 Or8h10c olfactory receptor family 8 subfamily H member 10C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332696 Or4a77b olfactory receptor family 4 subfamily A member 77B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332697 Or2n1k olfactory receptor family 2 subfamily N member 1K gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332698 Or8d6 olfactory receptor family 8 subfamily D member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332701 Or2n1g olfactory receptor family 2 subfamily N member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332702 Or6c7 olfactory receptor family 6 subfamily C member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332704 Or5ak25 olfactory receptor family 5 subfamily AK member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332706 Olr1433 olfactory receptor 1433 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332707 Or4c104 olfactory receptor family 4 subfamily C member 104 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332708 Or2ak6c olfactory receptor family 2 subfamily AK member 6C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332714 Or8c15b olfactory receptor family 8 subfamily C member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332715 Or7g41 olfactory receptor family 7 subfamily G member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332716 Or2a25 olfactory receptor family 2 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332717 Or6c207 olfactory receptor family 6 subfamily C member 207 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332718 Olr220 olfactory receptor 220 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332720 Olr716 olfactory receptor 716 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332721 Or52j3b olfactory receptor family 52 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332722 Or2y16 olfactory receptor family 2 subfamily Y member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332723 Or4c112b olfactory receptor family 4 subfamily C member 112B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332725 Or2h2c olfactory receptor family 2 subfamily H member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332726 Or8g20b olfactory receptor family 8 subfamily G member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332727 Or8b55 olfactory receptor family 8 subfamily B member 55 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332728 Or8c18 olfactory receptor family 8 subfamily C member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332732 Or6c33 olfactory receptor family 6 subfamily C member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332733 Or14j3d olfactory receptor family 14 subfamily J member 3D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332734 Or4f6 olfactory receptor family 4 subfamily F member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332735 Or8a1 olfactory receptor family 8 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332737 Or9a4 olfactory receptor family 9 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332740 Or7a44 olfactory receptor family 7 subfamily A member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332741 Or2ag17 olfactory receptor family 2 subfamily AG member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332742 Or7d11c olfactory receptor family 7 subfamily D member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332743 Or5p60b olfactory receptor family 5 subfamily P member 60B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332744 Or8g23 olfactory receptor family 8 subfamily G member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332745 Or5m11 olfactory receptor family 5 subfamily M member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332746 Or6b2 olfactory receptor family 6 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332747 Or13c7c olfactory receptor family 13 subfamily C member 7C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332749 Or4k77 olfactory receptor family 4 subfamily K member 77 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332754 Or13a26c olfactory receptor family 13 subfamily A member 26C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332756 Or1e22 olfactory receptor family 1 subfamily E member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332757 Or1e31 olfactory receptor family 1 subfamily E member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332758 Or12k7b olfactory receptor family 12 subfamily K member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332759 Or2p2 olfactory receptor family 2 subfamily P member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332760 Or52e5 olfactory receptor family 52 subfamily E member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332761 Or6z7 olfactory receptor family 6 subfamily Z member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332763 Or14j5b olfactory receptor family 14 subfamily J member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332764 Or13f5l1 olfactory receptor family 13 subfamily F member 5 like 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332765 Or10d5jl olfactory receptor family 10 subfamily D member 5J like gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332767 Or51i2 olfactory receptor family 51 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332768 Or14a257 olfactory receptor family 14 subfamily A member 257 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332769 Or5p76 olfactory receptor family 5 subfamily P member 76 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332770 Or5al7 olfactory receptor family 5 subfamily AL member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332771 Or6z1 olfactory receptor family 6 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332772 Or4f61d olfactory receptor family 4 subfamily F member 61D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332773 Or51f2 olfactory receptor family 51 subfamily F member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332774 Or2ak6b olfactory receptor family 2 subfamily AK member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332775 Or6c74 olfactory receptor family 6 subfamily C member 74 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332776 Or52l1 olfactory receptor family 52 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332777 Or10ag59b olfactory receptor family 10 subfamily AG member 59B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332780 Or52e4 olfactory receptor family 52 subfamily E member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332781 Or5p6 olfactory receptor family 5 subfamily P member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332782 Or2b4 olfactory receptor family 2 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332783 Or4x6 olfactory receptor family 4 subfamily X member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332786 Or1f33 olfactory receptor family 1 subfamily F member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332788 Or8g20e olfactory receptor family 8 subfamily G member 20E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332789 Or56a5 olfactory receptor family 56 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332791 Or10d1b olfactory receptor family 10 subfamily D member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332792 Or2y1e olfactory receptor family 2 subfamily Y member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332793 Or1f21c olfactory receptor family 1 subfamily F member 21C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332794 Or1x2d olfactory receptor family 1 subfamily X member 2D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332795 Or8k27 olfactory receptor family 8 subfamily K member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332799 Or4c124b olfactory receptor family 4 subfamily C member 124B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332801 Or4x5 olfactory receptor family 4 subfamily X member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332804 Or1p1e olfactory receptor family 1 subfamily P member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332806 Or2y11 olfactory receptor family 2 subfamily Y member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332807 Or4k49 olfactory receptor family 4 subfamily K member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332808 Or10j7 olfactory receptor family 10 subfamily J member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332809 Or9e1 olfactory receptor family 9 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332810 Or6c69 olfactory receptor family 6 subfamily C member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332811 Or4c117 olfactory receptor family 4 subfamily C member 117 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332812 Or5b116 olfactory receptor family 5 subfamily B member 116 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332813 Or5p69b olfactory receptor family 5 subfamily P member 69B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332815 Or52r1c olfactory receptor family 52 subfamily R member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332816 Olr1563 olfactory receptor 1563 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332818 Or6d13 olfactory receptor family 6 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332819 Or5ap2b olfactory receptor family 5 subfamily AP member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332820 Or9g20 olfactory receptor family 9 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332822 Or4a15b olfactory receptor family 4 subfamily A member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332823 Or8b12d olfactory receptor family 8 subfamily B member 12D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332824 Or6c35f olfactory receptor family 6 subfamily C member 35F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332825 Or1l4b olfactory receptor family 1 subfamily L member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332827 Or10d4 olfactory receptor family 10 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332829 Or8k23 olfactory receptor family 8 subfamily K member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332833 Or51e1 olfactory receptor family 51 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332834 Or4c11 olfactory receptor family 4 subfamily C member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332835 Or2ak4 olfactory receptor family 2 subfamily AK member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332836 Or8b101c olfactory receptor family 8 subfamily B member 101C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332841 Or52e7 olfactory receptor family 52 subfamily E member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332842 Or4c108b olfactory receptor family 4 subfamily C member 108B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332843 Or1x2 olfactory receptor family 1 subfamily X member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332844 Or1e28 olfactory receptor family 1 subfamily E member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332845 Or13p9 olfactory receptor family 13 subfamily P member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332846 Or2ag2 olfactory receptor family 2 subfamily AG member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332847 Or5h17 olfactory receptor family 5 subfamily H member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332848 Or7g16 olfactory receptor family 7 subfamily G member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332849 Or4a66b olfactory receptor family 4 subfamily A member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332850 Or4k52 olfactory receptor family 4 subfamily K member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332851 Or1e20b olfactory receptor family 1 subfamily E member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332860 Or4k51 olfactory receptor family 4 subfamily K member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332862 Or1f20 olfactory receptor family 1 subfamily F member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332863 Or4d5 olfactory receptor family 4 subfamily D member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332867 Olr1092 olfactory receptor 1092 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332868 Or4f59 olfactory receptor family 4 subfamily F member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332869 Or10am5 olfactory receptor family 10 subfamily AM member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332870 Or10d4b olfactory receptor family 10 subfamily D member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332871 Or52n4e olfactory receptor family 52 subfamily N member 4E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332872 Or2a51 olfactory receptor family 2 subfamily A member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332873 Or7e174 olfactory receptor family 7 subfamily E member 174 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332874 Or8b1d olfactory receptor family 8 subfamily B member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332875 Or6d12c olfactory receptor family 6 subfamily D member 12C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332876 Or2h2 olfactory receptor family 2 subfamily H member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332880 Or6c215 olfactory receptor family 6 subfamily C member 215 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332881 Or8g2c olfactory receptor family 8 subfamily G member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332882 Or2ag1 olfactory receptor family 2 subfamily AG member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332883 Or6c202f olfactory receptor family 6 subfamily C member 202F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332884 Or8g34 olfactory receptor family 8 subfamily G member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332887 Olr193 olfactory receptor 193 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332888 Olr943 olfactory receptor 943 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332889 Or51f1f olfactory receptor family 51 subfamily F member 1F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332890 Or6c3d olfactory receptor family 6 subfamily C member 3D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332891 Or6c203l1 olfactory receptor family 6 subfamily C member 203 like 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332892 Or5d37 olfactory receptor family 5 subfamily D member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332893 Or10ak7 olfactory receptor family 10 subfamily AK member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332894 Or51ah3 olfactory receptor family 51 subfamily AH member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332901 Olr385 olfactory receptor 385 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332902 Or13n4b olfactory receptor family 13 subfamily N member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332903 Or52n2 olfactory receptor family 52 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332905 Or14n1 olfactory receptor family 14 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332907 Or5ak4 olfactory receptor family 5 subfamily AK member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332908 Or6c33b olfactory receptor family 6 subfamily C member 33B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332909 Or10p1 olfactory receptor family 10 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332910 Or6c8 olfactory receptor family 6 subfamily C member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332911 Or8k30b olfactory receptor family 8 subfamily K member 30B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332916 Or1j13b olfactory receptor family 1 subfamily J member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332919 Or4f52 olfactory receptor family 4 subfamily F member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332920 Or2k2 olfactory receptor family 2 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332921 Or10ak7f olfactory receptor family 10 subfamily AK member 7F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332922 Or5aq1b olfactory receptor family 5 subfamily AQ member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332924 Or5ac23b olfactory receptor family 5 subfamily AC member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332925 Or1f19e olfactory receptor family 1 subfamily F member 19E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332926 Or8u10 olfactory receptor family 8 subfamily U member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332928 Or5p72 olfactory receptor family 5 subfamily P member 72 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332929 Or14a260 olfactory receptor family 14 subfamily A member 260 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332930 Olr1520 olfactory receptor 1520 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332931 Or51k1 olfactory receptor family 51 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332933 Or13c3g olfactory receptor family 13 subfamily C member 3G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332937 Or5w20 olfactory receptor family 5 subfamily W member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332939 Or52h7 olfactory receptor family 52 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332940 Or5g27 olfactory receptor family 5 subfamily G member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332941 Or4p18b olfactory receptor family 4 subfamily P member 18B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332942 Or5w13 olfactory receptor family 5 subfamily W member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332943 Or2ak5f olfactory receptor family 2 subfamily AK member 5F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332944 Or1l4 olfactory receptor family 1 subfamily L member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332945 Or2ak5d olfactory receptor family 2 subfamily AK member 5D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332947 Or4c3e olfactory receptor family 4 subfamily C member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332948 Or5af1 olfactory receptor family 5 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332950 Or5p78 olfactory receptor family 5 subfamily P member 78 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332951 Or5d14 olfactory receptor family 5 subfamily D member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332952 Or4c31e olfactory receptor family 4 subfamily C member 31E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332953 Or51f5 olfactory receptor family 51 subfamily F member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332954 Or52u1 olfactory receptor family 52 subfamily U member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332955 Or1j15 olfactory receptor family 1 subfamily J member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332956 Or4c31c olfactory receptor family 4 subfamily C member 31C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332957 Or13a27c olfactory receptor family 13 subfamily A member 27C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332958 Or52b2 olfactory receptor family 52 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332964 Or4g7 olfactory receptor family 4 subfamily G member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332965 Or5k3 olfactory receptor family 5 subfamily K member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332966 Or5h17b olfactory receptor family 5 subfamily H member 17B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332967 Or8u3 olfactory receptor family 8 subfamily U member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332969 Or1f30 olfactory receptor family 1 subfamily F member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332970 Or6c6h olfactory receptor family 6 subfamily C member 6H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332971 Or52e19 olfactory receptor family 52 subfamily E member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332974 Or8b57 olfactory receptor family 8 subfamily B member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332976 Or6c212 olfactory receptor family 6 subfamily C member 212 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332977 Olr703 olfactory receptor 703 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332978 Olr995 olfactory receptor 995 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332979 Or5d40 olfactory receptor family 5 subfamily D member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332980 Or51b4b olfactory receptor family 51 subfamily B member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332981 Olr1471 olfactory receptor 1471 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332982 Or2at1 olfactory receptor family 2 subfamily AT member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332984 Or52ac1 olfactory receptor family 52 subfamily AC member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332985 Or56b2k olfactory receptor family 56 subfamily B member 2K gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332986 Or6p1 olfactory receptor family 6 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332988 Or8b51 olfactory receptor family 8 subfamily B member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332991 Or5m3 olfactory receptor family 5 subfamily M member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332992 Or7e173d olfactory receptor family 7 subfamily E member 173D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332993 Or4p8 olfactory receptor family 4 subfamily P member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332994 Or6k14 olfactory receptor family 6 subfamily K member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332995 Or5h17c olfactory receptor family 5 subfamily H member 17C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332997 Or4a77c olfactory receptor family 4 subfamily A member 77C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1332998 Or7g35 olfactory receptor family 7 subfamily G member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333000 Or11a4 olfactory receptor family 11 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333004 Or8g18e olfactory receptor family 8 subfamily G member 18E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333008 Or52a5b olfactory receptor family 52 subfamily A member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333009 Or8c10b olfactory receptor family 8 subfamily C member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333011 Or2a20 olfactory receptor family 2 subfamily A member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333012 Or1e16 olfactory receptor family 1 subfamily E member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333013 Olr1428 olfactory receptor 1428 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333014 Or6c1 olfactory receptor family 6 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333015 Or5a3 olfactory receptor family 5 subfamily A member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333016 Or10g1 olfactory receptor family 10 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333017 Or1e21b olfactory receptor family 1 subfamily E member 21B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333018 Or8s8 olfactory receptor family 8 subfamily S member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333019 Or12e13b olfactory receptor family 12 subfamily E member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333020 Or7g26b olfactory receptor family 7 subfamily G member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333021 Or1m1 olfactory receptor family 1 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333022 Or6c68 olfactory receptor family 6 subfamily C member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333023 Or11i1 olfactory receptor family 11 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333024 Or2v2 olfactory receptor family 2 subfamily V member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333026 Or6b6 olfactory receptor family 6 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333028 Or52k2 olfactory receptor family 52 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333030 Or9i16 olfactory receptor family 9 subfamily I member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333031 Or7g12 olfactory receptor family 7 subfamily G member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333032 Or13a18c olfactory receptor family 13 subfamily A member 18C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333035 Or7g34 olfactory receptor family 7 subfamily G member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333036 Or2av10 olfactory receptor family 2 subfamily AV member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333038 Or10ag52 olfactory receptor family 10 subfamily AG member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333039 Or10g9 olfactory receptor family 10 subfamily G member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333041 Or8b51b olfactory receptor family 8 subfamily B member 51B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333042 Or4c114 olfactory receptor family 4 subfamily C member 114 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333044 Or7a38b olfactory receptor family 7 subfamily A member 38B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333045 Or10q12 olfactory receptor family 10 subfamily Q member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333046 Or8h7b olfactory receptor family 8 subfamily H member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333047 Or6d13c olfactory receptor family 6 subfamily D member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333048 Or6d12 olfactory receptor family 6 subfamily D member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333049 Or8w1b olfactory receptor family 8 subfamily W member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333050 Or10q1 olfactory receptor family 10 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333051 Or2ak4e olfactory receptor family 2 subfamily AK member 4E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333052 Or4c31 olfactory receptor family 4 subfamily C member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333053 Or4p22d olfactory receptor family 4 subfamily P member 22D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333055 Or9k2 olfactory receptor family 9 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333057 Or14c39b olfactory receptor family 14 subfamily C member 39B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333058 Or1r1 olfactory receptor family 1 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333059 Or8b1 olfactory receptor family 8 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333060 Or12d2c olfactory receptor family 12 subfamily D member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333061 Or2t47e olfactory receptor family 2 subfamily T member 47E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333063 Or4p18 olfactory receptor family 4 subfamily P member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333064 Olr1523 olfactory receptor 1523 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333066 Or8k39 olfactory receptor family 8 subfamily K member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333067 Or4f14e olfactory receptor family 4 subfamily F member 14E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333068 Olr1564 olfactory receptor 1564 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333069 Or5w14 olfactory receptor family 5 subfamily W member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333070 Or9s14 olfactory receptor family 9 subfamily S member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333072 Olr1049 olfactory receptor 1049 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333073 Or5h18 olfactory receptor family 5 subfamily H member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333074 Or10d4c olfactory receptor family 10 subfamily D member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333075 Or2d36b olfactory receptor family 2 subfamily D member 36B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333076 Olr1093 olfactory receptor 1093 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333078 Or7h7 olfactory receptor family 7 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333079 Or11m3 olfactory receptor family 11 subfamily M member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333080 Olr1143 olfactory receptor 1143 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333081 Or5ac22 olfactory receptor family 5 subfamily AC member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333082 Or1j4 olfactory receptor family 1 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333084 Or1j15b olfactory receptor family 1 subfamily J member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333085 Or9e1b olfactory receptor family 9 subfamily E member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333086 Or5ap2 olfactory receptor family 5 subfamily AP member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333088 Or1e26b olfactory receptor family 1 subfamily E member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333089 Or4a80 olfactory receptor family 4 subfamily A member 80 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333092 Or5w16 olfactory receptor family 5 subfamily W member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333093 Or6z5 olfactory receptor family 6 subfamily Z member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333097 Or1j22 olfactory receptor family 1 subfamily J member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333098 Or2a14 olfactory receptor family 2 subfamily A member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333100 Or2y1h olfactory receptor family 2 subfamily Y member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333102 Or5m5 olfactory receptor family 5 subfamily M member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333103 Or1n2 olfactory receptor family 1 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333104 Or6c203c olfactory receptor family 6 subfamily C member 203C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333105 Or4a73 olfactory receptor family 4 subfamily A member 73 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333109 Or2ad1 olfactory receptor family 2 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333111 Or7d12 olfactory receptor family 7 subfamily D member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333113 Or10ak7e olfactory receptor family 10 subfamily AK member 7E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333115 Or6c3b olfactory receptor family 6 subfamily C member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333116 Or10k2 olfactory receptor family 10 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333119 Or4a77 olfactory receptor family 4 subfamily A member 77 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333121 Or8b37 olfactory receptor family 8 subfamily B member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333123 Or10al6 olfactory receptor family 10 subfamily AL member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333124 Or13a18 olfactory receptor family 13 subfamily A member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333125 Or5b24 olfactory receptor family 5 subfamily B member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333126 Or4d10c olfactory receptor family 4 subfamily D member 10C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333127 Or14j1 olfactory receptor family 14 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333128 Or5g24 olfactory receptor family 5 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333129 Or8k20 olfactory receptor family 8 subfamily K member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333133 Or13c3e olfactory receptor family 13 subfamily C member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333134 Or10d5b olfactory receptor family 10 subfamily D member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333136 Or4f53b olfactory receptor family 4 subfamily F member 53B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333138 Or12d14c olfactory receptor family 12 subfamily D member 14C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333139 Or5c1 olfactory receptor family 5 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333140 Or4a47 olfactory receptor family 4 subfamily A member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333141 Or52a5 olfactory receptor family 52 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333142 Or8b4 olfactory receptor family 8 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333144 Or5ak24 olfactory receptor family 5 subfamily AK member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333145 Or10d1g olfactory receptor family 10 subfamily D member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333146 Or3a1f olfactory receptor family 3 subfamily A member 1F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333149 Or1f28 olfactory receptor family 1 subfamily F member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333150 Or4z4 olfactory receptor family 4 subfamily Z member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333151 Or11g2 olfactory receptor family 11 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333156 Or10a49 olfactory receptor family 10 subfamily A member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333157 Or52e15c olfactory receptor family 52 subfamily E member 15C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333158 Or52s1 olfactory receptor family 52 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333161 Or51s1 olfactory receptor family 51 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333164 Or8b101 olfactory receptor family 8 subfamily B member 101 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333165 Or5w12 olfactory receptor family 5 subfamily W member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333167 Or52n4c olfactory receptor family 52 subfamily N member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333171 Or6d15b olfactory receptor family 6 subfamily D member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333172 Or4a2 olfactory receptor family 4 subfamily A member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333174 Or5p1 olfactory receptor family 5 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333175 Or8g4 olfactory receptor family 8 subfamily G member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333176 Or52s1b olfactory receptor family 52 subfamily S member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333177 Or2j3 olfactory receptor family 2 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333178 Or1e35b olfactory receptor family 1 subfamily E member 35B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333181 Or9i2 olfactory receptor family 9 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333182 Olr1088 olfactory receptor 1088 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333183 Or8s10 olfactory receptor family 8 subfamily S member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333184 Or10x1 olfactory receptor family 10 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333185 Or12j2 olfactory receptor family 12 subfamily J member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333186 Or14j5e olfactory receptor family 14 subfamily J member 5E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333188 Or2r3 olfactory receptor family 2 subfamily R member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333189 Or4a78 olfactory receptor family 4 subfamily A member 78 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333191 Or2g1 olfactory receptor family 2 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333192 Or10al5b olfactory receptor family 10 subfamily AL member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333194 Or6c211 olfactory receptor family 6 subfamily C member 211 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333195 Or8g36b olfactory receptor family 8 subfamily G member 36B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333196 Or6c3 olfactory receptor family 6 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333198 Or6c214 olfactory receptor family 6 subfamily C member 214 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333199 Or12j3 olfactory receptor family 12 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333201 Or52n4 olfactory receptor family 52 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333203 Or6e1 olfactory receptor family 6 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333205 Or13a25 olfactory receptor family 13 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333207 Or52e3 olfactory receptor family 52 subfamily E member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333209 Or1j20 olfactory receptor family 1 subfamily J member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333211 Or13p5 olfactory receptor family 13 subfamily P member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333212 Or1f26 olfactory receptor family 1 subfamily F member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333213 Or8b50 olfactory receptor family 8 subfamily B member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333214 Or8c16c olfactory receptor family 8 subfamily C member 16C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333217 Or8g50b olfactory receptor family 8 subfamily G member 50B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333218 Or51f23c olfactory receptor family 51 subfamily F member 23C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333219 Or5bb12 olfactory receptor family 5 subfamily BB member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333221 Or6ae1 olfactory receptor family 6 subfamily A member E1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333222 Or5t7 olfactory receptor family 5 subfamily T member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333223 Or52s6 olfactory receptor family 52 subfamily S member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333224 Or12e7 olfactory receptor family 12 subfamily E member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333225 Or8w1 olfactory receptor family 8 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333226 Or7c19 olfactory receptor family 7 subfamily C member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333227 Or56b6 olfactory receptor family 56 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333228 Or51f4 olfactory receptor family 51 subfamily F member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333229 Or52b1 olfactory receptor family 52 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333231 Or5h24b olfactory receptor family 5 subfamily H member 24B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333235 Or12e8 olfactory receptor family 12 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333237 Or5w15 olfactory receptor family 5 subfamily W member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333238 Or5an10 olfactory receptor family 5 subfamily AN member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333239 Or5h26b olfactory receptor family 5 subfamily H member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333240 Or51a25 olfactory receptor family 51 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333241 Or10al4b olfactory receptor family 10 subfamily AL member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333242 Or11g24 olfactory receptor family 11 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333243 Or6c69d olfactory receptor family 6 subfamily C member 69D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333245 Or2av9 olfactory receptor family 2 subfamily AV member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333246 Or8h10 olfactory receptor family 8 subfamily H member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333247 Or8g26 olfactory receptor family 8 subfamily G member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333249 Or10n1 olfactory receptor family 10 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333250 Or5b116b olfactory receptor family 5 subfamily B member 116B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333251 Or1f21b olfactory receptor family 1 subfamily F member 21B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333253 Or1e1e olfactory receptor family 1 subfamily E member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333254 Or4c127 olfactory receptor family 4 subfamily C member 127 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333255 Or5p66b olfactory receptor family 5 subfamily P member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333258 Or2m12 olfactory receptor family 2 subfamily M member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333259 Or8k40 olfactory receptor family 8 subfamily K member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333260 Or6c70 olfactory receptor family 6 subfamily C member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333263 Or52e18 olfactory receptor family 52 subfamily E member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333264 Or10ag2 olfactory receptor family 10 subfamily AG member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333265 Or8b1b olfactory receptor family 8 subfamily B member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333266 Or8g52b olfactory receptor family 8 subfamily G member 52B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333268 Or10ak14b olfactory receptor family 10 subfamily AK member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333269 Or11j4 olfactory receptor family 11 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333270 Or8c16 olfactory receptor family 8 subfamily C member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333276 Or10v1 olfactory receptor family 10 subfamily V member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333281 Or6aa1b olfactory receptor family 6 subfamily A member A1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333285 Or5j1 olfactory receptor family 5 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333287 Or6al1 olfactory receptor family 6 subfamily A member L1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333288 Or9i14 olfactory receptor family 9 subfamily I member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333289 Or10w1 olfactory receptor family 10 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333290 Or7r1 olfactory receptor family 7 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333293 Or52k1 olfactory receptor family 52 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333294 Or9s23b olfactory receptor family 9 subfamily S member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333297 Olr1585 olfactory receptor 1585 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333299 Or10s1 olfactory receptor family 10 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333300 Or2v2c olfactory receptor family 2 subfamily V member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333302 Or13a19b olfactory receptor family 13 subfamily A member 19B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333303 Or9i13 olfactory receptor family 9 subfamily I member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333305 Or4p22e olfactory receptor family 4 subfamily P member 22E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333306 Or7a36 olfactory receptor family 7 subfamily A member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333309 Or5ac23 olfactory receptor family 5 subfamily AC member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333310 Or5l13 olfactory receptor family 5 subfamily L member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333311 Or2h1 olfactory receptor family 2 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333316 Or52z12 olfactory receptor family 52 subfamily Z member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333318 Or11h4c olfactory receptor family 11 subfamily H member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333319 Or8s2 olfactory receptor family 8 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333320 Or52d3 olfactory receptor family 52 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333321 Or13c3c olfactory receptor family 13 subfamily C member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333323 Or5b96 olfactory receptor family 5 subfamily B member 96 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333325 Olr36 olfactory receptor 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333326 Or4f58 olfactory receptor family 4 subfamily F member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333328 Or5an6 olfactory receptor family 5 subfamily AN member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333329 Or8g20 olfactory receptor family 8 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333331 Or10ak7b olfactory receptor family 5 subfamily AK member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333332 Or1af1 olfactory receptor family 1 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333333 Or1b1 olfactory receptor family 1 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333334 Or7g25 olfactory receptor family 7 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333335 Or4f7c olfactory receptor family 4 subfamily F member 7C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333336 Or5p50 olfactory receptor family 5 subfamily P member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333343 Or5g25 olfactory receptor family 5 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333345 Or9s23 olfactory receptor family 9 subfamily S member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333346 Or5aq1d olfactory receptor family 5 subfamily AQ member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333347 Or5h25b olfactory receptor family 5 subfamily H member 25B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333349 Or8h9 olfactory receptor family 8 subfamily H member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333350 Or4c1 olfactory receptor family 4 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333353 Or13a26 olfactory receptor family 13 subfamily A member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333354 Or4c103b olfactory receptor family 4 subfamily C member 103B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333356 Or55b4 olfactory receptor family 55 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333358 Or6b13 olfactory receptor family 6 subfamily B member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333360 Or8g52 olfactory receptor family 8 subfamily G member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333361 Or6c75 olfactory receptor family 6 subfamily C member 75 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333362 Or2l13 olfactory receptor family 2 subfamily L member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333363 Olr1057 olfactory receptor 1057 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333365 Or8k1 olfactory receptor family 8 subfamily K member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333366 Or5b106 olfactory receptor family 5 subfamily B member 106 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333367 Or6b1 olfactory receptor family 6 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333368 Or6s1 olfactory receptor family 6 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333369 Or5ac25 olfactory receptor family 5 subfamily AC member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333370 Or4c102 olfactory receptor family 4 subfamily C member 102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333371 Or51b6 olfactory receptor family 51 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333372 Or13a23 olfactory receptor family 13 subfamily A member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333374 Or13c7 olfactory receptor family 13 subfamily C member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333377 Or51a25b olfactory receptor family 51 subfamily A member 25B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333379 Or51a42 olfactory receptor family 51 subfamily A member 42 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333381 Or10ac1 olfactory receptor family 10 subfamily AC member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333383 Or5au1 olfactory receptor family 5 subfamily AU member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333384 Or13c3f olfactory receptor family 13 subfamily C member 3F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333385 Or7g26 olfactory receptor family 7 subfamily G member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333387 Or14a257c olfactory receptor family 14 subfamily A member 257C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333390 Or52e5b olfactory receptor family 52 subfamily E member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333391 Or10g9b olfactory receptor family 10 subfamily G member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333392 Or8b46b olfactory receptor family 8 subfamily B member 46B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333393 Or4m1 olfactory receptor family 4 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333394 Or51b17 olfactory receptor family 51 subfamily B member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333395 Or2h1b olfactory receptor family 2 subfamily H member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333397 Olr1214 olfactory receptor 1214 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333398 Or13c25 olfactory receptor family 13 subfamily C member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333399 Or7g23c olfactory receptor family 7 subfamily G member 23C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333400 Or5m8 olfactory receptor family 5 subfamily M member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333402 Or2y1g olfactory receptor family 2 subfamily Y member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333403 Or8b53b olfactory receptor family 8 subfamily B member 53B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333406 Or8b101b olfactory receptor family 8 subfamily B member 101B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333407 Olr387 olfactory receptor 387 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333409 Or14j15 olfactory receptor family 14 subfamily J member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333410 Or8h7 olfactory receptor family 8 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333411 Or12k5 olfactory receptor family 12 subfamily K member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333415 Or4c103 olfactory receptor family 4 subfamily C member 103 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333416 Or51v14 olfactory receptor family 51 subfamily V member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333417 Or4c99 olfactory receptor family 4 subfamily C member 99 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333418 Or1j10 olfactory receptor family 1 subfamily J member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333419 Or2y15 olfactory receptor family 2 subfamily Y member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333420 Or5d41 olfactory receptor family 5 subfamily D member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333421 Or5p5b olfactory receptor family 5 subfamily P member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333422 Or2t48 olfactory receptor family 2 subfamily T member 48 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333423 Or5b107 olfactory receptor family 5 subfamily B member 107 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333424 Or52s19 olfactory receptor family 52 subfamily S member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333425 Or9s18 olfactory receptor family 9 subfamily S member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333427 Or10g1b olfactory receptor family 10 subfamily G member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333428 Olr35 olfactory receptor 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333430 Or4c122 olfactory receptor family 4 subfamily C member 122 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333431 Or8g36c olfactory receptor family 8 subfamily G member 36C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333434 Or7a35 olfactory receptor family 7 subfamily A member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333435 Or52ae7 olfactory receptor family 52 subfamily AE member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333436 Or8b46c olfactory receptor family 8 subfamily B member 46C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333437 Or5t9b olfactory receptor family 5 subfamily T member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333439 Or4s2 olfactory receptor family 4 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333440 Or2y1 olfactory receptor family 2 subfamily Y member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333441 Or5p66 olfactory receptor family 5 subfamily P member 66 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333442 Or1j8b olfactory receptor family 1 subfamily J member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333443 Or2d4 olfactory receptor family 2 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333444 Or52h2 olfactory receptor family 52 subfamily H member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333445 Olr5 olfactory receptor 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333448 Or10j3b olfactory receptor family 10 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333449 Or5h27 olfactory receptor family 5 subfamily H member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333452 Or56b2b olfactory receptor family 56 subfamily B member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333453 Olr1610 olfactory receptor 1610 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333455 Or8j3 olfactory receptor family 8 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333456 Or4p4 olfactory receptor family 4 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333461 Or4x13 olfactory receptor family 4 subfamily X member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333462 Or6c202 olfactory receptor family 6 subfamily C member 202 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333463 Olr1537 olfactory receptor 1537 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333465 Olr1675 olfactory receptor 1675 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333466 Or7g33c olfactory receptor family 7 subfamily G member 33C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333467 Or1j13 olfactory receptor family 1 subfamily J member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333468 Olr951 olfactory receptor 951 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333472 Or8k16b olfactory receptor family 8 subfamily K member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333473 Or5d47 olfactory receptor family 5 subfamily D member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333475 Or5b102 olfactory receptor family 5 subfamily B member 102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333476 Or8b46 olfactory receptor family 8 subfamily B member 46 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333477 Or5b123b olfactory receptor family 5 subfamily B member 123B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333478 Or8g36 olfactory receptor family 8 subfamily G member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333480 Or4a15 olfactory receptor family 4 subfamily A member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333481 Or51k7 olfactory receptor family 51 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333482 Or1p1 olfactory receptor family 1 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333483 Or5b123 olfactory receptor family 5 subfamily B member 123 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333485 Or9s14b olfactory receptor family 9 subfamily S member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333486 Or51l14 olfactory receptor family 51 subfamily L member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333489 Or9s15 olfactory receptor family 9 subfamily S member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333491 Or4f47 olfactory receptor family 4 subfamily F member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333492 Or8b52 olfactory receptor family 8 subfamily B member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333493 Or4x11 olfactory receptor family 4 subfamily X member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333494 Or8s5 olfactory receptor family 8 subfamily S member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333496 Or1l8 olfactory receptor family 1 subfamily L member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333498 Or5ak22 olfactory receptor family 5 subfamily AK member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333499 Or4f14 olfactory receptor family 4 subfamily F member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333500 Or2d2 olfactory receptor family 2 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333502 Or2n1 olfactory receptor family 2 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333503 Or4e5 olfactory receptor family 4 subfamily E member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333504 Or13m2 olfactory receptor family 13 subfamily M member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333506 Or14j5c olfactory receptor family 14 subfamily J member 5C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333510 Or4p19 olfactory receptor family 4 subfamily P member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333511 Or6c213f olfactory receptor family 6 subfamily C member 213F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333512 Or8c20 olfactory receptor family 8 subfamily C member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333513 Or13a27d olfactory receptor family 13 subfamily A member 27D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333514 Or51r1 olfactory receptor family 51 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333516 Or10u3 olfactory receptor family 10 subfamily U member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333517 Or1e27 olfactory receptor family 1 subfamily E member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333520 Or8b3c olfactory receptor family 8 subfamily B member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333521 Or4k42b olfactory receptor family 4 subfamily K member 42B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333522 Or6b9 olfactory receptor family 6 subfamily B member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333525 Or8b59 olfactory receptor family 8 subfamily B member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333526 Or4k48 olfactory receptor family 4 subfamily K member 48 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333528 Or5k16 olfactory receptor family 5 subfamily K member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333529 Or4k1 olfactory receptor family 4 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333531 Or52p2 olfactory receptor family 52 subfamily P member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333532 Or51l1 olfactory receptor family 51 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333536 Or1j13c olfactory receptor family 1 subfamily J member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333537 Or5m13b olfactory receptor family 5 subfamily M member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333538 Or5w19 olfactory receptor family 5 subfamily W member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333539 Or7g18 olfactory receptor family 7 subfamily G member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333543 Olr1090 olfactory receptor 1090 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333545 Or4k37 olfactory receptor family 4 subfamily K member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333546 Or52ae9 olfactory receptor family 52 subfamily AE member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333547 Or52m1 olfactory receptor family 52 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333548 Or10p22 olfactory receptor family 10 subfamily P member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333549 Or6c69b olfactory receptor family 6 subfamily C member 69B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333550 Or5g28 olfactory receptor family 5 subfamily G member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333551 Or13c9 olfactory receptor family 13 subfamily C member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333552 Or9g19 olfactory receptor family 9 subfamily G member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333556 Or5m10b olfactory receptor family 5 subfamily M member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333557 Olr920 olfactory receptor 920 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333560 Or52z13 olfactory receptor family 52 subfamily Z member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333561 Or8g26c olfactory receptor family 8 subfamily G member 26C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333562 Or4c123 olfactory receptor family 4 subfamily C member 123 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333563 Or6c208b olfactory receptor family 6 subfamily C member 208B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333565 Or10h1d olfactory receptor family 10 subfamily H member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333568 Or1o2 olfactory receptor family 1 subfamily O member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333569 Olr908 olfactory receptor 908 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333571 Or2y1c olfactory receptor family 2 subfamily Y member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333574 Or11h4 olfactory receptor family 11 subfamily H member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333575 Or5a21 olfactory receptor family 5 subfamily A member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333576 Or52ab4 olfactory receptor family 52 subfamily AB member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333577 Or13a27 olfactory receptor family 13 subfamily A member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333578 Or4n4 olfactory receptor family 4 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333581 Or1f29 olfactory receptor family 1 subfamily F member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333582 Or6c206 olfactory receptor family 6 subfamily C member 206 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333584 Or13g1 olfactory receptor family 13 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333585 Or1e33 olfactory receptor family 1 subfamily E member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333588 Or4f14f olfactory receptor family 4 subfamily F member 14F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333590 Or1e16d olfactory receptor family 1 subfamily E member 16D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333592 Or7g20 olfactory receptor family 7 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333594 Or4a77e olfactory receptor family 4 subfamily A member 77E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333595 Or9q2 olfactory receptor family 9 subfamily Q member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333596 Or1ad5 olfactory receptor family 1 subfamily AD member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333597 Or6n2 olfactory receptor family 6 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333598 Or5g27b olfactory receptor family 5 subfamily G member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333601 Or4d6 olfactory receptor family 4 subfamily D member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333603 Or4a69 olfactory receptor family 4 subfamily A member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333604 Or4k35 olfactory receptor family 4 subfamily K member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333605 Or5p81 olfactory receptor family 5 subfamily P member 81 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333606 Or5w8 olfactory receptor family 5 subfamily W member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333608 Or1aa2 olfactory receptor family 1 subfamily AA member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333610 Or7e173 olfactory receptor family 7 subfamily E member 173 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333612 Or1e27b olfactory receptor family 1 subfamily E member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333615 Or9s27 olfactory receptor family 9 subfamily S member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333617 Or7e169 olfactory receptor family 7 subfamily E member 169 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333618 Or2n1j olfactory receptor family 2 subfamily N member 1J gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333619 Or5ac24 olfactory receptor family 5 subfamily AC member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333620 Or7a38e olfactory receptor family 7 subfamily A member 38E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333621 Or2d36 olfactory receptor family 2 subfamily D member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333622 Or2aj4 olfactory receptor family 1 subfamily O member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333623 Or5ar1 olfactory receptor family 5 subfamily AR member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333624 Or5g29 olfactory receptor family 5 subfamily G member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333625 Or5b99 olfactory receptor family 5 subfamily B member 99 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333626 Or5k17 olfactory receptor family 5 subfamily K member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333628 Or6d15 olfactory receptor family 6 subfamily D member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333629 Olr1720 olfactory receptor 1720 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333630 Or1f19f olfactory receptor family 1 subfamily F member 19F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333631 Or10h1 olfactory receptor family 10 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333633 Or5h25d olfactory receptor family 5 subfamily H member 25D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333635 Or6c219 olfactory receptor family 6 subfamily C member 219 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333636 Or2ag18 olfactory receptor family 2 subfamily AG member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333637 Or8b54c olfactory receptor family 8 subfamily B member 54C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333639 Or5p60c olfactory receptor family 5 subfamily P member 60C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333640 Or2t48b olfactory receptor family 2 subfamily T member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333641 Or4f6b olfactory receptor family 4 subfamily F member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333643 Or4c109b olfactory receptor family 4 subfamily C member 109B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333644 Or1e23 olfactory receptor family 1 subfamily E member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333645 Or5l14b olfactory receptor family 5 subfamily L member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333647 Or14a258 olfactory receptor family 14 subfamily A member 258 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333650 Or4c107 olfactory receptor family 4 subfamily C member 107 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333653 Or5t9 olfactory receptor family 5 subfamily T member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333654 Or4f4a olfactory receptor family 4 subfamily F member 4A gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333655 Or8h10b olfactory receptor family 8 subfamily H member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333656 Or1q1 olfactory receptor family 1 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333657 Or7a37 olfactory receptor family 7 subfamily A member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333658 Or7a41 olfactory receptor family 7 subfamily A member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333659 Or7g89 olfactory receptor family 7 subfamily G member 89 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333660 Or4c121 olfactory receptor family 4 subfamily C member 121 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333662 Or52r1 olfactory receptor family 52 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333663 Or8k32 olfactory receptor family 8 subfamily K member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333664 Or2ag19 olfactory receptor family 2 subfamily AG member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333665 Or7g31 olfactory receptor family 7 subfamily G member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333667 Or14j10b olfactory receptor family 14 subfamily J member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333668 Or10d3 olfactory receptor family 10 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333669 Or2ag13 olfactory receptor family 2 subfamily AG member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333670 Or6c63 olfactory receptor family 6 subfamily C member 63 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333671 Or5i1 olfactory receptor family 5 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333672 Or10j3 olfactory receptor family 10 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333673 Or10d5 olfactory receptor family 10 subfamily D member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333675 Or10x1b olfactory receptor family 10 subfamily X member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333677 Or2f1b olfactory receptor family 2 subfamily F member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333681 Or2w2 olfactory receptor family 2 subfamily W member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333682 Or9m1b olfactory receptor family 9 subfamily M member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333684 Olr1571 olfactory receptor 1571 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333686 Or10ag57 olfactory receptor family 10 subfamily AG member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333687 Or5d41b olfactory receptor family 5 subfamily D member 41B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333691 Or2ag2b olfactory receptor family 2 subfamily AG member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333692 Or9g10 olfactory receptor family 9 subfamily G member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333693 Or4c15b olfactory receptor family 4 subfamily C member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333696 Or2n1l olfactory receptor family 2 subfamily N member 1L gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333697 Or52e51 olfactory receptor family 52 subfamily E member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333698 Or8b42 olfactory receptor family 8 subfamily B member 42 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333700 Or6z3 olfactory receptor family 6 subfamily Z member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333701 Or8g37b olfactory receptor family 8 subfamily G member 37B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333702 Or10j5 olfactory receptor family 10 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333703 Or12e9 olfactory receptor family 12 subfamily E member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333707 Or51ac3 olfactory receptor family 51 subfamily AC member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333710 Olr936 olfactory receptor 936 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333711 Or1o1 olfactory receptor family 1 subfamily O member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333712 Or2l13c olfactory receptor family 2 subfamily L member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333714 Or2g25 olfactory receptor family 2 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333715 Or52h1 olfactory receptor family 52 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333720 Or51a41 olfactory receptor family 51 subfamily A member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333722 Or8b56 olfactory receptor family 8 subfamily B member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333724 Or13j1 olfactory receptor family 13 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333726 Or9r3 olfactory receptor family 9 subfamily R member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333728 Or5p69 olfactory receptor family 5 subfamily P member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333730 Or12j5 olfactory receptor family 12 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333732 Or2y12 olfactory receptor family 2 subfamily Y member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333734 Or8c19 olfactory receptor family 8 subfamily C member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333735 Or5k15 olfactory receptor family 5 subfamily K member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333736 Or2t47d olfactory receptor family 2 subfamily T member 47D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333738 Or1o2e olfactory receptor family 1 subfamily O member 2E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333739 Or8b54b olfactory receptor family 8 subfamily B member 54 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333740 Or8d4 olfactory receptor family 8 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333741 Or8g24 olfactory receptor family 8 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333742 Or12k8 olfactory receptor family 12 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333743 Olr1451 olfactory receptor 1451 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333744 Or4g16 olfactory receptor family 4 subfamily G member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333745 Or7g22 olfactory receptor family 7 subfamily G member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333746 Or4p22 olfactory receptor family 4 subfamily P member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333747 Or4a70 olfactory receptor family 4 subfamily A member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333748 Or4x11c olfactory receptor family 4 subfamily X member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333749 Or13p4 olfactory receptor family 13 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333751 Or2aj4b olfactory receptor family 2 subfamily AJ member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333752 Or10a3 olfactory receptor family 10 subfamily A member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333754 Or4b1 olfactory receptor family 4 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333756 Or4c116 olfactory receptor family 4 subfamily C member 116 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333757 Or56b2 olfactory receptor family 56 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333758 Or5w18 olfactory receptor family 5 subfamily W member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333760 Or5b100 olfactory receptor family 5 subfamily B member 100 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333761 Or7h7b olfactory receptor family 7 subfamily H member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333763 Or14c39 olfactory receptor family 14 subfamily C member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333764 Or8b44 olfactory receptor family 8 subfamily B member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333767 Or6al2 olfactory receptor family 6 subfamily A member L2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333768 Or8c10 olfactory receptor family 8 subfamily C member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333770 Or52e15b olfactory receptor family 52 subfamily E member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333771 Or52h9 olfactory receptor family 52 subfamily H member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333773 Or4c108 olfactory receptor family 4 subfamily C member 108 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333774 Or5al1 olfactory receptor family 5 subfamily AL member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333775 Or5h24 olfactory receptor family 5 subfamily H member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333777 Or2b11 olfactory receptor family 2 subfamily B member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333779 Or7g29 olfactory receptor family 7 subfamily G member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333781 Olr1633 olfactory receptor 1633 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333782 Or5w13b olfactory receptor family 5 subfamily W member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333783 Or4d2b olfactory receptor family 4 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333784 Or6k2 olfactory receptor family 6 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333788 Or8b47 olfactory receptor family 8 subfamily B member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333789 Or5aq1 olfactory receptor family 5 subfamily AQ member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333791 Or51ag1 olfactory receptor family 51 subfamily AG member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333793 Or6c35 olfactory receptor family 6 subfamily C member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333794 Or52s20 olfactory receptor family 52 subfamily S member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333795 Or4k44 olfactory receptor family 4 subfamily K member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333796 Or5a1 olfactory receptor family 5 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333797 Or9g4b olfactory receptor family 9 subfamily G member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333798 Or4c3 olfactory receptor family 4 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333800 Or7g25c olfactory receptor family 7 subfamily G member 25C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333801 Or7a38d olfactory receptor family 7 subfamily A member 38D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333803 Or8g28 olfactory receptor family 8 subfamily G member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333804 Or5k8 olfactory receptor family 5 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333806 Or51a7b olfactory receptor family 51 subfamily A member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333808 Olr673 olfactory receptor 673 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333809 Or14c40 olfactory receptor family 14 subfamily C member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333811 Or2r3b olfactory receptor family 2 subfamily R member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333812 Or1j12b olfactory receptor family 1 subfamily J member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333813 Or14j5 olfactory receptor family 14 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333814 Or6d13b olfactory receptor family 6 subfamily D member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333815 Or5m13 olfactory receptor family 5 subfamily M member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333816 Or51b4 olfactory receptor family 51 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333817 Or4c110 olfactory receptor family 4 subfamily C member 110 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333818 Or52n1b olfactory receptor family 52 subfamily N member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333819 Or8c17 olfactory receptor family 8 subfamily C member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333821 Or4f56 olfactory receptor family 4 subfamily F member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333823 Or5t18 olfactory receptor family 5 subfamily T member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333825 Or12e1 olfactory receptor family 12 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333826 Or7e169c olfactory receptor family 7 subfamily E member 169C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333828 Or13a19c olfactory receptor family 13 subfamily A member 19C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333829 Or4k48b olfactory receptor family 4 subfamily K member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333833 Or4c10b olfactory receptor family 4 subfamily C member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333835 Or52x1 olfactory receptor family 52 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333836 Or5aq7 olfactory receptor family 5 subfamily AQ member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333837 Or6c203 olfactory receptor family 6 subfamily C member 203 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333840 Or8g17d olfactory receptor family 8 subfamily G member 17D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333841 Or52n4d olfactory receptor family 52 subfamily N member 4D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333843 Or13p3 olfactory receptor family 13 subfamily P member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333844 Or6c35d olfactory receptor family 6 subfamily C member 35D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333845 Or1d2 olfactory receptor family 1 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333846 Or1x2b olfactory receptor family 1 subfamily X member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333847 Or6c202d olfactory receptor family 6 subfamily C member 202D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333848 Or9s13 olfactory receptor family 9 subfamily S member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333849 Or4k6 olfactory receptor family 4 subfamily K member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333851 Olr1177 olfactory receptor 1177 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333852 Olr1454 olfactory receptor 1454 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333853 Or5ac16 olfactory receptor family 5 subfamily AC member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333854 Or1e25 olfactory receptor family 1 subfamily E member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333856 Or1ad8 olfactory receptor family 1 subfamily AD member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333858 Or2y1i olfactory receptor family 2 subfamily Y member 1I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333859 Or8u9 olfactory receptor family 8 subfamily U member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333860 Or10d1 olfactory receptor family 10 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333861 Or51q1 olfactory receptor family 51 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333864 Or8b43b olfactory receptor family 8 subfamily B member 43B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333865 Or52ab2b olfactory receptor family 52 subfamily AB member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333866 Or2ag20 olfactory receptor family 2 subfamily AG member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333867 Or4f15 olfactory receptor family 4 subfamily F member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333870 Olr1198 olfactory receptor 1198 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333873 Or7g21 olfactory receptor family 7 subfamily G member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333874 Or52ae10 olfactory receptor family 52 subfamily AE member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333875 Or7a38 olfactory receptor family 7 subfamily A member 38 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333878 Or5af1b olfactory receptor family 5 subfamily AF member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333879 Or7g23 olfactory receptor family 7 subfamily G member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333881 Or52n1 olfactory receptor family 52 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333882 Or1j19 olfactory receptor family 1 subfamily J member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333884 Or8s16 olfactory receptor family 8 subfamily S member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333885 Or2ag16b olfactory receptor family 2 subfamily AG member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333886 Or1f32 olfactory receptor family 1 subfamily F member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333888 Or1s2 olfactory receptor family 1 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333892 Or3a1 olfactory receptor family 3 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333893 Or10u3b olfactory receptor family 10 subfamily U member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333894 Or8g30 olfactory receptor family 8 subfamily G member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333897 Or7g23e olfactory receptor family 7 subfamily G member 23E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333898 Or2ak5e olfactory receptor family 2 subfamily AK member 5E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333900 Or1j14 olfactory receptor family 1 subfamily J member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333901 Or5p78c olfactory receptor family 5 subfamily P member 78C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333902 Or13a1 olfactory receptor family 13 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333903 Or10g3c olfactory receptor family 10 subfamily G member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333904 Or4k50 olfactory receptor family 4 subfamily K member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333906 Or10z1 olfactory receptor family 10 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333908 Or8b45 olfactory receptor family 8 subfamily B member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333909 Or10a4 olfactory receptor family 10 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333910 Or5g9 olfactory receptor family 5 subfamily G member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333911 Or2ak5 olfactory receptor family 2 subfamily AK member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333912 Or5b104b olfactory receptor family 5 subfamily B member 104B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333913 Or4c112 olfactory receptor family 4 subfamily C member 112 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333914 Or1j21 olfactory receptor family 1 subfamily J member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333916 Or8j3b olfactory receptor family 8 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333918 Or8g50 olfactory receptor family 8 subfamily G member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333920 Or8b9 olfactory receptor family 8 subfamily B member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333922 Or5b124 olfactory receptor family 5 subfamily B member 124 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333923 Or12j4 olfactory receptor family 12 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333926 Or1f31 olfactory receptor family 1 subfamily F member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333927 Olr1400 olfactory receptor 1400 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333928 Or2ah1 olfactory receptor family 2 subfamily AH member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333929 Or5k14 olfactory receptor family 5 subfamily K member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333930 Or9i1b olfactory receptor family 9 subfamily I member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333931 Or13p10 olfactory receptor family 13 subfamily P member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333932 Or5as1 olfactory receptor family 5 subfamily AS member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333933 Olr1731 olfactory receptor 1731 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333934 Or52j3 olfactory receptor family 52 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333935 Or10ag54b olfactory receptor family 10 subfamily AG member 54B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333936 Or8b49 olfactory receptor family 8 subfamily B member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333938 Or2ak6e olfactory receptor family 2 subfamily AK member 6E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333940 Or1o2b olfactory receptor family 1 subfamily O member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333941 Or9k7 olfactory receptor family 9 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333942 Or2n1i olfactory receptor family 2 subfamily N member 1I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333944 Or12e14 olfactory receptor family 12 subfamily E member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333946 Or11g1 olfactory receptor family 11 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333947 Or2t35 olfactory receptor family 2 subfamily T member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333948 Or5aq7b olfactory receptor family 5 subfamily AQ member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333950 Or2f2 olfactory receptor family 2 subfamily F member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333951 Or4f60 olfactory receptor family 4 subfamily F member 60 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333952 Olr1481 olfactory receptor 1481 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333953 Or51a10 olfactory receptor family 51 subfamily A member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333955 Or52e8b olfactory receptor family 52 subfamily E member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333956 Or52ab2 olfactory receptor family 52 subfamily AB member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333957 Or6k6 olfactory receptor family 6 subfamily K member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333958 Or5p52 olfactory receptor family 5 subfamily P member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333960 Or1f21 olfactory receptor family 1 subfamily F member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333961 Or52ad1 olfactory receptor family 52 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333962 Or4c12 olfactory receptor family 4 subfamily C member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333964 Or4k2 olfactory receptor family 4 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333969 Or2aa1 olfactory receptor family 2 subfamily AA member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333970 Or6c6f olfactory receptor family 6 subfamily C member 6F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333972 Or52d1 olfactory receptor family 52 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333973 Or7e171d olfactory receptor family 7 subfamily E member 171D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333974 Or52n3 olfactory receptor family 52 subfamily N member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333975 Or2q1 olfactory receptor family 2 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333977 Or5p79 olfactory receptor family 5 subfamily P member 79 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333978 Or4c129 olfactory receptor family 4 subfamily C member 129 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333980 Or4k36 olfactory receptor family 4 subfamily K member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333981 Or7g23b olfactory receptor family 7 subfamily G member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333983 Or52d13 olfactory receptor family 52 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333985 Or4c15 olfactory receptor family 4 subfamily C member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333987 Or5an9 olfactory receptor family 5 subfamily AN member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333988 Or5t5 olfactory receptor family 5 subfamily T member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333989 Or1e1 olfactory receptor family 1 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333990 Or2t44b olfactory receptor family 2 subfamily T member 44B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333993 Or4c52 olfactory receptor family 4 subfamily C member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333994 Or2n1h olfactory receptor family 2 subfamily N member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333996 Or2w6 olfactory receptor family 2 subfamily W member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333997 Or51af1 olfactory receptor family 51 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333998 Or6aa1 olfactory receptor family 6 subfamily A member A1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1333999 Or4c125 olfactory receptor family 4 subfamily C member 125 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334000 Or1o2c olfactory receptor family 1 subfamily O member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334001 Or12d2 olfactory receptor family 12 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334002 Or10a2 olfactory receptor family 10 subfamily A member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334003 Or8b46d olfactory receptor family 8 subfamily B member 46D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334007 Or10ak14 olfactory receptor family 10 subfamily AK member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334008 Or5p4 olfactory receptor family 5 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334009 Or52m2 olfactory receptor family 52 subfamily M member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334011 Or4f7 olfactory receptor family 4 subfamily F member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334013 Olr1500 olfactory receptor 1500 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334014 Or7c70 olfactory receptor family 7 subfamily C member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334015 Or52e2 olfactory receptor family 52 subfamily E member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334017 Or6c1h olfactory receptor family 6 subfamily C member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334018 Or2ag19b olfactory receptor family 2 subfamily AG member 19B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334019 Or1o11c olfactory receptor family 1 subfamily O member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334023 Olr623 olfactory receptor 623 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334025 Or8k33 olfactory receptor family 8 subfamily K member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334026 Or8b35 olfactory receptor family 8 subfamily B member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334027 Or12e10 olfactory receptor family 12 subfamily E member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334028 Or2d3 olfactory receptor family 2 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334030 Olr1191 olfactory receptor 1191 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334032 Olr765 olfactory receptor 765 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334033 Or8b56g olfactory receptor family 8 subfamily B member 56G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334034 Or6d14 olfactory receptor family 6 subfamily D member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334037 Or51ab3 olfactory receptor family 51 subfamily AB member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334039 Or8b3 olfactory receptor family 8 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334040 Or14j3 olfactory receptor family 14 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334041 Or2w1 olfactory receptor family 2 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334043 Or2d3c olfactory receptor family 2 subfamily D member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334046 Or4c29 olfactory receptor family 4 subfamily C member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334047 Or4k46 olfactory receptor family 4 subfamily K member 46 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334048 Or56b6b olfactory receptor family 56 subfamily B member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334050 Or8i2 olfactory receptor family 8 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334051 Or12j2b olfactory receptor family 12 subfamily J member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334053 Or2t45 olfactory receptor family 2 subfamily T member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334054 Or14a257b olfactory receptor family 14 subfamily A member 257B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334055 Olr1096 olfactory receptor 1096 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334056 Or6c2b olfactory receptor family 6 subfamily C member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334058 Or14p1 olfactory receptor family 14 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334059 Or4n5 olfactory receptor family 4 subfamily N member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334060 Or52e15 olfactory receptor family 52 subfamily E member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334062 Or5v1b olfactory receptor family 5 subfamily V member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334063 Or5b12b olfactory receptor family 5 subfamily B member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334067 Or7e166 olfactory receptor family 7 subfamily E member 166 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334069 Or4c120 olfactory receptor family 4 subfamily C member 120 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334070 Or5an1 olfactory receptor family 5 subfamily AN member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334071 Or4b1c olfactory receptor family 4 subfamily B member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334072 Or10v9b olfactory receptor family 10 subfamily V member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334073 Or4e2 olfactory receptor family 4 subfamily E member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334075 Or4k15c olfactory receptor family 4 subfamily K member 15C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334076 Or13c7b olfactory receptor family 13 subfamily C member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334077 Or2t45b olfactory receptor family 2 subfamily T member 45B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334078 Or1x2c olfactory receptor family 1 subfamily O member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334079 Or5an1b olfactory receptor family 5 subfamily AN member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334081 Or52b4 olfactory receptor family 52 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334083 Or1e21 olfactory receptor family 1 subfamily E member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334086 Or1f34 olfactory receptor family 1 subfamily F member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334087 Or10aa1 olfactory receptor family 10 subfamily AA member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334088 Or2ab1 olfactory receptor family 2 subfamily AB member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334089 Or52n20 olfactory receptor family 52 subfamily N member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334091 Or5b21 olfactory receptor family 5 subfamily B member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334093 Or52p1 olfactory receptor family 52 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334096 Or2ak6 olfactory receptor family 2 subfamily AK member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334098 Or6c6i olfactory receptor family 6 subfamily C member 6I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334099 Or13a26b olfactory receptor family 13 subfamily A member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334102 Or2t6 olfactory receptor family 2 subfamily T member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334104 Or8c11 olfactory receptor family 8 subfamily C member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334106 Olr1052 olfactory receptor 1052 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334108 Or9q1 olfactory receptor family 9 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334110 Olr947 olfactory receptor 947 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334112 Or5t5b olfactory receptor family 5 subfamily T member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334113 Or1f27 olfactory receptor family 1 subfamily F member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334115 Or8h11 olfactory receptor family 8 subfamily H member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334116 Or4a66 olfactory receptor family 4 subfamily A member 66 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334120 Or8b1c olfactory receptor family 8 subfamily B member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334121 Or10ag58 olfactory receptor family 10 subfamily AG member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334122 Or14j6 olfactory receptor family 14 subfamily J member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334123 Or5h25 olfactory receptor family 5 subfamily H member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334127 Or51i1 olfactory receptor family 51 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334128 Or7g32 olfactory receptor family 7 subfamily G member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334132 Or10al27 olfactory receptor family 10 subfamily AL member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334138 Or13d1 olfactory receptor family 13 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334139 Or2y14 olfactory receptor family 2 subfamily Y member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334141 Or6b3 olfactory receptor family 6 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334144 Or4a68 olfactory receptor family 4 subfamily A member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334147 Or8b101d olfactory receptor family 8 subfamily B member 101D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334148 Or7e171b olfactory receptor family 7 subfamily E member 171B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334149 Or7e171 olfactory receptor family 7 subfamily E member 171 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334151 Or4c115 olfactory receptor family 4 subfamily C member 115 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334152 Or2y1d olfactory receptor family 2 subfamily Y member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334153 Or56b6c olfactory receptor family 56 subfamily B member 6C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334154 Or5b95 olfactory receptor family 5 subfamily B member 95 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334155 Or5af1c olfactory receptor family 5 subfamily AF member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334157 Or1j16b olfactory receptor family 1 subfamily J member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334159 Or2a57 olfactory receptor family 2 subfamily A member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334160 Or2d2b olfactory receptor family 2 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334162 Or4f7b olfactory receptor family 4 subfamily F member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334163 Or7d11 olfactory receptor family 7 subfamily D member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334164 Or11l3 olfactory receptor family 11 subfamily L member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334165 Or5p53 olfactory receptor family 5 subfamily P member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334167 Or2ak5b olfactory receptor family 2 subfamily AK member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334168 Or5p68 olfactory receptor family 5 subfamily P member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334171 Or10a3c olfactory receptor family 10 subfamily A member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334173 Or13n4 olfactory receptor family 13 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334176 Or4c105 olfactory receptor family 4 subfamily C member 105 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334178 Or9r3c olfactory receptor family 9 subfamily R member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334180 Or10ab4 olfactory receptor family 10 subfamily AB member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334181 Or1e32 olfactory receptor family 1 subfamily E member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334182 Or11h4d olfactory receptor family 11 subfamily H member 4D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334183 Or8c9 olfactory receptor family 8 subfamily C member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334187 Or8k24 olfactory receptor family 8 subfamily K member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334188 Or8b8 olfactory receptor family 8 subfamily B member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334189 Or8g35b olfactory receptor family 8 subfamily G member 35B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334190 Or1e18 olfactory receptor family 1 subfamily E member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334192 Or5d20 olfactory receptor family 5 subfamily D member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334193 Or7g33 olfactory receptor family 7 subfamily G member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334194 Or2r11 olfactory receptor family 2 subfamily R member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334195 Or3a4 olfactory receptor family 3 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334196 Or7g24 olfactory receptor family 7 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334197 Or4e1 olfactory receptor family 4 subfamily E member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334198 Or6c76b olfactory receptor family 6 subfamily C member 76B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334200 Or8g18c olfactory receptor family 8 subfamily G member 18C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334201 Olr952 olfactory receptor 952 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334203 Or13l2 olfactory receptor family 13 subfamily L member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334204 Or55b10 olfactory receptor family 55 subfamily B member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334206 Or5ac21 olfactory receptor family 5 subfamily AC member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334209 Or2a7 olfactory receptor family 2 subfamily A member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334210 Or4c35 olfactory receptor family 4 subfamily C member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334212 Or51v8 olfactory receptor family 51 subfamily V member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334213 Olr990 olfactory receptor 990 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334214 Or6b2b olfactory receptor family 6 subfamily B member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334216 Or13a18b olfactory receptor family 13 subfamily A member 18B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334217 Or1j16 olfactory receptor family 1 subfamily J member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334218 Or4c109 olfactory receptor family 4 subfamily C member 109 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334219 Or5p5 olfactory receptor family 5 subfamily P member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334220 Or6c201 olfactory receptor family 6 subfamily C member 201 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334222 Or2h15 olfactory receptor family 2 subfamily H member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334224 Or6y1 olfactory receptor family 6 subfamily Y member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334226 Or5ac19 olfactory receptor family 5 subfamily AC member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334227 Or8k22 olfactory receptor family 8 subfamily K member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334228 Or1e1c olfactory receptor family 1 subfamily E member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334232 Or12d13 olfactory receptor family 12 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334235 Or6c208 olfactory receptor family 6 subfamily C member 208 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334237 Or3a1e olfactory receptor family 3 subfamily A member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334238 Or52z14 olfactory receptor family 52 subfamily Z member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334242 Or8a1b olfactory receptor family 8 subfamily A member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334246 Or1i2 olfactory receptor family 1 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334248 Or4k5 olfactory receptor family 4 subfamily K member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334249 Or4f60b olfactory receptor family 4 subfamily F member 60B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334251 Or13a27e olfactory receptor family 13 subfamily A member 27E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334252 Or4c111 olfactory receptor family 4 subfamily C member 111 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334253 Olr1505 olfactory receptor 1505 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334254 Or6c2 olfactory receptor family 6 subfamily C member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334255 Or5p60d olfactory receptor family 5 subfamily P member 60D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334258 Or1ad1 olfactory receptor family 1 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334259 Or11h23b olfactory receptor family 11 subfamily H member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334260 Or51k2 olfactory receptor family 51 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334262 Or52ae7b olfactory receptor family 52 subfamily AE member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334263 Or10g3 olfactory receptor family 10 subfamily G member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334264 Or13c7e olfactory receptor family 13 subfamily C member 7E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334265 Or1f20b olfactory receptor family 1 subfamily F member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334266 Or7d10 olfactory receptor family 7 subfamily D member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334267 Or14a257d olfactory receptor family 14 subfamily A member 257D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334269 Or5al5b olfactory receptor family 5 subfamily AL member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334273 Olr440 olfactory receptor 440 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334276 Or8u8 olfactory receptor family 8 subfamily U member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334277 Or51q1e olfactory receptor family 51 subfamily Q member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334278 Or8k25 olfactory receptor family 8 subfamily K member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334279 Or7a39 olfactory receptor family 7 subfamily A member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334280 Or4c31b olfactory receptor family 4 subfamily C member 31B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334281 Olr726 olfactory receptor 726 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334282 Or5t16 olfactory receptor family 5 subfamily T member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334283 Or52l1b olfactory receptor family 52 subfamily L member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334285 Or5w22 olfactory receptor family 5 subfamily W member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334286 Or4a77d olfactory receptor family 4 subfamily A member 77D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334287 Or4b1d olfactory receptor family 4 subfamily B member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334290 Or1f20d olfactory receptor family 1 subfamily F member 20D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334291 Or7e176 olfactory receptor family 7 subfamily E member 176 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334292 Or51g1 olfactory receptor family 51 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334294 Or4f14d olfactory receptor family 4 subfamily F member 14D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334296 Or12d14b olfactory receptor family 12 subfamily D member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334297 Or7d9 olfactory receptor family 7 subfamily D member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334301 Or5p73 olfactory receptor family 5 subfamily P member 73 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334302 Or51aa2 olfactory receptor family 51 subfamily AA member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334305 Or1n1b olfactory receptor family 1 subfamily N member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334306 Or8b12 olfactory receptor family 8 subfamily B member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334309 Or10ag54 olfactory receptor family 10 subfamily AG member 54 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334310 Or8g21 olfactory receptor family 8 subfamily G member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334311 Olr551 olfactory receptor 551 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334313 Or9g4 olfactory receptor family 9 subfamily G member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334315 Or10d5j olfactory receptor family 10 subfamily D member 5J gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334316 Or52ae8 olfactory receptor family 52 subfamily AE member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334317 Or6c214b olfactory receptor family 6 subfamily C member 214B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334318 Or10ak13 olfactory receptor family 10 subfamily AK member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334321 Or1ad6 olfactory receptor family 1 subfamily AD member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334322 Or6c202e olfactory receptor family 6 subfamily C member 202E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334323 Or4b13b olfactory receptor family 4 subfamily B member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334326 Or2t44 olfactory receptor family 2 subfamily T member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334327 Or52z1 olfactory receptor family 52 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334332 Or8b53 olfactory receptor family 8 subfamily B member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334333 Olr520 olfactory receptor 520 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334334 Or4g17 olfactory receptor family 4 subfamily G member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334335 Or7g34b olfactory receptor family 7 subfamily G member 34B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334338 Or6k8 olfactory receptor family 6 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334339 Olr655 olfactory receptor 655 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334340 Or5h26 olfactory receptor family 5 subfamily H member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334341 Or4a72 olfactory receptor family 4 subfamily A member 72 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334346 Or4d11 olfactory receptor family 4 subfamily D member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334348 Or2ag16 olfactory receptor family 2 subfamily AG member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334349 Or11h6 olfactory receptor family 11 subfamily H member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334352 Or8g35 olfactory receptor family 8 subfamily G member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334353 Or2v1 olfactory receptor family 2 subfamily V member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334354 Or51q1d olfactory receptor family 51 subfamily Q member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334356 Or5w17 olfactory receptor family 5 subfamily W member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334358 Olr906 olfactory receptor 906 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334360 Or5w1 olfactory receptor family 5 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334361 Or2t1 olfactory receptor family 2 subfamily T member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334362 Or5p6b olfactory receptor family 5 subfamily P member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334364 Or52e8 olfactory receptor family 52 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334368 Or1f20e olfactory receptor family 1 subfamily F member 20E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334370 Or5p59 olfactory receptor family 5 subfamily P member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334372 Or5w11 olfactory receptor family 5 subfamily W member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334373 Or5ae1 olfactory receptor family 5 subfamily AE member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334374 Or5b12 olfactory receptor family 5 subfamily B member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334376 Or2c1 olfactory receptor family 2 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334377 Or4a81 olfactory receptor family 4 subfamily A member 81 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334379 Or4f53 olfactory receptor family 4 subfamily F member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334380 Or2l5 olfactory receptor family 2 subfamily L member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334384 Or5bh3 olfactory receptor family 5 subfamily BH member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334385 Or6x1 olfactory receptor family 6 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334386 Or10n7 olfactory receptor family 10 subfamily N member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334387 Or10a48 olfactory receptor family 10 subfamily A member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334388 Or14j3b olfactory receptor family 14 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334389 Or12k7 olfactory receptor family 12 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334390 Or51v8b olfactory receptor family 51 subfamily V member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334391 Or8g34b olfactory receptor family 8 subfamily G member 34B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334393 Or52n2f olfactory receptor family 52 subfamily N member 2F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334395 Or6c213c olfactory receptor family 6 subfamily C member 213C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334396 Or10w3 olfactory receptor family 10 subfamily W member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334397 Or51a7 olfactory receptor family 51 subfamily A member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334399 Or6f1 olfactory receptor family 6 subfamily F member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334400 Or7g30 olfactory receptor family 7 subfamily G member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334403 Or5o1 olfactory receptor family 5 subfamily O member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334404 Or10al4c olfactory receptor family 10 subfamily AL member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334405 Or8h6 olfactory receptor family 8 subfamily H member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334406 Or5b104 olfactory receptor family 5 subfamily B member 104 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334407 Or10aa3 olfactory receptor family 10 subfamily AA member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334408 Or4f57 olfactory receptor family 4 subfamily F member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334409 Or9k2b olfactory receptor family 9 subfamily K member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334410 Olr1024 olfactory receptor 1024 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334411 Or56b1 olfactory receptor family 56 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334412 Or4c105b olfactory receptor family 4 subfamily C member 105B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334413 Or6c38 olfactory receptor family 6 subfamily C member 38 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334415 Or2a5 olfactory receptor family 2 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334416 Or5b3 olfactory receptor family 5 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334418 Or6c6b olfactory receptor family 6 subfamily C member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334421 Or51a39 olfactory receptor family 51 subfamily A member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334422 Olr621 olfactory receptor 621 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334424 Or52a20 olfactory receptor family 52 subfamily A member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334425 Or51b6b olfactory receptor family 51 subfamily B member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334426 Or9g3 olfactory receptor family 9 subfamily G member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334428 Or5ac15 olfactory receptor family 5 subfamily AC member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334429 Or4p7 olfactory receptor family 4 subfamily P member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334430 Or6c69e olfactory receptor family 6 subfamily C member 69E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334431 Or4k15 olfactory receptor family 4 subfamily K member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334432 Or51f1g olfactory receptor family 51 subfamily F member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334433 Or6c88 olfactory receptor family 6 subfamily C member 88 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334434 Or4a66c olfactory receptor family 4 subfamily A member 66C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334435 Or6n1 olfactory receptor family 6 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334436 Or1a1b olfactory receptor family 1 subfamily A member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
1334437 Or1ak2 olfactory receptor family 1 subfamily AK member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20201210 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
13432064 Ugt1a1<sup>j</sup> UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432148 SS.ZUC-<i>Lepr<sup>fa-/-</sup></i>/Slc strain MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001261 obese IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase
13432153 Lepr<sup>fa</sup> leptin receptor; fa mutant gene MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
13432199 SHRSP.WKY-(<i>D3Wox20-D3Rat114</i>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432200 SHRSP.WKY-(<i>D3Mgh16-D3Rat80</i>)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432200 SHRSP.WKY-(<i>D3Mgh16-D3Rat80</i>)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432200 SHRSP.WKY-(<i>D3Mgh16-D3Rat80</i>)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432200 SHRSP.WKY-(<i>D3Mgh16-D3Rat80</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432201 SHRSP.WKY-(<i>D3Mgh16-D3Wox3</i>)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432201 SHRSP.WKY-(<i>D3Mgh16-D3Wox3</i>)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432201 SHRSP.WKY-(<i>D3Mgh16-D3Wox3</i>)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432201 SHRSP.WKY-(<i>D3Mgh16-D3Wox3</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432201 SHRSP.WKY-(<i>D3Mgh16-D3Wox3</i>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432202 SHRSP.WKY-(<i>D3Mgh16-rs65433898</i>)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432202 SHRSP.WKY-(<i>D3Mgh16-rs65433898</i>)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432202 SHRSP.WKY-(<i>D3Mgh16-rs65433898</i>)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432202 SHRSP.WKY-(<i>D3Mgh16-rs65433898</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432202 SHRSP.WKY-(<i>D3Mgh16-rs65433898</i>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13432203 SHRSP.WKY-(<i>D3Mgh16-rs197649383</i>)/Gcrc strain MP:0002962 increased urine protein level IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to WKY/Gcrc
13432203 SHRSP.WKY-(<i>D3Mgh16-rs197649383</i>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437612 SS-<i>Adamts16<sup>em1Bj</sup></i> strain MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents
13437613 Adamts16<sup>em1Bj</sup> ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD
13450922 SD-<i>GEPR-3</i> strain MP:0001496 audiogenic seizures induced IAGP XCO:0000048 N RGD:13450923|PMID:29105300 20171108 RGD
13450922 SD-<i>GEPR-3</i> strain MP:0012348 decreased susceptibility to induction of seizure by inducing agent treatment IAGP XCO:0000638 N RGD:13450923|PMID:29105300 20200615 RGD associated with audiogenic seizure
13451132 BN-<i>Crb1<sup>m1</sup></i> strain MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451132 BN-<i>Crb1<sup>m1</sup></i> strain MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451132 BN-<i>Crb1<sup>m1</sup></i> strain MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451133 Crb1<sup>m1</sup> crumbs 1, cell polarity complex component, mutant 1 gene MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451133 Crb1<sup>m1</sup> crumbs 1, cell polarity complex component, mutant 1 gene MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451133 Crb1<sup>m1</sup> crumbs 1, cell polarity complex component, mutant 1 gene MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD
13451538 FHH-Chr 1<sup>BN</sup>-<i>Dusp5<sup>em1Mcwi</sup></i> strain MP:0003026 decreased vasoconstriction induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN
13451539 Dusp5<sup>em1Mcwi</sup> dual specificity phosphatase 5; ZFN induced mutant1, Mcwi gene MP:0003026 decreased vasoconstriction IMP N RGD:13446412|PMID:25397684 20210114 RGD compared to FHH.1BN
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0001262 decreased body weight IMP N RGD:13452381|PMID:12620967 20190726 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0001524 impaired limb coordination IMP N RGD:13452381|PMID:12620967 20171117 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0002229 neurodegeneration IMP N RGD:13452380|PMID:25162006 20171117 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0004191 neuronal intranuclear inclusions IMP N RGD:13452381|PMID:12620967 20190726 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0005643 decreased dopamine level IMP N RGD:13452381|PMID:12620967 20171117 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0008535 enlarged lateral ventricles IMP N RGD:13452381|PMID:12620967 20190726 RGD
13452382 SD-Tg(Htt<sup>*</sup>) strain MP:0014115 cognitive inflexibility IMP N RGD:13452381|PMID:12620967 20171117 RGD
13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13464330 Frem2<sup>fpl</sup> Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13464330 Frem2<sup>fpl</sup> Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13464330 Frem2<sup>fpl</sup> Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD
13503336 W;Cg-<i>Acr<sup>tm1Osb</sup></i> Acr KO, Acr {tm1 Osb} strain MP:0001935 decreased litter size IMP N RGD:13464336|PMID:28859281 20180112 RGD
13503336 W;Cg-<i>Acr<sup>tm1Osb</sup></i> Acr KO, Acr {tm1 Osb} strain MP:0004542 impaired acrosome reaction IMP N RGD:13464336|PMID:28859281 20180112 RGD
13506737 GK strain MP:0001559 hyperglycemia IAGP N RGD:631853|PMID:12783625 20191126 RGD
13506737 GK strain MP:0005333 decreased heart rate IAGP N RGD:13513908|PMID:25903955 20191126 RGD
13506737 GK strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:13513908|PMID:25903955 20191126 RGD
13506737 GK strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513908|PMID:25903955 20191126 RGD
13506737 GK strain MP:0010087 increased circulating fructosamine level IAGP N RGD:13513908|PMID:25903955 20191126 RGD
13506738 GK/Par strain MP:0001262 decreased body weight IAGP N RGD:13506736|PMID:2010050 20180209 RGD compared to Wistar rats
13506738 GK/Par strain MP:0001559 hyperglycemia IAGP N RGD:13506736|PMID:2010050 20180209 RGD compared to Wistar rats
13506738 GK/Par strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats
13506738 GK/Par strain MP:0002833 increased heart weight IAGP N RGD:126775141|PMID:30621358 20210604 RGD compared to Crl:WI rats
13506738 GK/Par strain MP:0003564 abnormal insulin secretion IAGP N RGD:13506736|PMID:2010050 20180209 RGD
13506738 GK/Par strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats
13506738 GK/Par strain MP:0005559 increased circulating glucose level IAGP N RGD:126775141|PMID:30621358 20210604 RGD compared to Crl:WI rats
13506738 GK/Par strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats
13506738 GK/Par strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats
13506739 GK/Jcl strain MP:0001552 increased circulating triglyceride level IAGP N RGD:13506789|PMID:26447526 20191126 RGD
13506739 GK/Jcl strain MP:0001552 increased circulating triglyceride level IAGP N RGD:13592596|PMID:19966469 20191126 RGD
13506739 GK/Jcl strain MP:0002079 increased circulating insulin level IAGP N RGD:13592596|PMID:19966469 20191126 RGD
13506739 GK/Jcl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13506789|PMID:26447526 20191126 RGD
13506739 GK/Jcl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13592596|PMID:19966469 20191126 RGD
13506739 GK/Jcl strain MP:0009355 increased liver triglyceride level IAGP N RGD:13592596|PMID:19966469 20191126 RGD
13506739 GK/Jcl strain MP:0010027 increased liver cholesterol level IAGP N RGD:13592596|PMID:19966469 20191126 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0003066 increased liver copper level treatment IAGP N RGD:1554300|PMID:15511628 20200501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0004780 abnormal surfactant secretion IAGP N RGD:13524861|PMID:28438206 20180501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0006349 decreased circulating copper level treatment IAGP N RGD:1554300|PMID:15511628 20200501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0010815 enlarged alveolar lamellar bodies IAGP N RGD:13524861|PMID:28438206 20180501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD
13524863 LEC/Crlj Long Evans Cinnamon strain MP:0012612 decreased ceruloplasmin level treatment IAGP N RGD:1554300|PMID:15511628 20200429 RGD
13524998 UPL strain MP:0001306 small lens IAGP N RGD:727242|PMID:8282038 20180502 RGD
13524998 UPL strain MP:0003237 abnormal lens epithelium morphology IAGP N RGD:727242|PMID:8282038 20180502 RGD
1354580 Scort1 Serum corticosterone level QTL 1 qtl MP:0005345 abnormal circulating corticosterone level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354581 Bp247 Blood pressure QTL 247 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354581 Bp247 Blood pressure QTL 247 qtl MP:0006265 increased pulse pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354582 Stl11 Serum triglyceride level QTL 11 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354583 Despr3 Despair related QTL3 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354584 Despr6 Despair related QTL 6 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354585 Eae18a Experimental allergic encephalomyelitis QTL 18a qtl MP:0000753 paralysis QTM N RGD:1302437|PMID:15240732 19990101 RGD
1354586 Despr1 Despair related QTL 1 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354587 Kidm21 Kidney mass QTL 21 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354588 Bvd4 Brain ventricular dilatation QTL 4 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354588 Bvd4 Brain ventricular dilatation QTL 4 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354589 Bw31 Body weight QTL 31 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354590 Despr11 Despair related QTL 11 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354591 Cm36 Cardiac mass QTL 36 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354591 Cm36 Cardiac mass QTL 36 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354592 Rf50 Renal function QTL 50 qtl MP:0001762 polyuria QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354593 Stl12 Serum triglyceride level QTL 12 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354594 Despr10 Despair related QTL 10 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354595 Despr4 Despair related QTL 4 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354596 Bw32 Body weight QTL 32 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354597 Kidm13 Kidney mass QTL 13 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354598 Srn6 Serum renin concentration QTL 6 qtl MP:0003349 abnormal circulating renin level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354598 Srn6 Serum renin concentration QTL 6 qtl MP:0003353 decreased circulating renin level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354599 Bw29 Body weight QTL 29 qtl MP:0001263 weight loss IDA N RGD:1302889|PMID:15252022 20100217 RGD
1354600 Salc2 Saline consumption QTL 2 qtl MP:0001422 abnormal drinking behavior QTM N RGD:1302889|PMID:15252022 19990101 RGD
1354601 Slep1 Serum leptin concentration QTL 1 qtl MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354602 Bw35 Body weight QTL 35 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354603 Bp243 Blood pressure QTL 243 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354603 Bp243 Blood pressure QTL 243 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354604 Bw36 Body weight QTL 36 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354605 Rf48 Renal function QTL 48 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354606 Bp246 Blood pressure QTL 246 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354606 Bp246 Blood pressure QTL 246 qtl MP:0006265 increased pulse pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354607 Gmadr1 Adrenal mass QTL 1 qtl MP:0002768 small adrenal glands IAGP N RGD:1302889|PMID:15252022 19990101 RGD
1354608 Cm33 Cardiac mass QTL 33 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354608 Cm33 Cardiac mass QTL 33 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1302801|PMID:15266047 19990101 RGD
1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0003058 increased insulin secretion IAGP N RGD:1302801|PMID:15266047 19990101 RGD
1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:1302801|PMID:15266047 19990101 RGD
1354610 Bw34 Body weight QTL 34 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354611 Despr2 Despair related QTL 2 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354612 Foco1 Food consumption QTL 1 qtl MP:0005449 abnormal food intake QTM N RGD:1302889|PMID:15252022 19990101 RGD
1354613 Kidm14 Kidney mass QTL 14 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354614 Hpcl1 Hepatic cholesterol level QTL 1 qtl MP:0003191 abnormal cellular cholesterol metabolism IAGP N RGD:629576|PMID:9600105 19990101 RGD
1354614 Hpcl1 Hepatic cholesterol level QTL 1 qtl MP:0003982 increased cholesterol level IAGP N RGD:629576|PMID:9600105 19990101 RGD
1354615 Cm32 Cardiac mass QTL 32 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354615 Cm32 Cardiac mass QTL 32 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354616 Despr12 Despair related QTL 12 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354617 Bp240 Blood pressure QTL 240 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354617 Bp240 Blood pressure QTL 240 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354618 Kidm15 Kidney mass QTL 15 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354619 Bp242 Blood pressure QTL 242 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354619 Bp242 Blood pressure QTL 242 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354620 Kidm19 Kidney mass QTL 19 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354621 Rf47 Renal function QTL 47 qtl MP:0003349 abnormal circulating renin level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354622 Kidm16 Kidney mass QTL 16 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354623 Rf46 Renal function QTL 46 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354624 Cm35 Cardiac mass QTL35 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354624 Cm35 Cardiac mass QTL35 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354625 Despr7 Despair related QTL 7 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354626 Bvd1 Brain ventricular dilatation QTL 1 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354626 Bvd1 Brain ventricular dilatation QTL 1 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354627 Despr14 Despair related QTL 14 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0000187 abnormal triglyceride level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354629 Scl31 Serum cholesterol level QTL 31 qtl MP:0000180 abnormal circulating cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354629 Scl31 Serum cholesterol level QTL 31 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354630 Cm34 Cardiac mass QTL 34 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354630 Cm34 Cardiac mass QTL 34 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354631 Swd2 Spike wave discharge measurement QTL 2 qtl MP:0003219 increased spike-wave discharge type II QTM N RGD:1302436|PMID:15270755 19990101 RGD
1354632 Scl29 Serum cholesterol level QTL 29 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354633 Bw28 Body weight QTL 28 qtl MP:0001263 weight loss IDA N RGD:1302889|PMID:15252022 20100217 RGD
1354634 Kidm12 Kidney mass QTL 12 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354635 Bp245 Blood pressure QTL 245 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354635 Bp245 Blood pressure QTL 245 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354636 Lmblg1 Limb length QTL 1 qtl MP:0000558 abnormal tibia morphology QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354637 Scl30 Serum cholesterol level QTL 30 qtl MP:0000180 abnormal circulating cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354637 Scl30 Serum cholesterol level QTL 30 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354638 Insul1 Insulin level QTL 1 qtl MP:0001560 abnormal circulating insulin level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354639 Spl5 Serum phospholipid level QTL 5 qtl MP:0000181 abnormal circulating LDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354640 Scl32 Serum cholesterol level QTL 32 qtl MP:0000184 abnormal circulating HDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354640 Scl32 Serum cholesterol level QTL 32 qtl MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354641 Bvd2 Brain ventricular dilatation QTL 2 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354641 Bvd2 Brain ventricular dilatation QTL 2 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354642 Despr15 Despair related QTL 15 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354643 Foco2 Food consumption QTL 2 qtl MP:0005449 abnormal food intake QTM N RGD:1302889|PMID:15252022 19990101 RGD
1354644 Spl4 Serum phospholipid level QTL 4 qtl MP:0006084 abnormal circulating phospholipid level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354645 Swd1 Spike wave discharge measurement QTL 1 qtl MP:0003217 increased spike-wave discharge type I QTM N RGD:1302436|PMID:15270755 19990101 RGD
1354646 Kidm18 Kidney mass QTL 18 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354647 Despr8 Despair related QTL 8 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354648 Bp239 Blood pressure QTL 239 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:629612|PMID:9260980 19990101 RGD
1354649 Kidm17 Kidney mass QTL 17 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354650 Despr5 Despair related QTL 5 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354651 Lmblg2 Limb length QTL 2 qtl MP:0000558 abnormal tibia morphology QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354652 Kidm20 Kidney mass QTL 20 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354653 Despr9 Despair related QTL 9 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354654 Spl7 Serum phospholipid level QTL 7 qtl MP:0006084 abnormal circulating phospholipid level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354655 Bp241 Blood pressure QTL 241 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354655 Bp241 Blood pressure QTL 241 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1354656 Bvd3 Brain ventricular dilatation QTL 3 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354656 Bvd3 Brain ventricular dilatation QTL 3 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354657 Despr13 Despair related QTL 13 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD
1354658 Spl8 Serum phospholipid level QTL 8 qtl MP:0005144 abnormal circulating VLDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354659 Scl68 Serum cholesterol level QTL 68 qtl MP:0005144 abnormal circulating VLDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354660 Salc1 Saline consumption QTL 1 qtl MP:0001422 abnormal drinking behavior QTM N RGD:1302889|PMID:15252022 19990101 RGD
1354661 Bw33 Body weight QTL 33 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354662 Rf49 Renal function QTL 49 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354663 Bvd5 Brain ventricular dilatation QTL 5 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354663 Bvd5 Brain ventricular dilatation QTL 5 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD
1354664 Slep2 Serum leptin concentration QTL 2 qtl MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354665 Stl10 Serum triglyceride level QTL 10 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD
1354666 Bp244 Blood pressure QTL 244 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD
1354666 Bp244 Blood pressure QTL 244 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD
1357172 WF.BBDR-(<i>D4Arb29-D4Rat44</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD
1357176 WF.BBDR-(<i>D4Arb29-D4Rat96</i>)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 19990101 RGD
1357178 CD Cohen diabetic rat strain MP:0000230 abnormal systemic arterial blood pressure IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0000231 hypertension IAGP XCO:0000212,XCO:0000211,XCO:0000658 N RGD:1354518|PMID:8467325 19990101 RGD
1357178 CD Cohen diabetic rat strain MP:0000231 hypertension susceptibility IAGP XCO:0000094|XCO:0000201 N RGD:1354519|PMID:6365715 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0001559 hyperglycemia IAGP XCO:0000212,XCO:0000211 N RGD:1354520 19990101 RGD
1357178 CD Cohen diabetic rat strain MP:0001559 hyperglycemia IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD
1357178 CD Cohen diabetic rat strain MP:0002962 increased urine protein level IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD
1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000212,XCO:0000211 N RGD:1354520 19990101 RGD
1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD
1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000212,XCO:0000211 N RGD:1354520 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0005328 abnormal circulating creatinine level IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0009644 uremia IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD
1357178 CD Cohen diabetic rat strain MP:0011855 abnormal glomerular filtration barrier morphology IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD
1357178 CD Cohen diabetic rat strain MP:0011856 abnormal glomerular filtration barrier function IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD
1357179 SS.WKY-(<i>D2N35-Mme</i>),MNS-(<i>D10Mit11-D10M11Mit119</i>)/Mco strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
1357179 SS.WKY-(<i>D2N35-Mme</i>),MNS-(<i>D10Mit11-D10M11Mit119</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
1357180 SS.LEW-(<I>D8Chm14-D8Rat16</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
1357183 SS.MNS-(<i>D10Mco10-Aldoc</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 20070607 RGD compared to SS/Jr
1357185 RHA.Gunn-<i>Ugt1a1</i><sup>j</sup>/N strain MP:0004773 abnormal bile composition IAGP N RGD:13432068|PMID:12143043 20200421 RGD
1357185 RHA.Gunn-<i>Ugt1a1</i><sup>j</sup>/N strain MP:0005344 increased circulating bilirubin level IAGP N RGD:13432068|PMID:12143043 20170918 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20200416 RGD compared to Gunn rats
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20200414 RGD compared to Gunn rats
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20180502 RGD compared to Gunn rats
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20190802 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20200414 RGD compared to Gunn rats
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD
1357186 Gunn-<i>Ugt1a1</i><sup>j</sup>/BluHsd Gunn rat strain MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD
1357187 WF.BBDR-(<i>D4Rat16-D4Got39</i>)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 19990101 RGD
1357189 SS.LEW-(<I>D8Rat56-D8Rat51</I>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0003674 oxidative stress IAGP N RGD:13825197|PMID:30361421 20220111 RGD compared to CDR/Ygl
1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0003917 increased kidney weight IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD compared to SBN/Ygl
1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200131 RGD compared to SBN/Ygl
1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005558 decreased creatinine clearance IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD
1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005565 increased blood urea nitrogen level IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD
1357192 WF.BBDR-(<i>D4Got39-D4Rat44</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20200225 RGD
1357193 WF.BBDR-(<i>D4Got51-D4Rat44</i>)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20200225 RGD
1357194 WF.BBDR-(<i>D4Rat96-D4Rat44</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD
1357194 WF.BBDR-(<i>D4Rat96-D4Rat44</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20200225 RGD
1357196 WF.BBDR-(<i>D4Arb29-D4Rat265</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD
1357336 Gluco6 Glucose level QTL 6 qtl MP:0005291 abnormal glucose tolerance IAGP N RGD:619533|PMID:12016513 19990101 RGD
1357336 Gluco6 Glucose level QTL 6 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:619533|PMID:12016513 19990101 RGD
1357337 Gluco3 Glucose level QTL 3 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD
1357338 Stl17 Serum triglyceride level QTL 17 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357339 Stl14 Serum triglyceride level QTL 14 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357340 Bp250 Blood pressure QTL 250 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619625|PMID:9607182 19990101 RGD
1357341 Gluco5 Glucose level QTL 5 qtl MP:0001553 abnormal circulating free fatty acids level IAGP N RGD:61078|PMID:9171835 19990101 RGD
1357342 Bw40 Body weight QTL 40 qtl MP:0001260 increased body weight IAGP N RGD:69707|PMID:9530522 19990101 RGD
1357343 Gluco4 Glucose level QTL 4 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD
1357344 Bp249 Blood pressure QTL 249 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619626|PMID:9096100 19990101 RGD
1357346 BB.SHR-(<i>D4Mit6-Spr</i>)/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619667|PMID:9633608 20191220 RGD compared to strain BB/OK
1357346 BB.SHR-(<i>D4Mit6-Spr</i>)/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619667|PMID:9633608 19990101 RGD compared to strain BB/OK
1357396 Bw44 Body weight QTL 44 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357397 Bw41 Body weight QTL 41 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357398 Slep3 Serum leptin concentration QTL 3 qtl MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357399 Bw45 Body weight QTL 45 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357400 Bw62 Body weight QTL62 qtl MP:0010024 increased total body fat amount IDA N RGD:1357168|PMID:11374884 20111107 RGD
1357401 Bw43 Body weight QTL 43 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357402 Bw46 Body weight QTL 46 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357403 Slep4 Serum leptin concentration QTL 4 qtl MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357404 Bw42 Body weight QTL 42 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD
1357417 SD-Tg(Npy)400Mcwi strain MP:0000280 thin ventricular wall induced IAGP XCO:0000285 N RGD:1357410|PMID:15699473 19990101 RGD compared to wild-type littermate
1357417 SD-Tg(Npy)400Mcwi strain MP:0002834 decreased heart weight induced IAGP XCO:0000285 N RGD:1357410|PMID:15699473 19990101 RGD compared to wild-type littermate
1357954 F344/NHfr strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1342467|PMID:15471977 19990101 RGD compared to BN/RijHfr
1357959 FHH.BN-(<i>D1Hmgc14-D1Hmgc15</i>)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:1357409|PMID:15758045 19990101 RGD compared to BN
1357959 FHH.BN-(<i>D1Hmgc14-D1Hmgc15</i>)/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:1357409|PMID:15758045 20120112 RGD compared to BN
1357959 FHH.BN-(<i>D1Hmgc14-D1Hmgc15</i>)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN
1357974 BB.SHR-(<i>D4Got41-Gimap5</i>)/K strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357974 BB.SHR-(<i>D4Got41-Gimap5</i>)/K strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357974 BB.SHR-(<i>D4Got41-Gimap5</i>)/K strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357974 BB.SHR-(<i>D4Got41-Gimap5</i>)/K strain MP:0005293 impaired glucose tolerance IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K, with age
1357974 BB.SHR-(<i>D4Got41-Gimap5</i>)/K strain MP:0005668 decreased circulating leptin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0002727 decreased circulating insulin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K and BB.SHR-(D4Got41-Gimap5)/K
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0005293 impaired glucose tolerance IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K, with age
1357976 BB.SHR-(<i>D4Got41-D4Rat171</i>)/K strain MP:0005668 decreased circulating leptin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K
1357980 BB.SHR-(<i>D4Got41-Tacr1</i>)/K strain MP:0009292 increased inguinal fat pad weight IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-D4Rat171)/K and BB.SHR-(D4Got41-Gimap5)/K
1357981 SS.LEW-(<i>D3Mco21-D3Rat17</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD
1357982 SS.LEW-(<i>D3Rat52-D3Chm63</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr
1357982 SS.LEW-(<i>D3Rat52-D3Chm63</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
1357982 SS.LEW-(<i>D3Rat52-D3Chm63</i>)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr
1357982 SS.LEW-(<i>D3Rat52-D3Chm63</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr
1357988 SS.LEW-(<i>D3Rat52-D3Rat17</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr
1357988 SS.LEW-(<i>D3Rat52-D3Rat17</i>)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD
1357988 SS.LEW-(<i>D3Rat52-D3Rat17</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr
1357990 Ael1 Aortic elastin QTL 1 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1357991 Ael2 Aortic elastin QTL 2 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358112 WKY/NCrl strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to SHRSP/A3N
1358112 WKY/NCrl strain MP:0011506 glomerular crescent susceptibility IAGP XCO:0000255 N RGD:2293335|PMID:16482158 20080528 RGD
1358112 WKY/NCrl strain MP:0012613 increased ceruloplasmin level induces IAGP XCO:0000769 N RGD:150521658|PMID:28450461 20211116 RGD compared to LEW
1358114 SS-Chr 5<sup>BN</sup>/Mcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358114 SS-Chr 5<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
1358114 SS-Chr 5<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
1358114 SS-Chr 5<sup>BN</sup>/Mcwi strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
1358152 SS-Chr 14<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 14BN/Mcwi
1358152 SS-Chr 14<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi��
1358152 SS-Chr 14<sup>BN</sup>/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358153 COP/CrCrl strain MP:0004955 increased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd
1358153 COP/CrCrl strain MP:0004956 decreased thymus weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd
1358153 COP/CrCrl strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd
1358153 COP/CrCrl strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to COP/CrCrl
1358153 COP/CrCrl strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd
1358153 COP/CrCrl strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to COP/CrCrl
1358153 COP/CrCrl strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD
1358154 SS-Chr 3<sup>BN</sup>/Mcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358154 SS-Chr 3<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 3BN/Mcwi��
1358154 SS-Chr 3<sup>BN</sup>/Mcwi strain MP:0009828 increased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358154 SS-Chr 3<sup>BN</sup>/Mcwi strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358156 SS.MNS-(<i>D2Rat183-D2Chm113</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
1358160 SS.BN-(<i>D8Rat163-D8Rat81</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS/JrHsdMCWi
1358160 SS.BN-(<i>D8Rat163-D8Rat81</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi��
1358162 SS-Chr 12<sup>BN</sup>/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi
1358162 SS-Chr 12<sup>BN</sup>/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in male
1358171 SS-Chr 17<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female
1358174 SS-Chr 19<sup>BN</sup>/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358174 SS-Chr 19<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMCWi
1358174 SS-Chr 19<sup>BN</sup>/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
1358177 SS.MNS-(<i>D2Chm25-D2Mit14</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
1358178 SS-Chr 10<sup>BN</sup>/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi
1358178 SS-Chr 10<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMCWi
1358178 SS-Chr 10<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr10BN/MCWi, female SS/JrHsdMcwi��
1358178 SS-Chr 10<sup>BN</sup>/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20191211 RGD compared to SS/JrHsdMcwi
1358185 Ept6 Estrogen-induced pituitary tumorigenesis QTL 6 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358187 Emca1 Estrogen-induced mammary cancer QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1358124|PMID:15611180 19990101 RGD
1358188 Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0002067 abnormal sensory capabilities/reflexes/nociception IAGP N RGD:1302892|PMID:15480093 19990101 RGD
1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302892|PMID:15480093 19990101 RGD
1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1302892|PMID:15480093 19990101 RGD
1358190 Ept1 Estrogen-induced pituitary tumorigenesis QTL 1 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358192 Ept13 Estrogen-induced pituitary tumorigenesis QTL 13 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD
1358193 Emca2 Estrogen-induced mammary cancer QTL 2 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1358124|PMID:15611180 19990101 RGD
1358200 Insglur2 Insulin/glucose ratio QTL 2 qtl MP:0005331 insulin resistance IAGP N RGD:619533|PMID:12016513 19990101 RGD
1358201 Gluco12 Glucose level QTL12 qtl MP:0001669 abnormal intestinal glucose absorption IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358201 Gluco12 Glucose level QTL12 qtl MP:0002078 abnormal glucose homeostasis IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358202 Gluco11 Glucose level QTL 11 qtl MP:0001669 abnormal intestinal glucose absorption IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358202 Gluco11 Glucose level QTL 11 qtl MP:0002078 abnormal glucose homeostasis IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358203 Stl19 Serum triglyceride level QTL 19 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358203 Stl19 Serum triglyceride level QTL 19 qtl MP:0005317 increased triglyceride level IAGP N RGD:1357415|PMID:15752738 19990101 RGD
1358204 Insglur1 Insulin/glucose ratio QTL 1 qtl MP:0005331 insulin resistance IAGP N RGD:619533|PMID:12016513 19990101 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0001326 retina degeneration IAGP N RGD:632096|PMID:1164921 20200421 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0005103 abnormal retina pigmentation IAGP N RGD:632096|PMID:1164921 20200421 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008450 retina photoreceptor degeneration IAGP N RGD:632096|PMID:1164921 20200421 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008456 abnormal retina rod cell outer segment morphology IAGP N RGD:632096|PMID:1164921 20200429 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:632096|PMID:1164921 20200421 RGD
1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008518 retina outer nuclear layer degeneration IAGP N RGD:632096|PMID:1164921 20200429 RGD
1358277 RCS-<I>rdy</I><sup>+</sup>/LavRrrc strain MP:0001326 retina degeneration MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD
1358277 RCS-<I>rdy</I><sup>+</sup>/LavRrrc strain MP:0005103 abnormal retina pigmentation IAGP N RGD:1358250|PMID:7216680 19990101 RGD
1358278 RCS-<i>rdy</I><sup>+</sup><I>p</I><sup>+</sup>/LavRrrc strain MP:0001326 retina degeneration MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD
1358278 RCS-<i>rdy</I><sup>+</sup><I>p</I><sup>+</sup>/LavRrrc strain MP:0005103 abnormal retina pigmentation MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD
1358292 Cm37 Cardiac mass QTL 37 qtl MP:0002833 increased heart weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358293 Bw38 Body weight QTL 38 qtl MP:0001260 increased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358293 Bw38 Body weight QTL 38 qtl MP:0001262 decreased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358294 Bw37 Body weight QTL 37 qtl MP:0001260 increased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358294 Bw37 Body weight QTL 37 qtl MP:0001262 decreased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358295 Aocep1 Aortic cell protein QTL 1 qtl MP:0003903 increased cell mass IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358296 Ael3 Aortic elastin QTL 3 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD
1358302 SD-Tg(Rho*S334X)3Lav strain MP:0006068 abnormal retina horizontal cell morphology IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model
1358302 SD-Tg(Rho*S334X)3Lav strain MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model
1358302 SD-Tg(Rho*S334X)3Lav strain MP:0031186 abnormal retina horizontal cell density IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model
1358302 SD-Tg(Rho*S334X)3Lav strain MP:0031189 abnormal retina rod bipolar cell density IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model
1358352 Srcrt3 Stress Responsive Cort QTL 3 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358353 Srcrtb2 Stress Responsive Cort Basal QTL 2 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358354 Srcrt5 Stress Responsive Cort QTL 5 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358355 Srcrt4 Stress Responsive Cort QTL 4 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358356 Srcrt1 Stress Responsive Cort QTL1 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358357 Srcrtb1 Stress Responsive Cort Basal QTL 1 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358358 Sradr6 Stress Responsive Adrenal Weight QTL 6 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358359 Sradr1 Stress Responsive Adrenal Weight QTL 1 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358360 Sradr2 Stress Responsive Adrenal Weight QTL 2 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358361 Sradr5 Stress Responsive Adrenal Weight QTL 5 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358362 Srcrt2 Stress Responsive Cort QTL 2 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358363 Sradr3 Stress Responsive Adrenal Weight QTL 3 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358364 Sradr4 Stress Responsive Adrenal Weight QTL 4 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD
1358885 Bp251 Blood pressure QTL 251 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD
1358886 Bp260 Blood pressure QTL 260 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358887 Bw50 Body weight QTL 50 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD
1358888 Bp264 Blood pressure QTL 264 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358889 Bp261 Blood pressure QTL 261 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358890 Bp259 Blood pressure QTL 259 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358891 Bp265 Blood pressure QTL 265 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358892 Kidm26 Kidney mass QTL 26 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358892 Kidm26 Kidney mass QTL 26 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358894 Kidm24 Kidney mass QTL 24 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358894 Kidm24 Kidney mass QTL 24 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358895 Bp254 Blood pressure QTL 254 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD
1358896 Bp262 Blood pressure QTL 262 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358897 Stresp6 Stress response QTL 6 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1332590|PMID:15547139 19990101 RGD
1358898 Bp255 Blood pressure QTL 255 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD
1358899 Kidm23 Kidney mass QTL 23 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358899 Kidm23 Kidney mass QTL 23 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358900 Bw48 Body weight QTL 48 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD
1358901 Cm38 Cardiac mass QTL 38 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358902 Bw47 Body weight QTL 47 qtl MP:0001260 increased body weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358903 Bp252 Blood pressure QTL 252 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD
1358904 Cm39 Cardiac mass QTL 39 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358905 Hrtrt17 Heart rate QTL 17 qtl MP:0002626 increased heart rate IAGP N RGD:1358133|PMID:9286932 19990101 RGD
1358906 Bp253 Blood pressure QTL 253 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD
1358907 Cm40 Cardiac mass QTL 40 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358908 Bw49 Body weight QTL 49 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD
1358909 Kidm25 Kidney mass QTL 25 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358910 Kidm27 Kidney mass QTL 27 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358910 Kidm27 Kidney mass QTL 27 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358911 Kidm28 Kidney mass QTL 28 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358911 Kidm28 Kidney mass QTL 28 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358912 Bw51 Body weight QTL 51 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD
1358913 Cm41 Cardiac mass QTL 41 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358914 Bp266 Blood pressure QTL 266 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358915 Stresp7 Stress response QTL 7 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1332590|PMID:15547139 19990101 RGD
1358916 Kidm22 Kidney mass QTL 22 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358917 Cm42 Cardiac mass QTL 42 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD
1358918 W-<i>Plp1<sup>md</sup></i>/Nya W-<i>Plp1</i><sup>md</sup> strain MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 20170412 RGD
1358918 W-<i>Plp1<sup>md</sup></i>/Nya W-<i>Plp1</i><sup>md</sup> strain MP:0000745 tremors IAGP N RGD:1358782|PMID:434110 19990101 RGD
1358918 W-<i>Plp1<sup>md</sup></i>/Nya W-<i>Plp1</i><sup>md</sup> strain MP:0002064 seizures IAGP N RGD:1358782|PMID:434110 19990101 RGD
1358918 W-<i>Plp1<sup>md</sup></i>/Nya W-<i>Plp1</i><sup>md</sup> strain MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 20170412 RGD
1358923 LE-<i>Mbp<sup>md</sup></i> strain MP:0000745 tremors IAGP N RGD:1358775|PMID:8569154 19990101 RGD
1358923 LE-<i>Mbp<sup>md</sup></i> strain MP:0001393 ataxia IAGP N RGD:1358775|PMID:8569154 19990101 RGD
1358923 LE-<i>Mbp<sup>md</sup></i> strain MP:0013438 dysmyelination IAGP N RGD:1358775|PMID:8569154 19990101 RGD
1358989 WKY.SHR-(<I>D2Rat174-D2Rat28</I>)(<I>D2Rat161-D2Rat185</I>) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl
1358992 SHR.WKY-(<I>D2Rat40-D2Rat50</I>) strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 20201117 RGD compared to SHR/NCrlPrin on a 8% NaCl diet
1358994 SHR.WKY-(<I>D2Rat161-D2Rat241</I>) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin
1358995 F344.OLETF-(<i>D1Rat166-D1Rat90</i>)/Tj strain MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj
1358995 F344.OLETF-(<i>D1Rat166-D1Rat90</i>)/Tj strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj
1358995 F344.OLETF-(<i>D1Rat166-D1Rat90</i>)/Tj strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj
1358995 F344.OLETF-(<i>D1Rat166-D1Rat90</i>)/Tj strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj
1358995 F344.OLETF-(<i>D1Rat166-D1Rat90</i>)/Tj strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj
1358996 SHR.WKY-(<I>D2Rat10-D2Mgh13</I>) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin
1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, M520/N HS founder strains
1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female ACI/N
1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:6893578|PMID:22947656 20131021 RGD
1358998 BUF/NHsd strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, F344/NHsd
1358998 BUF/NHsd strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20200413 RGD
1358998 BUF/NHsd strain MP:0006087 increased body mass index IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, F344/NHsd, M520/N, WKY/NHsd inbred HS founder strains
1358998 BUF/NHsd strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, F344/NHsd, M520/N, WKY/NHsd inbred HS founder strains
1358998 BUF/NHsd strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, M520/N, WKY/NHsd inbred HS founder strains
1358998 BUF/NHsd strain MP:0010123 increased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD female
1358998 BUF/NHsd strain MP:0013617 increased areal bone mineral density IAGP N RGD:6480192|PMID:21334473 20200414 RGD female
1358999 WKY.SHR-(<I>D2Rat174-D2Rat28</i>) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl
1359000 DA.F344-(<i>D10Arb27-D10Rat6</i>)/Nsi strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD
1359000 DA.F344-(<i>D10Arb27-D10Rat6</i>)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD
1359001 WKY.SHR-(<I>D2Rat42-D2Rat139</I>) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl
1359004 DA.F344-(<i>D10Mit9-D10Rat11</i>)/Nsi strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD
1359004 DA.F344-(<i>D10Mit9-D10Rat11</i>)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD
1359005 SHR.WKY-(<I>D2Rat15-D2Rat50</I>) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin
1359007 WKY.SHR-(<I>D2Rat174-D2Rat62</I>) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl
1359009 WKY.SHR-(<I>D2Rat174-D2Rat185</I>) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl
1359017 Hrtrt21 Heart rate QTL 21 qtl MP:0002626 increased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD
1359018 Hrtrt20 Heart rate QTL 20 qtl MP:0002626 increased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD
1359019 Hrtrt19 Heart rate QTL 19 qtl MP:0005333 decreased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD
1359020 Ppulsi2 Prepulse inhibition QTL 2 qtl MP:0003088 abnormal prepulse inhibition QTM N RGD:629579|PMID:12426667 19990101 RGD
1359021 Bp271 Blood pressure QTL 271 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:625381|PMID:11882571 19990101 RGD
1359022 Ppulsi1 Prepulse inhibition QTL 1 qtl MP:0003088 abnormal prepulse inhibition QTM N RGD:629579|PMID:12426667 19990101 RGD
1359023 Bp272 Blood pressure QTL 272 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:625381|PMID:11882571 19990101 RGD
1359030 Bp277 Blood pressure QTL 277 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD
1359031 Bp275 Blood pressure QTL 275 qtl MP:0006144 increased systemic arterial systolic blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD
1359032 Hrtrt18 Heart rate QTL 18 qtl MP:0001629 abnormal heart rate QTM N RGD:629618|PMID:12209022 19990101 RGD
1359032 Hrtrt18 Heart rate QTL 18 qtl MP:0005333 decreased heart rate IAGP N RGD:629618|PMID:12209022 19990101 RGD
1359033 Bp273 Blood pressure QTL 273 qtl MP:0001968 abnormal touch/ nociception IAGP N RGD:1358955|PMID:12388796 19990101 RGD
1359033 Bp273 Blood pressure QTL 273 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:1358955|PMID:12388796 19990101 RGD
1359034 Bp274 Blood pressure QTL 274 qtl MP:0006144 increased systemic arterial systolic blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD
1359035 Bp276 Blood pressure QTL 276 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD
1359346 Agtrap angiotensin II receptor-associated protein gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
13627261 Avp<sup>di</sup> arginine vasopressin; diabetes insipidus mutant gene MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20201210 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628730 SD-<i>Il2rg<sup>em1Ang</sup></i> strain MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
13628731 Il2rg<sup>em1Ang</sup> interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
13702080 SD-<i>Ahr<sup>em1Soar</sup></i> strain MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240726 RGD
13702080 SD-<i>Ahr<sup>em1Soar</sup></i> strain MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240716 RGD
13702080 SD-<i>Ahr<sup>em1Soar</sup></i> strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240726 RGD
13702080 SD-<i>Ahr<sup>em1Soar</sup></i> strain MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240716 RGD
13702081 Ahr<sup>em1Soar</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD
13702081 Ahr<sup>em1Soar</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240718 RGD
13702081 Ahr<sup>em1Soar</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD
13702081 Ahr<sup>em1Soar</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240822 RGD
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703119 SD-<i>Lamp2<sup>em1</sup></i> strain MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13703121 Lamp2<sup>em1</sup> lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
13781890 SD-<i>Rnaset2<sup>em1Sage</sup></i> strain MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD
13781890 SD-<i>Rnaset2<sup>em1Sage</sup></i> strain MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD
13781891 Rnaset2<sup>em1Sage</sup> ribonuclease T2; CRISPR/Cas9 induced mutant 1, Sage gene MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD
13781891 Rnaset2<sup>em1Sage</sup> ribonuclease T2; CRISPR/Cas9 induced mutant 1, Sage gene MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782146 SD-<i>Bace1<sup>em1Sage-/-</sup></i> SD-<i>Bace1<sup>em1Sage-</sup></i>/<i>Bace1<sup>em1Sage-</sup></i> strain MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782148 Bace1<sup>em1Sage</sup> gene MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD
13782351 SS-<i>Kcnj1<sup>em1Kasu+/-</sup></i> strain MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782351 SS-<i>Kcnj1<sup>em1Kasu+/-</sup></i> strain MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782352 Kcnj1<sup>em1Kasu</sup> potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782353 SS-<i>Kcnj1<sup>em1Kasu-/-</sup></i> strain MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782371 SD-<i>Cacna1f <sup>csnb</sup></i> congenital stationary night blindness rat strain MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13782372 Cacna1f <sup>csnb</sup> calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210520 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210520 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210520 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210520 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210520 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD
13792571 Oprl1<sup>m1Hubr</sup> opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:14349028|PMID:25704616 20190206 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210517 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210517 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210517 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210517 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210517 RGD
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD morphine: morphine hydrochloride trihydrate (CHEBI:55348)
13792572 WI-<i>Oprl1<sup>m1Hubr-/-</sup></i> NOPr knockout rat strain MP:0020954 decreased mechanical nociceptive threshold induced IMP XCO:0000610 N RGD:14349028|PMID:25704616 20190206 RGD
13792573 SD-<i>Lep<sup>em1Sage+/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20180913 RGD
13792606 SD-<i>Cd59<sup>em1Ask</sup>-/-</sup></i> SD-<i>Cd59<sup>em1</sup>-/</sup></i><i>Cd59<sup>em1</sup>-</sup></i> strain MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792606 SD-<i>Cd59<sup>em1Ask</sup>-/-</sup></i> SD-<i>Cd59<sup>em1</sup>-/</sup></i><i>Cd59<sup>em1</sup>-</sup></i> strain MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792606 SD-<i>Cd59<sup>em1Ask</sup>-/-</sup></i> SD-<i>Cd59<sup>em1</sup>-/</sup></i><i>Cd59<sup>em1</sup>-</sup></i> strain MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792606 SD-<i>Cd59<sup>em1Ask</sup>-/-</sup></i> SD-<i>Cd59<sup>em1</sup>-/</sup></i><i>Cd59<sup>em1</sup>-</sup></i> strain MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0002626 increased heart rate induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to untreated
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0005610 increased circulating antidiuretic hormone level induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0005633 increased circulating sodium level induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792701 SD-<i>Trpv1<sup>em1Sage-/-</sup></i> strain MP:0008997 increased blood osmolality induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min
13792720 Cd59<sup>em1Ask</sup> CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792720 Cd59<sup>em1Ask</sup> CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792720 Cd59<sup>em1Ask</sup> CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792720 Cd59<sup>em1Ask</sup> CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only;
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792794 SD-<i>Fh<sup>em1+/-</sup></i> strain MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only;
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0008762 embryonic lethality IMP N RGD:13792708|PMID:27556703 20181008 RGD
13792797 Fh<sup>em1</sup> fumarate hydratase; TALEN induced mutant 1 gene MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220131 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800556 F344-<i>Hsd11b2<sup>em1Jmul-/-</sup></i> F344-<i>Hsd11b2<sup>em1Jmul-</sup>/Hsd11b2<sup>em1Jmul-</sup></i> strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220203 RGD
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800560 Hsd11b2<sup>em1Jmul</sup> hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
13800746 SS-<i>F8<sup>em1Mcwi</sup></i> strain MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
13800746 SS-<i>F8<sup>em1Mcwi</sup></i> strain MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
13800746 SS-<i>F8<sup>em1Mcwi</sup></i> strain MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
13800747 F8<sup>em1Mcwi</sup> coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
13800747 F8<sup>em1Mcwi</sup> coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
13800747 F8<sup>em1Mcwi</sup> coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201012 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210623 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210623 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210623 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD compared with Wistar/Crl
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210609 RGD compared with WI-MC4r^m1Hubr
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825199 WI-<i>Mc4r<sup>m1Hubr</sup></i> strain MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201210 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210624 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210624 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210624 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210610 RGD compared with WI-MC4r^m1Hubr
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD
13825200 Mc4r<sup>m1Hubr</sup> melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838727 Bscl2<sup>m1Kyo</sup> BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD males compared to Hsd:SD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210707 RGD
13838845 SD-<i>Ahr<sup>em2Sage</sup></i> strain MP:0020969 impaired conditioned taste aversion behavior sexual_dimorphism IMP N RGD:407419883|PMID:30769105 20240724 RGD
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210521 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210521 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20231215 RGD
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240102 RGD
14390067 WI-<i>Slc6a4<sup>m1Hubr-/-</sup></i> strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20231221 RGD
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240104 RGD
14390068 Slc6a4<sup>m1Hubr</sup> solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392814 Cftr<sup>em1Sage</sup> cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20220118 RGD
14392815 SD-<i>Cftr<sup>em1Sage-/-</sup></i> strain MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD
14398460 SS-<i>Cd40<sup>em1Uthal-/-</sup></I> strain MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd
14398460 SS-<i>Cd40<sup>em1Uthal-/-</sup></I> strain MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd
14398460 SS-<i>Cd40<sup>em1Uthal-/-</sup></I> strain MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd
14398460 SS-<i>Cd40<sup>em1Uthal-/-</sup></I> strain MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd
14398461 Cd40<sup>em1Uthal</sup> CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD
14398461 Cd40<sup>em1Uthal</sup> CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD
14398461 Cd40<sup>em1Uthal</sup> CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD
14398461 Cd40<sup>em1Uthal</sup> CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20201217 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20201214 RGD in females, compared to heterozygous animals
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD
14398765 Edaradd<sup><i>swhKyo</i></sup> EDAR-associated death domain;swh Kyo mutant gene MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
14398825 SD-<i>Fah<sup>em15Dlli-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
14398825 SD-<i>Fah<sup>em15Dlli-/-</sup></i> strain MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD
14398825 SD-<i>Fah<sup>em15Dlli-/-</sup></i> strain MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD
14398825 SD-<i>Fah<sup>em15Dlli-/-</sup></i> strain MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
14398826 Fah<sup>em15Dlli-/-</sup> fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
14398826 Fah<sup>em15Dlli-/-</sup> fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD
14398826 Fah<sup>em15Dlli-/-</sup> fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD
14398826 Fah<sup>em15Dlli-/-</sup> fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
14402419 LE-<i>Chrna5<sup>em18Pas</sup></i> strain MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211207 RGD
14402419 LE-<i>Chrna5<sup>em18Pas</sup></i> strain MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211207 RGD
14402420 Chrna5<sup>em18Pas</sup> cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 18,Pas gene MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211209 RGD
14402420 Chrna5<sup>em18Pas</sup> cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 18,Pas gene MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD
14402421 LE-<i>Chrna5<sup>em20(D398N)Pas</sup></i> strain MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211207 RGD compared to wild type
14402421 LE-<i>Chrna5<sup>em20(D398N)Pas</sup></i> strain MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211207 RGD compared to wild type
14402421 LE-<i>Chrna5<sup>em20(D398N)Pas</sup></i> strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211207 RGD
14402422 Chrna5<sup>em20(D398N)Pas</sup> cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type
14402422 Chrna5<sup>em20(D398N)Pas</sup> cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type
14402422 Chrna5<sup>em20(D398N)Pas</sup> cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD
14695004 BBDR.F344-(D4Mgh24-D4Rhw6),BBDP-(D4Rhw6-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
14696715 SD-<i>Htr7<sup>em1Msu</sup></i> strain MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
14696715 SD-<i>Htr7<sup>em1Msu</sup></i> strain MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
14696715 SD-<i>Htr7<sup>em1Msu</sup></i> strain MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD venous contraction induced by 5 HT
14696715 SD-<i>Htr7<sup>em1Msu</sup></i> strain MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
14696716 Htr7<sup>em1Msu</sup> 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
14696716 Htr7<sup>em1Msu</sup> 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
14696716 Htr7<sup>em1Msu</sup> 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD
14696716 Htr7<sup>em1Msu</sup> 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
149735330 Kcnn2<sup>Trdk</sup> potassium calcium-activated channel subfamily N member 2; Trdk mutant gene MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210722 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat)
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211013 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735334 SD-<i>Wfs1<sup>em1Ptsn</sup></i> strain MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211013 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735335 Wfs1<sup>em1Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD
149735336 SD-<i>Wfs1<sup>em2Ptsn</sup></i> strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735337 Wfs1<sup>em2Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 2 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735338 SD-<i>Wfs1<sup>em3Ptsn</sup></i> strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD
149735339 Wfs1<sup>em3Ptsn</sup> wolframin ER transmembrane glycoprotein; ZFN induced mutant 3 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240611 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735560 LE-<i>Gad1<sup>em15Yyan</sup></i> strain MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240531 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240613 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735561 Gad1<sup>em15Yyan</sup> glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240606 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20210729 RGD compared to wild type
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001489 decreased startle reflex IMP N RGD:39457703|PMID:32259258 20210729 RGD compared to wild type
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20210729 RGD
149735565 Ngly1<sup>em1Ta</sup> N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20210729 RGD
14985210 LE-<i>Cyfip1<sup>em1Sage+/-</sup></i> strain MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD
14985210 LE-<i>Cyfip1<sup>em1Sage+/-</sup></i> strain MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD
14985210 LE-<i>Cyfip1<sup>em1Sage+/-</sup></i> strain MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD
14985211 Cyfip1<sup>em1Sage</sup> cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD
14985211 Cyfip1<sup>em1Sage</sup> cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD
14985211 Cyfip1<sup>em1Sage</sup> cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995941 Wpk Wistar polycystic kidney rat strain MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20191115 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20201210 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20200130 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200131 RGD
14995943 Tmem67<sup>wpk</sup> transmembrane protein 67; wpk mutant gene MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD
15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD
15017093 Wpk <sup>+/-</sup> Wpk heterozygous rat strain MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk
15017093 Wpk <sup>+/-</sup> Wpk heterozygous rat strain MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/-
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/-
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD compared to Wild-type and Wpk +/-
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20191118 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20191118 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20191118 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/-
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20191118 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20191121 RGD
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk
15017094 Wpk <sup>-/-</sup> Wpk homozygous rat strain MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/-
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0001805 decreased IgG level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP/BbbUtx renal anti-dsDNA antibodies at 18 weeks old
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0002494 increased IgM level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx renal anti-dsDNA antibodies
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0002871 albuminuria IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0005014 increased B cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0005015 increased T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0006413 increased T cell apoptosis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx CD4+ T cells
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0008074 increased CD4-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0008688 decreased interleukin-2 secretion IAGP XCO:0000891,XCO:0000889 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHR/Utx T cells
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0020879 abnormal calcium level IAGP XCO:0000178,XCO:0000185 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHR/Utx PBMC
150340617 SHRSP.SHR-(<i>rs197197017 -rs198445122</i>)/Utx strain MP:0020992 increased urine HAVCR1 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY and heterozygous
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340622 Dnd1<sup>ter</sup> DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220203 RGD
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150340624 Zbtb16<sup>em1Ipcv</sup> zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
150404267 LEW-<i>Myo15a<sup>ci2</sup></i>/Ztm strain MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm
150404267 LEW-<i>Myo15a<sup>ci2</sup></i>/Ztm strain MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm
150404267 LEW-<i>Myo15a<sup>ci2</sup></i>/Ztm strain MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm
150404267 LEW-<i>Myo15a<sup>ci2</sup></i>/Ztm strain MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm
150404267 LEW-<i>Myo15a<sup>ci2</sup></i>/Ztm strain MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm
150404269 Myo15a<sup>ci2</sup> myosin XVA; ci2 mutant gene MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
150404269 Myo15a<sup>ci2</sup> myosin XVA; ci2 mutant gene MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
150404269 Myo15a<sup>ci2</sup> myosin XVA; ci2 mutant gene MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
150404269 Myo15a<sup>ci2</sup> myosin XVA; ci2 mutant gene MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
150404269 Myo15a<sup>ci2</sup> myosin XVA; ci2 mutant gene MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
150429606 MWF.SHR-(<i>D6Rat1-D6Rat81</i>)/Rkb strain MP:0004505 decreased renal glomerulus number IAGP N RGD:15023481|PMID:30900988 20210908 RGD compared to MWF.SHR-(D6Rat1-D6Mgh4)
150429614 FHH-Tg(CAG-Add3)McwiRoman strain MP:0003025 increased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to FHH
150429615 SD-<i>Add3<sup>em1Mcwi</sup></i>/ Roman strain MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to wild-type
150429615 SD-<i>Add3<sup>em1Mcwi</sup></i>/ Roman strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to wild-type
150429617 Add3<sup>em1Mcwi</sup> adducin 3; ZFN induced mutant1, Mcwi gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210923 RGD compared to wild-type
150429617 Add3<sup>em1Mcwi</sup> adducin 3; ZFN induced mutant1, Mcwi gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210923 RGD compared to wild-type
150429618 FHH-Chr 1<sup>BN</sup>-<i>Add3<sup>em2Mcwi</sup></i> /Roman strain MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to WT
150429618 FHH-Chr 1<sup>BN</sup>-<i>Add3<sup>em2Mcwi</sup></i> /Roman strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to WT
150429619 Add3<sup>em2Mcwi</sup> adducin 3; ZFN induced mutant2, Mcwi gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT
150429619 Add3<sup>em2Mcwi</sup> adducin 3; ZFN induced mutant2, Mcwi gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211104 RGD
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211104 RGD
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211104 RGD compared to untreated
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211104 RGD
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211104 RGD
150429632 Hcn1<sup>em1Kyo</sup> hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211104 RGD
150429634 F344 -<i>Aspa<sup>em34Kyo</sup> Hcn1<sup>em1Kyo</sup></i> strain MP:0000745 tremors treatment IAGP N RGD:150429620|PMID:32507787 20220225 RGD
150429707 SD-<i>Cyp2c11<sup>em1Nju</sup></i> strain MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
150429707 SD-<i>Cyp2c11<sup>em1Nju</sup></i> strain MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
150429707 SD-<i>Cyp2c11<sup>em1Nju</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
150429707 SD-<i>Cyp2c11<sup>em1Nju</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared between male and female
150429708 Cyp2c11<sup>em1Nju</sup> cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type
150429708 Cyp2c11<sup>em1Nju</sup> cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type
150429708 Cyp2c11<sup>em1Nju</sup> cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type
150429708 Cyp2c11<sup>em1Nju</sup> cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210923 RGD compared between male and female
150429760 SHRSP.SHR-(<i>rs198233821-rs198932221</i>)/Utx strain MP:0009764 decreased susceptibility to induced morbidity/mortality IAGP XCO:0000795 N RGD:150429755|PMID:31608789 20210927 RGD compared to SHRSP/BbbUtx
150429814 SD-<i>Gnal<sup>em1Hpng+/-</sup></i> strain MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls
150429814 SD-<i>Gnal<sup>em1Hpng+/-</sup></i> strain MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls
150429814 SD-<i>Gnal<sup>em1Hpng+/-</sup></i> strain MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls
150429814 SD-<i>Gnal<sup>em1Hpng+/-</sup></i> strain MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls and heterozygotes
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls and heterozygotes
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls
150429816 Gnal<sup>em1Hpng</sup></i> G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls
150429817 SD-<i>Gnal<sup>em1Hpng-/-</sup></i> strain MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls and heterozygotes
150429817 SD-<i>Gnal<sup>em1Hpng-/-</sup></i> strain MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls and heterozygotes
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211004 RGD
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211004 RGD
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211004 RGD
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211004 RGD
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211004 RGD
150429825 SD-<i>Scn9a*<sup>tm1Amgn</sup></i>/Crl strain MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211004 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211007 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD
150429827 Scn9a*<sup>tm1Amgn</sup> sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211007 RGD
150429828 SD-<i>Tspo<sup>em1Vpl</sup></i> strain MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD
150429828 SD-<i>Tspo<sup>em1Vpl</sup></i> strain MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD
150429828 SD-<i>Tspo<sup>em1Vpl</sup></i> strain MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211005 RGD
150429830 SD-<i>Tspo<sup>em2Vpl</sup></i> strain MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD
150429830 SD-<i>Tspo<sup>em2Vpl</sup></i> strain MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD
150429830 SD-<i>Tspo<sup>em2Vpl</sup></i> strain MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211005 RGD
150429831 Tspo<sup>em1Vpl</sup> translocator protein; ZFN induced mutant1, Vpl gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
150429831 Tspo<sup>em1Vpl</sup> translocator protein; ZFN induced mutant1, Vpl gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
150429831 Tspo<sup>em1Vpl</sup> translocator protein; ZFN induced mutant1, Vpl gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD
150429832 Tspo<sup>em2Vpl</sup> translocator protein; ZFN induced mutant2, Vpl gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
150429832 Tspo<sup>em2Vpl</sup> translocator protein; ZFN induced mutant2, Vpl gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
150429832 Tspo<sup>em2Vpl</sup> translocator protein; ZFN induced mutant2, Vpl gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429960 WIC-<i>Wwox<sup>lde</sup></i>/Fta strain MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429961 Wwox<sup>lde</sup> WW domain-containing oxidoreductase; lde mutant gene MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220511 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211014 RGD
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type
150429963 WI-<i>Pmch<sup>m1Hubr</sup></i> strain MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220511 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220512 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211021 RGD
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
150429964 Pmch<sup>m1Hubr</sup> pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220512 RGD
150429965 SD-<i>Apoa4<sup>em1Bcgen</sup></i> strain MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211012 RGD compared to wild type
150429965 SD-<i>Apoa4<sup>em1Bcgen</sup></i> strain MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211012 RGD compared to wild type
150429966 Apoa4<sup>em1Bcgen</sup> apolipoprotein A4; TALEN induced mutant 1, Bcgn gene MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type
150429966 Apoa4<sup>em1Bcgen</sup> apolipoprotein A4; TALEN induced mutant 1, Bcgn gene MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type
150429988 SHR-Tg(EEF1A1-Wars2)Ipcv strain MP:0001262 decreased body weight IMP N RGD:150429949|PMID:29261326 20211013 RGD
150429988 SHR-Tg(EEF1A1-Wars2)Ipcv strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:150429949|PMID:29261326 20211013 RGD
150519901 F344-<i>Prkar1b<sup>em2Tua</sup></i> strain MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211018 RGD
150519901 F344-<i>Prkar1b<sup>em2Tua</sup></i> strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211018 RGD
150519901 F344-<i>Prkar1b<sup>em2Tua</sup></i> strain MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211018 RGD
150519901 F344-<i>Prkar1b<sup>em2Tua</sup></i> strain MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211018 RGD
150519901 F344-<i>Prkar1b<sup>em2Tua</sup></i> strain MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211018 RGD
150519903 Prkar1b<sup>em2Tua</sup> protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211021 RGD
150519903 Prkar1b<sup>em2Tua</sup> protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211021 RGD
150519903 Prkar1b<sup>em2Tua</sup> protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211021 RGD
150519903 Prkar1b<sup>em2Tua</sup> protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211021 RGD
150519903 Prkar1b<sup>em2Tua</sup> protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211021 RGD
150520049 WBN-<i>Ht</i>/Kob strain MP:0000324 increased mast cell number IAGP N RGD:150520053|PMID:16858425 20211025 RGD compared to wild type
150520049 WBN-<i>Ht</i>/Kob strain MP:0001242 hyperkeratosis IAGP N RGD:150520054|PMID:10889953 20211025 RGD compared to wild type
150520049 WBN-<i>Ht</i>/Kob strain MP:0002083 premature death IAGP N RGD:150520054|PMID:10889953 20211025 RGD compared to wild type
150520189 SD-<i>Apoe<sup>em1Ejt</sup></i> strain MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD
150520189 SD-<i>Apoe<sup>em1Ejt</sup></i> strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD
150520190 Apoe<sup>em1Ejt</sup> apolipoprotein E; TALEN induced mutant 1, Ejt gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211111 RGD
150520190 Apoe<sup>em1Ejt</sup> apolipoprotein E; TALEN induced mutant 1, Ejt gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211111 RGD
150520204 SHR/OlaIpcv-mt<sup>LEW/Ipcv</sup> strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:150429987|PMID:22414913 20211108 RGD
150520204 SHR/OlaIpcv-mt<sup>LEW/Ipcv</sup> strain MP:0001554 increased circulating free fatty acids level induces IAGP XCO:0000244,XCO:0000275,XCO:0000102 N RGD:150429987|PMID:22414913 20211108 RGD
150520204 SHR/OlaIpcv-mt<sup>LEW/Ipcv</sup> strain MP:0002078 abnormal glucose homeostasis induces IAGP XCO:0000245,XCO:0000244 N RGD:150429987|PMID:22414913 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20211109 RGD
150520205 SHR-<i>Gja8</i><sup>m1+/-Cub</sup> strain MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20211108 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520220 SD-<i>Ccdc39<sup>em1Jgn</sup></i> strain MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD
150520221 SD-<i>Slco1b2<sup>em1Myliu</sup></i> strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211109 RGD
150521524 Slco1b2<sup>em1Myliu</sup> solute carrier organic anion transporter family member 1B2; CRISPR/Case9 induced mutant 1, Myliu gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521525 Ccdc39<sup>em1Jgn</sup> coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211111 RGD
150521538 SD-<i>Uox<sup>em1Cya</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211109 RGD
150521538 SD-<i>Uox<sup>em1Cya</sup></i> strain MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211109 RGD
150521538 SD-<i>Uox<sup>em1Cya</sup></i> strain MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211109 RGD
150521540 Uox<sup>em1Cya</sup> urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211111 RGD
150521540 Uox<sup>em1Cya</sup> urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211111 RGD
150521540 Uox<sup>em1Cya</sup> urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211111 RGD
150521554 Cntrob<sup>hd</sup> centrobin, centriole duplication and spindle assembly protein; hypodacty mutant gene MP:0000565 oligodactyly IAGP N RGD:150521555|PMID:19710508 20211110 RGD DNA:insertion:intron 10 (rat)
150521556 SD-<i>Trpm4<sup>em1Sage</sup></i> strain MP:0001900 impaired synaptic plasticity induces IMP XCO:0000521 N RGD:150521558|PMID:29971514 20211110 RGD
150521556 SD-<i>Trpm4<sup>em1Sage</sup></i> strain MP:0008428 abnormal spatial working memory IMP N RGD:150521558|PMID:29971514 20211110 RGD
150521556 SD-<i>Trpm4<sup>em1Sage</sup></i> strain MP:0008432 abnormal long-term spatial reference memory IMP N RGD:150521558|PMID:29971514 20211110 RGD
150521556 SD-<i>Trpm4<sup>em1Sage</sup></i> strain MP:0012006 abnormal hippocampus physiology induces IMP XCO:0000521 N RGD:150521526|PMID:30553915 20211110 RGD
150521556 SD-<i>Trpm4<sup>em1Sage</sup></i> strain MP:0012006 abnormal hippocampus physiology induces IMP XCO:0000521 N RGD:150521558|PMID:29971514 20211110 RGD
150521559 LEW.SD-<i>CD8a<sup>m1Trg</sup></i> strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induces IMP XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to Wildtype
150521599 SD-<i>Tshr<sup>em1Mlit</sup></i> strain MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211111 RGD
150521599 SD-<i>Tshr<sup>em1Mlit</sup></i> strain MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211111 RGD
150521599 SD-<i>Tshr<sup>em1Mlit</sup></i> strain MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211111 RGD
150521599 SD-<i>Tshr<sup>em1Mlit</sup></i> strain MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211111 RGD
150521599 SD-<i>Tshr<sup>em1Mlit</sup></i> strain MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211111 RGD
150521600 Tshr<sup>em1Mlit</sup> thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211118 RGD
150521600 Tshr<sup>em1Mlit</sup> thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211118 RGD
150521600 Tshr<sup>em1Mlit</sup> thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211118 RGD
150521600 Tshr<sup>em1Mlit</sup> thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211118 RGD
150521600 Tshr<sup>em1Mlit</sup> thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211118 RGD
150521602 OFA(SD)-<i>Dsg4<sup>hr</sup></i>/Crl strain MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211111 RGD
150521603 Dsg4<sup>hr</sup> desmoglein 4; hairless mutant gene MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211118 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211124 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211123 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type and heterozygous
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211124 RGD
150521708 SD-<i>Tbc1d1<sup>Tn(sb)1Fkh</sup></i> strain MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type and heterozygous
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD
150521709 Tbc1d1<sup>Tn(sb)1Fkh</sup> TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523755 SD-<i>Ighm<sup>em1Ang</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523756 Ighm<sup>em1Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523757 SD-<i>Ighm<sup>em2Ang</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211125 RGD
150523758 Ighm<sup>em2Ang</sup> immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211125 RGD
150573816 SD-<i>Nkx3-1<sup>em1Pjhak+/-</sup></i> strain MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573818 SD-<i>Nkx3-1<sup>em1Pjhak-/-</sup></i> strain MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573818 SD-<i>Nkx3-1<sup>em1Pjhak-/-</sup></i> strain MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573818 SD-<i>Nkx3-1<sup>em1Pjhak-/-</sup></i> strain MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573818 SD-<i>Nkx3-1<sup>em1Pjhak-/-</sup></i> strain MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573818 SD-<i>Nkx3-1<sup>em1Pjhak-/-</sup></i> strain MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type
150573819 Nkx3-1<sup>em1Pjhak</sup> NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
150573819 Nkx3-1<sup>em1Pjhak</sup> NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
150573819 Nkx3-1<sup>em1Pjhak</sup> NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
150573819 Nkx3-1<sup>em1Pjhak</sup> NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
150573819 Nkx3-1<sup>em1Pjhak</sup> NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type
151232284 Prkdc<sup>em1Sage</sup> protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20220120 RGD
151232284 Prkdc<sup>em1Sage</sup> protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20220120 RGD
151232284 Prkdc<sup>em1Sage</sup> protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20220120 RGD
151232284 Prkdc<sup>em1Sage</sup> protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20220120 RGD
151347430 Mstn<sup>em1Cqin</sup> myostatin; ZFN induced mutant 1, Cqin gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220127 RGD compared to wild type male
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD
151347605 SD-<i>Ddah1<sup>em1Ywxu</sup></i> strain MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
151347606 Ddah1<sup>em1Ywxu</sup> dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151347865 Gper1<sup>em1Bj</sup> G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
151356741 SD-Tg(Alb-TAg)Mlcr strain MP:0003331 increased hepatocellular carcinoma incidence IMP N RGD:151356742|PMID:8053496 20220211 RGD
151356741 SD-Tg(Alb-TAg)Mlcr strain MP:0003430 increased pancreatic islet cell adenoma incidence IMP N RGD:151356742|PMID:8053496 20220211 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664748 SD-<i>Slc9a6 <sup>em1Moro</sup></i> strain MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20231218 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231221 RGD
151664749 Slc9a6 <sup>em1Moro</sup> solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20240321 RGD
152600899 Mir146b<sup>em1Mcwi</sup> microRNA 146b; CRISPR/Cas9 induced mutant 1, Mcwi gene MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220526 RGD
1547869 ACI/Eur August x Copenhagen Irish strain MP:0003059 decreased insulin secretion IAGP N RGD:6893578|PMID:22947656 20131021 RGD
1547869 ACI/Eur August x Copenhagen Irish strain MP:0005293 impaired glucose tolerance IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131021 RGD
1547869 ACI/Eur August x Copenhagen Irish strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316693|PMID:20068026 20200825 RGD compared to BN/SsN, BUF/N, F344/N
1547869 ACI/Eur August x Copenhagen Irish strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:6893578|PMID:22947656 20131021 RGD
1549794 SS.LEW-(<i>D2Rat199-D2Mco17</i>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0001830 decreased activated T cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
1549799 BB.SHR-<i>(D6Rat184-D6Rat3)</i>/K strain MP:0008090 increased T-helper 2 cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
1549811 ACI/NJcl strain MP:0010301 increased stomach tumor incidence IAGP N RGD:69698|PMID:10706129 20201029 RGD compared to BUF
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0000592 short tail IAGP N RGD:1549451|PMID:15804398 20080423 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0000755 hindlimb paralysis IAGP N RGD:1549451|PMID:15804398 20201112 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0000780 abnormal corpus callosum morphology IAGP N RGD:1549451|PMID:15804398 20080423 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0000820 abnormal choroid plexus morphology IAGP N RGD:1549451|PMID:15804398 20080423 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0000851 cerebellum hypoplasia IAGP N RGD:1549451|PMID:15804398 20080423 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0001523 impaired righting response IAGP N RGD:1549451|PMID:15804398 20201112 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0002730 head shaking IAGP N RGD:1549451|PMID:15804398 20201112 RGD
1549813 F344.ACI-<i>Lmx1a<sup>qc</sup></i>/Kyo strain MP:0008283 small hippocampus IAGP N RGD:1549451|PMID:15804398 20201112 RGD
1549827 Scl46 Serum cholesterol level QTL 46 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD
1549828 Bp258 Blood pressure QTL 258 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD
1549829 Scl48 Serum cholesterol level QTL 48 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD
1549830 Bss1 Bone structure and strength QTL 1 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549831 Bss6 Bone structure and strength QTL 6 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549832 Bss3 Bone structure and strength QTL 3 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549833 Bp257 Blood pressure QTL 257 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD
1549834 Scl45 Serum cholesterol level QTL 45 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD
1549835 Tcas7 Tongue tumor susceptibility QTL 7 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:1358147|PMID:15876484 20111115 RGD
1549836 Bss2 Bone structure and strength QTL 2 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549836 Bss2 Bone structure and strength QTL 2 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0006043 decreased apoptosis IAGP N RGD:1358145|PMID:15771619 19990101 RGD
1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:1358145|PMID:15771619 20111107 RGD
1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:1358145|PMID:15771619 20111107 RGD
1549838 Bss4 Bone structure and strength QTL 4 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549838 Bss4 Bone structure and strength QTL 4 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549839 Bw52 Body weight QTL 52 qtl MP:0001260 increased body weight IAGP N RGD:1358143|PMID:15833945 19990101 RGD
1549840 Bss5 Bone structure and strength QTL 5 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549841 Bp256 Blood pressure QTL 256 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD
1549842 Bp248 Blood pressure QTL 248 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1300037|PMID:15080379 19990101 RGD
1549843 Bw53 Body weight QTL 53 qtl MP:0001260 increased body weight IAGP N RGD:1358143|PMID:15833945 19990101 RGD
1549844 Bss7 Bone structure and strength QTL 7 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549845 Scl44 Serum cholesterol level QTL 44 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD
1549846 Scl47 Serum cholesterol level QTL 47 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD
1549847 Bss8 Bone structure and strength QTL 8 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD
1549848 Bvd6 Brain ventricular dilatation QTL 6 qtl MP:0001891 hydrocephaly IAGP N RGD:68693|PMID:11178739 20100217 RGD
1549897 Stresp12 Stress response QTL 12 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549897 Stresp12 Stress response QTL 12 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549897 Stresp12 Stress response QTL 12 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549898 Neuinf3 Neuroinflammation QTL 3 qtl MP:0005042 abnormal level of surface class II molecules IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549899 Stresp8 Stress response QTL 8 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549899 Stresp8 Stress response QTL 8 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549899 Stresp8 Stress response QTL 8 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549900 Iddm20 Insulin dependent diabetes mellitus QTL 20 qtl MP:0001559 hyperglycemia IAGP N RGD:1358924|PMID:15793267 19990101 RGD
1549900 Iddm20 Insulin dependent diabetes mellitus QTL 20 qtl MP:0001844 autoimmune response IAGP N RGD:1358924|PMID:15793267 19990101 RGD
1549901 Neudeg2 Neurodegradation QTL 2 qtl MP:0000939 decreased motor neuron number IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549901 Neudeg2 Neurodegradation QTL 2 qtl MP:0005090 increased double-negative T cell number IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549902 Bp269 Blood pressure QTL 269 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD
1549903 Bp267 Blood pressure QTL 267 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD
1549903 Bp267 Blood pressure QTL 267 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD
1549904 Neuinf1 Neuroinflammation QTL 1 qtl MP:0005090 increased double-negative T cell number IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549905 Stresp10 Stress response QTL 10 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549905 Stresp10 Stress response QTL 10 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549905 Stresp10 Stress response QTL 10 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549907 Neuinf2 Neuroinflammation QTL 2 qtl MP:0005042 abnormal level of surface class II molecules IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549908 Neudeg1 Neurodegradation QTL 1 qtl MP:0000938 motor neuron degeneration IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549908 Neudeg1 Neurodegradation QTL 1 qtl MP:0000939 decreased motor neuron number IAGP N RGD:1358788|PMID:14586010 19990101 RGD
1549909 Stresp11 Stress response QTL 11 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549909 Stresp11 Stress response QTL 11 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549909 Stresp11 Stress response QTL 11 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549910 Bw54 Body weight QTL 54 qtl MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 19990101 RGD
1549910 Bw54 Body weight QTL 54 qtl MP:0005334 abnormal fat pad morphology IAGP N RGD:1358859|PMID:15883013 19990101 RGD
1549911 Stresp9 Stress response QTL 9 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549911 Stresp9 Stress response QTL 9 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549911 Stresp9 Stress response QTL 9 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549912 Bp268 Blood pressure QTL 268 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD
1549912 Bp268 Blood pressure QTL 268 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD
1549913 Stresp13 Stress response QTL 13 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549913 Stresp13 Stress response QTL 13 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1549913 Stresp13 Stress response QTL 13 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD
1554302 HOB-<I>Unc5c<sup>hob</sup></I>/Snk hobble rat strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD
1554317 Bmd4 Bone mineral density QTL 4 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD
1554318 Bmd5 Bone mineral density QTL 5 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD
1554319 Bmd2 Bone mineral density QTL 2 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD
1554320 Bmd1 Bone mineral density QTL 1 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD
1554321 Bmd3 Bone mineral density QTL 3 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to males
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0002044 increased colon adenoma incidence IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females, mock treated males
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20201210 RGD
1554322 Apc<sup>Pirc</sup> APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221025 RGD in female
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0006274 abnormal urine sodium level sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221025 RGD in male
155598601 SD-<i>Bmal1<sup>em1Mcwi</sup></i> strain MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in female
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006274 abnormal urine sodium level sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in male
155598603 Bmal1<sup>em1Mcwi</sup> basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
155631259 Taiep strain MP:0000745 tremors IAGP N RGD:155631258|PMID:2724922 20221028 RGD
155631259 Taiep strain MP:0001921 reduced fertility IAGP N RGD:155631258|PMID:2724922 20221028 RGD
155641235 WMI/Eer WKY most immobile strain MP:0001402 decreased locomotor activity IAGP N RGD:4891104|PMID:14593430 20110107 RGD compared to WLI/Eer
155641235 WMI/Eer WKY most immobile strain MP:0001522 impaired swimming IAGP N RGD:4891104|PMID:14593430 20110105 RGD compared to WLI/Eer
155641235 WMI/Eer WKY most immobile strain MP:0001522 impaired swimming IAGP XCO:0000561 N RGD:4891104|PMID:14593430 20110105 RGD compared to treated
155641235 WMI/Eer WKY most immobile strain MP:0002665 decreased circulating corticosterone level IAGP N RGD:4891104|PMID:14593430 20110105 RGD compared to WLI/Eer
155641237 WLI/Eer WKY least immobile strain MP:0001522 impaired swimming IAGP XCO:0000561 N RGD:4891104|PMID:14593430 20110107 RGD compared to treated
1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0000659 prostate gland hyperplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD
1558641 Cm47 Cardiac mass QTL 47 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558641 Cm47 Cardiac mass QTL 47 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0005147 prostate gland hypoplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD
1558643 Cm44 Cardiac mass QTL 44 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558643 Cm44 Cardiac mass QTL 44 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558644 Cm45 Cardiac mass QTL 45 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558644 Cm45 Cardiac mass QTL 45 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558645 Bw55 Body weight QTL 55 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558645 Bw55 Body weight QTL 55 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558646 Swd5 Spike wave discharge measurement QTL 5 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD
1558647 Cm46 Cardiac mass QTL 46 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558647 Cm46 Cardiac mass QTL 46 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558648 Smcn1 Smooth muscle cell number QTL 1 qtl MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:1357419|PMID:15741507 19990101 RGD
1558649 Bw58 Body weight QTL 58 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558649 Bw58 Body weight QTL 58 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558650 Cm48 Cardiac mass QTL 48 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558650 Cm48 Cardiac mass QTL 48 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558651 Swd3 Spike wave discharge measurement QTL 3 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD
1558652 Bw57 Body weight QTL 57 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558652 Bw57 Body weight QTL 57 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0005147 prostate gland hypoplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD
1558654 Bw56 Body weight QTL 56 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558654 Bw56 Body weight QTL 56 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558655 Swd4 Spike wave discharge measurement QTL 4 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD
1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0000659 prostate gland hyperplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD
1558657 Cm43 Cardiac mass QTL 43 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558657 Cm43 Cardiac mass QTL 43 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558658 Bw59 Body weight QTL 59 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558658 Bw59 Body weight QTL 59 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD
1558659 Tescar1 Testicular tumor resistance QTL 1 qtl MP:0006262 increased testis tumor incidence IAGP N RGD:1358944|PMID:15805257 19990101 RGD
1558660 SHRSP/Tkyo strain MP:0001262 decreased body weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1558660 SHRSP/Tkyo strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1558660 SHRSP/Tkyo strain MP:0002834 decreased heart weight treatment IAGP XCO:0000438 N RGD:18337260|PMID:19015604 20200117 RGD
1558660 SHRSP/Tkyo strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1558660 SHRSP/Tkyo strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000438|XCO:0000551 N RGD:18337260|PMID:19015604 20200117 RGD
1558662 SHR/Tkyo strain MP:0001262 decreased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1558662 SHR/Tkyo strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1558662 SHR/Tkyo strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo
1559030 LEC-Tg(ATP7B)Tohm strain MP:0001661 extended life span IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate
1559030 LEC-Tg(ATP7B)Tohm strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate
1559030 LEC-Tg(ATP7B)Tohm strain MP:0005632 decreased circulating aspartate transaminase level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate
1559030 LEC-Tg(ATP7B)Tohm strain MP:0005635 decreased circulating bilirubin level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate
1559030 LEC-Tg(ATP7B)Tohm strain MP:0010265 decreased hepatoma incidence IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate
1559030 LEC-Tg(ATP7B)Tohm strain MP:0012613 increased ceruloplasmin level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to LEC/Crlj
1559035 SS.LEW-(<I>D17Chm14-D17Rat181</I>)/Ayd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc
1559035 SS.LEW-(<I>D17Chm14-D17Rat181</I>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1601352|PMID:17420333 20071117 RGD
1559035 SS.LEW-(<I>D17Chm14-D17Rat181</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD as compared to SS/Jr
1559035 SS.LEW-(<I>D17Chm14-D17Rat181</I>)/Ayd strain MP:0005333 decreased heart rate IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr
1559036 LEW/Jms strain MP:0001891 hydrocephaly IAGP N RGD:1559416|PMID:12541080 19990101 RGD
1559036 LEW/Jms strain MP:0012676 dilated brain ventricle IAGP N RGD:1559416|PMID:12541080 20190827 RGD
1559039 ODS/Shi Osteogenic disorder Shionogi strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi strain
1559039 ODS/Shi Osteogenic disorder Shionogi strain MP:0031257 decreased circulating vitamin C level induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559043 MV/Opu myelin vacuolation rat strain MP:0000745 tremors IAGP N RGD:1299186|PMID:12379762 20090216 RGD
1559043 MV/Opu myelin vacuolation rat strain MP:0005404 abnormal axon morphology IAGP N RGD:1299186|PMID:12379762 20201215 RGD
1559043 MV/Opu myelin vacuolation rat strain MP:0008025 brain vacuoles IAGP N RGD:1299186|PMID:12379762 20201215 RGD
1559043 MV/Opu myelin vacuolation rat strain MP:0011731 decreased myelin sheath thickness IAGP N RGD:1299186|PMID:12379762 20201215 RGD
1559043 MV/Opu myelin vacuolation rat strain MP:0020456 decreased myelin sheath amount IAGP N RGD:1299186|PMID:12379762 20201215 RGD
1559044 SS.SR-(<i>D3Mco19-D3Mco5</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061213 RGD compared to SS/Jr
1559044 SS.SR-(<i>D3Mco19-D3Mco5</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:69705|PMID:9922389 19990101 RGD compared to SS/Jr
1559044 SS.SR-(<i>D3Mco19-D3Mco5</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:69705|PMID:9922389 19990101 RGD compared to SS/Jr
1559044 SS.SR-(<i>D3Mco19-D3Mco5</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061213 RGD compared to SS/Jr
1559045 LEW/Crlc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
1559047 SHRSP/Ezo strain MP:0003990 decreased neurotransmitter release IAGP N RGD:1556766|PMID:8610323 20200127 RGD compared to WKY
1559047 SHRSP/Ezo strain MP:0004000 impaired passive avoidance behavior IAGP XCO:0000055 N RGD:1556766|PMID:8610323 20190729 RGD compared to WKY
1559047 SHRSP/Ezo strain MP:0004836 abnormal synaptic acetylcholine release IAGP XCO:0000587 N RGD:1556766|PMID:8610323 20200127 RGD compared to WKY
1559047 SHRSP/Ezo strain MP:0030753 decreased choline level IAGP N RGD:1556766|PMID:8610323 20190729 RGD compared to WKY
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0001262 decreased body weight IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0002833 increased heart weight IAGP N RGD:1556471|PMID:11693268 20200128 RGD compared to ODS/Jcl strain
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0002833 increased heart weight induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0002981 increased liver weight IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Jcl strain
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0006264 decreased systemic arterial systolic blood pressure induced IDA N RGD:1556471|PMID:11693268 20200128 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0011585 decreased alkaline phosphatase activity induced IDA N RGD:1556471|PMID:11693268 20200128 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0031195 decreased testicular artery wall-to-lumen ratio induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0031257 decreased circulating vitamin C level IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain
1559048 SHR.ODS-<i>Gulo<sup>od</sup></i>/Shi strain MP:0031260 decreased liver vitamin C level induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg)
1559055 Bp278 Blood pressure QTL 278 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1547847|PMID:15632271 19990101 RGD
1559282 Emca5 Estrogen-induced mammary cancer QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced
1559283 Emca4 Estrogen-induced mammary cancer QTL 4 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced
1560339 Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1560339 Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1560849 Themis thymocyte selection associated gene MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0005348 increased T cell proliferation IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0008567 decreased interferon-gamma secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0008660 increased interleukin-10 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0008681 increased interleukin-17 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0008699 increased interleukin-4 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1560849 Themis thymocyte selection associated gene MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation:
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20201210 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0000208 decreased hematocrit IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002781 increased circulating testosterone level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0003058 increased insulin secretion IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005632 decreased circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20171206 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20171207 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD
1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20171207 RGD
1561201 Foxo4 forkhead box O4 gene MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240912 RGD
1561201 Foxo4 forkhead box O4 gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240912 RGD
1561201 Foxo4 forkhead box O4 gene MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240912 RGD
1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005293 impaired glucose tolerance IMP N RGD:38596323|PMID:32053588 20200903 RGD
1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005293 impaired glucose tolerance IMP N RGD:38596332|PMID:31034517 20200903 RGD
1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005331 insulin resistance IMP N RGD:38596323|PMID:32053588 20200903 RGD
1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005331 insulin resistance IMP N RGD:38596332|PMID:31034517 20200903 RGD
1561873 Myo15a myosin XVA gene MP:0002090 abnormal vision induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat)
1561873 Myo15a myosin XVA gene MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
1561873 Myo15a myosin XVA gene MP:0008450 retina photoreceptor degeneration induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat)
1561873 Myo15a myosin XVA gene MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
1561873 Myo15a myosin XVA gene MP:0008518 retina outer nuclear layer degeneration induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat)
1561873 Myo15a myosin XVA gene MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
1561873 Myo15a myosin XVA gene MP:0012038 abnormal a-wave implicit time induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat)
1561873 Myo15a myosin XVA gene MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
1561873 Myo15a myosin XVA gene MP:0012039 abnormal b-wave implicit time induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat)
1561873 Myo15a myosin XVA gene MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm
1562468 Aph1b aph-1 homolog B, gamma secretase subunit gene MP:0012344 decreased gnawing activity IAGP N RGD:13703127|PMID:15721236 20180803 RGD DNA:duplications
1562710 Nmb neuromedin B gene MP:0001402 decreased locomotor activity IDA N RGD:1642338|PMID:7823417 20070912 RGD
1562710 Nmb neuromedin B gene MP:0001412 excessive scratching IDA N RGD:1642338|PMID:7823417 20070912 RGD increased frequency of episodes, not necessarily time spent
1562710 Nmb neuromedin B gene MP:0001441 increased grooming behavior IDA N RGD:1642338|PMID:7823417 20070912 RGD increased frequency of episodes, not necessarily time spent
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231221 RGD
1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20240321 RGD
1563709 Tuba1c-ps1 tubulin, alpha 1C, pseudogene 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD
1564010 Edaradd EDAR associated via death domain gene MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20201217 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20201214 RGD in females, compared to heterozygous animals
1564010 Edaradd EDAR associated via death domain gene MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564010 Edaradd EDAR associated via death domain gene MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD
1564010 Edaradd EDAR associated via death domain gene MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
1564395 Plekha6 pleckstrin homology domain containing A6 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1564395 Plekha6 pleckstrin homology domain containing A6 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
1564507 Nckap5 NCK-associated protein 5 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD
1564531 Trpv3 transient receptor potential cation channel, subfamily V, member 3 gene MP:0000324 increased mast cell number IAGP N RGD:150520053|PMID:16858425 20211025 RGD DNA:missense mutation:cds:G1717T (rat)
1565378 Spata22 spermatogenesis associated 22 gene MP:0001930 abnormal meiosis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD
1565378 Spata22 spermatogenesis associated 22 gene MP:0004852 decreased testis weight treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD
1565378 Spata22 spermatogenesis associated 22 gene MP:0008279 arrest of spermiogenesis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD
1565378 Spata22 spermatogenesis associated 22 gene MP:0013236 ovary degeneration treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240118 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240118 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:329845598|PMID:34675305 20240115 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240115 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240115 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240118 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0011377 renal glomerulus fibrosis IMP N RGD:329845598|PMID:34675305 20240115 RGD
1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0011409 increased renal glomerulus basement membrane thickness IMP N RGD:329845598|PMID:34675305 20240115 RGD
1565754 Fxn frataxin gene MP:0011630 increased mitochondrial size IMP N RGD:401793739|PMID:29223733 20230817 RGD
1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD
1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD
1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD
1566437 SS-Chr X<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male S-Chr XBN/Mcwi
1566455 HTX/HcjRrrc strain MP:0001891 hydrocephaly IAGP N RGD:1559414|PMID:7257730 19990101 RGD
1566456 BDIX/Zte strain MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576302 Schws4 Schwannoma susceptibility QTL 4 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576303 Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:1642526|PMID:17876666 20070928 RGD
1576304 Schws7 Schwannoma susceptibility QTL 7 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576305 Emca6 Estrogen-induced mammary cancer QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced
1576306 Schws3 Schwannoma susceptibility QTL 3 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576308 Schws1 Schwannoma susceptibility QTL 1 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576309 Emca7 Estrogen-induced mammary cancer QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced
1576310 Schws2 Schwannoma susceptibility QTL 2 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576311 Pia26 Pristane induced arthritis QTL 26 qtl MP:0002936 joint swelling IDA N RGD:1358860|PMID:15641042 20081215 RGD
1576312 Emca8 Estrogen-induced mammary cancer QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced
1576314 Eutr1 Estrogen induced uterine response QTL 1 qtl MP:0002254 reproductive system inflammation IAGP N RGD:1559292|PMID:16284801 19990101 RGD
1576315 Schws6 Schwannoma susceptibility QTL 6 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1576316 Ept5 Estrogen-induced pituitary tumorigenesis QTL 5 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:1642526|PMID:17876666 20070928 RGD
1576317 Eutr2 Estrogen induced uterine response QTL 2 qtl MP:0002254 reproductive system inflammation IAGP N RGD:1559291|PMID:16284802 19990101 RGD
1576318 Schws5 Schwannoma susceptibility QTL 5 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD
1578646 Bmd18 Bone mineral density QTL 18 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578647 Bmd17 Bone mineral density QTL 17 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578648 Bss11 Bone structure and strength QTL 11 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578649 Bmd8 Bone mineral density QTL 8 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578650 Bmd6 Bone mineral density QTL 6 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578651 Bmd7 Bone mineral density QTL 7 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578652 Bmd15 Bone mineral density QTL 15 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578653 Vnigr3 Vascular neointimal growth QTL 3 qtl MP:0005489 vascular smooth muscle hyperplasia IDA N RGD:2316923|PMID:20026763 20100317 RGD
1578653 Vnigr3 Vascular neointimal growth QTL 3 qtl MP:0006134 artery occlusion IDA N RGD:2316923|PMID:20026763 20100317 RGD
1578654 Bss10 Bone structure and strength QTL 10 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578655 Bmd11 Bone mineral density QTL 11 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578657 Bss12 Bone structure and strength QTL 12 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578658 Bss13 Bone structure and strength QTL 13 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578659 Tspe1 Trichinella spiralis expulsion QTL 1 qtl MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD
1578660 Bss19 Bone structure and strength QTL 19 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578661 Bss20 Bone structure and strength QTL 20 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578662 Bss15 Bone structure and strength QTL 15 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578663 Bss18 Bone structure and strength QTL 18 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578664 Bmd9 Bone mineral QTL density 9 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578665 Bss16 Bone structure and strength QTL 16 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578667 Bss21 Bone structure and strength QTL 21 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578668 Bmd14 Bone mineral density QTL 14 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578669 Bss9 Bone structure and strength QTL 9 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578670 Bss14 Bone structure and strength QTL 14 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578671 Bmd10 Bone mineral density QTL 10 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578672 Bmd16 Bone mineral density QTL 16 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578673 Bmd13 Bone mineral density QTL 13 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578674 Bmd12 Bone mineral density QTL 12 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578675 Bss17 Bone structure and strength QTL 17 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD
1578692 BN.LEW-(<i>D10Rat32-D10Rat116</i>)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578693 LEW.BN-(<i>D10Mco17-D10Rat221</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578697 BN.LEW-(<i>D10Rat32-D10Rat31</i>)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578699 BG anemic Belgrade strain MP:0000691 enlarged spleen IAGP N RGD:1578513|PMID:9210290 20201112 RGD
1578699 BG anemic Belgrade strain MP:0001770 abnormal iron level IAGP N RGD:1578513|PMID:9210290 19990101 RGD
1578699 BG anemic Belgrade strain MP:0002810 microcytic anemia IAGP N RGD:729808|PMID:9448300 19990101 RGD
1578702 LEW.BN-(<i>D10Rat32-D10Rat133</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578704 WLP Warsaw Low Prefering strain MP:0003546 decreased alcohol consumption IAGP N RGD:1358540|PMID:15215567 19990101 RGD compared to WHP rats
1578704 WLP Warsaw Low Prefering strain MP:0012042 low alcohol preference IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WHP
1578705 LEW.BN-(<i>D10Arb4-D10Rat133</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578706 LEW.BN-(<i>D10Mco17-D10Mco14</i>)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578708 LEW.BN-(<i>D10Mgh7-D10Rat221</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578709 IA incisor absent strain MP:0003053 delayed tooth eruption IAGP N RGD:1578477|PMID:818350 19990101 RGD
1578710 LEW.1AR1-<I>iddm</I>/Ztm strain MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain
1578710 LEW.1AR1-<I>iddm</I>/Ztm strain MP:0003944 abnormal T cell subpopulation ratio IAGP N RGD:1547853|PMID:16075370 20200512 RGD compared to LEW.1AR1/Ztm strain
1578710 LEW.1AR1-<I>iddm</I>/Ztm strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain
1578710 LEW.1AR1-<I>iddm</I>/Ztm strain MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain
1578710 LEW.1AR1-<I>iddm</I>/Ztm strain MP:0014121 increased pancreatic islet cell apoptosis susceptibility IAGP N RGD:41412198|PMID:11596676 20210223 RGD
1578711 LEW.BN-(<i>D10Mco17-D10Rat133</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578712 BN.LEW-(<i>D10Mco17-D10Mco14</i>)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578714 BN.LEW-(<i>D10Mco17-D10Rat80</i>)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578715 ANT Alcohol-Nontolerant strain MP:0001393 ataxia induced IAGP XCO:0000325 N RGD:1578556|PMID:15082942 19990101 RGD compared to treated AT
1578717 WHP Warsaw High Prefering strain MP:0001987 alcohol preference IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP rats
1578717 WHP Warsaw High Prefering strain MP:0003545 increased alcohol consumption IAGP N RGD:1358540|PMID:15215567 19990101 RGD compared to WLP rats
1578717 WHP Warsaw High Prefering strain MP:0009751 enhanced behavioral response to alcohol IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP, Wistar, and saline treated WHP rats
1578717 WHP Warsaw High Prefering strain MP:0011940 decreased food intake IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP rats
1578755 Pur5 Proteinuria QTL 5 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578757 Pur6 Proteinuria QTL 6 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578758 Tcas9 Tongue tumor susceptibility QTL 9 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD
1578759 Uae30 Urinary albumin excretion QTL 30 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578760 Cm53 Cardiac mass QTL 53 qtl MP:0002834 decreased heart weight IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578762 Toxo1 Toxoplasma gondii resistance QTL 1 qtl MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD
1578763 Kidm29 Kidney mass QTL 29 qtl MP:0002135 abnormal kidney morphology IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578766 Tcas11 Tongue tumor susceptibility QTL 11 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:1578522|PMID:16527513 20111115 RGD
1578769 Uae31 Urinary albumin excretion QTL 31 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578770 Stresp23 Stress response QTL 23 qtl MP:0002626 increased heart rate IAGP N RGD:1578503|PMID:16239369 19990101 RGD
1578770 Stresp23 Stress response QTL 23 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1578503|PMID:16239369 19990101 RGD
1578770 Stresp23 Stress response QTL 23 qtl MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:1578503|PMID:16239369 19990101 RGD
1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578774 Tcas8 Tongue tumor susceptibility QTL 8 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD
1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD
1578778 Pur4 Proteinuria QTL 4 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578779 Tcas10 Tongue tumor susceptibility QTL 10 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD
1578780 Cm52 Cardiac mass QTL 52 qtl MP:0002834 decreased heart weight IAGP N RGD:1578520|PMID:16534143 19990101 RGD
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210304 RGD
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0013219 abnormal substantia nigra pars compacta morphology IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to wild-type and untreated
1578791 Nr4a1<i><sup>m1Mcwi</sup></i> nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0030585 enhanced behavioral response to amphetamine IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to saline-treated
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210916 RGD compared to wild type strain FHH/EurMcwi
1578794 Ghsr<i><sup>m1Mcwi</sup></i> growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210916 RGD compared to wild type strain FHH/EurMcwi
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD compared to wild type strain FHH/EurMcwi
1579683 FHH-<i>Ghsr<sup>m1Mcwi</i></sup> strain MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD compared to wild type strain FHH/EurMcwi
1579693 T2DN/Mcwi strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:1303373|PMID:14988259 20120112 RGD compared to GK/Far, BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0003917 increased kidney weight IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0005293 impaired glucose tolerance IAGP N RGD:1303373|PMID:14988259 20200302 RGD
1579693 T2DN/Mcwi strain MP:0005553 increased circulating creatinine level IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to GK/Far
1579693 T2DN/Mcwi strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0011353 expanded mesangial matrix IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to GK/Far
1579693 T2DN/Mcwi strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579693 T2DN/Mcwi strain MP:0011431 increased urine flow rate IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to GK/Far, BN/NHsdMcwi
1579697 SS.SHR-(<i>D13Rat63-D13Mit1</i>)/Mco strain MP:0001260 increased body weight IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr
1579697 SS.SHR-(<i>D13Rat63-D13Mit1</i>)/Mco strain MP:0002963 decreased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr
1579702 SS.SHR-(<i>D9Wox16-D9Rat64</i>)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD
1579702 SS.SHR-(<i>D9Wox16-D9Rat64</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
1579703 SS.SHR-(<i>D2Rat61-D2Mco18</i>)/Mco strain MP:0005540 decreased urine albumin level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210210 RGD
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0013219 abnormal substantia nigra pars compacta morphology induced IMP XCO:0000498 N RGD:40924655|PMID:29530712 20210210 RGD compared to wild-type and untreated
1579706 FHH-<i>Nr4a1<sup>m1Mcwi</i></sup> strain MP:0030585 enhanced behavioral response to amphetamine induced IMP XCO:0000520 N RGD:40924655|PMID:29530712 20210210 RGD compared to saline-treated
1579710 GK/Far Goto-Kakizaki strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579710 GK/Far Goto-Kakizaki strain MP:0003917 increased kidney weight IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579710 GK/Far Goto-Kakizaki strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579710 GK/Far Goto-Kakizaki strain MP:0005293 impaired glucose tolerance IAGP N RGD:1303373|PMID:14988259 19990101 RGD
1579710 GK/Far Goto-Kakizaki strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579710 GK/Far Goto-Kakizaki strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi
1579894 SS.LEW-(<i>D10Rat204-D10Rat9</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr
1579898 SS.LEW-(<i>D10Chm128-D10Chm121</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr
1579901 SS.LEW-(<i>D10Chm224-D10Chm6</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr
1579901 SS.LEW-(<i>D10Chm224-D10Chm6</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
1579903 SS.LEW-(<i>D10Chm10-D10Rat11</i>)/Ayd strain MP:0005333 decreased heart rate IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr
1579907 SS.LEW-(<i>D10Chm128-D10Chm169</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD similar to SS/Jr
1579913 SS.LEW-(<i>D10Chm224-D10Chm222</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr
1579914 SS.LEW-(<i>D10Mco30-D10Got92</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD similar to SS/Jr
1579915 Bp280 Blood pressure QTL 280 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
1579916 Bp270 Blood pressure QTL 270 qtl MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
1579917 Bp282 Blood pressure QTL 282 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1559293|PMID:16286573 20080418 RGD
1579918 Bp279 Blood pressure QTL 279 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1559293|PMID:16286573 20080418 RGD
1579919 Bp281 Blood pressure QTL 281 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1559293|PMID:16286573 20080418 RGD
158013766 SD-<i>Akt1<sup>em1Soar</sup></i> strain MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240618 RGD
158013766 SD-<i>Akt1<sup>em1Soar</sup></i> strain MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240618 RGD
158013766 SD-<i>Akt1<sup>em1Soar</sup></i> strain MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240618 RGD
158013767 Akt1<sup>em1Soar</sup> AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD
158013767 Akt1<sup>em1Soar</sup> AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240620 RGD
158013767 Akt1<sup>em1Soar</sup> AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0000522 kidney cortex cyst IAGP N RGD:13524566|PMID:25753522 20190903 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0001492 abnormal pilomotor reflex IAGP N RGD:1580540|PMID:10803363 20061024 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0001577 anemia IAGP N RGD:1580540|PMID:10803363 20061024 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0002962 increased urine protein level IAGP N RGD:628435|PMID:11135065 20180523 RGD compared to Crl:SD;
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0002981 increased liver weight IAGP N RGD:1580540|PMID:10803363 20191120 RGD compared to Crj:CD(SD)
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0002981 increased liver weight IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD;
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003327 liver cyst IAGP N RGD:13524566|PMID:25753522 20190903 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003333 liver fibrosis IAGP N RGD:13524566|PMID:25753522 20190903 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003675 kidney cyst IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:1580540|PMID:10803363 20061024 RGD compared to Crj:CD(SD)
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD;
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0004860 dilated kidney collecting duct IAGP N RGD:13524566|PMID:25753522 20190903 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0005553 increased circulating creatinine level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD;
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0009497 abnormal intrahepatic bile duct morphology IAGP N RGD:13524566|PMID:25753522 20190903 RGD
1580542 PCK-<i>Pkhd1<sup>pck</i></sup>/CrljCrl strain MP:0011307 kidney medulla cyst IAGP N RGD:1580540|PMID:10803363 20160923 RGD
1581550 Pur8 Proteinuria QTL 8 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581554 Pur11 Proteinuria QTL 11 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 qtl MP:0003491 abnormal voluntary movement IDA N RGD:629629|PMID:12517974 20121112 RGD
1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 qtl MP:0006082 CNS inflammation IDA N RGD:629629|PMID:12517974 20121112 RGD
1581563 Uae33 Urinary albumin excretion QTL 33 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581565 Pur10 Proteinuria QTL 10 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581569 Uae32 Urinary albumin excretion QTL 32 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 qtl MP:0003491 abnormal voluntary movement IDA N RGD:629629|PMID:12517974 20121112 RGD
1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 qtl MP:0006082 CNS inflammation IDA N RGD:629629|PMID:12517974 20121112 RGD
1581572 Uae35 Urinary albumin excretion QTL 35 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581573 Uae36 Urinary albumin excretion QTL 36 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581576 Pur7 Proteinuria QTL 7 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581580 Uae34 Urinary albumin excretion QTL 34 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
1581618 SHRSP/Bbb strain MP:0001262 decreased body weight IAGP N RGD:11040458|PMID:26888427 20200116 RGD compared to SHR/Bbb
1581618 SHRSP/Bbb strain MP:0001262 decreased body weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to SHRSP-Chr 1F344/Rkb
1581618 SHRSP/Bbb strain MP:0002626 increased heart rate susceptibility IAGP N RGD:1358133|PMID:9286932 20191206 RGD compared to control strain WKY/Bbb; males only
1581618 SHRSP/Bbb strain MP:0002626 increased heart rate susceptibility IAGP XCO:0000022 N RGD:1358133|PMID:9286932 20191206 RGD compared to control strain WKY/Bbb
1581618 SHRSP/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022, XCO:0000032, XCO:0000030 N RGD:11040458|PMID:26888427 20160816 RGD compared to SHR/Bbb
1581618 SHRSP/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022, XCO:0000164, XCO:0000032, XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
1581618 SHRSP/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022, XCO:0000164, XCO:0000032, XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
1581618 SHRSP/Bbb strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb
1581618 SHRSP/Bbb strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl, SHRSP-Chr 1F344/Rkb
1581618 SHRSP/Bbb strain MP:0003915 increased heart left ventricle weight susceptibility IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to F344
1581618 SHRSP/Bbb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl,
1581618 SHRSP/Bbb strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20201221 RGD compared to F344/DuCrl, SHRSP-Chr 1F344/Rkb
1581618 SHRSP/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb
1581618 SHRSP/Bbb strain MP:0008770 decreased survivor rate induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub)
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0003917 increased kidney weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0003975 increased circulating VLDL triglyceride level induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0009288 increased epididymal fat pad weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581619 BN.PD-(<i>D8Rat39-D8Rat35</i>),SHR-(<i>D2Mit4-D2Rat28</i>),SHR-(<i>D2Rat103-D2Rat107</i>)/Cub strain MP:0009304 increased retroperitoneal fat pad weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub
1581622 SD-Tg(Ubc-eGFP-RNAi:Dazl)17-9GarRrrc strain MP:0001925 male infertility IMP N RGD:1580353|PMID:16844779 20061024 RGD
1581626 FHL/EurMcwi Fawn Hooded Low blood pressure strain MP:0002962 increased urine protein level IAGP N RGD:61028|PMID:9887194 20120112 RGD compared to ACI/SegHsd
1581626 FHL/EurMcwi Fawn Hooded Low blood pressure strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHH/EurMcw, ACI/SegHsd
1581635 WKY/Bbb strain MP:0006263 decreased systemic arterial diastolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 20200108 RGD compared to WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb; MMO:0000015
1581635 WKY/Bbb strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 20200108 RGD compared to WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb; MMO:0000015
1582184 SR/JrHsd Dahl Salt-Resistant strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl
1582185 SS.SR-(<i>D3Mco36-D3Got166</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582185 SS.SR-(<i>D3Mco36-D3Got166</i>)/Jr strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582185 SS.SR-(<i>D3Mco36-D3Got166</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582186 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat183-D1Rat76</i>)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582186 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat183-D1Rat76</i>)/Mcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi
1582187 SS.SR-(<i>D3Mco24-D3Got130</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582188 SS.SR-(<i>D3Mco36-D3Mco46</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582188 SS.SR-(<i>D3Mco36-D3Mco46</i>)/Jr strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582188 SS.SR-(<i>D3Mco36-D3Mco46</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582189 SS.SR-(<i>D3Mco39-D3Got130</i>)/Jr strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582189 SS.SR-(<i>D3Mco39-D3Got130</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582189 SS.SR-(<i>D3Mco39-D3Got130</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0001463 abnormal spatial learning IAGP N RGD:1581736|PMID:14665699 20061115 RGD compared to SR/JrHsd
1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0005599 increased cardiac muscle contractility susceptibility IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis rat
1582191 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat287-D1Rat84</i>)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582191 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat287-D1Rat84</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582192 SS.SR-(<i>D3Mco36-D3Got159</i>)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582192 SS.SR-(<i>D3Mco36-D3Got159</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582192 SS.SR-(<i>D3Mco36-D3Got159</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr
1582193 FHH.FHH.1<sup>BN</sup>-(<i>D1Mgh13-D1Rat89</i>)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582193 FHH.FHH.1<sup>BN</sup>-(<i>D1Mgh13-D1Rat89</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582195 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat173F6B-D1Rat84</i>)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
1582196 FHH.FHH.1<sup>BN</sup>-(<i>D1Rat234-D1Rat265</i>)/Mcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi
1582197 Gluco27 Glucose level QTL 27 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582199 Insul5 Insulin level QTL 5 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582203 Gluco19 Glucose level QTL 19 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582204 Livw1 Liver weight QTL 1 qtl MP:0002981 increased liver weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582206 Kidm33 Kidney mass QTL 33 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582208 Kidm32 Kidney mass QTL 32 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582209 Gluco20 Glucose level QTL 20 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582210 Bw71 Body weight QTL 71 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582212 Livw2 Liver weight QTL 2 qtl MP:0002981 increased liver weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582213 Insul6 Insulin level QTL 6 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582214 Stl21 Serum triglyceride level QTL 21 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582216 Bw65 Body weight QTL 65 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582218 Bw74 Body weight QTL 74 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582219 Bw63 Body weight QTL 63 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582221 Kidm30 Kidney mass QTL 30 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582222 Epfw2 Epididymal fat weight QTL 2 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582224 Epfw4 Epididymal fat weight QTL 4 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582225 Bw67 Body weight QTL 67 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582226 Bw64 Body weight QTL 64 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582227 Gluco30 Glucose level QTL 30 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582228 Epfw3 Epididymal fat weight QTL 3 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582229 Stl20 Serum triglyceride level QTL 20 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582230 Bw78 Body weight QTL 78 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD
1582232 Gluco25 Glucose level QTL 25 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582233 Insul10 Insulin level QTL 10 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582234 Gluco18 Glucose level QTL 18 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582235 Insul8 Insulin level QTL 8 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582236 Gluco22 Glucose level QTL 22 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582237 Kidm34 Kidney mass QTL 34 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582238 Bw68 Body weight QTL 68 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582239 Epfw1 Epididymal fat weight QTL 1 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582241 Bw70 Body weight QTL 70 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582242 Gluco28 Glucose level QTL 28 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582243 Bw66 Body weight QTL 66 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582244 Bw79 Body weight QTL 79 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD
1582245 Bw73 Body weight QTL 73 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582246 Cm60 Cardiac mass QTL 60 qtl MP:0002833 increased heart weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582248 Insul7 Insulin level QTL 7 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582249 Bw77 Body weight QTL 77 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD
1582250 Gluco26 Glucose level QTL 26 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582251 Gluco24 Glucose level QTL 24 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582254 Kidm31 Kidney mass QTL 31 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582255 Gluco29 Glucose level QTL 29 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582256 Insul9 Insulin level QTL 9 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582257 Gluco21 Glucose level QTL 21 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582258 Bw76 Body weight QTL 76 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582259 Gluco23 Glucose level QTL 23 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582260 Bw72 Body weight QTL 72 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582261 Bw69 Body weight QTL 69 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1582262 Bw75 Body weight QTL 75 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD
1583565 Krt87 keratin 87 gene MP:0002073 abnormal hair growth IAGP N RGD:2316553|PMID:18420582 20100216 RGD DNA:deletion
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY and heterozygous
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY
1584538 Krt71 keratin 71 gene MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
1584538 Krt71 keratin 71 gene MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
1584538 Krt71 keratin 71 gene MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
1584538 Krt71 keratin 71 gene MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
1586167 Tmem67 transmembrane protein 67 gene MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0002962 increased urine protein level IAGP N RGD:1300514|PMID:11095650 20230706 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0002988 decreased urine osmolality IAGP N RGD:1300514|PMID:11095650 20230706 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:1300514|PMID:11095650 20230706 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20201210 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0008584 photoreceptor outer segment degeneration IAGP N RGD:11535084|PMID:23516626 20160920 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0009239 short sperm flagellum IAGP N RGD:8554306|PMID:19515853 20160920 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200131 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:8554306|PMID:19515853 20160929 RGD
1586167 Tmem67 transmembrane protein 67 gene MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD
1589721 Gla galactosidase, alpha gene MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240321 RGD
1589721 Gla galactosidase, alpha gene MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD
1589721 Gla galactosidase, alpha gene MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type females
1589721 Gla galactosidase, alpha gene MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
1589721 Gla galactosidase, alpha gene MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
1589721 Gla galactosidase, alpha gene MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
1589721 Gla galactosidase, alpha gene MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
1589721 Gla galactosidase, alpha gene MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD
1589721 Gla galactosidase, alpha gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type female
1589721 Gla galactosidase, alpha gene MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
1589721 Gla galactosidase, alpha gene MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0006298 abnormal platelet activation IMP N RGD:401976418|PMID:34320241 20240227 RGD
1589721 Gla galactosidase, alpha gene MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0009548 abnormal platelet aggregation IMP N RGD:401976418|PMID:34320241 20240227 RGD
1589721 Gla galactosidase, alpha gene MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240815 RGD
1589721 Gla galactosidase, alpha gene MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
1589721 Gla galactosidase, alpha gene MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240321 RGD
1589721 Gla galactosidase, alpha gene MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males
1589721 Gla galactosidase, alpha gene MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240815 RGD in eyes;compared to wild type
1589721 Gla galactosidase, alpha gene MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type
1589721 Gla galactosidase, alpha gene MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211020 RGD
1589721 Gla galactosidase, alpha gene MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type
1589721 Gla galactosidase, alpha gene MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female
1589755 Tyr tyrosinase gene MP:0005171 absent coat pigmentation IAGP N RGD:1599687|PMID:15760344 20180709 RGD DNA:missense mutation:exon:p.R299H
1589755 Tyr tyrosinase gene MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170317 RGD DNA:deletion:cds:
1589818 Ccdc85c coiled-coil domain containing 85C gene MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211028 RGD
1589818 Ccdc85c coiled-coil domain containing 85C gene MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211028 RGD
1591785 Pappa2 pappalysin 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD
1591785 Pappa2 pappalysin 2 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD
1592076 Psme2-ps1 proteasome activator subunit 2, pseudogene 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0000136 abnormal microglial cell morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593265 Atm ATM serine/threonine kinase gene MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20230119 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20230119 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20230119 RGD
1593265 Atm ATM serine/threonine kinase gene MP:0020448 increased microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon:
1593417 Wars2 tryptophanyl tRNA synthetase 2 (mitochondrial) gene MP:0003023 decreased coronary flow rate IMP N RGD:127338472|PMID:27389904 20210708 RGD
1593417 Wars2 tryptophanyl tRNA synthetase 2 (mitochondrial) gene MP:0005602 decreased angiogenesis IMP N RGD:127338472|PMID:27389904 20210708 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0002963 decreased urine protein level IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0003394 increased cardiac output IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004879 decreased systemic vascular resistance IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005540 decreased urine albumin level IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0011951 increased cardiac stroke volume IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11079199|PMID:25136115 20171102 RGD
1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
1598797 WF.WKY-(<i>D10Got124-D10Rat187</i>)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:1581951|PMID:16568087 20200925 RGD compared to WF/NHsd
1598797 WF.WKY-(<i>D10Got124-D10Rat187</i>)/Uwm strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000090 N RGD:1581951|PMID:16568087 20070103 RGD compared to WF/NHsd
1598798 BBDP/WorN strain MP:0004031 insulitis IAGP N RGD:1578691 20070214 RGD
1598798 BBDP/WorN strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20070214 RGD
1598799 ACI.FHH-(<i>D1Rat384-D1Rat452</i>)(<i>D17Rat61-D1Arb5</i>)(<i>D17Rat51</i>)/Eur strain MP:0001262 decreased body weight induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur
1598799 ACI.FHH-(<i>D1Rat384-D1Rat452</i>)(<i>D17Rat61-D1Arb5</i>)(<i>D17Rat51</i>)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur, ACI.FHH-(D1Rat384-D1Rat156)/Eur
1598800 ACI.FHH-(<i>D1Rat384-D1Rat156</i>)/Eur strain MP:0001262 decreased body weight induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur
1598800 ACI.FHH-(<i>D1Rat384-D1Rat156</i>)/Eur strain MP:0005264 glomerulosclerosis induced IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI/Eur
1598800 ACI.FHH-(<i>D1Rat384-D1Rat156</i>)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur
1598801 ACI.FHH-(<i>D1Mit18-D1Mit8</i>)(<i>D14Mit11-D14Hmgc14b</i>)(<i>D14Rat65-D14Rat90</i>)/Eur strain MP:0002962 increased urine protein level IAGP N RGD:1582571|PMID:16837819 20070111 RGD
1598801 ACI.FHH-(<i>D1Mit18-D1Mit8</i>)(<i>D14Mit11-D14Hmgc14b</i>)(<i>D14Rat65-D14Rat90</i>)/Eur strain MP:0005264 glomerulosclerosis IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI/Eur, ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur
1598801 ACI.FHH-(<i>D1Mit18-D1Mit8</i>)(<i>D14Mit11-D14Hmgc14b</i>)(<i>D14Rat65-D14Rat90</i>)/Eur strain MP:0005264 glomerulosclerosis induced IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI.FHH-(D1Rat384-D1Rat156)
1598801 ACI.FHH-(<i>D1Mit18-D1Mit8</i>)(<i>D14Mit11-D14Hmgc14b</i>)(<i>D14Rat65-D14Rat90</i>)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD
1598802 BBDR/WorN strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20070214 RGD compared to BBDP/WorN
1598803 BBNB/WorN strain MP:0004031 insulitis IAGP N RGD:1578691 20200225 RGD
1598803 BBNB/WorN strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20200225 RGD
1598804 WKY.GHS-(<i>D1Rat32-D1Mit32</i>) strain MP:0005441 increased urine calcium level IAGP N RGD:1582396|PMID:16611718 20070103 RGD compared to GHS
1598805 Memor8 Memory QTL 8 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598805 Memor8 Memory QTL 8 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598807 Glom12 Glomerulus QTL 12 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598809 Memor15 Memory QTL 15 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598809 Memor15 Memory QTL 15 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598811 Bp291 Blood pressure QTL 291 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598813 Memor9 Memory QTL 9 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598813 Memor9 Memory QTL 9 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598816 Memor12 Memory QTL 12 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598816 Memor12 Memory QTL 12 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598817 Glom13 Glomerulus QTL 13 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598819 Bp292 Blood pressure QTL 292 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598823 Memor16 Memory QTL 16 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598823 Memor16 Memory QTL 16 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598824 Memor4 Memory QTL 4 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598824 Memor4 Memory QTL 4 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598828 Glom14 Glomerulus QTL 14 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598830 Bp288 Blood pressure QTL 288 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598832 Glom11 Glomerulus QTL 11 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598833 Bp295 Blood pressure QTL 295 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598834 Memor11 Memory QTL 11 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598834 Memor11 Memory QTL 11 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598837 Memor13 Memory QTL 13 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598837 Memor13 Memory QTL 13 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598838 Bp290 Blood pressure QTL 290 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598841 Memor7 Memory QTL 7 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598841 Memor7 Memory QTL 7 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598842 Glom10 Glomerulus QTL 10 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598843 Cm63 Cardiac mass QTL 63 qtl MP:0002834 decreased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598846 Bp293 Blood pressure QTL 293 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598847 Cm62 Cardiac mass QTL 62 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598849 Memor17 Memory QTL 17 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598849 Memor17 Memory QTL 17 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598850 Bp297 Blood pressure QTL 297 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598853 Memor3 Memory QTL 3 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598853 Memor3 Memory QTL 3 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598854 Memor10 Memory QTL 10 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598854 Memor10 Memory QTL 10 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598855 Bp294 Blood pressure QTL 294 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598856 Memor1 Memory QTL 1 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598856 Memor1 Memory QTL 1 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598858 Cm61 Cardiac mass QTL 61 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598859 Cm66 Cardiac mass QTL 66 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598861 Cm64 Cardiac mass QTL 64 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598862 Glom9 Glomerulus QTL 9 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598863 Cm65 Cardiac mass QTL 65 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598865 Bp296 Blood pressure QTL 296 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598866 Bp287 Blood pressure QTL 287 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598869 Memor6 Memory QTL 6 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598869 Memor6 Memory QTL 6 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598870 Bp289 Blood pressure QTL 289 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD
1598871 Memor5 Memory QTL 5 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598871 Memor5 Memory QTL 5 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598872 Memor14 Memory QTL 14 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598872 Memor14 Memory QTL 14 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598873 Memor2 Memory QTL 2 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598873 Memor2 Memory QTL 2 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD
1598875 Bp286 Blood pressure QTL 286 qtl MP:0003917 increased kidney weight IDA N RGD:1581650|PMID:17028336 20070111 RGD
1598875 Bp286 Blood pressure QTL 286 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581650|PMID:17028336 20070111 RGD
1598877 Bp285 Blood pressure QTL 285 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581650|PMID:17028336 20070111 RGD
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0001613 abnormal vasodilation IMP N RGD:38548929|PMID:24322611 20200827 RGD
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:38548929|PMID:24322611 20200827 RGD XCO:0000145
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005590 increased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220127 RGD in lung
1599567 Sod3<i><sup>m1Mcwi</sup></i> superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
1599674 BBDP.WF-(<i>D8Rat59-D8Sunn1467</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD
1599689 Iddm24 Insulin dependent diabetes mellitus QTL 24 qtl MP:0001759 increased urine glucose level IDA N RGD:1624306|PMID:17389329 20111108 RGD
1599689 Iddm24 Insulin dependent diabetes mellitus QTL 24 qtl MP:0004031 insulitis NOT IDA N RGD:1624306|PMID:17389329 20070829 RGD
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0003025 increased vasoconstriction induced IMP XCO:0000145 N RGD:38548929|PMID:24322611 20200827 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0005590 increased vasodilation induced IMP XCO:0000143,XCO:0000022 N RGD:38548929|PMID:24322611 20210409 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0005591 decreased vasodilation induced IMP XCO:0000143 N RGD:38548929|PMID:24322611 20200827 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220125 RGD in lung
1599758 SS-<i>Sod3<sup>m1Mcwi</i></sup> strain MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi
1599759 GRY/Idr groggy rat strain MP:0001406 abnormal gait IAGP N RGD:1598976|PMID:17196942 20160613 RGD
1599759 GRY/Idr groggy rat strain MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20170504 RGD
1599760 SPRD.WKY-(<i>D18Wox8-D18Rat44</i>)/Ibmm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20200708 RGD compared to WKY
1599763 SPRD.WKY-(<i>D5Rat190-D5Rat114</i>)/Ibmm strain MP:0009828 increased tumor latency induced IAGP XCO:0000090 N RGD:1599390|PMID:17230524 20200316 RGD compared to 7,12-dimethyletraphene treated SPRD/Ztm
1599763 SPRD.WKY-(<i>D5Rat190-D5Rat114</i>)/Ibmm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20071118 RGD compared to WKY
1599764 COP.DA-(<I>D16Rat12-D16Rat90</I>)/Mco strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599764 COP.DA-(<I>D16Rat12-D16Rat90</I>)/Mco strain MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599764 COP.DA-(<I>D16Rat12-D16Rat90</I>)/Mco strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
1599764 COP.DA-(<I>D16Rat12-D16Rat90</I>)/Mco strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599769 COP.DA-(<I>D3Rat233-D3Mgh14</I>)/Mco strain MP:0001262 decreased body weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599769 COP.DA-(<I>D3Rat233-D3Mgh14</I>)/Mco strain MP:0003918 decreased kidney weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599769 COP.DA-(<I>D3Rat233-D3Mgh14</I>)/Mco strain MP:0009109 decreased pancreas weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1599769 COP.DA-(<I>D3Rat233-D3Mgh14</I>)/Mco strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:1300411|PMID:15112108 20070307 RGD DNA:point mutation:exon:p.M1I (rat)
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0004722 abnormal platelet dense granule number IAGP N RGD:2324691|PMID:18983523 20100511 RGD
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0004780 abnormal surfactant secretion IAGP N RGD:2324690|PMID:19897744 20100511 RGD
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13524861|PMID:28438206 20180501 RGD
1600311 Rab38<sup>ru</sup> Rab38, member of RAS oncogene family, ruby allele gene MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD
1600337 F344.GK-(<i>D1Mgh14-D1Rat90</i>)/Swe strain MP:0009113 increased pancreatic beta cell mass IAGP N RGD:1600083|PMID:17130497 20200423 RGD compared to F344/DuCrl2Swe
1600338 SHR.F344-(<i>D12Mgh5-D12Mgh6</i>)/Snk strain MP:0002834 decreased heart weight IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain
1600338 SHR.F344-(<i>D12Mgh5-D12Mgh6</i>)/Snk strain MP:0004867 decreased platelet calcium level IAGP XCO:0000177|XCO:0000178 N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain
1600338 SHR.F344-(<i>D12Mgh5-D12Mgh6</i>)/Snk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain
1600338 SHR.F344-(<i>D12Mgh5-D12Mgh6</i>)/Snk strain MP:0009549 decreased platelet aggregation IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain
1600339 BN.GK-(<i>D1Wox18-D1Got254</i>)/Ox strain MP:0001260 increased body weight IMP N RGD:2300263|PMID:18698428 20080910 RGD as compared to BN progenitor
1600339 BN.GK-(<i>D1Wox18-D1Got254</i>)/Ox strain MP:0009171 enlarged pancreatic islets IMP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0002962 increased urine protein level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, plasma and cortical
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul, plasma and cortical
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003352 increased circulating renin level IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to LEW/Crl��
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003352 increased circulating renin level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003915 increased heart left ventricle weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003918 decreased kidney weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0005583 decreased renin activity sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:2293121|PMID:18456730 20080513 RGD compared to LEW/Crl�
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006376 decreased circulating angiotensinogen level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0010212 abnormal circulating C-reactive protein level IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to LEW/Crl
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0010212 abnormal circulating C-reactive protein level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0011470 increased urine creatinine level IMP N RGD:2293121|PMID:18456730 20080513 RGD
1600341 LEW-Tg(Ren2)27/Jmul strain MP:0011470 increased urine creatinine level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul
1600342 F344.GK-(<i>D1Got250-D1Rat90</i>)/Swe strain MP:0001260 increased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600342 F344.GK-(<i>D1Got250-D1Rat90</i>)/Swe strain MP:0003058 increased insulin secretion IAGP N RGD:1600083|PMID:17130497 20200423 RGD compared to F344/DuCrl2Swe
1600342 F344.GK-(<i>D1Got250-D1Rat90</i>)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004183 abnormal sympathetic nervous system physiology IAGP N RGD:2302408|PMID:19047583 20081217 RGD
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to restraint stress
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0005264 glomerulosclerosis susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006058 decreased cerebral infarct size IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm
1600343 SHRSP.WKY-(<I>D1Wox29-D1Arb21</I>)/Izm strain MP:0030773 decreased urine noradrenaline level IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to cold stress
1600344 F344.GK-(<i>D1Rat175-D1Rat90</i>)/Swe strain MP:0001260 increased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600344 F344.GK-(<i>D1Rat175-D1Rat90</i>)/Swe strain MP:0002727 decreased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600344 F344.GK-(<i>D1Rat175-D1Rat90</i>)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600346 F344.GK-(<i>D1Swe4-D1Rat85</i>)/Swe strain MP:0001262 decreased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600346 F344.GK-(<i>D1Swe4-D1Rat85</i>)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600346 F344.GK-(<i>D1Swe4-D1Rat85</i>)/Swe strain MP:0005560 decreased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
1600358 Mamtr5 Mammary tumor resistance QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599390|PMID:17230524 20070314 RGD
1600358 Mamtr5 Mammary tumor resistance QTL 5 qtl MP:0003721 increased tumor growth/size IDA N RGD:1599390|PMID:17230524 20070314 RGD
1600360 Mcs16 Mammary carcinoma susceptibility QTL 16 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600362 Mcs19 Mammary carcinoma susceptibility QTL 19 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600363 Hc6 Hypercalciuria QTL 6 qtl MP:0002708 nephrolithiasis IDA N RGD:1582396|PMID:16611718 20070309 RGD
1600363 Hc6 Hypercalciuria QTL 6 qtl MP:0005441 increased urine calcium level IDA N RGD:1582396|PMID:16611718 20070309 RGD
1600365 Mcs20 Mammary carcinoma susceptibility QTL 20 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600367 Mcs15 Mammary carcinoma susceptibility QTL 15 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1581951|PMID:16568087 20070309 RGD
1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 qtl MP:0003893 increased hepatocyte proliferation IDA N RGD:1599590|PMID:17079458 20070314 RGD
1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 qtl MP:0010264 increased hepatoma incidence IDA N RGD:1599590|PMID:17079458 20111108 RGD
1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 qtl MP:0002020 increased tumor incidence TAS N RGD:2302423|PMID:19052818 20090204 RGD
1600373 Mamtr6 Mammary tumor resistance QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599390|PMID:17230524 20070314 RGD
1600373 Mamtr6 Mammary tumor resistance QTL 6 qtl MP:0004502 decreased incidence of tumors by chemical induction TAS N RGD:2302423|PMID:19052818 20090204 RGD
1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600375 Mcs22 Mammary carcinoma susceptibility QTL 22 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600375 Mcs22 Mammary carcinoma susceptibility QTL 22 qtl MP:0002020 increased tumor incidence TAS N RGD:2302423|PMID:19052818 20090204 RGD
1600376 Arunc5 Aerobic running capacity QTL 5 qtl MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD
1600378 Arunc4 Aerobic running capacity QTL 4 qtl MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD
1600379 Mcs18 Mammary carcinoma susceptibility QTL 18 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD
1600382 Edcs3 Endometrial carcinoma susceptibility QTL3 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD
1600384 Niddm66 Non-insulin dependent diabetes mellitus QTL 66 qtl MP:0005559 increased circulating glucose level IDA N RGD:1599587|PMID:16951059 20070824 RGD
1600386 Calcic2 Intracellular calcium level QTL 2 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1599588|PMID:17261463 20070314 RGD
1600390 Niddm64 Non-insulin dependent diabetes mellitus QTL 64 qtl MP:0005559 increased circulating glucose level IDA N RGD:1599587|PMID:16951059 20070824 RGD
1600391 Edcs2 Endometrial carcinoma susceptibility QTL2 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD
1600392 Bw123 Body weight QTL 123 qtl MP:0001262 decreased body weight TAS N RGD:1599587|PMID:16951059 20070824 RGD
1600394 Edcs1 Endometrial carcinoma susceptibility QTL1 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD
1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD
1600398 Edcs5 Endometrial carcinoma susceptibility QTL 5 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD
1600490 SS-Chr 1<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
1600490 SS-Chr 1<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
1641831 MWF-Chr 6<sup>SHR</sup>/Rkb strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain
1641831 MWF-Chr 6<sup>SHR</sup>/Rkb strain MP:0002834 decreased heart weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain
1641831 MWF-Chr 6<sup>SHR</sup>/Rkb strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20080311 RGD compared to males
1641831 MWF-Chr 6<sup>SHR</sup>/Rkb strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200128 RGD females compared to female MWF/FubRkb
1641831 MWF-Chr 6<sup>SHR</sup>/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600609|PMID:17167120 20080924 RGD compared to SHR/FubRkb strain
1641833 Alc21 Alcohol consumption QTL 21 qtl MP:0003545 increased alcohol consumption IDA N RGD:1578304|PMID:16470346 20080924 RGD
1641850 SHR.WKY-(<i>D1Got158-D1Got161</i>)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20071116 RGD compared to SHR/NCruk strain
1641851 SHR.PD-(<I>D8Rat42-D8Arb23</I>)/Cub strain MP:0001262 decreased body weight IAGP N RGD:1580747|PMID:16045236 20080924 RGD
1641851 SHR.PD-(<I>D8Rat42-D8Arb23</I>)/Cub strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1580747|PMID:16045236 20080924 RGD
1641851 SHR.PD-(<I>D8Rat42-D8Arb23</I>)/Cub strain MP:0005331 insulin resistance IAGP N RGD:1580747|PMID:16045236 20080924 RGD
1641851 SHR.PD-(<I>D8Rat42-D8Arb23</I>)/Cub strain MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20170626 RGD
1641852 WF.BBDR-(<i>D4Got48-D4Got43</i>)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD
1641853 SS.LEW-(<i>D10Mco38-D10Mgh1</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641853 SS.LEW-(<i>D10Mco38-D10Mgh1</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641854 HAS.LAS-(<i>D5Rat70-D5Rat37</i>)/Rar strain MP:0002863 improved righting response sexual_dimorphism IAGP XCO:0000325 N RGD:1600610|PMID:16953387 20080924 RGD compared to female HAS1
1641856 P.NP-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0000063 decreased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm
1641856 P.NP-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0001260 increased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm
1641856 P.NP-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD compared to P/Iusm
1641856 P.NP-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0003546 decreased alcohol consumption IAGP N RGD:1578304|PMID:16470346 20080924 RGD compared to P/Iusm
1641857 BBDP.WF-(<i>D8Rat16-D8Sunn1467</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD
1641858 SHR.WKY-(<i>D1Rat420-D1Rat278</i>)/Njs strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20200204 RGD compared to SHR.WKY-(D1Rat420-D1Got161)/Njs strain
1641859 SS.MNS-(<i>D10Bra1-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
1641859 SS.MNS-(<i>D10Bra1-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
1641860 SS.MNS-(<i>D10Mco62-D10Mit1</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
1641860 SS.MNS-(<i>D10Mco62-D10Mit1</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
1641861 HAS.LAS-(<i>D2Rat53-D2Rat138</i>)/Rar strain MP:0002863 improved righting response sexual_dimorphism IAGP XCO:0000325 N RGD:1600610|PMID:16953387 20080924 RGD compared to female HAS1
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20200319 RGD compared to males
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0002044 increased colon adenoma incidence induced IMP XCO:0000345 N RGD:1601201|PMID:17360473 20080924 RGD compared to treated females, mock treated males
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20080924 RGD compared to treated females
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20080924 RGD
1641862 F344-<i>Apc<sup>Pirc</i></sup>/Uwm strain MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females
1641863 SHR.PD-(<I>D8Mgh9-D8Rat149</I>)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000211|XCO:0000246 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv
1641863 SHR.PD-(<I>D8Mgh9-D8Rat149</I>)/Cub strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000211,XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv
1641863 SHR.PD-(<I>D8Mgh9-D8Rat149</I>)/Cub strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000246,XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv
1641863 SHR.PD-(<I>D8Mgh9-D8Rat149</I>)/Cub strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv
1641863 SHR.PD-(<I>D8Mgh9-D8Rat149</I>)/Cub strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000246 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv
1641864 WF/CrCrli strain MP:0009314 increased colon adenocarcinoma incidence induced IAGP XCO:0000393 N RGD:1625309|PMID:17510081 20200319 RGD compared to treated ACI/SegHsd
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641865 SD-<i>Brca2<sup>m1Uwm</i></sup> strain MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210426 RGD
1641866 SS.LEW-(<i>D10Mit10-D10Rat24</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641866 SS.LEW-(<i>D10Mit10-D10Rat24</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641867 Iusm:P alcohol-preferring strain MP:0000062 increased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0001262 decreased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0001262 decreased body weight onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0001399 hyperactivity IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0001745 increased circulating corticosterone level IAGP N RGD:8662401|PMID:24611993 20210714 RGD compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0001987 alcohol preference IAGP N RGD:156431211|PMID:9802545 20230306 RGD compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0002764 short tibia onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0002917 decreased synaptic depression IAGP N RGD:149735328|PMID:24082084 20210714 RGD compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0003109 short femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0004149 increased bone strength IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm
1641867 Iusm:P alcohol-preferring strain MP:0004351 short humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm
1641868 WF.BBDR-(<i>D4Rat93-D4Rat228</i>)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD
1641869 SS.MNS-(<i>D10Mco31-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr
1641869 SS.MNS-(<i>D10Mco31-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
1641871 SS.MNS-(<i>D10Mco62-D10Mco31</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080211 RGD compared to SS/Jr
1641871 SS.MNS-(<i>D10Mco62-D10Mco31</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080211 RGD compared to SS/Jr
1641872 SS.LEW-(<i>D10Mco38-D10Mco41</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641872 SS.LEW-(<i>D10Mco38-D10Mco41</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0000182 increased circulating LDL cholesterol level induced IAGP XCO:0000025 N RGD:619661|PMID:11304517 20201201 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000244 | XCO:0000025 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0001260 increased body weight induced IAGP XCO:0000022, XCO:0000367 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0005317 increased triglyceride level induced IAGP XCO:0000244 | XCO:0000025 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR
1641875 SHR-Chr Y<sup>BN</sup>/Cub strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR
1641876 BBDP.WF-(<i>D8Rat73-D8Sunn1467</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD
1641877 NP.P-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0000062 increased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm
1641877 NP.P-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0001262 decreased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm
1641877 NP.P-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0001399 hyperactivity IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm
1641877 NP.P-(<i>D4Rat119-D4Rat55</i>)/Iusm strain MP:0003545 increased alcohol consumption IAGP N RGD:1578304|PMID:16470346 20080924 RGD
1641878 WF.BBDR-(<i>Clcn1-D4Rat228</i>)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0002963 decreased urine protein level IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS/JrRkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0003918 decreased kidney weight IAGP N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20201022 RGD
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0005179 decreased circulating cholesterol level IMP N RGD:2307185|PMID:18824493 20090520 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0005540 decreased urine albumin level IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0005608 cardiac interstitial fibrosis severity IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS/JrRkb
1641879 SS-Chr 19<sup>SHR</sup>/Rkb strain MP:0031199 decreased aortic weight IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb
1641885 Alcrsp9 Alcohol response QTL 9 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641887 Alcrsp14 Alcohol response QTL 14 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641889 Colcr6 Colorectal carcinoma resistance QTL 6 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641891 Alcrsp17 Alcohol response QTL 17 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641893 Alcrsp7 Alcohol response QTL 7 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641893 Alcrsp7 Alcohol response QTL 7 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641894 Alcrsp12 Alcohol response QTL 12 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641895 Bp298 Blood pressure QTL 298 qtl MP:0004184 abnormal baroreceptor physiology TAS N RGD:2302408|PMID:19047583 20081217 RGD
1641895 Bp298 Blood pressure QTL 298 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1600255|PMID:17327494 20070824 RGD
1641897 Alcrsp1 Alcohol response QTL 1 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641897 Alcrsp1 Alcohol response QTL 1 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641898 Colcr4 Colorectal carcinoma resistance QTL4 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641900 Alcrsp11 Alcohol response QTL 11 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641901 Alcrsp6 Alcohol response QTL 6 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641901 Alcrsp6 Alcohol response QTL 6 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641902 Colcr7 Colorectal carcinoma resistance QTL 7 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641903 Alcrsp3 Alcohol response QTL 3 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641903 Alcrsp3 Alcohol response QTL 3 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641904 Alcrsp4 Alcohol response QTL 4 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641904 Alcrsp4 Alcohol response QTL 4 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641905 Colcr1 Colorectal carcinoma resistance QTL 1 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641906 Alcrsp16 Alcohol response QTL 16 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641908 Teswt1 Testicular weight QTL 1 qtl MP:0004852 decreased testis weight IDA N RGD:1625009|PMID:16651691 20080924 RGD
1641910 Colcr3 Colorectal carcinoma resistance QTL 3 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641911 Alcrsp13 Alcohol response QTL 13 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641912 Alcrsp18 Alcohol response QTL 18 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641913 Colcr2 Colorectal carcinoma resistance QTL 2 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641915 Colcr9 Colorectal carcinoma resistance QTL 9 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641917 Colcr5 Colorectal carcinoma resistance QTL 5 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641918 Alcrsp15 Alcohol response QTL 16 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641919 Alc22 Alcohol consumption QTL 22 qtl MP:0003545 increased alcohol consumption IDA N RGD:1578304|PMID:16470346 20080924 RGD
1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641922 Alcrsp8 Alcohol response QTL 8 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641923 Colcr8 Colorectal carcinoma resistance QTL 8 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD
1641925 Alcrsp2 Alcohol response QTL 2 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641925 Alcrsp2 Alcohol response QTL 2 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641926 Teswt2 Testicular weight QTL 2 qtl MP:0004852 decreased testis weight IDA N RGD:1625009|PMID:16651691 20080924 RGD
1641927 Alcrsp10 Alcohol response QTL 10 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1641928 Alcrsp5 Alcohol response QTL 5 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD
1641928 Alcrsp5 Alcohol response QTL 5 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD
1642017 BBDR/WorBrm strain MP:0004031 insulitis induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD
1642017 BBDR/WorBrm strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20070829 RGD
1642017 BBDR/WorBrm strain MP:0020163 increased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD
1642018 BBDP/WorBrm strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20070829 RGD
1642018 BBDP/WorBrm strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm
1642036 SHR/OlaIpcv-mt<sup>BN/Crl</sup> strain MP:0001262 decreased body weight IAGP N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv
1642036 SHR/OlaIpcv-mt<sup>BN/Crl</sup> strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv
1642036 SHR/OlaIpcv-mt<sup>BN/Crl</sup> strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv
1642036 SHR/OlaIpcv-mt<sup>BN/Crl</sup> strain MP:0010399 decreased skeletal muscle glycogen level IAGP N RGD:1627567|PMID:17693571 20070829 RGD
1642272 SS.LEW-(<i>D10Mco84-D10Got93</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642272 SS.LEW-(<i>D10Mco84-D10Got93</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642275 SS.LEW-(<i>D10Rat29-D10Mco88</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD
1642279 SS.LEW-(<i>D10Arb9-D10Rat161</i>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642279 SS.LEW-(<i>D10Arb9-D10Rat161</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD
1642283 SS.LEW-(<i>D10Rat29-D10Got93</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642283 SS.LEW-(<i>D10Rat29-D10Got93</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642285 SS.LEW-(<i>D10Arb9-D10Rat57</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642285 SS.LEW-(<i>D10Arb9-D10Rat57</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642287 SS.LEW-(<i>D10Arb9-D10Mco84</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD
1642288 SS.LEW-(<i>D10Mco89-D10Got101</i>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr
1642288 SS.LEW-(<i>D10Mco89-D10Got101</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD
1642689 BN.OLETF-(<i>D1Rat169-D1Rat90</i>)/Got strain MP:0001362 abnormal anxiety-related response IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj
1642689 BN.OLETF-(<i>D1Rat169-D1Rat90</i>)/Got strain MP:0012013 abnormal innate avoidance response IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj
1642689 BN.OLETF-(<i>D1Rat169-D1Rat90</i>)/Got strain MP:0013189 abnormal exploration in a new environment IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj
1642690 LA-<i>cp</i>/NJcr strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001260 increased body weight IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001260 increased body weight treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001260 increased body weight treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001261 obese IAGP N RGD:1642391|PMID:7600124 20071009 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001548 hyperlipidemia IAGP N RGD:1642389|PMID:17375078 20071009 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200320 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001554 increased circulating free fatty acids level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0002079 increased circulating insulin level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0002871 albuminuria IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0003711 pathological neovascularization treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0003980 increased circulating phospholipid level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005264 glomerulosclerosis IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005338 atherosclerotic lesions treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005338 atherosclerotic lesions treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005339 increased susceptibility to atherosclerosis IAGP N RGD:1642391|PMID:7600124 20071009 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005339 increased susceptibility to atherosclerosis treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005425 increased macrophage cell number treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005559 increased circulating glucose level IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005669 increased circulating leptin level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0005669 increased circulating leptin level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0008641 increased circulating interleukin-1 beta level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0009170 abnormal pancreatic islet size treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0011939 increased food intake IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0011939 increased food intake IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0011939 increased food intake treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642690 LA-<i>cp</i>/NJcr strain MP:0020411 increased abdominal adipose tissue amount treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0001625 cardiac hypertrophy IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0002833 increased heart weight IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0002953 thick ventricular wall IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0003394 increased cardiac output IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0003900 shortened QT interval IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0011951 increased cardiac stroke volume IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr
1642968 SS.LEW-(<i>D10Mco84-D10Rat58</i>)/Mco strain MP:0012436 increased colon tumor incidence induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20160726 RGD compared to SS/Jr
1642969 SS.LEW-(<i>D10Mco84-D10Mco134</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr
1642969 SS.LEW-(<i>D10Mco84-D10Mco134</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr
1642970 SS.LEW-(<i>D10Mco113-D10Got93</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD
1642971 SS.LEW-(<i>D10Mco84-D10Mco129</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20111115 RGD
1642972 SS.LEW-(<i>D10Mco84-D10Mco143</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr
1642976 Bp301 Blood pressure QTL 301 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD
1642980 Bp300 Blood pressure QTL 300 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD
1642982 Bp302 Blood pressure QTL 302 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD
1643001 FH/Unc Fawn-hooded strain MP:0001987 alcohol preference IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N
1643001 FH/Unc Fawn-hooded strain MP:0003545 increased alcohol consumption IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N
1643002 SHR.WKY-(<i>D1Rat420-D1Got161</i>)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20071117 RGD compared to SHR/NCruk strain
1643004 Pain2 Pain QTL 2 qtl MP:0001970 abnormal pain threshold IDA N RGD:1643003|PMID:17560719 20071117 RGD
1643006 Pain1 Pain QTL 1 qtl MP:0001970 abnormal pain threshold IDA N RGD:1643003|PMID:17560719 20071117 RGD
1643007 DA.ACI-(<i>D12Wox12-D12Rat53</i>)/Arb strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:1600250|PMID:17329308 20071117 RGD compared to DA/Hsd
1643010 F344.OLETF-(<i>D7Rat18-D7Mit2</i>)(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0001260 increased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1643010 F344.OLETF-(<i>D7Rat18-D7Mit2</i>)(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20201103 RGD
1643010 F344.OLETF-(<i>D7Rat18-D7Mit2</i>)(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc
1643010 F344.OLETF-(<i>D7Rat18-D7Mit2</i>)(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc
1643010 F344.OLETF-(<i>D7Rat18-D7Mit2</i>)(<i>D14Rat23-D14Rat12</i>)/Tj strain MP:0011939 increased food intake IAGP N RGD:1643009|PMID:17710484 20201119 RGD compared to F344/Slc
19165133 F344;SD-<i>C3<sup>em1Linf</sup></i> strain MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD
19165134 C3<sup>em1Linf</sup> complement C3; CRISPR/Cas9 system induced mutant 1, Linf gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:19165124|PMID:29695418 20201210 RGD
19165134 C3<sup>em1Linf</sup> complement C3; CRISPR/Cas9 system induced mutant 1, Linf gene MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259464 SHR-<i>Camk2n1<sup>em1Tja-/-</sup></i> SHR-<i>Camk2n1<sup>em1Tja-</sup>/Camk2n1<sup>em1Tja-</sup></i> strain MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
19259465 Camk2n1<sup>em1Tja</sup> calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD
2024 Acr acrosin gene MP:0001935 decreased litter size IMP N RGD:13464336|PMID:28859281 20180112 RGD
2024 Acr acrosin gene MP:0004542 impaired acrosome reaction IMP N RGD:13464336|PMID:28859281 20180112 RGD
2041 Add1 adducin 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302895|PMID:15474463 20070514 RGD
2043 Add3 adducin 3 gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT
2043 Add3 adducin 3 gene MP:0003071 decreased vascular permeability IMP N RGD:150340736|PMID:32029431 20210913 RGD
2043 Add3 adducin 3 gene MP:0003985 renal fibrosis IMP N RGD:150340736|PMID:32029431 20210913 RGD
2043 Add3 adducin 3 gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:150340736|PMID:32029431 20210913 RGD
2043 Add3 adducin 3 gene MP:0005540 decreased urine albumin level IMP N RGD:150340736|PMID:32029431 20210913 RGD
2043 Add3 adducin 3 gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:150340736|PMID:32029431 20210910 RGD
2043 Add3 adducin 3 gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT
2043 Add3 adducin 3 gene MP:0011402 renal cast IMP N RGD:150340736|PMID:32029431 20210913 RGD
2043 Add3 adducin 3 gene MP:0020849 abnormal actin cytoskeleton morphology IMP N RGD:150340736|PMID:32029431 20210910 RGD
2050 Adora2b adenosine A2B receptor gene MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD
2050 Adora2b adenosine A2B receptor gene MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD
2050 Adora2b adenosine A2B receptor gene MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD
2050 Adora2b adenosine A2B receptor gene MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD
2050 Adora2b adenosine A2B receptor gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD
2050 Adora2b adenosine A2B receptor gene MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD
2070 Agtr1a angiotensin II receptor, type 1a gene MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210715 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates
2074 Ahr aryl hydrocarbon receptor gene MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
2074 Ahr aryl hydrocarbon receptor gene MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
2074 Ahr aryl hydrocarbon receptor gene MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
2074 Ahr aryl hydrocarbon receptor gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females
2074 Ahr aryl hydrocarbon receptor gene MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240718 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates
2074 Ahr aryl hydrocarbon receptor gene MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD males compared to Hsd:SD
2074 Ahr aryl hydrocarbon receptor gene MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210715 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240822 RGD
2074 Ahr aryl hydrocarbon receptor gene MP:0020969 impaired conditioned taste aversion behavior sexual_dimorphism IMP N RGD:407419883|PMID:30769105 20240912 RGD
2081 Akt1 AKT serine/threonine kinase 1 gene MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD
2081 Akt1 AKT serine/threonine kinase 1 gene MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240620 RGD
2081 Akt1 AKT serine/threonine kinase 1 gene MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD
2085 Alb albumin gene MP:0005419 decreased circulating serum albumin level IAGP N RGD:734959|PMID:1690892 20070112 RGD
2087 Aldh1a1 aldehyde dehydrogenase 1 family, member A1 gene MP:0001987 alcohol preference IAGP N RGD:2306323|PMID:11825850 20090408 RGD DNA:polymorphism
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079475 SD-<i>Lepr<sup>em4Lizh</sup></i> strain MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD
21079476 Lepr<sup>em4Lizh</sup> leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD
2123 Apc APC regulator of WNT signaling pathway gene MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
2123 Apc APC regulator of WNT signaling pathway gene MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
2123 Apc APC regulator of WNT signaling pathway gene MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to males
2123 Apc APC regulator of WNT signaling pathway gene MP:0002044 increased colon adenoma incidence IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females, mock treated males
2123 Apc APC regulator of WNT signaling pathway gene MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females
2123 Apc APC regulator of WNT signaling pathway gene MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20201210 RGD
2123 Apc APC regulator of WNT signaling pathway gene MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females
2132 Apoa4 apolipoprotein A4 gene MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type
2132 Apoa4 apolipoprotein A4 gene MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type
2138 Apoe apolipoprotein E gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD
2138 Apoe apolipoprotein E gene MP:0000186 decreased circulating HDL cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD
2138 Apoe apolipoprotein E gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD
2138 Apoe apolipoprotein E gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD
2138 Apoe apolipoprotein E gene MP:0005178 increased circulating cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD
2138 Apoe apolipoprotein E gene MP:0010535 myocardium steatosis IMP N RGD:13703132|PMID:28808185 20180803 RGD
2143 Aqp4 aquaporin 4 gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220120 RGD
2147 Ar androgen receptor gene MP:0002152 abnormal brain morphology IAGP N RGD:10043338|PMID:17490813 20150521 RGD
2147 Ar androgen receptor gene MP:0002797 increased thigmotaxis IAGP N RGD:10043340|PMID:24269497 20150521 RGD
2157 Arrb2 arrestin, beta 2 gene MP:0001987 alcohol preference IAGP N RGD:401938607|PMID:18367649 20231213 RGD
2158 Arsb arylsulfatase B gene MP:0000130 abnormal trabecular bone morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0001405 impaired coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0001524 impaired limb coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0002282 abnormal trachea morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0010867 abnormal bone trabecula morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0013498 trachea inflammation IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0030866 abnormal synovial joint membrane morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2158 Arsb arylsulfatase B gene MP:0030895 abnormal tibiofemoral joint morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20201214 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0001262 decreased body weight IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20210218 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0003066 increased liver copper level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0003402 decreased liver weight IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0005344 increased circulating bilirubin level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0006349 decreased circulating copper level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20210218 RGD compared to LEC/Tj;
2180 Atp7b ATPase copper transporting beta gene MP:0009355 increased liver triglyceride level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0010027 increased liver cholesterol level IAGP N RGD:2292672|PMID:17303181 20210211 RGD
2180 Atp7b ATPase copper transporting beta gene MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20201214 RGD
2184 Avp arginine vasopressin gene MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20201210 RGD
2191 Bace1 beta-secretase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD
2191 Bace1 beta-secretase 1 gene MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000556 abnormal hindlimb morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000574 abnormal foot pad morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000583 long toenails IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001106 abnormal Schwann cell morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001265 decreased body size IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001922 reduced male fertility IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001940 testis hypoplasia IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0002175 decreased brain weight IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0002651 abnormal sciatic nerve morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0003081 abnormal soleus morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0008535 enlarged lateral ventricles IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030716 decreased circulating isoleucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030728 decreased circulating valine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030751 decreased circulating leucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat)
2202 Bdnf brain-derived neurotrophic factor gene MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20201210 RGD compared to WT
2202 Bdnf brain-derived neurotrophic factor gene MP:0001260 increased body weight severity IMP N RGD:38501054|PMID:23583595 20210416 RGD
2202 Bdnf brain-derived neurotrophic factor gene MP:0001262 decreased body weight IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to homozygous rats
2202 Bdnf brain-derived neurotrophic factor gene MP:0001363 increased anxiety-related response IAGP N RGD:1600586|PMID:16899727 20070316 RGD
2202 Bdnf brain-derived neurotrophic factor gene MP:0001988 cocaine preference severity IMP N RGD:38501054|PMID:23583595 20210416 RGD
2202 Bdnf brain-derived neurotrophic factor gene MP:0002555 addiction IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to heterozygous rats
2202 Bdnf brain-derived neurotrophic factor gene MP:0002555 addiction severity IMP N RGD:38501054|PMID:23583595 20210416 RGD
2202 Bdnf brain-derived neurotrophic factor gene MP:0003545 increased alcohol consumption IAGP N RGD:1600586|PMID:16899727 20070316 RGD
2202 Bdnf brain-derived neurotrophic factor gene MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210218 RGD compared to WT
2202 Bdnf brain-derived neurotrophic factor gene MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to heterozygous rats
2204 Cfb complement factor B gene MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2204 Cfb complement factor B gene MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR
2219 Brca2 BRCA2, DNA repair associated gene MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210426 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0001156 abnormal spermatogenesis IAGP N RGD:1599505|PMID:16964288 20070206 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210429 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210426 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210426 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0003205 testicular atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20210218 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210426 RGD
2219 Brca2 BRCA2, DNA repair associated gene MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210426 RGD
2225 Btg2 BTG anti-proliferation factor 2 gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD
2225 Btg2 BTG anti-proliferation factor 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD
2228 Tspo translocator protein gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
2228 Tspo translocator protein gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD
2228 Tspo translocator protein gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD
2232 C3 complement C3 gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:19165124|PMID:29695418 20201210 RGD
2232 C3 complement C3 gene MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD
2238 C6 complement C6 gene MP:0004824 decreased susceptibility to experimental autoimmune myasthenia gravis IAGP N RGD:1600670|PMID:17034580 20070322 RGD
2244 Cacna1a calcium voltage-gated channel subunit alpha1 A gene MP:0001406 abnormal gait IAGP N RGD:1598976|PMID:17196942 20160613 RGD
2244 Cacna1a calcium voltage-gated channel subunit alpha1 A gene MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20240926 RGD
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to female wild-type
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to male wild-type
2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male
2246 Cacna1e calcium voltage-gated channel subunit alpha1 E gene MP:0020424 increased kindling response IAGP N RGD:6907065|PMID:20638246 20180712 RGD
2252 Ddr1 discoidin domain receptor tyrosine kinase 1 gene MP:0005023 abnormal wound healing IGI RGD:3140 N RGD:151347403|PMID:28199848 20220119 RGD Myh9 NMIIA RGDID 3140
2252 Ddr1 discoidin domain receptor tyrosine kinase 1 gene MP:0008438 abnormal cutaneous collagen fibril morphology IGI RGD:3140 N RGD:151347403|PMID:28199848 20220119 RGD Myh9 NMIIA RGDID 3140
2263 Camk2d calcium/calmodulin-dependent protein kinase II delta gene MP:0002064 seizures IAGP N RGD:6907065|PMID:20638246 20190823 RGD DNA:SNP:intron:g.24024428G>T
2289 Cckar cholecystokinin A receptor gene MP:0001433 polyphagia IAGP N RGD:7257724|PMID:9530226 20070529 RGD
2289 Cckar cholecystokinin A receptor gene MP:0001777 abnormal body temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20070529 RGD
2289 Cckar cholecystokinin A receptor gene MP:0001986 abnormal taste sensitivity IAGP N RGD:1625203|PMID:16081877 20070529 RGD
2289819 SS.MNS-(<i>D10Mco62-D10Got99</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289819 SS.MNS-(<i>D10Mco62-D10Got99</i>)/Mco strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289821 SS.MNS-(<i>D10Mco30-D10Got91</i>)/3Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289822 SS.MNS-(<i>D10Mco30-D10Got112</i>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289823 SS.MNS-(<i>D10Mco62-D10Mco30</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289823 SS.MNS-(<i>D10Mco62-D10Mco30</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289824 SS.MNS-(<i>D10Mco30-D10Got101</i>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289826 SS.MNS-(<i>D10Mco30-D10Got91</i>)/2Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289826 SS.MNS-(<i>D10Mco30-D10Got91</i>)/2Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr
2289827 SS.MNS-(<i>D10Mco30-D10Mco31</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr
2289827 SS.MNS-(<i>D10Mco30-D10Mco31</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr
2289916 SS.MNS-(<i>D10Mco15-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200206 RGD compared to SS/Jr
2289916 SS.MNS-(<i>D10Mco15-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200206 RGD compared to SS/Jr
2289982 Bp303 Blood pressure QTL 303 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD
2289983 Bp304 Blood pressure QTL 304 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD
2289985 Bp305 Blood pressure QTL 305 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD
2290005 Mcs24 Mammary carcinoma susceptibility QTL 24 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1601189|PMID:17404222 20080222 RGD
2290007 Mcs23 Mammary carcinoma susceptibility QTL 23 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1601189|PMID:17404222 20080222 RGD
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to mutant male
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240425 RGD compared to female
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20210211 RGD compared to wild-type
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to wild type female
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD
2290090 Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup> neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240425 RGD
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD compared to F344
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240419 RGD compared to mutant male
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240419 RGD compared to female
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20210208 RGD compared to wild-type
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240419 RGD compared to wild type female
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD compared to F344
2290103 F344-<i>Nrg1<sup>Tn(sb-T2/Bart3)2.183Mcwi</sup></i> strain MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240419 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0000755 hindlimb paralysis IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0000938 motor neuron degeneration IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0001262 decreased body weight IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0002066 abnormal motor capabilities/coordination/movement IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0002083 premature death IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0002111 abnormal tail morphology IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0003354 astrocytosis IMP N RGD:2290184|PMID:11717358 20200924 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0004263 abnormal limb posture IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0008918 microgliosis IMP N RGD:2290184|PMID:11717358 20200924 RGD
2290186 SD-Tg(SOD1*G93A)39 strain MP:0030706 increased glutamine level IMP N RGD:2290184|PMID:11717358 20200924 RGD CSF, compared to control littermates
2290187 SD-Tg(SOD1*H46R)4 strain MP:0000755 hindlimb paralysis IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0000938 motor neuron degeneration IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0001262 decreased body weight IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0002066 abnormal motor capabilities/coordination/movement IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0002083 premature death IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0002111 abnormal tail morphology IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0003354 astrocytosis IMP N RGD:2290184|PMID:11717358 20200924 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0004263 abnormal limb posture IMP N RGD:2290184|PMID:11717358 20080228 RGD
2290187 SD-Tg(SOD1*H46R)4 strain MP:0008918 microgliosis IMP N RGD:2290184|PMID:11717358 20200924 RGD
2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0001516 abnormal motor coordination/balance IAGP N RGD:2290297|PMID:17169350 20080305 RGD compared to SHR
2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0002229 neurodegeneration IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0003214 neurofibrillary tangles IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0004250 tau protein deposits IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0012307 impaired spatial learning IAGP N RGD:2290297|PMID:17169350 20080305 RGD compared to SHR
2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0002229 neurodegeneration IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0003214 neurofibrillary tangles IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0004250 tau protein deposits IMP N RGD:2290296|PMID:16753151 20080305 RGD
2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0000938 motor neuron degeneration IMP N RGD:729817|PMID:11818550 20080307 RGD
2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0002083 premature death IMP N RGD:729817|PMID:11818550 20080307 RGD
2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0002269 muscular atrophy IMP N RGD:729817|PMID:11818550 20080307 RGD
2290372 Gluco33 Glucose level QTL 33 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD
2290374 Gluco32 Glucose level QTL 32 qtl MP:0002727 decreased circulating insulin level IDA N RGD:1626640|PMID:17213368 20080311 RGD
2290374 Gluco32 Glucose level QTL 32 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD
2290375 Gluco34 Glucose level QTL 34 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD
2290386 SD-Tg(Wld<sup>s</sup>)23Cole strain MP:0000940 abnormal motor neuron innervation pattern IMP N RGD:2290382|PMID:15654865 20180815 RGD
2290386 SD-Tg(Wld<sup>s</sup>)23Cole strain MP:0010654 slow Wallerian degeneration IMP N RGD:2290382|PMID:15654865 20180815 RGD
2290387 SD-Tg(UbC-APPswe)6590 strain MP:0003329 amyloid beta deposits IMP N RGD:2290385|PMID:17506994 20080311 RGD human transgene in a rat model
2290391 SD-Tg(Wld<sup>s</sup>)79Cole strain MP:0000940 abnormal motor neuron innervation pattern IMP N RGD:2290382|PMID:15654865 20180815 RGD
2290391 SD-Tg(Wld<sup>s</sup>)79Cole strain MP:0010654 slow Wallerian degeneration IMP N RGD:2290382|PMID:15654865 20180815 RGD
2290393 Uae37 Urinary albumin excretion QTL 37 qtl MP:0002871 albuminuria IDA N RGD:1642911|PMID:17953514 20080311 RGD
2290393 Uae37 Urinary albumin excretion QTL 37 qtl MP:0002962 increased urine protein level IDA N RGD:1642911|PMID:17953514 20120112 RGD
2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd
2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd
2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0002083 premature death IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd
2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd
2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0005339 increased susceptibility to atherosclerosis IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd
2290448 Scl54 Serum cholesterol level QTL 54 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD
2290450 Scl57 Serum cholesterol level QTL 57 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD
2290451 Scl58 Serum cholesterol level QTL 58 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD
2290452 Scl56 Serum cholesterol level QTL 56 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD
2290453 Scl55 Serum cholesterol level QTL 55 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0001441 increased grooming behavior IAGP N RGD:2306974|PMID:19089625 20200123 RGD as compared to WAG rats
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0001745 increased circulating corticosterone level IAGP N RGD:2306974|PMID:19089625 20090520 RGD as compared to WAG rats
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0002833 increased heart weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0003917 increased kidney weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1626643|PMID:16700878 20080411 RGD as compared to WAG/Nov
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2306974|PMID:19089625 20200123 RGD as compared to WAG rats
2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0013307 increased adrenal gland weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov
2292216 Bw80 Body weight QTL 80 qtl MP:0001262 decreased body weight IAGP N RGD:1626643|PMID:16700878 20080415 RGD
2292218 Kidm35 Kidney mass QTL 35 qtl MP:0003918 decreased kidney weight IDA N RGD:1626643|PMID:16700878 20080415 RGD
2292220 Bp306 Blood pressure QTL 306 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1626643|PMID:16700878 20080415 RGD
2292222 Bp307 Blood pressure QTL 307 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1626643|PMID:16700878 20080415 RGD stress induced
2292232 Pur16 Proteinuria QTL 16 qtl MP:0002962 increased urine protein level IDA N RGD:2292230|PMID:18064521 20080416 RGD
2292384 SS.LEW-(<i>D10Chm167-D10Chm257</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292385 SS.LEW-(<i>D10Mco30-D10Got107</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD
2292386 SS.LEW-(<i>D10Chm155-D10Rat127</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292387 SS.LEW-(<i>D10Chm224-D10Chm259</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292388 SS.LEW-(<i>D10Chm246-D10Chm257</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292388 SS.LEW-(<i>D10Chm246-D10Chm257</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to SS/Jr
2292389 SS.LEW-(<i>D10Chm10-D10Chm14</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292390 SS.LEW-(<i>D10Rat194-D10Chm243</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr
2292436 Bp310 Blood pressure QTL 310 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD
2292438 Bp311 Blood pressure QTL 311 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD
2292439 Bp309 Blood pressure QTL 309 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD
2292440 Bp312 Blood pressure QTL 312 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD
2292441 Bp308 Blood pressure QTL 308 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD
2292459 WF.LEW-<i>RVFV</i> strain MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality IAGP N RGD:2292456|PMID:2063951 20080423 RGD compared to WF/Mai
2292526 SS-Tg(Atp1a1)48Opaz strain MP:0001661 extended life span IMP N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd
2292526 SS-Tg(Atp1a1)48Opaz strain MP:0005166 decreased susceptibility to injury induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd
2292528 F344-Tg(APPswe)Opaz strain MP:0012306 enhanced spatial learning IAGP N RGD:2292518|PMID:15502881 20080514 RGD compared to F344 control
2292564 ACI.COP-(<i>D6Rat80-D6Rat146</i>)/Shul strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd
2292564 ACI.COP-(<i>D6Rat80-D6Rat146</i>)/Shul strain MP:0004956 decreased thymus weight IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl, ACI/SegHsd
2292564 ACI.COP-(<i>D6Rat80-D6Rat146</i>)/Shul strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd
2292564 ACI.COP-(<i>D6Rat80-D6Rat146</i>)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to untreated COP/CrCrl
2292564 ACI.COP-(<i>D6Rat80-D6Rat146</i>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd, ACI.COP-(D3Mgh16-D3Rat119)/Shul, ACI.COP-(D3Rat130-D3Rat114)/Shul, COP/CrCrl, ACI.COP-(D10Mgh20-D10Rat4)/Shul�
2292565 ACI.COP-(<i>D3Mgh16-D3Rat119</i>)/Shul strain MP:0004955 increased thymus weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl
2292565 ACI.COP-(<i>D3Mgh16-D3Rat119</i>)/Shul strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl
2292565 ACI.COP-(<i>D3Mgh16-D3Rat119</i>)/Shul strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl
2292565 ACI.COP-(<i>D3Mgh16-D3Rat119</i>)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd and COP/CrCrl
2292566 ACI.COP-(<i>D3Rat130-D3Rat114</i>)/Shul strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd
2292566 ACI.COP-(<i>D3Rat130-D3Rat114</i>)/Shul strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd
2292567 ACI.COP-(<i>D10Mgh20-D10Rat4</i>)/Shul strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl, ACI/SegHsd
2292567 ACI.COP-(<i>D10Mgh20-D10Rat4</i>)/Shul strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared COP/CrCrl
2292567 ACI.COP-(<i>D10Mgh20-D10Rat4</i>)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared COP/CrCrl
2292589 Emca10 Estrogen-induced mammary cancer QTL 10 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:2292503|PMID:18420736 20111107 RGD
2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 qtl MP:0003644 thymus atrophy IDA N RGD:2292503|PMID:18420736 20080424 RGD E2 induced for 12 weeks
2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks
2292615 Ept17 Estrogen-induced pituitary tumorigenesis QTL 17 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks
2292616 Ept15 Estrogen-induced pituitary tumorigenesis QTL 15 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks
2292617 Ept18 Estrogen-induced pituitary tumorigenesis QTL 18 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks
2292647 SS.LEW-(<I>D1Mco36-D1Rat106</I>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292648 SS.LEW-(<I>D1Mco36-D1Mco77</I>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292648 SS.LEW-(<I>D1Mco36-D1Mco77</I>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191127 RGD
2292648 SS.LEW-(<I>D1Mco36-D1Mco77</I>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292649 SS.LEW-(<I>D1Mco36-D1Rat131</I>)/1Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292650 SS.LEW-(<I>D1Mco36-D1Rat131</I>)/2Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292651 SS.LEW-(<I>D1Mco99-D1Rat49</I>)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292651 SS.LEW-(<I>D1Mco99-D1Rat49</I>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD
2292652 SS.LEW-(<I>D1Mco85-D1Rat49</I>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292652 SS.LEW-(<I>D1Mco85-D1Rat49</I>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292653 SS.LEW-(<i>D1Mco36-D1Mco101</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292653 SS.LEW-(<i>D1Mco36-D1Mco101</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
2292653 SS.LEW-(<i>D1Mco36-D1Mco101</i>)/Mco strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191127 RGD compared to SS/Jr
2293012 ACI.BBDP-(<i>RT1<sup>u</sup></i>)(<i>Gimap5</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2293011|PMID:1446803 20080507 RGD
2293012 ACI.BBDP-(<i>RT1<sup>u</sup></i>)(<i>Gimap5</i>)/Sunn strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:2293011|PMID:1446803 20200128 RGD
2293012 ACI.BBDP-(<i>RT1<sup>u</sup></i>)(<i>Gimap5</i>)/Sunn strain MP:0020192 decreased lymphocyte activation involved in immune response IAGP N RGD:2293011|PMID:1446803 20200128 RGD
2293083 Iddm25 Insulin dependent diabetes mellitus QTL 25 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293084 Iddm26 Insulin dependent diabetes mellitus QTL 26 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293085 Iddm29 Insulin dependent diabetes mellitus QTL 29 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293086 Iddm30 Insulin dependent diabetes mellitus QTL 30 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293087 Iddm27 Insulin dependent diabetes mellitus QTL 27 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293088 Iddm28 Insulin dependent diabetes mellitus QTL 28 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293089 Iddm31 Insulin dependent diabetes mellitus QTL 31 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2293120 LOU.BN-(<i>D10Mgh1-D10Mgh14</i>)/Ins strain MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:2293119|PMID:18462270 20080513 RGD compared to LOU
2293120 LOU.BN-(<i>D10Mgh1-D10Mgh14</i>)/Ins strain MP:0003184 increased angiotensin I-converting enzyme activity induced IAGP XCO:0000005 N RGD:2293119|PMID:18462270 20201202 RGD compared to LOU
2293140 Bp313 Blood pressure QTL 313 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2291850|PMID:18324438 20080514 RGD as compared to SS/Jr
2293142 Bp314 Blood pressure QTL 314 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2291850|PMID:18324438 20080514 RGD as compared to SS/Jr
2293143 SS.BN-(<i>D13Rat20-D13Rat127</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male
2293143 SS.BN-(<i>D13Rat20-D13Rat127</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in female, compared to SS/JrHsdMcwi
2293143 SS.BN-(<i>D13Rat20-D13Rat127</i>)/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD
2293144 SS.BN-(<i>D13Rat91-D13Rat179</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male
2293144 SS.BN-(<i>D13Rat91-D13Rat179</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD in male
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD in male
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in female, compared to SS/JrHsdMcwi;
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi;
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0005582 increased renin activity IAGP N RGD:2289092|PMID:18198281 20080515 RGD
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD
2293145 SS.BN-(<i>D13Hmgc64-RN34_13048990782</i>)/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
2293146 SS.BN-(<i>D13Rat20-D13Got22</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD
2293341 Glom15 Glomerulus QTL 15 qtl MP:0002743 glomerulonephritis susceptibility IDA N RGD:2293335|PMID:16482158 20080528 RGD
2293343 Glom16 Glomerulus QTL 16 qtl MP:0002743 glomerulonephritis susceptibility IDA N RGD:2293335|PMID:16482158 20080528 RGD
2293354 LEW.WKY-(<i>D16Rat88-D16Rat40</i>)/Tja strain MP:0002962 increased urine protein level induced IAGP XCO:0000769 N RGD:2293336|PMID:18443593 20080529 RGD compared to LEW/Crl
2293355 WKY.LEW-(<i>D16Rat88-D16Rat40</i>)/Tja strain MP:0011079 decreased macrophage cytokine production IAGP N RGD:2293336|PMID:18443593 20080529 RGD compared to WKY/NCrl
2293642 Bss37 Bone structure and strength QTL 37 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293644 Bmd29 Bone mineral density QTL 29 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293644 Bmd29 Bone mineral density QTL 29 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293646 Bss25 Bone structure and strength QTL 25 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293648 Bmd31 Bone mineral density QTL 31 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293648 Bmd31 Bone mineral density QTL 31 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293650 Bss31 Bone structure and strength QTL 31 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293652 Bmd22 Bone mineral density QTL 22 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293654 Bss30 Bone structure and strength QTL 30 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293655 Bss36 Bone structure and strength QTL 36 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293656 Bss28 Bone structure and strength QTL 28 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293658 Bmd23 Bone mineral density QTL 23 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293659 Bmd35 Bone mineral density QTL 35 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293661 Bss50 Bone structure and strength QTL 50 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293663 Bss33 Bone structure and strength QTL 33 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293664 Bmd28 Bone mineral density QTL 28 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293664 Bmd28 Bone mineral density QTL 28 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293666 Bmd38 Bone mineral density QTL 38 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293667 Bss42 Bone structure and strength QTL 42 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293669 Bmd33 Bone mineral density QTL 33 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293671 Bss44 Bone structure and strength QTL 44 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293673 Bss27 Bone structure and strength QTL 27 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293674 Bss39 Bone structure and strength QTL 39 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293676 Bmd19 Bone mineral density QTL 19 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293677 Bss41 Bone structure and strength QTL 41 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293678 Bss24 Bone structure and strength QTL 24 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293679 Bmd30 Bone mineral density QTL 30 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293679 Bmd30 Bone mineral density QTL 30 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293680 Bss40 Bone structure and strength QTL 40 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293682 Bmd24 Bone mineral density QTL 24 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293682 Bmd24 Bone mineral density QTL 24 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293684 Bmd26 Bone mineral density QTL 26 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293684 Bmd26 Bone mineral density QTL 26 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293685 Bmd21 Bone mineral density QTL 21 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293686 Bmd36 Bone mineral density QTL 36 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293687 Bss26 Bone structure and strength QTL 26 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293688 Bss29 Bone structure and strength QTL 29 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293689 Bss47 Bone structure and strength QTL 47 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293690 Bss45 Bone structure and strength QTL 45 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293691 Bmd37 Bone mineral density QTL 37 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293693 Bss22 Bone structure and strength QTL 22 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293694 Bss38 Bone structure and strength QTL 38 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293696 Bmd32 Bone mineral density QTL 32 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293697 Bmd39 Bone mineral density QTL 39 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293698 Bss43 Bone structure and strength QTL 43 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293699 Bss49 Bone structure and strength QTL 49 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293700 Bmd27 Bone mineral density QTL 27 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293700 Bmd27 Bone mineral density QTL 27 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293701 Bmd34 Bone mineral density QTL 34 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293702 Bss34 Bone structure and strength QTL 34 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293703 Bss48 Bone structure and strength QTL 48 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293704 Bss35 Bone structure and strength QTL 35 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293705 Bmd25 Bone mineral density QTL 25 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293705 Bmd25 Bone mineral density QTL 25 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293706 Bmd20 Bone mineral density QTL 20 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD
2293707 Bss32 Bone structure and strength QTL 32 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293708 Bss46 Bone structure and strength QTL 46 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293709 Bss23 Bone structure and strength QTL 23 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20080611 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20080611 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20211109 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20211109 RGD
2293729 SHR-<i>Gja8</i><sup>m1-/-Cub</sup> strain MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20211109 RGD
2293761 LH-Chr 17<sup>BN</sup>/Mav strain MP:0001262 decreased body weight IAGP N RGD:2290181|PMID:18285521 20080612 RGD as comapred to LH/Mav
2293761 LH-Chr 17<sup>BN</sup>/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2290181|PMID:18285521 20080612 RGD as compared to BN/NHsdMcwi
2293761 LH-Chr 17<sup>BN</sup>/Mav strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2290181|PMID:18285521 20200611 RGD
2293761 LH-Chr 17<sup>BN</sup>/Mav strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2290181|PMID:18285521 20080612 RGD as comapred to LH/Mav
2293761 LH-Chr 17<sup>BN</sup>/Mav strain MP:0005318 decreased triglyceride level IAGP N RGD:2290181|PMID:18285521 20080612 RGD as compared to LH/Mav
2293770 SHHF/Bbb strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb
2293770 SHHF/Bbb strain MP:0005598 decreased heart ventricle muscle contractility IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to as compared to WKY/Bbb, WKY/Bbb
2293770 SHHF/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb
2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0005161 hematuria IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293837 Kiddil1 Kidney dilation QTL 1 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293837 Kiddil1 Kidney dilation QTL 1 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293839 Kiddil2 Kidney dilation QTL 2 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293839 Kiddil2 Kidney dilation QTL 2 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293840 Kiddil9 Kidney dilation QTL 9 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293840 Kiddil9 Kidney dilation QTL 9 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293841 Kiddil4 Kidney dilation QTL 4 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293841 Kiddil4 Kidney dilation QTL 4 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293842 Kiddil3 Kidney dilation QTL 3 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293842 Kiddil3 Kidney dilation QTL 3 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293843 Kiddil6 Kidney dilation QTL 6 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293843 Kiddil6 Kidney dilation QTL 6 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD
2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0005161 hematuria IDA N RGD:2293631|PMID:18523158 20080616 RGD
2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to LEW allele
2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele
2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele
2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele
2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele
2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele
2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele
2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16
2298494 Kini:DA,PVG-G10 strain MP:0001263 weight loss MODEL: induced IAGP N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG
2298494 Kini:DA,PVG-G10 strain MP:0006082 CNS inflammation induced IAGP N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG
2298495 Eae23 Experimental allergic encephalomyelitis QTL 23 qtl MP:0001263 weight loss IDA N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG
2298495 Eae23 Experimental allergic encephalomyelitis QTL 23 qtl MP:0006082 CNS inflammation IDA N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG
2298498 W/Gaox strain MP:0002725 abnormal vein morphology IAGP N RGD:2298497|PMID:18211296 20080703 RGD compared to wild type Wistar
2298542 Neuinf11 Neuroinflammation QTL 11 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298544 Neuinf9 Neuroinflammation QTL 9 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298545 Neuinf8 Neuroinflammation QTL 8 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298546 Neuinf4 Neuroinflammation QTL 4 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298547 Neuinf5 Neuroinflammation QTL 5 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298548 Neuinf7 Neuroinflammation QTL 7 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298549 Neuinf12 Neuroinflammation QTL 12 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298550 Neuinf6 Neuroinflammation QTL 6 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298551 Neuinf10 Neuroinflammation QTL 10 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD
2298772 WF<sup>fzHsd</sup> Fuzzy rat strain MP:0009930 fuzzy hair IAGP N RGD:150520038|PMID:20201958 20211022 RGD
2298772 WF<sup>fzHsd</sup> Fuzzy rat strain MP:0009930 fuzzy hair IAGP N RGD:625461|PMID:12195039 20080723 RGD
2299160 Iddm35 Insulin dependent diabetes mellitus QTL 35 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD
2299161 Iddm33 Insulin dependent diabetes mellitus QTL 33 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD
2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD
2299163 Iddm34 Insulin dependent diabetes mellitus QTL 34 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD
2300002 Iddm36 Insulin dependent diabetes mellitus QTL 36 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0001260 increased body weight IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2300017|PMID:14756693 20080829 RGD compared to SHRSP/Izm and Slc:ZUC-Leprfa
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0002079 increased circulating insulin level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0002981 increased liver weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0005559 increased circulating glucose level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0005669 increased circulating leptin level IAGP N RGD:2300017|PMID:14756693 20080829 RGD compared to SHRSP/Izm and Slc:ZUC-Leprfa
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm
2300018 SHRSP.ZUC-(<i>D5Rat4-D5Rat36</i>)/IzmDmcr strain MP:0011758 renal ischemia IAGP N RGD:2300016|PMID:18712058 20080829 RGD
2300157 Bmd66 Bone mineral density QTL 66 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300159 Bmd61 Bone mineral density QTL 61 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300161 Bmd43 Bone mineral density QTL 43 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300163 Bmd64 Bone mineral density QTL 64 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300164 Bmd44 Bone mineral density QTL 44 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300165 Bmd49 Bone mineral density QTL 49 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300167 Bmd63 Bone mineral density QTL 63 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300168 Bmd47 Bone mineral density QTL 47 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300170 Bmd45 Bone mineral density QTL 45 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300171 Bmd58 Bone mineral density QTL 58 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300172 Bmd57 Bone mineral density QTL 57 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300173 Bmd62 Bone mineral density QTL 62 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300174 Bmd42 Bone mineral density QTL 42 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300175 Bmd40 Bone mineral density QTL 40 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300176 Bmd51 Bone mineral density QTL 51 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300177 Bmd65 Bone mineral density QTL 65 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300178 Bmd54 Bone mineral density QTL 54 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300179 Bmd50 Bone mineral density QTL 50 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300180 Bmd67 Bone mineral density QTL 67 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300181 Bmd55 Bone mineral density QTL 55 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300182 Bmd56 Bone mineral density QTL 56 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300183 Bmd60 Bone mineral density QTL 60 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300184 Bmd53 Bone mineral density QTL 53 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300185 Bmd46 Bone mineral density QTL 46 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300186 Bmd59 Bone mineral density QTL 59 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300187 Bmd41 Bone mineral density QTL 41 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300188 Bmd68 Bone mineral density QTL 68 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300189 Bmd48 Bone mineral density QTL 48 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300190 Bmd52 Bone mineral density QTL 52 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD
2300195 EHC.BN-(<i>D14Rat43-D14Rat132</i>)/Kyu strain MP:0005179 decreased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000025 N RGD:2300117|PMID:18753676 20080908 RGD compared to ExHC/Seac
2300197 Scl59 Serum cholesterol level QTL 59 qtl MP:0005179 decreased circulating cholesterol level IDA N RGD:2300117|PMID:18753676 20080908 RGD cholesterol containing diet
2300215 SHR.BN-(<i>D10Mgh3-D10Rat85</i>)/Ipcv strain MP:0009356 decreased liver triglyceride level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR.BN-(<i>D10Mgh3-Srebf1</i>)/Ipcv
2300215 SHR.BN-(<i>D10Mgh3-D10Rat85</i>)/Ipcv strain MP:0010026 decreased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR.BN-(<i>D10Mgh3-Srebf1</i>)/Ipcv
2300216 SHR-Tg(PEPCK-SREBF1)1Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20090929 RGD compared to SHR/OlaIpcv;
2300217 SHR.BN-(<i>D10Mgh3-Srebf1</i>)/Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR/OlaIpcv, SHR.BN-(D10Mgh3-D10Rat85)/Ipcv;
2300218 Hpcl2 Hepatic cholesterol level QTL 2 qtl MP:0003982 increased cholesterol level susceptibility IDA N RGD:1643359|PMID:18071061 20080909 RGD
2300324 Fetw1 Fetal weight QTL 1 qtl MP:0004197 abnormal fetal growth/weight/body size IDA N RGD:2300320|PMID:16914718 20080912 RGD
2300326 Plaw1 Placental weight QTL 1 qtl MP:0004921 decreased placenta weight IDA N RGD:2300320|PMID:16914718 20080912 RGD
2301 Cd36 CD36 molecule gene MP:0002702 decreased circulating free fatty acids level IMP N RGD:68930|PMID:11175782 20070321 RGD
2301 Cd36 CD36 molecule gene MP:0002702 decreased circulating free fatty acids level IMP XCO:0000244 N RGD:1600636|PMID:14640889 20070322 RGD
2301 Cd36 CD36 molecule gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:6893560|PMID:22128087 20120907 RGD
2301 Cd36 CD36 molecule gene MP:0006237 abnormal choroid vasculature morphology IAGP N RGD:2307226|PMID:18288886 20090522 RGD
2301 Cd36 CD36 molecule gene MP:0008032 abnormal lipolysis IAGP N RGD:619666|PMID:9916795 19990101 RGD
2301 Cd36 CD36 molecule gene MP:0008515 thin retina outer nuclear layer IAGP N RGD:2307226|PMID:18288886 20090522 RGD
2301 Cd36 CD36 molecule gene MP:0031001 increased glycogen synthesis IMP N RGD:1600636|PMID:14640889 20070322 RGD compared to SHR/OlaIpcv
2301246 SS.LEW-(<i>D3Rat61-D3Wox1</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0001146 abnormal testis morphology IAGP N RGD:2301309|PMID:9334653 20081006 RGD
2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0002990 short ureter IAGP N RGD:2301308|PMID:16952701 20081006 RGD
2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0005149 abnormal gubernaculum morphology IAGP N RGD:2301308|PMID:16952701 20170710 RGD
2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0005149 abnormal gubernaculum morphology MODEL: spontaneous IAGP N RGD:2301310|PMID:9016404 20081006 RGD
2301330 KH strain MP:0001156 abnormal spermatogenesis IAGP N RGD:2301322|PMID:6140035 20081006 RGD
2301330 KH strain MP:0001925 male infertility IAGP N RGD:2301322|PMID:6140035 20081006 RGD
2301330 KH strain MP:0001940 testis hypoplasia IAGP N RGD:2301322|PMID:6140035 20081006 RGD
2301330 KH strain MP:0002286 cryptorchism IAGP N RGD:2301322|PMID:6140035 20081006 RGD
2301330 KH strain MP:0002784 abnormal Sertoli cell morphology IAGP N RGD:2301322|PMID:6140035 20081006 RGD
2301330 KH strain MP:0011410 ectopic testis IAGP N RGD:2301322|PMID:6140035 20180504 RGD
2301367 SHRSP.WKY-(<I>D2Mit5-D2Rat133</I>)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015
2301368 SHRSP.WKY-(<I>D2Wox15-D2Rat133</I>)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015
2301369 SHRSP.WKY-(<I>D2Rat132-D2Rat53</I>)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015
2301370 SHRSP.WKY-(<I>D2Wox9-D2Rat231</I>)/Gcrc strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015
2301370 SHRSP.WKY-(<I>D2Wox9-D2Rat231</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc
2301370 SHRSP.WKY-(<I>D2Wox9-D2Rat231</I>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc
2301371 SHRSP.WKY-(<I>D2Mit21-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD compared to SHRSP/Gcrc
2301371 SHRSP.WKY-(<I>D2Mit21-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2301356|PMID:18819818 20200414 RGD compared to SHRSP/Gcrc; MMO:0000015
2301371 SHRSP.WKY-(<I>D2Mit21-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015
2301371 SHRSP.WKY-(<I>D2Mit21-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc
2301371 SHRSP.WKY-(<I>D2Mit21-D2Rat157</I>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc
2301381 SS.LEW-(<I>D18Chm41-D18Rat92</I>)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2301381 SS.LEW-(<I>D18Chm41-D18Rat92</I>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
2301381 SS.LEW-(<I>D18Chm41-D18Rat92</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2301381 SS.LEW-(<I>D18Chm41-D18Rat92</I>)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW
2301381 SS.LEW-(<I>D18Chm41-D18Rat92</I>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
2301385 SS.LEW-(<I>D18Rat29-D18Rat55</I>)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2301385 SS.LEW-(<I>D18Rat29-D18Rat55</I>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
2301385 SS.LEW-(<I>D18Rat29-D18Rat55</I>)/Ayd strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr
2301385 SS.LEW-(<I>D18Rat29-D18Rat55</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2301385 SS.LEW-(<I>D18Rat29-D18Rat55</I>)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW
2301386 SS.LEW-(<I>D18Rat61-D18Rat45</I>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr
2301386 SS.LEW-(<I>D18Rat61-D18Rat45</I>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
2301398 Kidm38 Kidney mass QTL 38 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301400 Cm68 Cardiac mass QTL 68 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301402 Bp316 Blood pressure QTL 316 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301404 Bp321 Blood pressure QTL 321 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301405 Cm69 Cardiac mass QTL 69 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301406 Kidm39 Kidney mass QTL 39 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301408 Kidm36 Kidney mass QTL 36 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301409 Cm70 Cardiac mass QTL 70 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301410 Bp317 Blood pressure QTL 317 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301411 Bp320 Blood pressure QTL 320 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301412 Kidm40 Kidney mass QTL 40 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301413 Bp318 Blood pressure QTL 318 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301414 Kidm37 Kidney mass QTL 37 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301415 Cm67 Cardiac mass QTL 67 qtl MP:0002845 abnormal aortic weight IDA N RGD:1599557|PMID:17143582 20081029 RGD
2301415 Cm67 Cardiac mass QTL 67 qtl MP:0003918 decreased kidney weight IDA N RGD:1599557|PMID:17143582 20081029 RGD
2301415 Cm67 Cardiac mass QTL 67 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301416 Bp315 Blood pressure QTL 315 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301417 Bp319 Blood pressure QTL 319 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD
2301937 BN.GH-(<i>D18Rat41-D18Mgh4</i>)/Mcwi strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20081113 RGD
2301939 BN.GH-(<i>D2Rat22-D2Mgh11</i>)/Mcwi strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20191125 RGD
2301962 Cm72 Cardiac mass QTL 72 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301964 Bp323 Blood pressure QTL 323 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301966 Bp322 Blood pressure QTL 322 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301967 Cm73 Cardiac mass QTL 73 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301969 Bp324 Blood pressure QTL 324 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301970 Bw81 Body weight QTL 81 qtl MP:0001260 increased body weight IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301971 Cm71 Cardiac mass QTL 71 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD
2301972 Bp325 Blood pressure QTL 325 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD
2302038 Pia31 Pristane induced arthritis QTL 31 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302038 Pia31 Pristane induced arthritis QTL 31 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302040 Pia35 Pristane induced arthritis QTL 35 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302040 Pia35 Pristane induced arthritis QTL 35 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302042 Pia38 Pristane induced arthritis QTL 38 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302042 Pia38 Pristane induced arthritis QTL 38 qtl MP:0003724 increased susceptibility to induced arthritis severity IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302043 Pia27 Pristane induced arthritis QTL 27 qtl MP:0002936 joint swelling no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced
2302043 Pia27 Pristane induced arthritis QTL 27 qtl MP:0003724 increased susceptibility to induced arthritis no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced
2302045 Pia39 Pristane induced arthritis QTL 39 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302045 Pia39 Pristane induced arthritis QTL 39 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302047 Pia34 Pristane induced arthritis QTL 34 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302047 Pia34 Pristane induced arthritis QTL 34 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302049 Pia32 Pristane induced arthritis QTL 32 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302049 Pia32 Pristane induced arthritis QTL 32 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302051 Pia28 Pristane induced arthritis QTL 28 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302051 Pia28 Pristane induced arthritis QTL 28 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302053 Pia33 Pristane induced arthritis QTL 33 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302053 Pia33 Pristane induced arthritis QTL 33 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302055 Pia30 Pristane induced arthritis QTL 30 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302055 Pia30 Pristane induced arthritis QTL 30 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302057 Pia29 Pristane induced arthritis QTL 29 qtl MP:0002936 joint swelling no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced
2302057 Pia29 Pristane induced arthritis QTL 29 qtl MP:0003724 increased susceptibility to induced arthritis no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced
2302059 Pia36 Pristane induced arthritis QTL 36 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302059 Pia36 Pristane induced arthritis QTL 36 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302060 Pia37 Pristane induced arthritis QTL 37 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302060 Pia37 Pristane induced arthritis QTL 37 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced
2302081 DA.E3-(<i>D11Got79-D11Wox5</i>)/Rhd strain MP:0002493 increased IgG level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA
2302081 DA.E3-(<i>D11Got79-D11Wox5</i>)/Rhd strain MP:0002494 increased IgM level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA
2302081 DA.E3-(<i>D11Got79-D11Wox5</i>)/Rhd strain MP:0002497 increased IgE level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA
2302081 DA.E3-(<i>D11Got79-D11Wox5</i>)/Rhd strain MP:0005011 increased eosinophil cell number induces IAGP XCO:0000906, XCO:0000908 N RGD:2302066|PMID:18779593 20210930 RGD compared to DA
2302081 DA.E3-(<i>D11Got79-D11Wox5</i>)/Rhd strain MP:0031055 bronchitis induces IAGP XCO:0000906, XCO:0000908 N RGD:2302066|PMID:18779593 20210929 RGD compared to DA
2302106 SHRSP.WKY-(<I>D1Rat44-D1Arb21</I>)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031
2302106 SHRSP.WKY-(<I>D1Rat44-D1Arb21</I>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496
2302108 SHRSP.WKY-(<I>D1Mgh5-D1Wox29</I>)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031
2302108 SHRSP.WKY-(<I>D1Mgh5-D1Wox29</I>)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031
2302108 SHRSP.WKY-(<I>D1Mgh5-D1Wox29</I>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496
2302109 SHRSP.WKY-(<I>D1Mgh5-D1Rat44</I>)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031
2302109 SHRSP.WKY-(<I>D1Mgh5-D1Rat44</I>)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031
2302109 SHRSP.WKY-(<I>D1Mgh5-D1Rat44</I>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496
2302110 SHRSP.WKY-(<I>Apbb1-D1Arb21</I>)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD MMO:0000031
2302110 SHRSP.WKY-(<I>Apbb1-D1Arb21</I>)/Izm strain MP:0005264 glomerulosclerosis susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496
2302110 SHRSP.WKY-(<I>Apbb1-D1Arb21</I>)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm
2302132 SHRSP-Tg(Tagln-ACE2)6918Bdr strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302131|PMID:18809792 20081120 RGD as compared to SHRSP
2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0001263 weight loss MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced
2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0001762 polyuria MODEL: induced IMP N RGD:2302140|PMID:11448960 20180508 RGD indole-3 carbinol induced
2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0002962 increased urine protein level MODEL: induced IMP N RGD:2302140|PMID:11448960 20120112 RGD
2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0003352 increased circulating renin level MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced
2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0006144 increased systemic arterial systolic blood pressure MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced
2302148 SHR-Tg(EEF1A1-Cd36)10Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000244 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv
2302148 SHR-Tg(EEF1A1-Cd36)10Ipcv strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000244, XCO:0000275 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv
2302149 SHR-Tg(EEF1A1-Cd36)19Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000244 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv
2302149 SHR-Tg(EEF1A1-Cd36)19Ipcv strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000244, XCO:0000275 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv
2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IMP XCO:0000244 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0005292 improved glucose tolerance induced IMP XCO:0000244, XCO:0000103 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0020867 increased lipogenesis induced IMP XCO:0000245 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0031001 increased glycogen synthesis IMP N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302151 SHR-Tg(EEF1A1-Cd36)106Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IMP XCO:0000244 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302151 SHR-Tg(EEF1A1-Cd36)106Ipcv strain MP:0031001 increased glycogen synthesis IMP XCO:0000099|XCO:0000245 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv
2302273 Gluco35 Glucose level QTL 35 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302275 Gluco37 Glucose level QTL 37 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302276 Bw82 Body weight QTL 82 qtl MP:0001260 increased body weight IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302277 Gluco38 Glucose level QTL 38 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302278 Gluco36 Glucose level QTL 36 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302279 F344.SDT-(<i>D3Wox9-D3Arb20</i>)/Kbe strain MP:0001869 pancreas inflammation IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302279 F344.SDT-(<i>D3Wox9-D3Arb20</i>)/Kbe strain MP:0003334 pancreas fibrosis IAGP N RGD:2298688|PMID:18612083 20081208 RGD
2302365 Gluco40 Glucose level QTL 40 qtl MP:0005559 increased circulating glucose level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302367 Slep5 Serum leptin concentration QTL 5 qtl MP:0005669 increased circulating leptin level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302369 Scl60 Serum cholesterol level QTL 60 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302371 Stl22 Serum triglyceride level QTL 22 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302373 Gluco39 Glucose level QTL 39 qtl MP:0005559 increased circulating glucose level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302375 Bw83 Body weight QTL 83 qtl MP:0001260 increased body weight IDA N RGD:619689|PMID:10720472 20081215 RGD
2302375 Bw83 Body weight QTL 83 qtl MP:0006087 increased body mass index IDA N RGD:619689|PMID:10720472 20081215 RGD
2302377 Scl61 Serum cholesterol level QTL 61 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302378 Insul11 Insulin level QTL 11 qtl MP:0002079 increased circulating insulin level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302380 Slep6 Serum leptin concentration QTL 6 qtl MP:0005669 increased circulating leptin level IDA N RGD:619689|PMID:10720472 20081215 RGD
2302381 Bw84 Body weight QTL 84 qtl MP:0001260 increased body weight IDA N RGD:619689|PMID:10720472 20081215 RGD
2302381 Bw84 Body weight QTL 84 qtl MP:0006087 increased body mass index IDA N RGD:619689|PMID:10720472 20081215 RGD
2302387 DA.ACI-(<i>D2Mit12-D2Mgh29</i>)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1358860|PMID:15641042 20081215 RGD
2302387 DA.ACI-(<i>D2Mit12-D2Mgh29</i>)/Nsi strain MP:0003436 decreased susceptibility to induced arthritis IAGP N RGD:1358860|PMID:15641042 20081215 RGD compared to DA rats
2302666 Scr:sP Sardinian alcohol-preferring rats strain MP:0003545 increased alcohol consumption MODEL IAGP N RGD:2302665|PMID:18946467 20090106 RGD compared to Wistar
2302984 SS.BN-(<i>D13Rat151-D13Rat197</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2302984 SS.BN-(<i>D13Rat151-D13Rat197</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi
2302985 SS.BN-(<i>D13Rat111-D13Got22</i>)/Mcwi strain MP:0002959 increased urine microalbumin level induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi
2302985 SS.BN-(<i>D13Rat111-D13Got22</i>)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
2302985 SS.BN-(<i>D13Rat111-D13Got22</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
2302985 SS.BN-(<i>D13Rat111-D13Got22</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi
2302986 SS.BN-(<i>D13Rat88-D13Rat91</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female
2302986 SS.BN-(<i>D13Rat88-D13Rat91</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female
2302986 SS.BN-(<i>D13Rat88-D13Rat91</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female SS/JrHsdMcwi
2302987 SS.BN-(<i>D13Rat7-D13Rat60</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD
2302987 SS.BN-(<i>D13Rat7-D13Rat60</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2302987 SS.BN-(<i>D13Rat7-D13Rat60</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi
2302989 SS.BN-(<i>D13Rat57-D13Rat192</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2302994 SS.BN-(<i>D13Rat127-D13Rat61</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2302995 SS.BN-(<i>D13Rat115-D13Rat101</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to female on 8% NaCl diet
2302995 SS.BN-(<i>D13Rat115-D13Rat101</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female SS/JrHsdMcwi on 8% NaCl diet
2302996 SS.BN-(<i>D13Rat7-D13Rat88</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male, compared to SS/JrHsdMcwi
2302997 SS.BN-(<i>D13Rat91-D13Got45</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2302999 SS.BN-(<i>D13Rat178-D13Got45</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303000 SS.BN-(<i>D13Rat123-D13Rat150</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female
2303000 SS.BN-(<i>D13Rat123-D13Rat150</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female
2303001 SS.BN-(<i>D13Rat111-D13Rat127</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303001 SS.BN-(<i>D13Rat111-D13Rat127</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi
2303002 SS.BN-(<i>D13Rat123-D13Rat197</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303002 SS.BN-(<i>D13Rat123-D13Rat197</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi
2303003 SS.BN-(<i>D13Rat7-D13Rat127</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi
2303004 SS.BN-(<i>D13Rat115-D13Rat61</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303004 SS.BN-(<i>D13Rat115-D13Rat61</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi
2303005 SS.BN-(<i>D13Rat127-D13Rat77</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male
2303005 SS.BN-(<i>D13Rat127-D13Rat77</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2303006 SS.BN-(<i>D13Rat101-D13Rat46</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi
2303007 SS.BN-(<i>D13Rat127-D13Rat46</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303007 SS.BN-(<i>D13Rat127-D13Rat46</i>)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi
2303008 SS.BN-(<i>D13Rat61-D13GRat197</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male
2303008 SS.BN-(<i>D13Rat61-D13GRat197</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303009 SS.BN-(<i>D13Rat183-D13Rat192</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male
2303009 SS.BN-(<i>D13Rat183-D13Rat192</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male
2303010 SS.BN-(<i>D13Got51-D13Rat192</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191205 RGD in male
2303010 SS.BN-(<i>D13Got51-D13Rat192</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2303011 SS.BN-(<i>D13Got51-D13Rat57</i>)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191205 RGD in male
2303011 SS.BN-(<i>D13Got51-D13Rat57</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD
2303028 Bp329 Blood pressure QTL 329 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet
2303030 Bp327 Blood pressure QTL 327 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet
2303031 Bp326 Blood pressure QTL 326 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet
2303032 Bp328 Blood pressure QTL 328 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet
2303116 SPRD.WKY-(<i>D10Rat91-D10Rat135</i>)/Ibmm strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000090 N RGD:2302423|PMID:19052818 20200318 RGD compared to treated SPRD/Ztm
2303117 SPRD.WKY-(<i>D5Rat190-D5Rat114</i>)(<i>D18Rat102-D18Rat44</i>)/Ibmm strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000090 N RGD:2302423|PMID:19052818 20200318 RGD compared to treated SPRD/Ztm, SPRD.WKY-(D18Wox-D18Rat44)/Ibmm
2303118 Mamtr7 Mammary tumor resistance QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:2302423|PMID:19052818 20090204 RGD
2303118 Mamtr7 Mammary tumor resistance QTL 7 qtl MP:0004502 decreased incidence of tumors by chemical induction IDA N RGD:2302423|PMID:19052818 20090204 RGD
2303120 Mamtr8 Mammary tumor resistance QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:2302423|PMID:19052818 20090204 RGD
2303120 Mamtr8 Mammary tumor resistance QTL 8 qtl MP:0004502 decreased incidence of tumors by chemical induction IDA N RGD:2302423|PMID:19052818 20090204 RGD
2303148 SS.SHR-(<i>D9Wox16-D9Rat76</i>)/Mco strain MP:0001260 increased body weight IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303150 SS.SHR-(<i>D9Mco74-D9Rat64</i>)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD
2303150 SS.SHR-(<i>D9Mco74-D9Rat64</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303152 SS.SHR-(<i>D9Mco72-D9Mco93</i>)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD
2303152 SS.SHR-(<i>D9Mco72-D9Mco93</i>)/Mco strain MP:0002963 decreased urine protein level IMP N RGD:2302803|PMID:18854752 20201016 RGD
2303152 SS.SHR-(<i>D9Mco72-D9Mco93</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303153 SS.SHR-(<i>D9Rat7-D9Mco93</i>)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD
2303153 SS.SHR-(<i>D9Rat7-D9Mco93</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303154 SS.SHR-(<i>D9Wox16-D9Mco85</i>)/Mco strain MP:0001262 decreased body weight IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303154 SS.SHR-(<i>D9Wox16-D9Mco85</i>)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD
2303154 SS.SHR-(<i>D9Wox16-D9Mco85</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat
2303168 Bp330 Blood pressure QTL 330 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD
2303170 Bp332 Blood pressure QTL 332 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD
2303171 Bp331 Blood pressure QTL 331 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD
2303178 Bp334 Blood pressure QTL 334 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet
2303180 Bp333 Blood pressure QTL 333 qtl MP:0002963 decreased urine protein level IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet
2303180 Bp333 Blood pressure QTL 333 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet
2303559 Gluco54 Glucose level QTL 54 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303561 Bw91 Body weight QTL 91 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303563 Bw89 Body weight QTL 89 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303564 Gluco43 Glucose level QTL 43 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303566 Bw90 Body weight QTL 90 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303568 Bw88 Body weight QTL 88 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303569 Gluco44 Glucose level QTL 44 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303570 Gluco48 Glucose level QTL 48 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303571 Bw92 Body weight QTL 92 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303572 Insul13 Insulin level QTL 13 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303574 Gluco42 Glucose level QTL 42 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303575 Insul14 Insulin level QTL 14 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303576 Gluco45 Glucose level QTL 45 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303577 Gluco47 Glucose level QTL 47 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303578 Gluco50 Glucose level QTL 50 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303579 Insul12 Insulin level QTL 12 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303580 Gluco49 Glucose level QTL 49 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303581 Bw85 Body weight QTL 85 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303582 Gluco53 Glucose level QTL 53 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303584 Gluco55 Glucose level QTL 55 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303585 Bw86 Body weight QTL 86 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303586 Gluco52 Glucose level QTL 52 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303587 Bw93 Body weight QTL 93 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303589 Bw87 Body weight QTL 87 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD
2303591 Gluco41 Glucose level QTL 41 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303592 Gluco51 Glucose level QTL 51 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303593 Gluco46 Glucose level QTL 46 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD
2303640 WAG/RijCmcr strain MP:0003426 pulmonary interstitial fibrosis MODEL: induced IAGP N RGD:2303635|PMID:18470747 20090220 RGD whole thorax irradiation
2303759 WT/Jtt whitish teeth rat strain MP:0002576 abnormal enamel morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD
2303759 WT/Jtt whitish teeth rat strain MP:0002650 abnormal ameloblast morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD
2303759 WT/Jtt whitish teeth rat strain MP:0002689 abnormal molar morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD
2303759 WT/Jtt whitish teeth rat strain MP:0010096 abnormal incisor color IAGP N RGD:13593564|PMID:16324133 20090225 RGD
2303759 WT/Jtt whitish teeth rat strain MP:0030450 abnormal enamel mineralization IAGP N RGD:2303758|PMID:17710440 20180523 RGD
2303792 WTC.ZI-<i>Atrn<sup>zi</sup></i>/Kyo strain MP:0000745 tremors IAGP N RGD:67998|PMID:11209055 20090209 RGD compared to WTC
2303792 WTC.ZI-<i>Atrn<sup>zi</sup></i>/Kyo strain MP:0005409 darkened coat color IAGP N RGD:67998|PMID:11209055 20201116 RGD compared to WTC
2303792 WTC.ZI-<i>Atrn<sup>zi</sup></i>/Kyo strain MP:0008025 brain vacuoles IAGP N RGD:67998|PMID:11209055 20090209 RGD compared to WTC
2303792 WTC.ZI-<i>Atrn<sup>zi</sup></i>/Kyo strain MP:0008025 brain vacuoles severity IMP N RGD:2303790|PMID:9606416 20090226 RGD
2303986 WKAH.LEC-<i>Atp7b<sup>hts</sup></i>/Tj strain MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20191119 RGD
2303986 WKAH.LEC-<i>Atp7b<sup>hts</sup></i>/Tj strain MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20191119 RGD
2303986 WKAH.LEC-<i>Atp7b<sup>hts</sup></i>/Tj strain MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20191119 RGD compared to LEC/Tj;
2303986 WKAH.LEC-<i>Atp7b<sup>hts</sup></i>/Tj strain MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20191119 RGD
2304017 F344.CVD-<i>Unc5c<sup>cvd</sup></i>/Kyo strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20180607 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20180607 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20180607 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20180607 RGD
2304039 WIC-<i>Tg<sup>rdw</sup></i>/Kts strain MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0001260 increased body weight IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc;
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0003059 decreased insulin secretion IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc;
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:11532750|PMID:27523322 20160906 RGD
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0005331 insulin resistance IAGP N RGD:11532750|PMID:27523322 20160906 RGD
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0005559 increased circulating glucose level IAGP N RGD:7394771|PMID:23304119 20131104 RGD at 15 wks of age
2304047 F344.ZUC-<i>Lepr<sup>fa</sup></i>/Tj strain MP:0011939 increased food intake IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc;
2304098 SHRSP.WKY-(<i>D1Smu13-D1Arb21</i>)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm
2304098 SHRSP.WKY-(<i>D1Smu13-D1Arb21</i>)/Izm strain MP:0030773 decreased urine noradrenaline level IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to cold stress
2304221 WTC-<i>swh</i>/Kyo strain MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20090310 RGD in females, compared to heterozygous animals
2304221 WTC-<i>swh</i>/Kyo strain MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304221 WTC-<i>swh</i>/Kyo strain MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD
2304221 WTC-<i>swh</i>/Kyo strain MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat)
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0000035 abnormal membranous labyrinth morphology IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20170411 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0010799 stomach mucosa hyperplasia IAGP N RGD:1581602|PMID:16368876 20170411 RGD compared to WTC/Kyo
2304242 WTC-<i>Kcnq1<sup>dfk</sup></i>Kyo strain MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD compared to WTC/Kyo
2305 Cd247 Cd247 molecule gene MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
2305 Cd247 Cd247 molecule gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:13442481|PMID:24343121 20201210 RGD compared to wild-type
2305 Cd247 Cd247 molecule gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type
2305 Cd247 Cd247 molecule gene MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
2305 Cd247 Cd247 molecule gene MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
2305 Cd247 Cd247 molecule gene MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type
2305 Cd247 Cd247 molecule gene MP:0005540 decreased urine albumin level IMP N RGD:13442481|PMID:24343121 20201210 RGD
2305 Cd247 Cd247 molecule gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
2305 Cd247 Cd247 molecule gene MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD
2305926 Iddm37 Insulin dependent diabetes mellitus QTL 37 qtl MP:0004031 insulitis IDA N RGD:2313174|PMID:19720792 20120918 RGD
2305971 SHRSP.SHR-(<i>D18Rat73-D18Rat11</i>)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm
2305973 SHRSP.SHR-(<i>D1Rat93-D1Rat269</i>)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm
2306022 KCI/Kyo strain MP:0001394 circling IAGP N RGD:2306012|PMID:19151506 20090318 RGD
2306022 KCI/Kyo strain MP:0001522 impaired swimming IAGP N RGD:2306012|PMID:19151506 20090318 RGD
2306022 KCI/Kyo strain MP:0004408 decreased cochlear hair cell number IAGP N RGD:2306012|PMID:19151506 20090318 RGD
2306022 KCI/Kyo strain MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:2306012|PMID:19151506 20201218 RGD
2306022 KCI/Kyo strain MP:0006336 abnormal otoacoustic response IAGP N RGD:2306012|PMID:19151506 20090318 RGD
2306022 KCI/Kyo strain MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:2306012|PMID:19151506 20201218 RGD
2306041 F344-<i>Scn1a<sup>m2Kyo</sup></i> strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170315 RGD
2306042 F344-<i>Scn1a<sup>m1Kyo</sup></i> strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170315 RGD
2306059 DA.Cg-<i>Foxn1<sup>rnu</sup> Lyst<sup>bg</sup></i>/Slc strain MP:0000705 athymia IAGP N RGD:2306054|PMID:15516787 20200508 RGD
2306059 DA.Cg-<i>Foxn1<sup>rnu</sup> Lyst<sup>bg</sup></i>/Slc strain MP:0003815 hairless IAGP N RGD:2306054|PMID:15516787 20200508 RGD
2306059 DA.Cg-<i>Foxn1<sup>rnu</sup> Lyst<sup>bg</sup></i>/Slc strain MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:2306054|PMID:15516787 20160829 RGD
2306059 DA.Cg-<i>Foxn1<sup>rnu</sup> Lyst<sup>bg</sup></i>/Slc strain MP:0005606 increased bleeding time IAGP N RGD:2306054|PMID:15516787 20160829 RGD
2306064 MPR/Iar strain MP:0000130 abnormal trabecular bone morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated
2306064 MPR/Iar strain MP:0001405 impaired coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated
2306064 MPR/Iar strain MP:0001524 impaired limb coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated
2306064 MPR/Iar strain MP:0002282 abnormal trachea morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated
2306064 MPR/Iar strain MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated
2306064 MPR/Iar strain MP:0013498 trachea inflammation IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated
2306064 MPR/Iar strain MP:0030866 abnormal synovial joint membrane morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated
2306064 MPR/Iar strain MP:0030895 abnormal tibiofemoral joint morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated
2306070 WIC-Tg(Wap-GH1)1Mni strain MP:0001260 increased body weight IAGP N RGD:13593540|PMID:7889111 20180522 RGD
2306070 WIC-Tg(Wap-GH1)1Mni strain MP:0008994 early vaginal opening IAGP N RGD:13593540|PMID:7889111 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0001260 increased body weight IAGP N RGD:13593541|PMID:9645676 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0001559 hyperglycemia IAGP N RGD:13593541|PMID:9645676 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0002079 increased circulating insulin level IAGP N RGD:13593541|PMID:9645676 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0006094 increased fat cell size IAGP N RGD:13593541|PMID:9645676 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0008994 early vaginal opening IAGP N RGD:13593540|PMID:7889111 20180522 RGD
2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:13593541|PMID:9645676 20180522 RGD
2306529 BBDR.BBDP-(<I>D4Rhw11-D4Rhw10</I>)/Rhw strain MP:0004031 insulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306529 BBDR.BBDP-(<I>D4Rhw11-D4Rhw10</I>)/Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR/Rhw
2306529 BBDR.BBDP-(<I>D4Rhw11-D4Rhw10</I>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR/Rhw
2306529 BBDR.BBDP-(<I>D4Rhw11-D4Rhw10</I>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306529 BBDR.BBDP-(<I>D4Rhw11-D4Rhw10</I>)/Rhw strain MP:0012765 decreased alpha-beta T cell number IAGP N RGD:1598569|PMID:17130479 20200306 RGD compared to BBDR
2306532 BBDR.F344-(<i>D4Rat27-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306532 BBDR.F344-(<i>D4Rat27-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306532 BBDR.F344-(<i>D4Rat27-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306533 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/2Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306533 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/2Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306533 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/2Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306534 BBDR.F344-(<i>D4Rat102-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306534 BBDR.F344-(<i>D4Rat102-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306534 BBDR.F344-(<i>D4Rat102-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306535 BBDR.F344-(<i>D4Rat253-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306535 BBDR.F344-(<i>D4Rat253-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306535 BBDR.F344-(<i>D4Rat253-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306536 BBDR.F344-(<i>D4Arb11-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306536 BBDR.F344-(<i>D4Arb11-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306536 BBDR.F344-(<i>D4Arb11-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306537 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/1Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306537 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/1Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306537 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/1Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306538 BBDR.F344-(<i>D4Rat153-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306538 BBDR.F344-(<i>D4Rat153-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306538 BBDR.F344-(<i>D4Rat153-D4Rat27</i>),BBDP-(<i>D4Rhw11-D4Rhw10</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306539 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/3Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306539 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/3Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306539 BBDR.F344-(<i>D4Rat102-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/3Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306540 BBDR.F344-(<i>D4Got33-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306540 BBDR.F344-(<i>D4Got33-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306540 BBDR.F344-(<i>D4Got33-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306541 BBDR.F344-(<i>D4Rat153-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1598569|PMID:17130479 20200306 RGD BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306541 BBDR.F344-(<i>D4Rat153-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306541 BBDR.F344-(<i>D4Rat153-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306541 BBDR.F344-(<i>D4Rat153-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306541 BBDR.F344-(<i>D4Rat153-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0012765 decreased alpha-beta T cell number IAGP N RGD:1598569|PMID:17130479 20200306 RGD BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306542 BBDR.F344-(<i>D4Rat253-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306542 BBDR.F344-(<i>D4Rat253-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306542 BBDR.F344-(<i>D4Rat253-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306543 BBDR.F344-(<i>D4Got59-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw
2306543 BBDR.F344-(<i>D4Got59-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306543 BBDR.F344-(<i>D4Got59-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306544 BBDR.F344-(<i>D4Rat26-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306544 BBDR.F344-(<i>D4Rat26-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD
2306544 BBDR.F344-(<i>D4Rat26-D4Rhw8</i>),BBDP-(<i>D4Rhw6-D4Rat62</i>)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD
2306545 Iddm39 Insulin dependent diabetes mellitus QTL 39 qtl MP:0004031 insulitis resistance IDA N RGD:2306526|PMID:19351909 20090427 RGD
2306545 Iddm39 Insulin dependent diabetes mellitus QTL 39 qtl MP:0004804 decreased susceptibility to autoimmune diabetes IDA N RGD:2306526|PMID:19351909 20090427 RGD
2306547 Iddm38 Insulin dependent diabetes mellitus QTL 38 qtl MP:0004031 insulitis resistance IDA N RGD:2306526|PMID:19351909 20090427 RGD
2306547 Iddm38 Insulin dependent diabetes mellitus QTL 38 qtl MP:0004804 decreased susceptibility to autoimmune diabetes IDA N RGD:2306526|PMID:19351909 20090427 RGD
2306717 BBDP/WorSunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn
2306717 BBDP/WorSunn strain MP:0002497 increased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to congenic strains
2306717 BBDP/WorSunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen
2306784 Kini:DA,PVG-G12 strain MP:0000747 muscle weakness induced IAGP XCO:0000292,XCO:0000265 N RGD:2306769|PMID:19299744 20090506 RGD
2306784 Kini:DA,PVG-G12 strain MP:0001263 weight loss induced IAGP XCO:0000292,XCO:0000265 N RGD:2306769|PMID:19299744 20090506 RGD
2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0001263 weight loss IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306789 Ean6 Experimental allergic neuritis QTL 6 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306789 Ean6 Experimental allergic neuritis QTL 6 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306790 Ean1 Experimental allergic neuritis QTL 1 qtl MP:0000747 muscle weakness IDA N RGD:2306736|PMID:15342198 20090506 RGD
2306790 Ean1 Experimental allergic neuritis QTL 1 qtl MP:0000921 demyelination IDA N RGD:2306736|PMID:15342198 20090506 RGD
2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD
2306815 SS.SR-(<I>D7Rat67-D7Mco7</I>)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr
2306815 SS.SR-(<I>D7Rat67-D7Mco7</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% Nacl diet
2306816 SS.SR-(<I>D7Mco19-D7Mco7</I>)/Jr strain MP:0002834 decreased heart weight IMP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr
2306816 SS.SR-(<I>D7Mco19-D7Mco7</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IMP N RGD:629613|PMID:12682779 20090507 RGD compared to SS/Jr on 2% Nacl diet
2306817 SS.SR-(<I>D7Uia1-D7Mco19</I>)/Jr strain MP:0004217 salt-sensitive hypertension IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr and congenics
2306818 SS.SR-(<I>D7Rat131-D7Mco7</I>)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr
2306818 SS.SR-(<I>D7Rat131-D7Mco7</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 4% Nacl diet
2306819 SS.SR-(<I>D7Uia1-D7Rat131</I>)/Jr strain MP:0004217 salt-sensitive hypertension IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr and congenics
2306820 SS.SR-(<i>D3Arb14-D3Mco36</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:2306800|PMID:19255363 20201023 RGD as compared to SS/Jr and RNO7 congenic on 2% NaCl diet
2306821 Bp335 Blood pressure QTL 335 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% NaCl diet
2306840 E3.DA-(<i>D4Wox22-D4Got132</i>)(<i>D12Wox5-D12Rat26</i>)/Rhd strain MP:0002493 increased IgG level IMP N RGD:2306838|PMID:19180494 20090508 RGD compared to the parental E3/ZtmRhd rats
2306841 E3.DA-(<i>D12Wox5-D12Rat26</i>)/Rhd strain MP:0002493 increased IgG level IMP N RGD:2306838|PMID:19180494 20090508 RGD compared to the parental E3/ZtmRhd rats
2306850 Pia40 Pristane induced arthritis QTL 40 qtl MP:0002933 joint inflammation IDA N RGD:2306838|PMID:19180494 20090508 RGD Induced by Pristane
2306850 Pia40 Pristane induced arthritis QTL 40 qtl MP:0003079 decreased susceptibility to induced joint inflammation IDA N RGD:2306838|PMID:19180494 20090508 RGD Induced by Pristane
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0005333 decreased heart rate MODEL: induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD as compared to SHR
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306892 SHR.BN-(<i>D2Rat114-D2Rat123</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain
2306893 SHR.BN-(<i>D16Rat87-D16Mgh1</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306893 SHR.BN-(<i>D16Rat87-D16Mgh1</i>)/Jk strain MP:0005333 decreased heart rate induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306893 SHR.BN-(<i>D16Rat87-D16Mgh1</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306893 SHR.BN-(<i>D16Rat87-D16Mgh1</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain
2306894 SHR.BN-(<i>D4Rat33-D4Rat54</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306894 SHR.BN-(<i>D4Rat33-D4Rat54</i>)/Jk strain MP:0005333 decreased heart rate IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306894 SHR.BN-(<i>D4Rat33-D4Rat54</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306894 SHR.BN-(<i>D4Rat33-D4Rat54</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0001260 increased body weight IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0005333 decreased heart rate IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0005333 decreased heart rate induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain
2306895 SHR.BN-(<i>D2Rat226-D2Rat294</i>)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain
2306899 Bp338 Blood pressure QTL 338 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD
2306901 Bp337 Blood pressure QTL 337 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD
2306902 Bp339 Blood pressure QTL 339 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD
2306903 Bp336 Blood pressure QTL 336 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD
2306968 Anxrr23 Anxiety related response QTL 23 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD
2306970 Anxrr22 Anxiety related response QTL 22 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD
2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD
2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0001442 decreased grooming behavior IDA N RGD:625384|PMID:11932246 20090513 RGD
2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0004000 impaired passive avoidance behavior IDA N RGD:2313899|PMID:18971309 20091030 RGD
2307156 DA/ZtmKini strain MP:0000921 demyelination induced IAGP XCO:0000195 N RGD:4889889|PMID:20856809 20210104 RGD compared to DA.PVG-Eae23
2307156 DA/ZtmKini strain MP:0001263 weight loss severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0001263 weight loss susceptibility IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1/Kini
2307156 DA/ZtmKini strain MP:0001846 increased inflammatory response severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0002933 joint inflammation susceptibility IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20200815 RGD compared to control strain PVG.1AV1/Kini
2307156 DA/ZtmKini strain MP:0002936 joint swelling severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0002936 joint swelling severity IAGP XCO:0000265,XCO:0000281 N RGD:737659|PMID:8972741 20200814 RGD compared to LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:61087|PMID:9600974 19990101 RGD
2307156 DA/ZtmKini strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:737659|PMID:8972741 20200814 RGD
2307156 DA/ZtmKini strain MP:0002993 autoimmune arthritis severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0003561 rheumatoid arthritis severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1/Kini
2307156 DA/ZtmKini strain MP:0004847 abnormal liver weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0004951 abnormal spleen weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0004954 abnormal thymus weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4888518|PMID:21041731 20200505 RGD
2307156 DA/ZtmKini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4889889|PMID:20856809 20210104 RGD compared to DA.PVG-Eae23
2307156 DA/ZtmKini strain MP:0009623 enlarged inguinal lymph nodes severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307156 DA/ZtmKini strain MP:0010211 abnormal acute phase protein level severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini
2307157 PVG.1AV1/Kini strain MP:0002933 joint inflammation penetrance IAGP XCO:0000281,XCO:0000265|XCO:0000263 N RGD:629560|PMID:12571866 20200815 RGD
2307157 PVG.1AV1/Kini strain MP:0003436 decreased susceptibility to induced arthritis penetrance IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
2307157 PVG.1AV1/Kini strain MP:0008499 increased IgG1 level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
2307157 PVG.1AV1/Kini strain MP:0008501 increased IgG2b level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
2307157 PVG.1AV1/Kini strain MP:0008896 increased IgG2c level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
2307159 SHRSR.SHRSP-(<i>Klk1-Mt1-ps1</i>)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
2307159 SHRSR.SHRSP-(<i>Klk1-Mt1-ps1</i>)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
2307160 SHRSR.SHRSP-(<i>Klk1-D1Mit3</i>)/Bbb strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb
2307160 SHRSR.SHRSP-(<i>Klk1-D1Mit3</i>)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
2307161 SHRSR.SHRSP-(<i>D1Rat134-Mt1-ps1</i>)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
2307161 SHRSR.SHRSP-(<i>D1Rat134-Mt1-ps1</i>)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb
2307166 SHRSP.SHRSR-(<i>Klk1-Mt1-ps1</i>)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
2307166 SHRSP.SHRSR-(<i>Klk1-Mt1-ps1</i>)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb
2307167 SHRSP.SHRSR-(<i>Klk1-D1Mit3</i>)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
2307167 SHRSP.SHRSR-(<i>Klk1-D1Mit3</i>)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSP/Bbb
2307167 SHRSP.SHRSR-(<i>Klk1-D1Mit3</i>)/Bbb strain MP:0008770 decreased survivor rate induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
2307168 SHRSR/Bbb Spontaneously Hypertensive Rat, Stroke Resistant strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb
2307169 SHRSP.SHRSR-(<i>D1Rat134-Mt1-ps1</i>)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb
2307169 SHRSP.SHRSR-(<i>D1Rat134-Mt1-ps1</i>)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb
2307172 Activ4 Activity QTL 4 qtl MP:0001399 hyperactivity IDA N RGD:2306974|PMID:19089625 20090520 RGD
2307172 Activ4 Activity QTL 4 qtl MP:0001415 increased exploration in new environment IDA N RGD:2306974|PMID:19089625 20090520 RGD
2307174 Activ3 Activity QTL 3 qtl MP:0001399 hyperactivity IDA N RGD:2306974|PMID:19089625 20090520 RGD
2307174 Activ3 Activity QTL 3 qtl MP:0001415 increased exploration in new environment IDA N RGD:2306974|PMID:19089625 20090520 RGD
2307300 LEW.1AV1/Kini strain MP:0002936 joint swelling penetrance IAGP XCO:0000265, XCO:0000281 N RGD:737659|PMID:8972741 19990101 RGD
2307317 MHS Milan Hypertensive Strain strain MP:0004217 salt-sensitive hypertension IAGP N RGD:126848752|PMID:18480177 20210429 RGD compared to MNS
2307318 BDIX/Ifz strain MP:0002030 increased neurofibrosarcoma incidence IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain
2307318 BDIX/Ifz strain MP:0008770 decreased survivor rate IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain
2307318 BDIX/Ifz strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain
2308852 Crl:LE Long-Evans Rats strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm
2308886 SS/HsdMcwiCrl strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated FHH/EurMcwiCrl
2311 Cd59b CD59b molecule gene MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD
2311 Cd59b CD59b molecule gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD
2311 Cd59b CD59b molecule gene MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD
2311 Cd59b CD59b molecule gene MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0002959 increased urine microalbumin level susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0003915 increased heart left ventricle weight susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0005167 abnormal blood-brain barrier function susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0005591 decreased vasodilation susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006060 increased cerebral infarct size susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006080 brain ischemia susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006316 increased urine sodium level susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0008770 decreased survivor rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0011402 renal cast disease_progression IAGP N RGD:30296658|PMID:22031827 20200831 RGD compared to Crl:WI Wistar rat renal cortex
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0011431 increased urine flow rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl
2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0020455 increased erythrocyte aggregation disease_progression IAGP N RGD:30296658|PMID:22031827 20200831 RGD compared to Crl:WI Wistar rat renal cortex
2311072 FHH/EurMcwiCrl strain MP:0001260 increased body weight IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
2311072 FHH/EurMcwiCrl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
2311072 FHH/EurMcwiCrl strain MP:0005557 increased creatinine clearance IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and MWF/Hsd
2311072 FHH/EurMcwiCrl strain MP:0010754 abnormal heart left ventricle pressure IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
2311072 FHH/EurMcwiCrl strain MP:0030662 decreased circulating arginine level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
2312418 Kidm41 Kidney mass QTL 41 qtl MP:0003918 decreased kidney weight IDA N RGD:2312387|PMID:19448344 20090812 RGD
2312420 Pur17 Proteinuria QTL 17 qtl MP:0002962 increased urine protein level IDA N RGD:2312387|PMID:19448344 20090812 RGD
2312447 SD-Tg(Pmp22)Kan strain MP:0000747 muscle weakness IMP N RGD:2312445|PMID:8630243 20090817 RGD
2312447 SD-Tg(Pmp22)Kan strain MP:0000920 abnormal myelination IMP N RGD:2312445|PMID:8630243 20090817 RGD
2312447 SD-Tg(Pmp22)Kan strain MP:0001406 abnormal gait IMP N RGD:2312445|PMID:8630243 20090817 RGD
2312447 SD-Tg(Pmp22)Kan strain MP:0008814 decreased nerve conduction velocity IMP N RGD:2312445|PMID:8630243 20090817 RGD
2312558 Glom17 Glomerulus QTL 17 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312560 Pur20 Proteinuria QTL 20 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312560 Pur20 Proteinuria QTL 20 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312562 Pur18 Proteinuria QTL 18 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312562 Pur18 Proteinuria QTL 18 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312564 Glom18 Glomerulus QTL 18 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312566 Glom20 Glomerulus QTL 20 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312567 Glom19 Glomerulus QTL 19 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312568 Glom21 Glomerulus QTL 21 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312569 Pur19 Proteinuria QTL 19 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312569 Pur19 Proteinuria QTL 19 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD
2312577 SHR.BN-(<i>D18Rat99-D18Rat82</i>)/Ipcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD
2312577 SHR.BN-(<i>D18Rat99-D18Rat82</i>)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD
2312577 SHR.BN-(<i>D18Rat99-D18Rat82</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain
2312578 SHR.BN-(<i>D18Rat82</i>)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD compared to SHR/OlaIpcv strain
2312579 SHR.BN-(<i>D18Rat40-D18Rat82</i>)/Ipcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200505 RGD
2312579 SHR.BN-(<i>D18Rat40-D18Rat82</i>)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD
2312579 SHR.BN-(<i>D18Rat40-D18Rat82</i>)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain
2312579 SHR.BN-(<i>D18Rat40-D18Rat82</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain
2312580 SHR.BN-(<i>D18Rat113-D18Rat82</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20090821 RGD compared to SHR/OlaIpcv strain
2312598 Bp340 Blood pressure QTL 340 qtl MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD
2312598 Bp340 Blood pressure QTL 340 qtl MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090824 RGD
2312600 Bp341 Blood pressure QTL 341 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20090824 RGD
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0002962 increased urine protein level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0003215 renal interstitial fibrosis IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0003918 decreased kidney weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0005557 increased creatinine clearance IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to MWF/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312609 MWF-Chr 8<sup>SHR</sup>/Rkb strain MP:0010064 increased circulating creatine level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
2312644 DA.WOKW-(<i>D3Mit10-D3Rat189</i>)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312645 DA.WOKW-(<i>D16Rat88-D16Wox7</i>)/K strain MP:0002079 increased circulating insulin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312645 DA.WOKW-(<i>D16Rat88-D16Wox7</i>)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312645 DA.WOKW-(<i>D16Rat88-D16Wox7</i>)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K
2312645 DA.WOKW-(<i>D16Rat88-D16Wox7</i>)/K strain MP:0010024 increased total body fat amount IAGP N RGD:2312642|PMID:19584880 20111107 RGD only in females; compared to DA/K
2312646 DA.WOKW-(<i>D5Mgh6-D5Mit5</i>)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312647 DA.WOKW-(<i>D3Mgh5-D3Rat1</i>)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312647 DA.WOKW-(<i>D3Mgh5-D3Rat1</i>)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K
2312647 DA.WOKW-(<i>D3Mgh5-D3Rat1</i>)/K strain MP:0010024 increased total body fat amount IAGP N RGD:2312642|PMID:19584880 20111107 RGD compared to DA/K
2312648 DA.WOKW-(<i>D10Mgh2-D10Rat4</i>)/K strain MP:0002079 increased circulating insulin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K
2312648 DA.WOKW-(<i>D10Mgh2-D10Rat4</i>)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K
2312648 DA.WOKW-(<i>D10Mgh2-D10Rat4</i>)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K
2312659 Slep7 Serum leptin concentration QTL 7 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312660 Bw95 Body weight QTL 95 qtl MP:0010024 increased total body fat amount IDA N RGD:2312642|PMID:19584880 20111107 RGD
2312662 Slep8 Serum leptin concentration QTL 8 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312663 Slep9 Serum leptin concentration QTL 9 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312664 Scl62 Serum cholesterol level QTL 62 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312666 Insul16 Insulin level QTL 16 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312668 Scl65 Serum cholesterol level QTL 65 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312669 Stl23 Serum triglyceride level QTL 23 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312670 Bw94 Body weight QTL 94 qtl MP:0010024 increased total body fat amount IDA N RGD:2312642|PMID:19584880 20111107 RGD
2312671 Scl64 Serum cholesterol level QTL 64 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312672 Insul15 Insulin level QTL 15 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2312673 Scl63 Serum cholesterol level QTL 63 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD
2313046 Bss78 Bone structure and strength QTL 78 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313046 Bss78 Bone structure and strength QTL 78 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313048 Bss84 Bone structure and strength QTL 84 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313048 Bss84 Bone structure and strength QTL 84 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313049 Bss72 Bone structure and strength QTL 72 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313049 Bss72 Bone structure and strength QTL 72 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313051 Bss57 Bone structure and strength QTL 57 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313051 Bss57 Bone structure and strength QTL 57 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313053 Bss51 Bone structure and strength QTL 51 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313053 Bss51 Bone structure and strength QTL 51 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313055 Bw96 Body weight QTL 96 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313057 Bss76 Bone structure and strength QTL 76 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313057 Bss76 Bone structure and strength QTL 76 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313059 Bss55 Bone structure and strength QTL 55 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313059 Bss55 Bone structure and strength QTL 55 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females
2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313062 Bmd73 Bone mineral density QTL 73 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313064 Bmd71 Bone mineral density QTL 71 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females
2313065 Bss67 Bone structure and strength QTL 67 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313065 Bss67 Bone structure and strength QTL 67 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313066 Bss63 Bone structure and strength QTL 63 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313066 Bss63 Bone structure and strength QTL 63 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313067 Bss77 Bone structure and strength QTL 77 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313067 Bss77 Bone structure and strength QTL 77 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313069 Bss68 Bone structure and strength QTL 68 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313069 Bss68 Bone structure and strength QTL 68 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313070 Bss52 Bone structure and strength QTL 52 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313070 Bss52 Bone structure and strength QTL 52 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313072 Bss53 Bone structure and strength QTL 53 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313072 Bss53 Bone structure and strength QTL 53 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313073 Bmd75 Bone mineral density QTL 75 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313075 Bss66 Bone structure and strength QTL 66 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313075 Bss66 Bone structure and strength QTL 66 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313076 Bss74 Bone structure and strength QTL 74 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313076 Bss74 Bone structure and strength QTL 74 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313077 Bss69 Bone structure and strength QTL 69 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313077 Bss69 Bone structure and strength QTL 69 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313078 Bss54 Bone structure and strength QTL 54 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313078 Bss54 Bone structure and strength QTL 54 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313079 Bss73 Bone structure and strength QTL 73 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313079 Bss73 Bone structure and strength QTL 73 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313080 Bss65 Bone structure and strength QTL 65 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313080 Bss65 Bone structure and strength QTL 65 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313081 Bss64 Bone structure and strength QTL 64 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313081 Bss64 Bone structure and strength QTL 64 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313082 Bss85 Bone structure and strength QTL 85 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313082 Bss85 Bone structure and strength QTL 85 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313083 Bmd74 Bone mineral density QTL 74 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313084 Bss83 Bone structure and strength QTL 83 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313084 Bss83 Bone structure and strength QTL 83 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313085 Bss59 Bone structure and strength QTL 59 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313085 Bss59 Bone structure and strength QTL 59 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313086 Bss60 Bone structure and strength QTL 60 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313086 Bss60 Bone structure and strength QTL 60 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313087 Bmd80 Bone mineral density QTL 80 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313088 Bss75 Bone structure and strength QTL 75 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313088 Bss75 Bone structure and strength QTL 75 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313089 Bss81 Bone structure and strength QTL 81 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313089 Bss81 Bone structure and strength QTL 81 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313090 Bmd69 Bone mineral density QTL 69 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females
2313092 Bmd72 Bone mineral density QTL 72 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313093 Bmd77 Bone mineral density QTL 77 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313094 Bss58 Bone structure and strength QTL 58 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313094 Bss58 Bone structure and strength QTL 58 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313095 Bss62 Bone structure and strength QTL 62 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313095 Bss62 Bone structure and strength QTL 62 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313096 Bmd78 Bone mineral density QTL 78 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females
2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313098 Bmd70 Bone mineral density QTL 70 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females
2313099 Bss56 Bone structure and strength QTL 56 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313099 Bss56 Bone structure and strength QTL 56 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313100 Bss82 Bone structure and strength QTL 82 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313100 Bss82 Bone structure and strength QTL 82 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313101 Bmd76 Bone mineral density QTL 76 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313102 Bmd79 Bone mineral density QTL 79 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males
2313103 Bss80 Bone structure and strength QTL 80 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313103 Bss80 Bone structure and strength QTL 80 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313104 Bss61 Bone structure and strength QTL 61 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313104 Bss61 Bone structure and strength QTL 61 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313105 Bss79 Bone structure and strength QTL 79 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313105 Bss79 Bone structure and strength QTL 79 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0001260 increased body weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0002963 decreased urine protein level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0002963 decreased urine protein level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20090918 RGD compared with LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:2313340|PMID:19462495 20090918 RGD compared with LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0005527 increased renal glomerular filtration rate IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313343 LH-Chr 13<sup>BN</sup>/Mav strain MP:0006317 decreased urine sodium level IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav
2313395 Anxrr26 Anxiety related response QTL 26 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313395 Anxrr26 Anxiety related response QTL 26 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313397 Coatc1 Coat color QTL1 qtl MP:0002938 white spotting IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313399 Anxrr28 Anxiety related response QTL 28 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313399 Anxrr28 Anxiety related response QTL 28 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313400 Anxrr25 Anxiety related response QTL 25 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313400 Anxrr25 Anxiety related response QTL 25 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313401 Anxrr27 Anxiety related response QTL 27 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313401 Anxrr27 Anxiety related response QTL 27 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313402 Anxrr24 Anxiety related response QTL 24 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313402 Anxrr24 Anxiety related response QTL 24 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0002727 decreased circulating insulin level IMP N RGD:2313576|PMID:15161755 20111109 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0003339 decreased pancreatic beta cell number IMP N RGD:2313576|PMID:15161755 20091002 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0009114 decreased pancreatic beta cell mass IMP N RGD:2313576|PMID:15161755 20091002 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0011818 abnormal pancreatic beta cell proliferation IMP N RGD:2313576|PMID:15161755 20091002 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0013279 increased fasting circulating glucose level IMP N RGD:2313576|PMID:15161755 20091002 RGD
2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0014117 increased pancreatic beta cell apoptosis IMP N RGD:2313576|PMID:15161755 20091002 RGD
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001262 decreased body weight IMP N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001552 increased circulating triglyceride level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001554 increased circulating free fatty acids level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002079 increased circulating insulin level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:2313691|PMID:15809359 20091009 RGD
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002981 increased liver weight IMP N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0005178 increased circulating cholesterol level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0005559 increased circulating glucose level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0009355 increased liver triglyceride level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv;
2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv:
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0001762 polyuria induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0002871 albuminuria induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0005331 insulin resistance induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD
2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD
2313735 SD-Tg(H1/tetO-RNAi:Insr)14Bdr strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD
2313735 SD-Tg(H1/tetO-RNAi:Insr)14Bdr strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0001263 weight loss IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0001492 abnormal pilomotor reflex IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0001657 abnormal induced morbidity/mortality IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0002064 seizures IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0002842 increased systemic arterial blood pressure no_association IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0005202 lethargy IDA N RGD:619627|PMID:10432379 20091022 RGD
2313854 Bp343 Blood pressure QTL 343 qtl MP:0010768 mortality/aging IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0001263 weight loss IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0001492 abnormal pilomotor reflex IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0001657 abnormal induced morbidity/mortality IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0002064 seizures IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0002842 increased systemic arterial blood pressure no_association IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0005202 lethargy IDA N RGD:619627|PMID:10432379 20091022 RGD
2313856 Bp342 Blood pressure QTL 342 qtl MP:0010768 mortality/aging IDA N RGD:619627|PMID:10432379 20091022 RGD
2313922 F344-Tg(Cyp1a1-Ren2)10.LEW-(<i>D10Rat142-D10Rat15</i>)/Jmul strain MP:0003185 decreased angiotensin I-converting enzyme activity IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to F344-Tg(Cyp1a1-Ren2)10Jmul
2313922 F344-Tg(Cyp1a1-Ren2)10.LEW-(<i>D10Rat142-D10Rat15</i>)/Jmul strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to F344-Tg(Cyp1a1-Ren2)10Jmul
2313923 LEW-Chr YF344-Tg(Cyp1a1-Ren2)10.F344-(<i>D10Rat99-D10Rat11</i>)/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to LEW-Chr YF344-Tg(Cyp1a1-Ren2)10/Jmul
2313923 LEW-Chr YF344-Tg(Cyp1a1-Ren2)10.F344-(<i>D10Rat99-D10Rat11</i>)/Jmul strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to LEW-Chr YF344-Tg(Cyp1a1-Ren2)10/Jmul
2314001 N:HS Heterogeneous stock strain MP:0001363 increased anxiety-related response IAGP N RGD:2313899|PMID:18971309 20091030 RGD
2314001 N:HS Heterogeneous stock strain MP:0004000 impaired passive avoidance behavior IAGP N RGD:2313899|PMID:18971309 20091030 RGD
2314009 NMcwi:HS Heterogeneous stock strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131022 RGD
2314011 Gluco56 Glucose level QTL 56 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316693|PMID:20068026 20100303 RGD
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT/Jcl and pair-fed SDT.ZDF-Leprfa/Jtt rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001304 cataract IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001325 abnormal retina morphology IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001326 retina degeneration IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001433 polyphagia IAGP N RGD:2314024|PMID:18421173 20091030 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats, only at young age
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats, only at young age
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0002705 dilated renal tubule IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0002840 abnormal lens fiber morphology IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0004892 increased adiponectin level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005264 glomerulosclerosis IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0006087 increased body mass index IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0006094 increased fat cell size IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0009294 increased interscapular fat pad weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0009643 abnormal urine homeostasis IAGP N RGD:2314024|PMID:18421173 20091030 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0011402 renal cast IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0011939 increased food intake IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0011939 increased food intake IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0012029 abnormal electroretinogram waveform feature IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats
2314027 SDT.Cg-<i>Lepr<sup>fa</sup></i>/Jtt SDT fatty strain MP:0030017 decreased adipocyte glucose uptake IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl and pair-fed SDT.ZDF-Leprfa/Jtt rats
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0000585 kinked tail IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0000592 short tail IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0001377 abnormal mating frequency IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0001688 abnormal somite development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0002823 abnormal rib development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0003049 abnormal lumbar vertebrae morphology IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0004709 cervical vertebrae degeneration IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314162 F344-<i>Oune</i>/Kyo Oune strain MP:0005225 abnormal vertebrae development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344
2314163 F344-<i>Kcna1<sup>Adms</sup></i>/Kyo ADMS (autosomal dominant myokymia and seizures) rat strain MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
2314163 F344-<i>Kcna1<sup>Adms</sup></i>/Kyo ADMS (autosomal dominant myokymia and seizures) rat strain MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
2314230 F344-<i>Hr<sup>krh</i></sup>/Kyo Hairless Kyoto, Hanako strain MP:0000580 deformed nails IMP N RGD:150520024|PMID:21325752 20211021 RGD
2314230 F344-<i>Hr<sup>krh</i></sup>/Kyo Hairless Kyoto, Hanako strain MP:0001211 wrinkled skin IMP N RGD:150520024|PMID:21325752 20211021 RGD
2314230 F344-<i>Hr<sup>krh</i></sup>/Kyo Hairless Kyoto, Hanako strain MP:0003815 hairless IMP N RGD:150520024|PMID:21325752 20211021 RGD
2314230 F344-<i>Hr<sup>krh</i></sup>/Kyo Hairless Kyoto, Hanako strain MP:0010699 dilated hair follicle IMP N RGD:150520024|PMID:21325752 20211021 RGD
2314230 F344-<i>Hr<sup>krh</i></sup>/Kyo Hairless Kyoto, Hanako strain MP:0030570 abnormal piliary canal morphology IMP N RGD:150520024|PMID:21325752 20211021 RGD
2314368 F344-<i>Kcnn2<sup>Trdk</sup></i>/Kyo Tremor dominant Kyoto strain MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210715 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat)
2314376 KFRS4/Kyo strain MP:0001194 dermatitis sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females
2314376 KFRS4/Kyo strain MP:0001246 mixed cellular infiltration to dermis sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females
2314376 KFRS4/Kyo strain MP:0001304 cataract IAGP N RGD:126925973|PMID:23226368 20210524 RGD
2314376 KFRS4/Kyo strain MP:0001412 excessive scratching sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females
2314376 KFRS4/Kyo strain MP:0002092 abnormal eye morphology IAGP N RGD:150429836|PMID:22736458 20211005 RGD compared to heterozygous controls
2314376 KFRS4/Kyo strain MP:0002102 abnormal ear morphology IAGP N RGD:150429836|PMID:22736458 20211005 RGD compared to heterozygous controls
2314376 KFRS4/Kyo strain MP:0002579 disorganized secondary lens fibers IAGP N RGD:126925973|PMID:23226368 20210524 RGD
2314376 KFRS4/Kyo strain MP:0002796 impaired skin barrier function sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females
2314376 KFRS4/Kyo strain MP:0002939 head spot IAGP N RGD:150429837|PMID:28356074 20211005 RGD compared to control PVG/Seac strain
2314376 KFRS4/Kyo strain MP:0011697 lens vacuoles IAGP N RGD:126925973|PMID:23226368 20210524 RGD
2314381 KFRS5A/Kyo strain MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
2314381 KFRS5A/Kyo strain MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
2314381 KFRS5A/Kyo strain MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
2314381 KFRS5A/Kyo strain MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del
2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2314493 SBH.SBN-(<i>D1Mgh2-D1Rat74</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314494 SBH.SBN-(<i>D1Rat137-D1Rat123</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314496 SBH.SBN-(<i>D1Mgh2-D1Mgh11</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314498 SBH.SBN-(<i>D1Rat137-D1Rat83</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314500 SBH.SBN-(<i>D1Mgh2-D1Rat101</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314501 SBH.SBN-(<i>D1Wox11-D1Rat137</i>)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl
2314530 SS.SHR-(<i>D8Uia1-D8Rat90</i>)/Mco strain MP:0002963 decreased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr
2314531 SHR.SS-(<i>D13Rat1-D13Mgh6</i>)/Mco strain MP:0002962 increased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SHR/NHsd
2314532 SHR.SS-(<i>D8Uia1-D8Rat90</i>)/Mco strain MP:0002962 increased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SHR/NHsd
2314655 BRAT-<i>Avp<sup>di</i></sup>/BluHsd Brattleboro strain MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20091123 RGD
2314861 WAG/RijYcb strain MP:0012359 increased partial thromboplastin time IAGP N RGD:7245962|PMID:20158945 20160825 RGD
2314885 Mir146b microRNA 146b gene MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220526 RGD
2314903 F8<i><sup>m1Ycb</sup></i> coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
2314903 F8<i><sup>m1Ycb</sup></i> coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
2314903 F8<i><sup>m1Ycb</sup></i> coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0002875 decreased erythrocyte cell number IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
2314904 WAG-<i>F8<sup>m1Ycb</sup></i> strain MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20130617 RGD
2314904 WAG-<i>F8<sup>m1Ycb</sup></i> strain MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20130617 RGD
2316631 F344.GK-(<i>D1Swe8-D1Gpam-1</i>)/Swe strain MP:0002727 decreased circulating insulin level induced IAGP XCO:0000102 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe
2316631 F344.GK-(<i>D1Swe8-D1Gpam-1</i>)/Swe strain MP:0003059 decreased insulin secretion induced IAGP XCO:0000275 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe
2316631 F344.GK-(<i>D1Swe8-D1Gpam-1</i>)/Swe strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316628|PMID:19965390 20200225 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe
2316631 F344.GK-(<i>D1Swe8-D1Gpam-1</i>)/Swe strain MP:0020848 abnormal exocytosis induced IAGP XCO:0000184 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe
2316649 Bp344 Blood pressure QTL 344 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2312639|PMID:19423552 20100222 RGD
2316896 Gluco57 Glucose level QTL 57 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316925 SHR.BN-(<i>D3Rat159-D3Rat1</i>)/Mco strain MP:0001863 blood vessel inflammation IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd
2316925 SHR.BN-(<i>D3Rat159-D3Rat1</i>)/Mco strain MP:0003025 increased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd
2316925 SHR.BN-(<i>D3Rat159-D3Rat1</i>)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD
2316927 SHR.BN-(<i>D6Rat40-D6Rat170</i>)/Mco strain MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:2316923|PMID:20026763 20100317 RGD
2316927 SHR.BN-(<i>D6Rat40-D6Rat170</i>)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD
2316928 SHR.BN-(<i>D3Rat159-D3Rat1</i>)(<i>D6Rat40-D6Rat170</i>)/Mco strain MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:2316923|PMID:20026763 20100317 RGD
2316928 SHR.BN-(<i>D3Rat159-D3Rat1</i>)(<i>D6Rat40-D6Rat170</i>)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD
2316947 Rf58 Renal function QTL 58 qtl MP:0003606 kidney failure IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316949 Gluco60 Glucose level QTL 60 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316950 Scl66 Serum cholesterol level QTL 66 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316952 Pur22 Proteinuria QTL 22 qtl MP:0002962 increased urine protein level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316954 Rf57 Renal function QTL 57 qtl MP:0003606 kidney failure IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316955 Stl24 Serum triglyceride level QTL 24 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316957 Pur21 Proteinuria QTL 21 qtl MP:0002962 increased urine protein level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316958 Gluco58 Glucose level QTL 58 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2316959 Gluco59 Glucose level QTL 59 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD
2317027 Aia22 Adjuvant induced arthritis QTL 22 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317029 Aia19 Adjuvant induced arthritis QTL 19 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317030 Wbc5 White blood cell count QTL 5 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317032 Ginf2 Gastrointestinal inflammation QTL 2 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317032 Ginf2 Gastrointestinal inflammation QTL 2 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317034 Aia9 Adjuvant induced arthritis QTL 9 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317035 Aia16 Adjuvant induced arthritis QTL 16 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317036 Livw3 Liver weight QTL 3 qtl MP:0003402 decreased liver weight IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317038 Ginf3 Gastrointestinal inflammation QTL 3 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317038 Ginf3 Gastrointestinal inflammation QTL 3 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317039 Aia6 Adjuvant induced arthritis QTL 6 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317040 Aia21 Adjuvant induced arthritis QTL 21 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317041 Aia14 Adjuvant induced arthritis QTL 14 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317042 Aia20 Adjuvant induced arthritis QTL 20 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317043 Aia7 Adjuvant induced arthritis QTL 7 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317044 Aia23 Adjuvant induced arthritis QTL 23 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317045 Aia11 Adjuvant induced arthritis QTL 11 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317046 Aia8 Adjuvant induced arthritis QTL 8 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317047 Wbc4 White blood cell count QTL 4 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317048 Ginf1 Gastrointestinal inflammation QTL 1 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317048 Ginf1 Gastrointestinal inflammation QTL 1 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317050 Aia24 Adjuvant induced arthritis QTL 24 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317051 Aia18 Adjuvant induced arthritis QTL 18 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317052 Aia17 Adjuvant induced arthritis QTL 17 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317053 Aia25 Adjuvant induced arthritis QTL 25 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317054 Aia12 Adjuvant induced arthritis QTL 12 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317055 Aia10 Adjuvant induced arthritis QTL 10 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317056 Wbc3 White blood cell count QTL 3 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317057 Aia27 Adjuvant induced arthritis QTL 27 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317058 Aia13 Adjuvant induced arthritis QTL 13 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317059 Aia15 Adjuvant induced arthritis QTL 15 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317060 Aia26 Adjuvant induced arthritis QTL 26 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide
2317196 DA.PVG.1AV1-(<i>D8Rat146-D8Got145</i>) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD
2317197 DA.PVG.1AV1-(<i>D8Rat41-D8Rat24</i>) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD
2317201 DA.PVG.1AV1-(<i>D8Rat24-D8Got145</i>) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD
2317278 Taiep/Dun strain MP:0000745 tremors IAGP N RGD:150429639|PMID:28393430 20210910 RGD progressive with age
2317278 Taiep/Dun strain MP:0000745 tremors IAGP N RGD:2317274|PMID:14694906 20201026 RGD
2317278 Taiep/Dun strain MP:0000921 demyelination IAGP N RGD:150429639|PMID:28393430 20210910 RGD progressive with age
2317278 Taiep/Dun strain MP:0005404 abnormal axon morphology IAGP N RGD:9999446|PMID:21107138 20201005 RGD
2317278 Taiep/Dun strain MP:0006219 optic nerve degeneration IAGP N RGD:9999446|PMID:21107138 20201005 RGD
2317278 Taiep/Dun strain MP:0008721 abnormal chemokine level IAGP N RGD:9999447|PMID:25883747 20150421 RGD compared to SD
2317577 Eae24 Experimental allergic encephalomyelitis QTL 24 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317586 Eae25 Experimental allergic encephalomyelitis QTL 25 qtl MP:0001263 weight loss IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317586 Eae25 Experimental allergic encephalomyelitis QTL 25 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317587 Eae26 Experimental allergic encephalomyelitis QTL 26 qtl MP:0001263 weight loss IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317587 Eae26 Experimental allergic encephalomyelitis QTL 26 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317588 Eae27 Experimental allergic encephalomyelitis QTL 27 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD
2317590 DA.PVG.1AV1-(<i>D4Rat23-D4Rat108</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini
2317595 DA.PVG.1AV1-(<i>D4Rat23-D4Mit12</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini
2317750 Glom26 Glomerulus QTL 26 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD
2317752 Glom23 Glomerulus QTL 23 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD
2317753 Glom24 Glomerulus QTL 24 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD
2317754 Glom25 Glomerulus QTL 25 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD
2317755 Glom22 Glomerulus QTL 22 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD
2317791 DA.PVG.1AV1-(<i>D4Got60-D4Kini1</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini
2317812 AT.ANT-(<i>D1Uia12-D1Rat288</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317812 AT.ANT-(<i>D1Uia12-D1Rat288</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317813 AT.ANT-(<i>D1Rat234-D1Rat47</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317813 AT.ANT-(<i>D1Rat234-D1Rat47</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317814 AT.ANT-(<i>D1Rat273-D1Rat158</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317814 AT.ANT-(<i>D1Rat273-D1Rat158</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317815 AT.ANT-(<i>D1Rat35-D1Rat47</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317815 AT.ANT-(<i>D1Rat35-D1Rat47</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317816 AT.ANT-(<i>D1Rat234-D1Rat158</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317816 AT.ANT-(<i>D1Rat234-D1Rat158</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317817 AT.ANT-(<i>D1Rat183-D1Rat288</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317817 AT.ANT-(<i>D1Rat183-D1Rat288</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317818 AT.ANT-(<i>D1Rat273-D1Rat288</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317819 AT.ANT-(<i>D1Rat35-D1Rat288</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317819 AT.ANT-(<i>D1Rat35-D1Rat288</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317820 AT.ANT-(<i>D1Rat158-D1Rat288</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317820 AT.ANT-(<i>D1Rat158-D1Rat288</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317822 AT.ANT-(<i>D1Rat35-D1Rat38</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317822 AT.ANT-(<i>D1Rat35-D1Rat38</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317825 AT.ANT-(<i>D1Rat234-D1Rat35</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317825 AT.ANT-(<i>D1Rat234-D1Rat35</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317827 AT.ANT-(<i>D1Rat234-D1Rat38</i>)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317827 AT.ANT-(<i>D1Rat234-D1Rat38</i>)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD
2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317840 Alcrsp20 Alcohol response QTL 20 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317840 Alcrsp20 Alcohol response QTL 20 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317848 Alcrsp21 Alcohol response QTL 21 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317848 Alcrsp21 Alcohol response QTL 21 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317880 Alcrsp25 Alcohol response QTL 25 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317880 Alcrsp25 Alcohol response QTL 25 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317882 Alcrsp24 Alcohol response QTL 24 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317882 Alcrsp24 Alcohol response QTL 24 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317883 Alcrsp26 Alcohol response QTL 26 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317883 Alcrsp26 Alcohol response QTL 26 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317885 Alcrsp28 Alcohol response QTL 28 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317885 Alcrsp28 Alcohol response QTL 28 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317886 Alcrsp23 Alcohol response QTL 23 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol
2317886 Alcrsp23 Alcohol response QTL 23 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD
2317891 SHR-Chr 6<sup>MWF</sup>/Rkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to MWF/FubRkb
2317891 SHR-Chr 6<sup>MWF</sup>/Rkb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to MWF/FubRkb
2317891 SHR-Chr 6<sup>MWF</sup>/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2317887|PMID:20388842 20100429 RGD compared to MWF/FubRkb
2317891 SHR-Chr 6<sup>MWF</sup>/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000121 N RGD:2317887|PMID:20388842 20200203 RGD compared to SHR/FubRkb
2318412 Oca2 OCA2 melanosomal transmembrane protein gene MP:0006159 ocular albinism IAGP N RGD:1579834|PMID:16245028 20140916 RGD
2320121 Angptl8 angiopoietin-like 8 gene MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2320121 Angptl8 angiopoietin-like 8 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats
2322311 Msh6 mutS homolog 6 gene MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210428 RGD
2322311 Msh6 mutS homolog 6 gene MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210428 RGD
2323 Cdkn2a cyclin-dependent kinase inhibitor 2A gene MP:0010309 increased mesothelioma incidence IAGP N RGD:7248760|PMID:20065947 20190813 RGD DNA:deletion
2324 Cdkn2b cyclin-dependent kinase inhibitor 2B gene MP:0010309 increased mesothelioma incidence IAGP N RGD:7248760|PMID:20065947 20190813 RGD DNA:deletion
2324617 Coatc2 Coat color QTL 2 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD
2324619 Coatc4 Coat color QTL 4 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD
2324620 Coatc3 Coat color QTL 3 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD
2324621 Coatc5 Coat color QTL 5 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD
2324631 DA.E3-(<i>D4Wox49-D4Got136</i>)/Rhd strain MP:0002933 joint inflammation susceptibility IAGP N RGD:2324629|PMID:20200546 20100506 RGD
2324631 DA.E3-(<i>D4Wox49-D4Got136</i>)/Rhd strain MP:0002936 joint swelling susceptibility IAGP N RGD:2324629|PMID:20200546 20100506 RGD
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0001262 decreased body weight IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0005554 decreased circulating creatinine level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0006316 increased urine sodium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0009349 increased urine pH IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
2325346 Mir195 microRNA 195 gene MP:0008469 abnormal protein level IMP N RGD:45073134|PMID:32272873 20210716 RGD Syp, Gap43
2325346 Mir195 microRNA 195 gene MP:0008946 abnormal neuron number IMP N RGD:45073134|PMID:32272873 20210715 RGD in hippocampus
2325346 Mir195 microRNA 195 gene MP:0020551 abnormal postsynaptic density morphology IMP N RGD:45073134|PMID:32272873 20210716 RGD
2325422 Mir542 microRNA 542 gene MP:0011346 renal tubule atrophy ameliorates IMP N RGD:401900731|PMID:32470449 20231117 RGD
2325495 Mir500 microRNA 500 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD
2325495 Mir500 microRNA 500 gene MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240606 RGD
2325495 Mir500 microRNA 500 gene MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD
2325544 Mir222 microRNA 222 gene MP:0002891 increased insulin sensitivity treatment IMP N RGD:151893462|PMID:33230470 20220420 RGD associated with polycystic ovary syndrome;
2325553 Mir200c microRNA 200c gene MP:0005257 abnormal intraocular pressure treatment IMP N RGD:155882562|PMID:23272142 20230130 RGD
2325591 Mir29b1 microRNA 29b-1 gene MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD
2325724 PVG.LEW-(<i>D1Rat270-D1Rat68</i>)/Kini strain MP:0002936 joint swelling IAGP N RGD:6892695|PMID:20072140 20100607 RGD
2325724 PVG.LEW-(<i>D1Rat270-D1Rat68</i>)/Kini strain MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:6892695|PMID:20072140 20100607 RGD
2325724 PVG.LEW-(<i>D1Rat270-D1Rat68</i>)/Kini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:6892695|PMID:20072140 20100607 RGD
2325725 Eae31 Experimental allergic encephalomyelitis QTL 31 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD
2325726 Eae30 Experimental allergic encephalomyelitis QTL 30 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD
2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0002936 joint swelling IDA N RGD:6892695|PMID:20072140 20100607 RGD
2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:6892695|PMID:20072140 20100607 RGD
2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD
2325754 SD-<i>Pax6<sup>Sey</sup></i>/Mce strain MP:0001297 microphthalmia IAGP N RGD:1601213|PMID:7981749 20100609 RGD
2325754 SD-<i>Pax6<sup>Sey</sup></i>/Mce strain MP:0001325 abnormal retina morphology IAGP N RGD:1601213|PMID:7981749 20170223 RGD
2325773 WKY.LEW-(<i>D13Arb15-D13Rat58</i>)/Tja strain MP:0002743 glomerulonephritis resistance IDA N RGD:2325762|PMID:20488952 20100610 RGD
2325773 WKY.LEW-(<i>D13Arb15-D13Rat58</i>)/Tja strain MP:0002962 increased urine protein level IDA N RGD:2325762|PMID:20488952 20120112 RGD
2325774 WKY.LEW-(<i>D13Arb10-D13Arb15</i>)(<i>D16Rat88-D16Rat40</i>)/Tja strain MP:0002743 glomerulonephritis resistance IDA N RGD:2325762|PMID:20488952 20100610 RGD
2325774 WKY.LEW-(<i>D13Arb10-D13Arb15</i>)(<i>D16Rat88-D16Rat40</i>)/Tja strain MP:0002962 increased urine protein level IDA N RGD:2325762|PMID:20488952 20120112 RGD
2325796 SS.LEW-(<i>D3Rat52-D3Chm57</i>)/Ayd strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325796 SS.LEW-(<i>D3Rat52-D3Chm57</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
2325796 SS.LEW-(<i>D3Rat52-D3Chm57</i>)/Ayd strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr
2325796 SS.LEW-(<i>D3Rat52-D3Chm57</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325796 SS.LEW-(<i>D3Rat52-D3Chm57</i>)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr
2325798 SS.LEW-(<i>D10Got112-Igfbp4</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
2325798 SS.LEW-(<i>D10Got112-Igfbp4</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325798 SS.LEW-(<i>D10Got112-Igfbp4</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to SS/Jr
2325801 SS.LEW-(<i>D16Chm36-D16Mit2</i>)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325801 SS.LEW-(<i>D16Chm36-D16Mit2</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW
2325801 SS.LEW-(<i>D16Chm36-D16Mit2</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325803 SS.LEW-(<i>D16Rat112-D16Chm60</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD
2325803 SS.LEW-(<i>D16Rat112-D16Chm60</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr
2325803 SS.LEW-(<i>D16Rat112-D16Chm60</i>)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW
2325836 Bp346 Blood pressure QTL 346 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD
2325838 Bp347 Blood pressure QTL 347 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD
2325839 Bp348 Blood pressure QTL 348 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD
2325840 Bp345 Blood pressure QTL 345 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD
2326 Cebpa CCAAT/enhancer binding protein alpha gene MP:0001547 abnormal lipid level IDA N RGD:704418|PMID:12865412 19990101 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
2332 Cftr CF transmembrane conductance regulator gene MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210527 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water
2332 Cftr CF transmembrane conductance regulator gene MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD
2332 Cftr CF transmembrane conductance regulator gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD
2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type
2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211209 RGD
2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type
2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD
2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD
2348 Chrna7 cholinergic receptor nicotinic alpha 7 subunit gene MP:0012307 impaired spatial learning IMP N RGD:151708697|PMID:17055644 20220414 RGD
2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0005167 abnormal blood-brain barrier function IAGP N RGD:704399|PMID:12663688 19990101 RGD
2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD
2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD
2370 Cntf ciliary neurotrophic factor gene MP:0005386 behavior/neurological phenotype IDA N RGD:628474|PMID:12040055 19990101 RGD
2375 Col2a1 collagen type II alpha 1 chain gene MP:0002657 chondrodystrophy IDA N RGD:704421|PMID:10853827 19990101 RGD
2379 Comt catechol-O-methyltransferase gene MP:0001905 abnormal dopamine level IDA N RGD:704422|PMID:12535946 19990101 RGD
2379 Comt catechol-O-methyltransferase gene MP:0002063 abnormal learning/memory/conditioning TAS N RGD:704422|PMID:12535946 19990101 RGD
2387 Cp ceruloplasmin gene MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2387 Cp ceruloplasmin gene MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD
2401 Crebbp CREB binding protein gene MP:0001625 cardiac hypertrophy IDA N RGD:1298794|PMID:12477714 20061031 RGD
2401 Crebbp CREB binding protein gene MP:0020422 decreased freezing behavior IMP N RGD:126848802|PMID:32206715 20210504 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0000259 abnormal vascular development IAGP N RGD:2303652|PMID:17931883 20090220 RGD DNA:insertion:exon
2415 Cryba1 crystallin, beta A1 gene MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD
2415 Cryba1 crystallin, beta A1 gene MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210519 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210414 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210413 RGD
2425 Csf1r colony stimulating factor 1 receptor gene MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210414 RGD
2453 Cyp11b1 cytochrome P450, family 11, subfamily b, polypeptide 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:69709|PMID:7981756 20150304 RGD
2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0000639 abnormal adrenal gland morphology IAGP N RGD:727991|PMID:11832364 19990101 RGD
2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0000706 small thymus IAGP N RGD:727991|PMID:11832364 19990101 RGD
2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0001745 increased circulating corticosterone level IAGP N RGD:727991|PMID:11832364 19990101 RGD
2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0002666 increased circulating aldosterone level IAGP N RGD:727991|PMID:11832364 19990101 RGD
2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0003916 decreased heart left ventricle weight IAGP N RGD:727991|PMID:11832364 19990101 RGD
2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type
2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared between male and female
2493 Ace angiotensin I converting enzyme gene MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:8157605|PMID:16229862 20140203 RGD DNA:insertion:intron:IVS16ins287
2493 Ace angiotensin I converting enzyme gene MP:0003185 decreased angiotensin I-converting enzyme activity IAGP N RGD:8157602|PMID:9484988 20140203 RGD DNA:repeat:intron:IVS13+40(CA)?-26
2507 Dmd dystrophin gene MP:0000747 muscle weakness IMP N RGD:11040981|PMID:25005781 20170428 RGD
2507 Dmd dystrophin gene MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170428 RGD
2507 Dmd dystrophin gene MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
2507 Dmd dystrophin gene MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
2507 Dmd dystrophin gene MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD
2507 Dmd dystrophin gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170428 RGD
2507 Dmd dystrophin gene MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD
2507 Dmd dystrophin gene MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD
2507 Dmd dystrophin gene MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001262 decreased body weight IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001263 weight loss IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001392 abnormal locomotor behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001422 abnormal drinking behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001970 abnormal pain threshold IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002799 abnormal passive avoidance behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005292 improved glucose tolerance IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2515 Dpp4 dipeptidylpeptidase 4 gene MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm
2518 Drd1 dopamine receptor D1 gene MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
2518 Drd1 dopamine receptor D1 gene MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
2518 Drd1 dopamine receptor D1 gene MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
2518 Drd1 dopamine receptor D1 gene MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
2518 Drd1 dopamine receptor D1 gene MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type
2520 Drd2 dopamine receptor D2 gene MP:0002806 abnormal conditioned emotional response IDA N RGD:1581463|PMID:11311883 19990101 RGD decreased after administration of D2 antagonist
2520 Drd2 dopamine receptor D2 gene MP:0003460 decreased fear-related response IDA N RGD:1581463|PMID:11311883 19990101 RGD decreased after administration of D2 antagonist
2520 Drd2 dopamine receptor D2 gene MP:0003545 increased alcohol consumption IDA N RGD:1580677|PMID:12086672 19990101 RGD
2520 Drd2 dopamine receptor D2 gene MP:0004924 abnormal behavior IAGP N RGD:1581462|PMID:11814400 19990101 RGD
2528 Dyrk1a dual specificity tyrosine phosphorylation regulated kinase 1A gene MP:0001262 decreased body weight IMP N RGD:14929209|PMID:28266534 20190918 RGD
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0000231 hypertension ameliorates IAGP XCO:0000555 N RGD:25314263|PMID:10516341 20210415 RGD compared to untreated MWF
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0000521 abnormal kidney cortex morphology sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0001260 increased body weight onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002608 increased hematocrit sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002828 abnormal renal glomerular capsule morphology onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002842 increased systemic arterial blood pressure sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002963 decreased urine protein level treatment IDA N RGD:25314243|PMID:7894005 20211108 RGD
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0003917 increased kidney weight sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0003917 increased kidney weight treatment IAGP XCO:0000555 N RGD:25314250|PMID:10703671 20210707 RGD compared to control MWF and Wi
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005264 glomerulosclerosis ameliorates IAGP XCO:0000555 N RGD:25314263|PMID:10516341 20210415 RGD compared to untreated MWF
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005527 increased renal glomerular filtration rate sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005556 abnormal renal filtration rate sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314250|PMID:10703671 20210707 RGD compared to control MWF and Wi
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IDA N RGD:25314243|PMID:7894005 20211108 RGD
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0008837 increased transforming growth factor beta level treatment IAGP XCO:0000555 N RGD:25314270|PMID:16395266 20210402 RGD compared to treated and Wi
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0010064 increased circulating creatine level treatment IAGP XCO:0000555 N RGD:25314270|PMID:16395266 20210402 RGD compared to treated and Wi
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:14401564|PMID:16400008 20210708 RGD compared to Wi and 10-20 week MWF
25314294 MWF/Ztm Munich Wistar Fromter strain MP:0011753 decreased podocyte number IAGP N RGD:14401564|PMID:16400008 20210708 RGD compared to Wi and 10-20 week MWF
25330093 SD-<i>Mir146b<sup>em1Mcwi</sup></i> strain MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220114 RGD
2535 Ednra endothelin receptor type A gene MP:0002625 heart left ventricle hypertrophy IDA N RGD:1581830|PMID:16157796 20061026 RGD
2535 Ednra endothelin receptor type A gene MP:0003215 renal interstitial fibrosis IMP N RGD:1581844|PMID:12538737 20061026 RGD
2535 Ednra endothelin receptor type A gene MP:0003675 kidney cyst IMP N RGD:1581844|PMID:12538737 20061026 RGD
2535 Ednra endothelin receptor type A gene MP:0005264 glomerulosclerosis IDA N RGD:1581830|PMID:16157796 20061026 RGD
2535 Ednra endothelin receptor type A gene MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581830|PMID:16157796 20061026 RGD
2536 Ednrb endothelin receptor type B gene MP:0000351 increased cell proliferation IMP N RGD:4892578|PMID:18683040 20061027 RGD
2536 Ednrb endothelin receptor type B gene MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD
2536 Ednrb endothelin receptor type B gene MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628515|PMID:8570650 20061030 RGD
2536 Ednrb endothelin receptor type B gene MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628516|PMID:9739043 20061026 RGD
2536 Ednrb endothelin receptor type B gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20061030 RGD
2536 Ednrb endothelin receptor type B gene MP:0002080 prenatal lethality IGI RGD:1554306 N RGD:126777688|PMID:31170185 20210407 RGD critical region in GK/Slc (RGD:1554306) Chr 2
2536 Ednrb endothelin receptor type B gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:1581856|PMID:16179487 20061027 RGD
2536 Ednrb endothelin receptor type B gene MP:0002926 aganglionic megacolon IAGP N RGD:6480215|PMID:22132166 20210218 RGD
2536 Ednrb endothelin receptor type B gene MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20170329 RGD
2536 Ednrb endothelin receptor type B gene MP:0003204 decreased neuron apoptosis IMP N RGD:4892578|PMID:18683040 20061027 RGD
2536 Ednrb endothelin receptor type B gene MP:0003215 renal interstitial fibrosis IMP N RGD:1581844|PMID:12538737 20061026 RGD
2536 Ednrb endothelin receptor type B gene MP:0003675 kidney cyst IMP N RGD:1581844|PMID:12538737 20061026 RGD
2536 Ednrb endothelin receptor type B gene MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20210218 RGD
2536 Ednrb endothelin receptor type B gene MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20210218 RGD
2536 Ednrb endothelin receptor type B gene MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD
2536 Ednrb endothelin receptor type B gene MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20170406 RGD
2536 Ednrb endothelin receptor type B gene MP:0005533 increased body temperature IDA N RGD:1581859|PMID:16123229 20061027 RGD
2536 Ednrb endothelin receptor type B gene MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD
2536 Ednrb endothelin receptor type B gene MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD
2536 Ednrb endothelin receptor type B gene MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20210218 RGD
2536 Ednrb endothelin receptor type B gene MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD
2543 Egfr epidermal growth factor receptor gene MP:0001927 abnormal estrous cycle IDA N RGD:70386|PMID:11796513 20061030 RGD
2543 Egfr epidermal growth factor receptor gene MP:0002625 heart left ventricle hypertrophy IDA N RGD:1580955|PMID:12624003 20061030 RGD
2543 Egfr epidermal growth factor receptor gene MP:0003985 renal fibrosis IDA N RGD:1581909|PMID:15033924 20061030 RGD
2561 Erbb2 erb-b2 receptor tyrosine kinase 2 gene MP:0001272 increased metastatic potential IDA N RGD:1582128|PMID:1359541 20061101 RGD
2581 Esr1 estrogen receptor 1 gene MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20140501 RGD
2581 Esr1 estrogen receptor 1 gene MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20140501 RGD
2581 Esr1 estrogen receptor 1 gene MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD
2581 Esr1 estrogen receptor 1 gene MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20140501 RGD
2581 Esr1 estrogen receptor 1 gene MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
2581 Esr1 estrogen receptor 1 gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD
2581 Esr1 estrogen receptor 1 gene MP:0002160 abnormal reproductive system morphology IMP N RGD:8552987|PMID:24506075 20140501 RGD
2581 Esr1 estrogen receptor 1 gene MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD
2581 Esr1 estrogen receptor 1 gene MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD
2582 Esr2 estrogen receptor 2 gene MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0004805 absent oocytes IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
2582 Esr2 estrogen receptor 2 gene MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20201214 RGD
2582 Esr2 estrogen receptor 2 gene MP:0004856 decreased ovary weight IMP N RGD:38548925|PMID:29580824 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0005158 ovary hypoplasia IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
2582 Esr2 estrogen receptor 2 gene MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0005185 decreased circulating progesterone level IMP N RGD:38548925|PMID:29580824 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0008869 anovulation IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
2582 Esr2 estrogen receptor 2 gene MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD
2582 Esr2 estrogen receptor 2 gene MP:0009819 abnormal circulating androgen level IMP N RGD:38548925|PMID:29580824 20200825 RGD
2583 Ets1 ETS proto-oncogene 1, transcription factor gene MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20211007 RGD compared to littermate
2583 Ets1 ETS proto-oncogene 1, transcription factor gene MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220630 RGD compared to wild type littermate
2586 F2r coagulation factor II (thrombin) receptor gene MP:0002736 abnormal nociception after inflammation IDA N RGD:1582348|PMID:12126749 20061106 RGD
2590 Fabp1 fatty acid binding protein 1 gene MP:0005516 enhanced liver regeneration IAGP N RGD:1578454|PMID:15532708 19990101 RGD
2609 Fgf2 fibroblast growth factor 2 gene MP:0001363 increased anxiety-related response IMP N RGD:405866182|PMID:25071177 20240620 RGD compared to control treated bHR strain
2614 Fh fumarate hydratase gene MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only;
2614 Fh fumarate hydratase gene MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0008762 embryonic lethality IMP N RGD:13792708|PMID:27556703 20181008 RGD
2614 Fh fumarate hydratase gene MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20200818 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8:
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240307 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20200818 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8:
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240328 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD DNA:deletion:intron 7, exon 8:
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240328 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240328 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20200818 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240307 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240328 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170119 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240307 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240321 RGD compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20200818 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020395 abnormal response to social novelty IMP N RGD:9831152|PMID:24773431 20170119 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240321 RGD in juveniles, compared to wild type controls
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240404 RGD compared to wild type
2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240328 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:401900162|PMID:24200867 20231108 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240613 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240606 RGD
2652 Gad1 glutamate decarboxylase 1 gene MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240606 RGD
2670 Gck glucokinase gene MP:0001552 increased circulating triglyceride level IDA N RGD:2301945|PMID:10512368 20081111 RGD overexpression sufficient to lower blood glucose significantly increased circulating FFA and TG levels (p<0.05)
2670 Gck glucokinase gene MP:0001554 increased circulating free fatty acids level IDA N RGD:2301945|PMID:10512368 20081111 RGD overexpression sufficient to lower blood glucose significantly increased circulating FFA and TG levels (p<0.05)
2670 Gck glucokinase gene MP:0005560 decreased circulating glucose level IDA N RGD:2301945|PMID:10512368 20081111 RGD
2686 Gh1 growth hormone 1 gene MP:0005136 decreased growth hormone level IAGP N RGD:1578506|PMID:2152867 20210416 RGD
2686 Gh1 growth hormone 1 gene MP:0005138 decreased prolactin level IAGP N RGD:1578506|PMID:2152867 20210416 RGD
2688 Ghrhr growth hormone releasing hormone receptor gene MP:0001501 abnormal sleep pattern IDA N RGD:728477|PMID:12161265 19990101 RGD
2703 Glp1r glucagon-like peptide 1 receptor gene MP:0002626 increased heart rate IDA N RGD:625448|PMID:12093887 20061129 RGD
2703 Glp1r glucagon-like peptide 1 receptor gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:625448|PMID:12093887 20061129 RGD
2703 Glp1r glucagon-like peptide 1 receptor gene MP:0003058 increased insulin secretion IDA N RGD:625448|PMID:12093887 20061129 RGD
2703 Glp1r glucagon-like peptide 1 receptor gene MP:0005560 decreased circulating glucose level NOT IDA N RGD:625448|PMID:12093887 20061129 RGD
2715 Gnal G protein subunit alpha L gene MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211004 RGD
2715 Gnal G protein subunit alpha L gene MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211004 RGD
2715 Gnal G protein subunit alpha L gene MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211004 RGD
2715 Gnal G protein subunit alpha L gene MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211004 RGD
2715 Gnal G protein subunit alpha L gene MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211004 RGD
2715 Gnal G protein subunit alpha L gene MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211004 RGD
2737 Grin2a glutamate ionotropic receptor NMDA type subunit 2A gene MP:0003076 increased susceptibility to ischemic brain injury IDA N RGD:734740|PMID:14502288 19990101 RGD
2737 Grin2a glutamate ionotropic receptor NMDA type subunit 2A gene MP:0020911 abnormal drug-induced reinstatement of an extinguished operant behavior for a drug reinforcer ameliorates IMP N RGD:401938637|PMID:23671067 20231215 RGD
2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate
2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241107 RGD compared to male wild type littermate
2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate
2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats
2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type
2806 Hmox1 heme oxygenase 1 gene MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1580453|PMID:12215473 19990101 RGD
2806 Hmox1 heme oxygenase 1 gene MP:0005590 increased vasodilation IDA N RGD:1580452|PMID:15057912 19990101 RGD
2827 Hras HRas proto-oncogene, GTPase gene MP:0006072 abnormal retina apoptosis IDA N RGD:1358731|PMID:14988264 19990101 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220203 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type
2846 Htr1b 5-hydroxytryptamine receptor 1B gene MP:0002065 abnormal fear/anxiety-related behavior IDA N RGD:625756|PMID:12040062 19990101 RGD
2868 Igf1 insulin-like growth factor 1 gene MP:0001625 cardiac hypertrophy IDA N RGD:1580474|PMID:15996002 19990101 RGD
2887 Il15 interleukin 15 gene MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD
2887 Il15 interleukin 15 gene MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD
2887 Il15 interleukin 15 gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
2887 Il15 interleukin 15 gene MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD
2912 Inha inhibin subunit alpha gene MP:0001927 abnormal estrous cycle IDA N RGD:2290396|PMID:15359127 20080311 RGD rat transgene introduced into female mice
2912 Inha inhibin subunit alpha gene MP:0001934 increased litter size IDA N RGD:2290396|PMID:15359127 20080311 RGD rat transgene introduced into female mice
2917 Insr insulin receptor gene MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2917 Insr insulin receptor gene MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2917 Insr insulin receptor gene MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2917 Insr insulin receptor gene MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD
2949 Kcna1 potassium voltage-gated channel subfamily A member 1 gene MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
2949 Kcna1 potassium voltage-gated channel subfamily A member 1 gene MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD
2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD
2961 Kcnmb1 potassium calcium-activated channel subfamily M regulatory beta subunit 1 gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:1298970|PMID:14551242 19990101 RGD
2963 Kcnn2 potassium calcium-activated channel subfamily N member 2 gene MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210805 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat)
2965 Kdr kinase insert domain receptor gene MP:0001463 abnormal spatial learning IDA N RGD:1581594|PMID:15258583 20080408 RGD
2965 Kdr kinase insert domain receptor gene MP:0002792 abnormal retina vasculature morphology IDA N RGD:1581593|PMID:15951738 20080408 RGD inhibition significantly reduces retinal neovascularization
2965 Kdr kinase insert domain receptor gene MP:0002799 abnormal passive avoidance behavior IDA N RGD:1581594|PMID:15258583 20080408 RGD
2965 Kdr kinase insert domain receptor gene MP:0003360 abnormal depression-related behavior IDA N RGD:2292006|PMID:17360578 20080408 RGD
2965 Kdr kinase insert domain receptor gene MP:0003711 pathological neovascularization IDA N RGD:2292014|PMID:14988842 20080408 RGD inhibition reduces portal-systemic collateral vessel formation
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-)
2998 Ldlr low density lipoprotein receptor gene MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20201210 RGD
2998 Ldlr low density lipoprotein receptor gene MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD
3000 Lep leptin gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds:
3000 Lep leptin gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds:
3000 Lep leptin gene MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20201210 RGD
3000 Lep leptin gene MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds:
3001 Lepr leptin receptor gene MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD
3001 Lepr leptin receptor gene MP:0000231 hypertension IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0000231 hypertension IMP N RGD:12911217|PMID:27465994 20170707 RGD
3001 Lepr leptin receptor gene MP:0000731 increased collagen deposition in the muscles treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
3001 Lepr leptin receptor gene MP:0000747 muscle weakness IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0001260 increased body weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat)
3001 Lepr leptin receptor gene MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
3001 Lepr leptin receptor gene MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa
3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0001261 obese treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
3001 Lepr leptin receptor gene MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa
3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD
3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD
3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
3001 Lepr leptin receptor gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD
3001 Lepr leptin receptor gene MP:0002079 increased circulating insulin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002747 abnormal aortic valve morphology IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
3001 Lepr leptin receptor gene MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats
3001 Lepr leptin receptor gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0002959 increased urine microalbumin level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002959 increased urine microalbumin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20170707 RGD
3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi
3001 Lepr leptin receptor gene MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0003915 increased heart left ventricle weight IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0004890 decreased energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD
3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0005264 glomerulosclerosis IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD
3001 Lepr leptin receptor gene MP:0005288 abnormal oxygen consumption treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi
3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005331 insulin resistance IMP N RGD:12911217|PMID:27465994 20170707 RGD
3001 Lepr leptin receptor gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0005450 abnormal energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
3001 Lepr leptin receptor gene MP:0005526 decreased renal plasma flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat)
3001 Lepr leptin receptor gene MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat)
3001 Lepr leptin receptor gene MP:0005531 increased renal vascular resistance IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat)
3001 Lepr leptin receptor gene MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
3001 Lepr leptin receptor gene MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates
3001 Lepr leptin receptor gene MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD
3001 Lepr leptin receptor gene MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi
3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
3001 Lepr leptin receptor gene MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD
3001 Lepr leptin receptor gene MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
3001 Lepr leptin receptor gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN
3001 Lepr leptin receptor gene MP:0010018 pulmonary vascular congestion treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0010754 abnormal heart left ventricle pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011353 expanded mesangial matrix IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase
3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20200702 RGD
3001 Lepr leptin receptor gene MP:0011929 abnormal aortic valve flow IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats
3001 Lepr leptin receptor gene MP:0011941 increased fluid intake IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat)
3001 Lepr leptin receptor gene MP:0012106 impaired exercise endurance treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
3001 Lepr leptin receptor gene MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD
3001 Lepr leptin receptor gene MP:0014144 abnormal white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
3001 Lepr leptin receptor gene MP:0014145 increased white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0020252 abnormal collagen level treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
3001 Lepr leptin receptor gene MP:0020989 increased urine lipocalin 2 level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat)
3001 Lepr leptin receptor gene MP:0021162 increased heart left ventricle anterior wall thickness IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat)
3020 Lta lymphotoxin alpha gene MP:0005671 abnormal response to transplant IDA N RGD:1580413|PMID:9798700 19990101 RGD
3032 Smad3 SMAD family member 3 gene MP:0003333 liver fibrosis IDA N RGD:2300428|PMID:14512875 20080919 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201012 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20120612 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001432 abnormal food preference IMP N RGD:6478803|PMID:21527895 20120612 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20120612 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210624 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210624 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210624 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210610 RGD compared with WI-MC4r^m1Hubr
3057 Mc4r melanocortin 4 receptor gene MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD
3057 Mc4r melanocortin 4 receptor gene MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to female heterozygote mutant
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001513 limb grasping IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to male SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
3075 Mecp2 methyl CpG binding protein 2 gene MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female
3075 Mecp2 methyl CpG binding protein 2 gene MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
3075 Mecp2 methyl CpG binding protein 2 gene MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type
3075 Mecp2 methyl CpG binding protein 2 gene MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male
3075 Mecp2 methyl CpG binding protein 2 gene MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210325 RGD
3075 Mecp2 methyl CpG binding protein 2 gene MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210325 RGD
3078 Men1 menin 1 gene MP:0000488 abnormal intestinal epithelium morphology severity IMP N RGD:1304318|PMID:15054094 20170825 RGD
3088 Mgp matrix Gla protein gene MP:0006133 calcified artery IDA N RGD:2293588|PMID:17138823 20080605 RGD
3115 Mstn myostatin gene MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
3115 Mstn myostatin gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220127 RGD compared to wild type male
3115 Mstn myostatin gene MP:0003397 increased muscle weight IMP N RGD:13831345|PMID:27289021 20190102 RGD
3115 Mstn myostatin gene MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
3115 Mstn myostatin gene MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
3115 Mstn myostatin gene MP:0010025 decreased total body fat amount IMP N RGD:13831345|PMID:27289021 20190102 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0003927 increased cellular glucose import IMP N RGD:7207891|PMID:22842522 20130212 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0005332 abnormal amino acid level IMP N RGD:7207891|PMID:22842522 20130212 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0010954 abnormal cellular respiration IMP N RGD:7207891|PMID:22842522 20130212 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011631 decreased mitochondrial size IMP N RGD:7240532|PMID:22629444 20130214 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011635 abnormal mitochondrial crista morphology IMP N RGD:7240532|PMID:22629444 20130214 RGD
3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011704 decreased fibroblast proliferation IMP N RGD:7207891|PMID:22842522 20130212 RGD
3143 Myo5a myosin VA gene MP:0001186 pigmentation phenotype IAGP N RGD:61493|PMID:10920234 20090206 RGD dilute coat color
3143 Myo5a myosin VA gene MP:0001393 ataxia IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582
3143 Myo5a myosin VA gene MP:0002880 opisthotonus IAGP N RGD:1600835|PMID:17185506 20070328 RGD DNA:rearrangement:exon:a 141-bp exon skipped
3143 Myo5a myosin VA gene MP:0003996 clonic seizures IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582
3143 Myo5a myosin VA gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582
3193 Nppa natriuretic peptide A gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
3193 Nppa natriuretic peptide A gene MP:0002833 increased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
3193 Nppa natriuretic peptide A gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
3193 Nppa natriuretic peptide A gene MP:0006143 increased systemic arterial diastolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
3193 Nppa natriuretic peptide A gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
3194 Nppb natriuretic peptide B gene MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20170609 RGD
3194 Nppb natriuretic peptide B gene MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20170609 RGD
3194 Nppb natriuretic peptide B gene MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20201210 RGD
3194 Nppb natriuretic peptide B gene MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20170609 RGD
3195 Npr1 natriuretic peptide receptor 1 gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1357231|PMID:7629399 19990101 RGD
3195 Npr1 natriuretic peptide receptor 1 gene MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:628585|PMID:12511524 19990101 RGD
3197 Npy neuropeptide Y gene MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
3197 Npy neuropeptide Y gene MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
3197 Npy neuropeptide Y gene MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm;
3227 Odc1 ornithine decarboxylase 1 gene MP:0003068 enlarged kidney TAS N RGD:1578327|PMID:12716758 19990101 RGD
3241 P2rx7 purinergic receptor P2X 7 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14995937|PMID:31630543 20191105 RGD
3241 P2rx7 purinergic receptor P2X 7 gene MP:0005556 abnormal renal filtration rate IMP N RGD:14995937|PMID:31630543 20191105 RGD
3249 Serpine1 serpin family E member 1 gene MP:0001273 decreased metastatic potential IMP N RGD:2306009|PMID:18460465 20170927 RGD
3258 Pax6 paired box 6 gene MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD
3258 Pax6 paired box 6 gene MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD
3258 Pax6 paired box 6 gene MP:0001297 microphthalmia IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0001325 abnormal retina morphology IAGP N RGD:1601213|PMID:7981749 20170223 RGD
3258 Pax6 paired box 6 gene MP:0002092 abnormal eye morphology QTM N RGD:731242|PMID:9247338 19990101 RGD
3258 Pax6 paired box 6 gene MP:0002233 abnormal nose morphology IAGP N RGD:1601213|PMID:7981749 20070410 RGD
3258 Pax6 paired box 6 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20170223 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:12790972|PMID:17178107 20170223 RGD
3258 Pax6 paired box 6 gene MP:0005253 abnormal eye physiology IAGP N RGD:1601213|PMID:7981749 20070410 RGD
3258 Pax6 paired box 6 gene MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20170223 RGD
3258 Pax6 paired box 6 gene MP:0009142 decreased prepulse inhibition IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20170223 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0010147 abnormal endocrine pancreas physiology IAGP N RGD:12790972|PMID:17178107 20170223 RGD
3258 Pax6 paired box 6 gene MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds:
3258 Pax6 paired box 6 gene MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20180403 RGD in female pups;DNA:frameshift mutation:cds:
329333019 SD-<i>Spon2<sup>em1Holi</sup></i> strain MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230427 RGD
329333021 Spon2<sup>em1Holi</sup> spondin 2; TALEN induced mutant1, Holi gene MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230504 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845597 WKY-<i>Col4a5<sup>em1Matsu</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845599 WKY-<i>Col4a5<sup>em2Matsu</sup></i> strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD
329845600 WKY-<i>Col4a5<sup>em3Matsu</sup></i> strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969888 Col4a5<sup>em1Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969892 Col4a5<sup>em2Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 2, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD
329969893 Col4a5<sup>em3Matsu</sup> collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 3, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20210211 RGD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 20210211 RGD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD
3343 Plau plasminogen activator, urokinase gene MP:0000598 abnormal liver morphology treatment IMP N RGD:7241553|PMID:23018346 20180109 RGD
3344 Plcb1 phospholipase C beta 1 gene MP:0003360 abnormal depression-related behavior IDA N RGD:1582557|PMID:15536495 20061113 RGD
3350 Pld2 phospholipase D2 gene MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:1642674|PMID:16113073 20071008 RGD angiotensin II induced
3354 Plp1 proteolipid protein 1 gene MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 19990101 RGD
3354 Plp1 proteolipid protein 1 gene MP:0000745 tremors IAGP N RGD:1358782|PMID:434110 19990101 RGD
3354 Plp1 proteolipid protein 1 gene MP:0002064 seizures IAGP N RGD:1358781|PMID:2479544 20241206 RGD
3354 Plp1 proteolipid protein 1 gene MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 20241206 RGD
3354 Plp1 proteolipid protein 1 gene MP:0002083 premature death IAGP N RGD:1358782|PMID:434110 19990101 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
3358 Pmch pro-melanin-concentrating hormone gene MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220512 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
3358 Pmch pro-melanin-concentrating hormone gene MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211021 RGD
3358 Pmch pro-melanin-concentrating hormone gene MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
3358 Pmch pro-melanin-concentrating hormone gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type
3358 Pmch pro-melanin-concentrating hormone gene MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220512 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220113 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220113 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220113 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD
3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220113 RGD
3382 Ppp3ca protein phosphatase 3 catalytic subunit alpha gene MP:0001625 cardiac hypertrophy IDA N RGD:1580700|PMID:16799071 19990101 RGD
3383 Ppp3cb protein phosphatase 3 catalytic subunit beta gene MP:0001625 cardiac hypertrophy IDA N RGD:1580703|PMID:16496058 19990101 RGD
3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211021 RGD
3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211021 RGD
3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211021 RGD
3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211021 RGD
3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211021 RGD
3399 Prkcz protein kinase C, zeta gene MP:0002805 abnormal conditioned taste aversion behavior IDA N RGD:1642657|PMID:17702943 20071005 RGD inhibition eliminates long term memory of taste aversion stimulus
3399 Prkcz protein kinase C, zeta gene MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:1642674|PMID:16113073 20071008 RGD angiotensin II induced
3399 Prkcz protein kinase C, zeta gene MP:0003008 enhanced long-term potentiation IDA N RGD:1642696|PMID:15728837 20071009 RGD normal enhancement of long-term potentiation
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0000165 abnormal long bone hypertrophic chondrocyte zone IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0000592 short tail IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001258 decreased body length IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001262 decreased body weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001732 postnatal growth retardation IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001732 postnatal growth retardation IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0002999 abnormal bone healing IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0006398 increased long bone epiphyseal plate size IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0008272 abnormal endochondral bone ossification IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0030315 small neurocranium IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat)
3419 Klk6 kallikrein related-peptidase 6 gene MP:0000921 demyelination IAGP N RGD:1358596|PMID:12023317 19990101 RGD
3425 Psen1 presenilin 1 gene MP:0006042 increased apoptosis IDA N RGD:1304239|PMID:11895366 19990101 RGD
3553 Reln reelin gene MP:0001392 abnormal locomotor behavior IAGP N RGD:729917|PMID:12820163 20100429 RGD
3554 Ren renin gene MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61046|PMID:8567976 19990101 RGD
3554 Ren renin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD
3554 Ren renin gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD
3554 Ren renin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
3554 Ren renin gene MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220203 RGD
3554 Ren renin gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
3554 Ren renin gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
3554 Ren renin gene MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3554 Ren renin gene MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
3555 Resp18 regulated endocrine-specific protein 18 gene MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD
3555 Resp18 regulated endocrine-specific protein 18 gene MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD
35668861 LEW-Tg(HLA-B*2705,B2M)<sup>Tg/0</sup>21-3Reh strain MP:0001150 enlarged scrotum sexual_dimorphism IAGP N RGD:25671476|PMID:22488218 20200709 RGD in males
35668863 LEW-Tg(HLA-B*2705,B2M)21-3Reh<sup>Tg/Tg</sup> strain MP:0001150 enlarged scrotum sexual_dimorphism IAGP N RGD:25671476|PMID:22488218 20200709 RGD in males
35668863 LEW-Tg(HLA-B*2705,B2M)21-3Reh<sup>Tg/Tg</sup> strain MP:0005036 diarrhea IAGP N RGD:25671476|PMID:22488218 19990101 RGD
35668863 LEW-Tg(HLA-B*2705,B2M)21-3Reh<sup>Tg/Tg</sup> strain MP:0020242 increased autopod size IAGP N RGD:25671476|PMID:22488218 20200709 RGD
3684 Slc11a2 solute carrier family 11 member 2 gene MP:0005637 abnormal iron homeostasis IAGP N RGD:1580428|PMID:14675167 19990101 RGD
3684 Slc11a2 solute carrier family 11 member 2 gene MP:0005637 abnormal iron homeostasis IAGP N RGD:729808|PMID:9448300 19990101 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0003026 decreased vasoconstriction IMP N RGD:4889513|PMID:18263707 20101203 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009676 abnormal hemostasis IMP N RGD:4889487|PMID:19246633 20101202 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20101202 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0010070 decreased serotonin level IMP N RGD:4889487|PMID:19246633 20101202 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20101202 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240104 RGD
3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate
3729 Snca synuclein alpha gene MP:0008236 decreased susceptibility to neuronal excitotoxicity IMP N RGD:13506279|PMID:16837598 20230412 RGD
3733 Sod3 superoxide dismutase 3 gene MP:0001613 abnormal vasodilation IMP N RGD:38548929|PMID:24322611 20200827 RGD DNA:missense mutation:CDS:p.E124D
3733 Sod3 superoxide dismutase 3 gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0003025 increased vasoconstriction IMP N RGD:38548929|PMID:24322611 20200827 RGD XCO:0000145;DNA:missense mutation:cds:p.E124D
3733 Sod3 superoxide dismutase 3 gene MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0005590 increased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D
3733 Sod3 superoxide dismutase 3 gene MP:0005591 decreased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D
3733 Sod3 superoxide dismutase 3 gene MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3733 Sod3 superoxide dismutase 3 gene MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220127 RGD in lung
3733 Sod3 superoxide dismutase 3 gene MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220113 RGD
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type male
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type
3804 Syt2 synaptotagmin 2 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
3804 Syt2 synaptotagmin 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
38456008 LOU/C strain MP:0002023 increased B cell derived lymphoma incidence susceptibility IAGP N RGD:634815|PMID:902252 20111114 RGD
3848 Tg thyroglobulin gene MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD
3848 Tg thyroglobulin gene MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat)
3848 Tg thyroglobulin gene MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20201210 RGD
3848 Tg thyroglobulin gene MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20201210 RGD
3848 Tg thyroglobulin gene MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD
3848 Tg thyroglobulin gene MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD
3848 Tg thyroglobulin gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat)
3848 Tg thyroglobulin gene MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD
3848 Tg thyroglobulin gene MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat)
38501060 SD-<i>Cp<sup>em1Ang+/-</sup></i> strain MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501060 SD-<i>Cp<sup>em1Ang+/-</sup></i> strain MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD compared to SD-Cpem1Ang+/- and wild-type
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD compared to SD-Cpem1Ang+/- and wild-type
38501061 SD-<i>Cp<sup>em1Ang-/-</sup></i> strain MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501062 Cp<sup>em1Ang</sup> ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD
38501086 SD-<i>Bmpr2<sup>em1Ang+/-</sup></i> strain MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD
38501087 Bmpr2<sup>em1Ang</sup> bone morphogenetic protein receptor type 2; ZFN induced mutant 1, Ang gene MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0000692 small spleen IMP N RGD:38508903|PMID:30206106 20200821 RGD
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508903|PMID:30206106 20200821 RGD compared to wild-type and heterozygous
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0004956 decreased thymus weight IMP N RGD:38508903|PMID:30206106 20200821 RGD
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0008044 increased NK cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD
38543943 SD-<i>Rag2<sup>em1Hera</sup></i> strain MP:0008212 absent mature B cells IMP N RGD:38508903|PMID:30206106 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0008044 increased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548914 SD-<i>Rag1/Rag2<sup>em1Mlit</sup></i> strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0001807 decreased IgA level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0008045 decreased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548915 SD-<i>Il2rg<sup>em1-/y</sup></i>/Mlit strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0001807 decreased IgA level IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0008045 decreased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548916 SD-<i>Rag1/Rag2<sup>em1Mlit</sup>Il2rg<sup>em1Mlit-/y</sup></i> strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0000221 decreased leukocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210713 RGD compared to control
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003215 renal interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003215 renal interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham and MWF-Nx-ACEI
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003916 decreased heart left ventricle weight treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx and MWF-Nx-ACEI
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005522 increased circulating atrial natriuretic factor treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005557 increased creatinine clearance treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham and WU-Nx
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005600 increased heart ventricle muscle contractility treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx and WU-sham
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005608 cardiac interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI
38548927 HsdCpb:WU Wistar Wu Rat strain MP:0020418 increased cardiac muscle relaxation treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx, MWF-Nx-ACEI and WU-sham
38549356 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup></i> strain MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549356 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup></i> strain MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549356 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup></i> strain MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549356 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup></i> strain MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549357 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup>Defb42<sup>em1Mlit</sup></i> strain MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549357 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup>Defb42<sup>em1Mlit</sup></i> strain MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549357 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup>Defb42<sup>em1Mlit</sup></i> strain MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20200831 RGD
38549357 SD-<i>Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup>Defb42<sup>em1Mlit</sup></i> strain MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20200831 RGD
38596327 WI-<i>Tbc1d4<sup>em1Gdcz</sup></i> strain MP:0005293 impaired glucose tolerance induced IMP XCO:0000103 N RGD:38596323|PMID:32053588 20200903 RGD
38596327 WI-<i>Tbc1d4<sup>em1Gdcz</sup></i> strain MP:0005293 impaired glucose tolerance induced IMP XCO:0000103 N RGD:38596332|PMID:31034517 20200903 RGD
38596327 WI-<i>Tbc1d4<sup>em1Gdcz</sup></i> strain MP:0005331 insulin resistance induced IMP XCO:0000103 N RGD:38596323|PMID:32053588 20200903 RGD compared to female wild-type
38596330 Tbc1d4<sup>em1</sup> TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005293 impaired glucose tolerance IMP N RGD:38596323|PMID:32053588 20200903 RGD
38596330 Tbc1d4<sup>em1</sup> TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005293 impaired glucose tolerance IMP N RGD:38596332|PMID:31034517 20200903 RGD
38596330 Tbc1d4<sup>em1</sup> TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005331 insulin resistance IMP N RGD:38596323|PMID:32053588 20200903 RGD
38596330 Tbc1d4<sup>em1</sup> TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005331 insulin resistance IMP N RGD:38596332|PMID:31034517 20200903 RGD
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20200904 RGD compared to male knockout
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0003025 increased vasoconstriction induced IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD compared to wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD compared to female knockout
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type
38596339 SD-<i>Rarres2<sup>em1Msu</sup></i> strain MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20201210 RGD compared to male knockout
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20201210 RGD compared to female knockout
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction sexual_dimorphism IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005333 decreased heart rate sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006265 increased pulse pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD
38596341 Rarres2<sup>em1Msu</sup> retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type
38599014 Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup> defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20201210 RGD
38599014 Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup> defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20201210 RGD
38599014 Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup> defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20201210 RGD
38599014 Defb23<sup>em2Mlit</sup>Defb26<sup>em2Mlit</sup> defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20201210 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599146 BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599147 SD.BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599147 SD.BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599147 SD.BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599147 SD.BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599147 SD.BN-<i>Aire<sup>em1Ang-/-</sup></i> strain MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599148 Aire<sup>em1Ang</sup> autoimmune regulator; ZFN induced mutant1, Ang gene MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD
38599152 WI-<i>Lpin1<sup>m1Hubr</sup></i> strain MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type
38599152 WI-<i>Lpin1<sup>m1Hubr</sup></i> strain MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type and heterozygous
38599152 WI-<i>Lpin1<sup>m1Hubr</sup></i> strain MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type
38599152 WI-<i>Lpin1<sup>m1Hubr</sup></i> strain MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type
38599152 WI-<i>Lpin1<sup>m1Hubr</sup></i> strain MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type
38599153 Lpin1<sup>m1Hubr</sup> lipin 1; ENU induced mutant 1, Hubr gene MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type
38599153 Lpin1<sup>m1Hubr</sup> lipin 1; ENU induced mutant 1, Hubr gene MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type and heterozygous
38599153 Lpin1<sup>m1Hubr</sup> lipin 1; ENU induced mutant 1, Hubr gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type
38599153 Lpin1<sup>m1Hubr</sup> lipin 1; ENU induced mutant 1, Hubr gene MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type
38599153 Lpin1<sup>m1Hubr</sup> lipin 1; ENU induced mutant 1, Hubr gene MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0005348 increased T cell proliferation induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0008567 decreased interferon-gamma secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0008660 increased interleukin-10 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0008681 increased interleukin-17 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0008699 increased interleukin-4 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599155 BN-<i>Themis<sup>m1Adej</sup></i> strain MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0005348 increased T cell proliferation IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0008567 decreased interferon-gamma secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0008660 increased interleukin-10 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0008681 increased interleukin-17 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0008699 increased interleukin-4 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599156 Themis<sup>m1Adej</sup> thymocyte selection associated; mutant1, Adej gene MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN
38599157 F344-<i>Depdc5<sup>em1Kyo+/-</sup></i> strain MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599157 F344-<i>Depdc5<sup>em1Kyo+/-</sup></i> strain MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599157 F344-<i>Depdc5<sup>em1Kyo+/-</sup></i> strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599157 F344-<i>Depdc5<sup>em1Kyo+/-</sup></i> strain MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599157 F344-<i>Depdc5<sup>em1Kyo+/-</sup></i> strain MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599158 F344-<i>Depdc5<sup>em2Kyo+/-</sup></i> strain MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599158 F344-<i>Depdc5<sup>em2Kyo+/-</sup></i> strain MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599158 F344-<i>Depdc5<sup>em2Kyo+/-</sup></i> strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599158 F344-<i>Depdc5<sup>em2Kyo+/-</sup></i> strain MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599158 F344-<i>Depdc5<sup>em2Kyo+/-</sup></i> strain MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD
38599194 Depdc5<sup>em1Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599194 Depdc5<sup>em1Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599194 Depdc5<sup>em1Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599194 Depdc5<sup>em1Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599194 Depdc5<sup>em1Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599195 Depdc5<sup>em2Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599195 Depdc5<sup>em2Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599195 Depdc5<sup>em2Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599195 Depdc5<sup>em2Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599195 Depdc5<sup>em2Kyo</sup> DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD
38599208 SHR-<i>Prdx2<sup>em1Izm</sup></i> strain MP:0002083 premature death IMP N RGD:151347623|PMID:30655626 20220131 RGD
38599208 SHR-<i>Prdx2<sup>em1Izm</sup></i> strain MP:0003674 oxidative stress exacerbates IMP N RGD:151347623|PMID:30655626 20220131 RGD compared to wild type
38599208 SHR-<i>Prdx2<sup>em1Izm</sup></i> strain MP:0005264 glomerulosclerosis exacerbates IMP N RGD:151347623|PMID:30655626 20220131 RGD ompared to wild type
38599208 SHR-<i>Prdx2<sup>em1Izm</sup></i> strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:151347623|PMID:30655626 20220131 RGD compared to wild type
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211028 RGD
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211028 RGD
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211101 RGD compared to untreated
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211028 RGD
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211028 RGD
38676253 F344-<i>Hcn1<sup>em1Kyo</sup></i> strain MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211028 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220111 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220111 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220111 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD
38676254 F344-<i>Pparg<sup>m1Kyo</sup></i> strain MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220111 RGD
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0001364 decreased anxiety-related response IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0001399 hyperactivity IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0002906 increased susceptibility to pharmacologically induced seizures IMP XCO:0000887|XCO:0000888 N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0013140 excessive vocalization IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm
38676450 F344-<i>Phf24<sup>em2Kyo</sup></i> strain MP:0020424 increased kindling response susceptibility IMP XCO:0000887 N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc
38676459 HHR/Hat Hirosaki hairless rat strain MP:0003815 hairless IAGP N RGD:2316553|PMID:18420582 20200918 RGD
38676459 HHR/Hat Hirosaki hairless rat strain MP:0006271 abnormal involution of the mammary gland IAGP N RGD:2291942|PMID:16227201 20200918 RGD
38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0001297 microphthalmia IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0009859 eye opacity disease_progression IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676462 Cryba1<sup>Hiser</sup> crystallin, beta A1; HiSER mutant gene MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676462 Cryba1<sup>Hiser</sup> crystallin, beta A1; HiSER mutant gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
38676462 Cryba1<sup>Hiser</sup> crystallin, beta A1; HiSER mutant gene MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD
3870 Tlr4 toll-like receptor 4 gene MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD
3876 Tnf tumor necrosis factor gene MP:0001260 increased body weight IAGP N RGD:1357163|PMID:9590569 19990101 RGD
3876 Tnf tumor necrosis factor gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1357163|PMID:9590569 19990101 RGD
3876 Tnf tumor necrosis factor gene MP:0005333 decreased heart rate IAGP N RGD:1357163|PMID:9590569 19990101 RGD
3880 Faslg Fas ligand gene MP:0002229 neurodegeneration IDA N RGD:1358616|PMID:15644446 19990101 RGD
3882 Tnnt2 troponin T2, cardiac type gene MP:0004084 abnormal cardiac muscle relaxation IDA N RGD:1580434|PMID:10946062 19990101 RGD
3886 Tnr tenascin R gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD
3886 Tnr tenascin R gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD
3889 Tp53 tumor protein p53 gene MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
3889 Tp53 tumor protein p53 gene MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
3889 Tp53 tumor protein p53 gene MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
3889 Tp53 tumor protein p53 gene MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD
3889 Tp53 tumor protein p53 gene MP:0002083 premature death IMP N RGD:12738450|PMID:27528400 20210428 RGD
3889 Tp53 tumor protein p53 gene MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
3889 Tp53 tumor protein p53 gene MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20191029 RGD
3889 Tp53 tumor protein p53 gene MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD
3889 Tp53 tumor protein p53 gene MP:0014052 increased male germ cell apoptosis IMP N RGD:14995504|PMID:28834365 20191029 RGD
3889 Tp53 tumor protein p53 gene MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210930 RGD seminiferous tubule; compared to SD
3908 Tsc2 TSC complex subunit 2 gene MP:0008762 embryonic lethality IMP N RGD:11568651|PMID:25088526 20161208 RGD
3911 Tshr thyroid stimulating hormone receptor gene MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211111 RGD
3911 Tshr thyroid stimulating hormone receptor gene MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211111 RGD
3911 Tshr thyroid stimulating hormone receptor gene MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211111 RGD
3911 Tshr thyroid stimulating hormone receptor gene MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211111 RGD
3911 Tshr thyroid stimulating hormone receptor gene MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211111 RGD
39128239 GK/CskCrlj strain MP:0001262 decreased body weight IAGP N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI.
39128239 GK/CskCrlj strain MP:0002079 increased circulating insulin level induces IAGP XCO:0000102 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI.
39128239 GK/CskCrlj strain MP:0003058 increased insulin secretion induces IAGP XCO:0000102,XCO:0000941,XCO:0000252,XCO:0000104 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI
39128239 GK/CskCrlj strain MP:0003059 decreased insulin secretion induces IAGP XCO:0000102,XCO:0000941,XCO:0000939,XCO:0000103 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI.
39128239 GK/CskCrlj strain MP:0005293 impaired glucose tolerance induces IAGP XCO:0000102,XCO:0000103 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI
39128239 GK/CskCrlj strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI.
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20201210 RGD
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD
39457699 LCR/Tol Low-capacity runners strain MP:0001260 increased body weight IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0001260 increased body weight IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Tol; sexual dimorphism, males only
39457699 LCR/Tol Low-capacity runners strain MP:0002833 increased heart weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20091112 RGD compared to HCR/Tol; sexual dimorphism, males only
39457699 LCR/Tol Low-capacity runners strain MP:0003022 increased coronary flow rate IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0003023 decreased coronary flow rate IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0003393 decreased cardiac output IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Tol
39457699 LCR/Tol Low-capacity runners strain MP:0011952 decreased cardiac stroke volume IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0001262 decreased body weight IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0001262 decreased body weight IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Tol; sexual dimorphism, males only
39457701 HCR/Tol High-capacity runners strain MP:0002834 decreased heart weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20091112 RGD compared to LCR/Tol; sexual dimorphism, males only
39457701 HCR/Tol High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0003394 increased cardiac output IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Tol
39457701 HCR/Tol High-capacity runners strain MP:0011951 increased cardiac stroke volume IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Tol
39457945 WI-<i> Lpar1<sup>m1Hubr</sup></i> strain MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20201012 RGD
39457945 WI-<i> Lpar1<sup>m1Hubr</sup></i> strain MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20201012 RGD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0000556 abnormal hindlimb morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0000574 abnormal foot pad morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0000583 long toenails IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0001265 decreased body size IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0001922 reduced male fertility IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0001940 testis hypoplasia IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0002175 decreased brain weight IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0003081 abnormal soleus morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0008535 enlarged lateral ventricles IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0030716 decreased circulating isoleucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0030728 decreased circulating valine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457947 SD-<i>Bckdk<sup>m1Dbsa</i></sup> strain MP:0030751 decreased circulating leucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20201013 RGD compared to wild type
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001489 decreased startle reflex penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD compared to wild type
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20201013 RGD
39457950 SD-<i>Ngly1<sup>em1Ta-/-</sup></i> strain MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20201013 RGD
3959 Vdr vitamin D receptor gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
3959 Vdr vitamin D receptor gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
3959 Vdr vitamin D receptor gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
3959 Vdr vitamin D receptor gene MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210401 RGD
3959 Vdr vitamin D receptor gene MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
3959 Vdr vitamin D receptor gene MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210401 RGD
3959 Vdr vitamin D receptor gene MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210401 RGD
3959 Vdr vitamin D receptor gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
3959 Vdr vitamin D receptor gene MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210325 RGD
3959 Vdr vitamin D receptor gene MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210401 RGD
3970 Foxn1 forkhead box N1 gene MP:0000705 athymia IAGP N RGD:1300512|PMID:8790387 19990101 RGD
3970 Foxn1 forkhead box N1 gene MP:0002073 abnormal hair growth IAGP N RGD:1300512|PMID:8790387 19990101 RGD
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0000231 hypertension IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0001261 obese IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0001625 cardiac hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901266|PMID:19836216 20231207 RGD compared to Wistar age-matched controls
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0001762 polyuria IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0002962 increased urine protein level IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0003141 cardiac fibrosis IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0003949 abnormal circulating lipid level IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0005331 insulin resistance IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901198 SHHF<i><sup>cp/cp</sup></i>/MccGmiCrl strain MP:0011402 renal cast IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901266|PMID:19836216 20231207 RGD compared to Wistar age-matched controls
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0001853 heart inflammation treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD
401901199 SHHF<i><sup>cp/+</sup></i>/MccGmiCrl strain MP:0003141 cardiac fibrosis treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD
401901201 SHHF<i><sup>cp/+</sup></i>/Mcc strain MP:0000231 hypertension IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls
401901201 SHHF<i><sup>cp/+</sup></i>/Mcc strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls
401901201 SHHF<i><sup>cp/+</sup></i>/Mcc strain MP:0003823 increased left ventricle developed pressure IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls
401901201 SHHF<i><sup>cp/+</sup></i>/Mcc strain MP:0005140 decreased cardiac muscle contractility IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls
401940195 SD-<i>Ahr<sup>em1Iexas-/-</sup></i> strain MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240115 RGD compared to wild type littermates
401940195 SD-<i>Ahr<sup>em1Iexas-/-</sup></i> strain MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240115 RGD compared to wild type littermates
401940199 Ahr<sup>em1Iexas</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Iexas gene MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates
401940199 Ahr<sup>em1Iexas</sup> aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Iexas gene MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0000231 hypertension IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0000731 increased collagen deposition in the muscles treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0000747 muscle weakness IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0001260 increased body weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0001261 obese IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0001261 obese IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0001261 obese treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002079 increased circulating insulin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002747 abnormal aortic valve morphology IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002833 increased heart weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR and WKY controls
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002959 increased urine microalbumin level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002959 increased urine microalbumin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003821 decreased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR controls
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003915 increased heart left ventricle weight IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003917 increased kidney weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, SHHF, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0004890 decreased energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005264 glomerulosclerosis IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005264 glomerulosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, SHHF, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005288 abnormal oxygen consumption treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005450 abnormal energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005526 decreased renal plasma flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005531 increased renal vascular resistance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005553 increased circulating creatinine level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0010018 pulmonary vascular congestion treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0010754 abnormal heart left ventricle pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011353 expanded mesangial matrix IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011402 renal cast IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011402 renal cast IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011929 abnormal aortic valve flow IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0011941 increased fluid intake IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0012106 impaired exercise endurance treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0014144 abnormal white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0014145 increased white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0020252 abnormal collagen level treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0020989 increased urine lipocalin 2 level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
401960101 ZSF1-<i>Lepr<sup>fa/cp</sup></i>/Crl strain MP:0021162 increased heart left ventricle anterior wall thickness IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317)
405100226 LE-<i>Fmr1<sup>em1Pwc</sup></i> strain MP:0001363 increased anxiety-related response IMP N RGD:405100224|PMID:33031903 20240322 RGD
405100226 LE-<i>Fmr1<sup>em1Pwc</sup></i> strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to wild type male
405100226 LE-<i>Fmr1<sup>em1Pwc</sup></i> strain MP:0003459 increased fear-related response sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to wild type female
405100226 LE-<i>Fmr1<sup>em1Pwc</sup></i> strain MP:0004994 abnormal brain wave pattern sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to male mutant
405847397 Wakil: bHR High Responder strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IAGP N RGD:405855871|PMID:27114539 20240614 RGD compared to bLR low responder strain
405847400 Wakil: bLR Low Responder strain MP:0001363 increased anxiety-related response IAGP N RGD:405866182|PMID:25071177 20240620 RGD compared to bHR strain
405850241 SD-<i>Mir500 <sup>em1Cgen</sup></i> strain MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240604 RGD
405850241 SD-<i>Mir500 <sup>em1Cgen</sup></i> strain MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240604 RGD
405850241 SD-<i>Mir500 <sup>em1Cgen</sup></i> strain MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240604 RGD
405850242 Mir500 <sup>em1Cgen</sup> microRNA 500 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD
405850242 Mir500 <sup>em1Cgen</sup> microRNA 500 gene MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240606 RGD
405850242 Mir500 <sup>em1Cgen</sup> microRNA 500 gene MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD
405855876 SD-<i>Foxo4<sup>em1Soar</sup></i> strain MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240618 RGD
405855876 SD-<i>Foxo4<sup>em1Soar</sup></i> strain MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240618 RGD
405855876 SD-<i>Foxo4<sup>em1Soar</sup></i> strain MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240618 RGD
405855878 Foxo4<sup>em1Soar</sup> forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD
405855878 Foxo4<sup>em1Soar</sup> forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240620 RGD
405855878 Foxo4<sup>em1Soar</sup> forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0000825 dilated lateral ventricle onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0001265 decreased body size IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to heterzygeous, wild type littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0002066 abnormal motor capabilities/coordination/movement onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0002152 abnormal brain morphology onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0008458 abnormal cortical ventricular zone morphology onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0011084 lethality at weaning, incomplete penetrance IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to heterzygeous, wild type littermate
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0011252 situs inversus totalis IMP N RGD:407420260|PMID:33916973 20240725 RGD
407420262 SD-<i>Nme7<sup>em1Pdra-/-</sup></i> strain MP:0012506 brain atrophy IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004805 absent oocytes IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004856 decreased ovary weight IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005158 ovary hypoplasia IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005185 decreased circulating progesterone level IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0008869 anovulation IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20201214 RGD
40902840 Esr2<sup><i>em1Soar</i></sup> estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0009819 abnormal circulating androgen level IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type
40902862 Kiss1<sup>tm1Nips</sup> KiSS-1 metastasis-suppressor; targeted mutant 1, Nips gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20201217 RGD
40902862 Kiss1<sup>tm1Nips</sup> KiSS-1 metastasis-suppressor; targeted mutant 1, Nips gene MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20201217 RGD
40924649 Beta IIM strain MP:0001552 increased circulating triglyceride level IAGP N RGD:724733|PMID:3440679 20210118 RGD compared to Alpha IIM
40924649 Beta IIM strain MP:0005559 increased circulating glucose level IAGP N RGD:724733|PMID:3440679 20210118 RGD compared to Alpha IIM
40924656 BN.ZUC-<i>Lepr<sup>fa</sup></i> strain MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates
40924656 BN.ZUC-<i>Lepr<sup>fa</sup></i> strain MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates
40924661 LA-<i>cp</i>/NRll strain MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates
40924661 LA-<i>cp</i>/NRll strain MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates
4107048 SS.SR-(<I>D7Rat16-D7Rat189</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20100712 RGD as compared to SS/Jr on 2% Nacl diet
4107052 SS.SR-(<I>D7Rat16-D7Mgh5</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20100712 RGD as compared to SS/Jr on 2% Nacl diet
4139856 Ets1<sup>em1Mcwi</sup> v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20211007 RGD compared to littermate
4139856 Ets1<sup>em1Mcwi</sup> v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220630 RGD compared to wild type littermate
4139858 Sh2b3<sup>em1Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD
4139858 Sh2b3<sup>em1Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD
4139858 Sh2b3<sup>em1Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220203 RGD
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139863 Ren<sup>em1Mcwi</sup> renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type
4139865 Rag1<sup>em1Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet
4139865 Rag1<sup>em1Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170417 RGD
4139865 Rag1<sup>em1Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD
4139865 Rag1<sup>em1Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD
4139865 Rag1<sup>em1Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20170417 RGD
4139866 Rag1<sup>em2Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet
4139866 Rag1<sup>em2Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170417 RGD
4139866 Rag1<sup>em2Mcwi</sup> recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20201210 RGD as compared to SS-Rag1<sup>em1Mcwi</sup> on 4% NaCl diet
4139867 Rab38<sup>em1Mcwi</sup> RAB38, member RAS oncogene family; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20201210 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
4139868 Nox4<sup>em2Mcwi</sup> NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231116 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
4139869 Mmp2<sup>em2Mcwi</sup> matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
4139873 SS-<i>Rag1<sup>em2Mcwi</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20130204 RGD on 4% NaCl diet
4139873 SS-<i>Rag1<sup>em2Mcwi</sup></i> strain MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20130204 RGD as compared to SS
4139873 SS-<i>Rag1<sup>em2Mcwi</sup></i> strain MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20130204 RGD as compared to SS-Rag1<sup>em1Mcwi</sup> on 4% NaCl diet
4139884 SS-<i>Rag1<sup>em1Mcwi</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20130204 RGD on 4% NaCl diet
4139884 SS-<i>Rag1<sup>em1Mcwi</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD as compared to SS
4139884 SS-<i>Rag1<sup>em1Mcwi</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD as compared to SS
4140405 LEXF6A/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
4140405 LEXF6A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
4140408 LEXF8C/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
4140413 LEXF1B/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404646 SD-<i>Lrp5<sup>em1Vari</sup></i> strain MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404647 Lrp5<sup>em1Vari</sup> LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404648 SD-<i>Lrp5<sup>em2Vari</sup></i> strain MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404650 Lrp5<sup>em2Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404651 SD-<i>Lrp5<sup>em3Vari</sup></i> strain MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210206 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404652 Lrp5<sup>em3Vari</sup> LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD
41404723 DA.W-<i>Ncf1<sup>W</sup></i>/Rhd strain MP:0003186 abnormal redox activity severity IAGP XCO:0000263 N RGD:41404729|PMID:21275845 20210208 RGD DNA:polymorphism:M153T (rat)
41404723 DA.W-<i>Ncf1<sup>W</sup></i>/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:41404729|PMID:21275845 20210208 RGD DNA:polymorphism:M153T (rat)
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0001263 weight loss induced IAGP XCO:0000801 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000103 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0005659 decreased susceptibility to diet-induced obesity induced IAGP XCO:0000015 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408337 DA.F344-Dpp4<sup>DPPIV</sup>/SvH strain MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408339 WI.SD-<i>Pclo<sup>Tn(sb-B-Geo)Fkh</sup></i> strain MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004770 abnormal synaptic vesicle recycling IMP N RGD:41408338|PMID:31074746 20210210 RGD
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004792 abnormal synaptic vesicle number IMP N RGD:41408338|PMID:31074746 20210210 RGD
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41408340 Pclo<sup>Tn(sb-B-Geo)Fkh</sup> presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats
41410881 WI-<i>Grm2<sup>em1</sup></i> strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats
41410882 Grm2<sup>em1</sup> glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats
4142544 WKY/Kiha strain MP:0001552 increased circulating triglyceride level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm
4142544 WKY/Kiha strain MP:0004892 increased adiponectin level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm
4142544 WKY/Kiha strain MP:0005178 increased circulating cholesterol level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm
4145088 SS.BN-(<i>D6Rat119-D6Arb3</i>)/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
4145088 SS.BN-(<i>D6Rat119-D6Arb3</i>)/Mcwi strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
4145088 SS.BN-(<i>D6Rat119-D6Arb3</i>)/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
4145089 SS.BN-(<i>D6Rat149-D6Rat18</i>)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
4145089 SS.BN-(<i>D6Rat149-D6Rat18</i>)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
4145090 SS.BN-(<i>D6Rat149-D6Got171</i>)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
4145090 SS.BN-(<i>D6Rat149-D6Got171</i>)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
4145091 SS.BN-(<i>D6Rat149-D6Arb3</i>)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi
4145091 SS.BN-(<i>D6Rat149-D6Arb3</i>)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
4145117 Mcs27 Mammary carcinoma susceptibility QTL 27 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:4143380|PMID:20737482 20101026 RGD DMBA induced
4145118 Mcs26 Mammary carcinoma susceptibility QTL 26 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:4143380|PMID:20737482 20101026 RGD DMBA induced
42721974 LEW-<i>Nek8<sup>lpk</sup></i>/Arc strain MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210302 RGD compared to control Lewis
42721975 Nek8<sup>lpkArc</sup> NIMA-related kinase 8; lpk mutant, Arc gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210304 RGD compared to control Lewis
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721977 SD-<i>Pde6b<sup>em1Baek</sup></i> strain MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42721979 Pde6b<sup>em1Baek</sup> phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type
42722004 F344-Tg(HIV)1Hsd strain MP:0000063 decreased bone mineral density IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0001392 abnormal locomotor behavior treatment IMP N RGD:598099561|PMID:29260441 20250402 RGD associated with Binge Drinking
42722004 F344-Tg(HIV)1Hsd strain MP:0003674 oxidative stress IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0004984 increased osteoclast cell number IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0004992 increased bone resorption IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0005443 abnormal ethanol metabolism IMP N RGD:405100715|PMID:23413777 20240326 RGD compared to wild type F344 controls
42722004 F344-Tg(HIV)1Hsd strain MP:0009322 increased splenocyte apoptosis IMP N RGD:42722619|PMID:11481487 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0009336 increased splenocyte proliferation IMP N RGD:42722619|PMID:11481487 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0009751 enhanced behavioral response to alcohol treatment IMP N RGD:598099561|PMID:29260441 20250402 RGD associated with Binge Drinking
42722004 F344-Tg(HIV)1Hsd strain MP:0010873 decreased trabecular bone mass IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0010879 decreased trabecular bone volume IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0010894 pulmonary alveolar edema IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0012604 decreased glutathione level IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0014026 abnormal respiratory epithelial transmembrane transport IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates
42722004 F344-Tg(HIV)1Hsd strain MP:0021033 decreased tumor necrosis factor receptor superfamily member 11b level IMP N RGD:42722617|PMID:20643942 20220420 RGD compared to WT littermates
45073130 SD-<i>Fmr1<sup>em1Mzhe</sup></i> strain MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4:
45073130 SD-<i>Fmr1<sup>em1Mzhe</sup></i> strain MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4:
45073130 SD-<i>Fmr1<sup>em1Mzhe</sup></i> strain MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4:
45073130 SD-<i>Fmr1<sup>em1Mzhe</sup></i> strain MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4:
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210715 RGD in peripheral blood, compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD in spleen, compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD in bone marrow and peripheral blood, compared to SD
45073133 SD-<i>Pon1<sup>em1Lizh</sup></i> strain MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD
4889411 SHRSP.WKY-(<i>D1Smu13-D1Wox33</i>)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to restraint stress
4889411 SHRSP.WKY-(<i>D1Smu13-D1Wox33</i>)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure severity IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20101202 RGD compared to SHRSP/Izm under cold and restraint stress
4889411 SHRSP.WKY-(<i>D1Smu13-D1Wox33</i>)/Izm strain MP:0030773 decreased urine noradrenaline level severity IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20101202 RGD compared to SHRSP/Izm in response to cold stress
4889414 WKY.SHRSP-(<i>D1Rat171-D1Wox33</i>)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to restraint stress
4889414 WKY.SHRSP-(<i>D1Rat171-D1Wox33</i>)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20101202 RGD baseline compared to WKY/Izm
4889414 WKY.SHRSP-(<i>D1Rat171-D1Wox33</i>)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm under cold and restraint stress
4889414 WKY.SHRSP-(<i>D1Rat171-D1Wox33</i>)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm under cold and restraint stress
4889419 Cstrr2 Cold stress response QTL 2 qtl MP:0004484 abnormal response of heart to induced stress IDA N RGD:4889147|PMID:21063213 20101202 RGD
4889419 Cstrr2 Cold stress response QTL 2 qtl MP:0030772 increased urine noradrenaline level IDA N RGD:4889147|PMID:21063213 20101202 RGD
4889428 Stresp24 Stress response QTL 24 qtl MP:0002067 abnormal sensory capabilities/reflexes/nociception IDA N RGD:4889147|PMID:21063213 20101202 RGD
4889428 Stresp24 Stress response QTL 24 qtl MP:0005665 increased circulating noradrenaline level IDA N RGD:4889147|PMID:21063213 20101202 RGD
4889450 DA.PVG.1AV1-(<i>D1Rat248-D1Rat10</i>)/Kini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4888518|PMID:21041731 20200505 RGD
4889451 Eae29 Experimental allergic encephalomyelitis QTL 29 qtl MP:0006082 CNS inflammation IDA N RGD:4888518|PMID:21041731 20101202 RGD
4889464 GK/Ox strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female GK/Ox
4889464 GK/Ox strain MP:0001260 increased body weight susceptibility IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox
4889464 GK/Ox strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to male BN/Crl
4889464 GK/Ox strain MP:0002079 increased circulating insulin level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox
4889464 GK/Ox strain MP:0002079 increased circulating insulin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female GK/Ox
4889464 GK/Ox strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:4889455|PMID:20878524 20111109 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0003059 decreased insulin secretion susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0003980 increased circulating phospholipid level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox
4889464 GK/Ox strain MP:0004702 increased circulating insulin-like growth factor I level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD male compared to female
4889464 GK/Ox strain MP:0005138 decreased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to male BN/Crl
4889464 GK/Ox strain MP:0005139 increased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to male GK/Ox
4889464 GK/Ox strain MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox
4889464 GK/Ox strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0005331 insulin resistance susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:4889455|PMID:20878524 20101202 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0009114 decreased pancreatic beta cell mass susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl
4889464 GK/Ox strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox
4889492 Pancm2 Pancreatic morphology QTL 2 qtl MP:0009114 decreased pancreatic beta cell mass IDA N RGD:4889455|PMID:20878524 20101203 RGD
4889494 Scort2 Serum corticosterone level QTL 2 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:4889455|PMID:20878524 20101203 RGD
4889499 CDS-Chr 4<sup>CDR</sup>/Ygl strain MP:0005559 increased circulating glucose level IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDR/Ygl
4889499 CDS-Chr 4<sup>CDR</sup>/Ygl strain MP:0005560 decreased circulating glucose level IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDS/Ygl on diabetogenic diet
4889499 CDS-Chr 4<sup>CDR</sup>/Ygl strain MP:0009108 increased pancreas weight IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDS/Ygl on diabetogenic diet
4889511 Gluco61 Glucose level QTL 61 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101203 RGD
4889511 Gluco61 Glucose level QTL 61 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101203 RGD
4889511 Gluco61 Glucose level QTL 61 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101203 RGD
4889521 Gluco62 Glucose level QTL 62 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889521 Gluco62 Glucose level QTL 62 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889521 Gluco62 Glucose level QTL 62 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889606 Gluco63 Glucose level QTL 63 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889606 Gluco63 Glucose level QTL 63 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889606 Gluco63 Glucose level QTL 63 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889610 Pancm3 Pancreatic morphology QTL 3 qtl MP:0009108 increased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD
4889817 SBN-Chr 1<sup>SBH</sup>/Ygl strain MP:0002962 increased urine protein level disease_progression IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl
4889817 SBN-Chr 1<sup>SBH</sup>/Ygl strain MP:0005554 decreased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl and SBN/Ygl
4889820 SBH-Chr 1<sup>SBN</sup>/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl
4889820 SBH-Chr 1<sup>SBN</sup>/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD compared to SBH/Ygl
4889820 SBH-Chr 1<sup>SBN</sup>/Ygl strain MP:0005264 glomerulosclerosis penetrance IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBH/Ygl and SBN/Ygl
4889820 SBH-Chr 1<sup>SBN</sup>/Ygl strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBN/Ygl
4889820 SBH-Chr 1<sup>SBN</sup>/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl
4889822 SBN-Chr 17<sup>SBH</sup>/Ygl strain MP:0002962 increased urine protein level disease_progression IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl
4889822 SBN-Chr 17<sup>SBH</sup>/Ygl strain MP:0005554 decreased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl
4889834 Pur24 Proteinuria QTL 24 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889848 Pur25 Proteinuria QTL 25 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889852 Pur26 Proteinuria QTL 26 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889857 Pur27 Proteinuria QTL 27 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889859 Pur28 Proteinuria QTL 28 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889861 Pur29 Proteinuria QTL 29 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889870 Pur30 Proteinuria QTL 30 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD
4889875 SBH-Chr 2<sup>SBN</sup>/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl
4889877 SBH-Chr 20<sup>SBN</sup>/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl
4889879 SBH-Chr X<sup>SBN</sup>/Ygl strain MP:0002962 increased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD same as SBH/Ygl
4889882 SBH-Chr 17<sup>SBN</sup>/Ygl strain MP:0002963 decreased urine protein level sexual_dimorphism IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl male
4889891 Eae32 Experimental allergic encephalomyelitis QTL 32 qtl MP:0006082 CNS inflammation resistance IDA N RGD:4889889|PMID:20856809 20101209 RGD
4889894 Eae33 Experimental allergic encephalomyelitis QTL 33 qtl MP:0006082 CNS inflammation resistance IDA N RGD:4889889|PMID:20856809 20101209 RGD
4889919 Bss86 Bone structure and strength QTL 86 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889929 Bss87 Bone structure and strength QTL 87 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889933 Bss88 Bone structure and strength QTL 88 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889938 Bss89 Bone structure and strength QTL 89 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889943 Bss90 Bone structure and strength QTL 90 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889948 Bss91 Bone structure and strength QTL 91 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889951 Bss92 Bone structure and strength QTL 92 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889955 Bss93 Bone structure and strength QTL 93 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889962 Bss94 Bone structure and strength QTL 94 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889966 Bss95 Bone structure and strength QTL 95 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889969 Bss96 Bone structure and strength QTL 96 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889972 Bss97 Bone structure and strength QTL 97 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD
4889975 Bmd81 Bone mineral density QTL 81 qtl MP:0000062 increased bone mineral density IDA N RGD:4889918|PMID:20699128 20101210 RGD
4891048 SS.LEW-(<i>D7Rat73-D7Rat128</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:4891049|PMID:21192272 20110105 RGD compared to SS/Jr
4891048 SS.LEW-(<i>D7Rat73-D7Rat128</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20110105 RGD compared to SS/Jr
4891165 Wig/Ymas wiggling strain MP:0001399 hyperactivity IAGP N RGD:4891167|PMID:17610585 20110111 RGD
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0001661 extended life span induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891380 SS.SR-(<i>D9Mco95-D9Mco98</i>)/Mco strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20191209 RGD compared to SS/Jr
4891383 SS.SR-(<i>D9Mco98-Resp18</i>)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
4891383 SS.SR-(<i>D9Mco98-Resp18</i>)/1Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891386 SS.SR-(<i>D9Mco98-Resp18</i>)/2Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891386 SS.SR-(<i>D9Mco98-Resp18</i>)/2Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr
4891388 SS.SR-(<i>D9Mco95-D9Mco100</i>)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
4891392 SS.SR-(<i>D9Mco95-D9Mco102</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
4891394 SS.SR-(<i>D9Mco101-Resp18</i>)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
4891400 SS.SR-(<i>D9Mco14-Resp18</i>)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
4891402 SS.SR-(<i>D9Mco14-Resp18</i>)/2Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD
5131906 Alms1<sup>em1Mcwi</sup> Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD
5131919 Cdh13<sup>em1Mcwi</sup> cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20201210 RGD knock-out compared to wild-type rats
5131919 Cdh13<sup>em1Mcwi</sup> cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20201210 RGD knock-out compared to wild-type rats
5131922 SS-<i>Cdh13<sup>em1Mcwi</sup></i> strain MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20200814 RGD knock-out compared to wild-type rats
5131922 SS-<i>Cdh13<sup>em1Mcwi</sup></i> strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats
5134683 WF.WKY-(<i>D7Rat171-D7Rat128</i>)/1Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd
5134685 WF.WKY-(<i>D7Rat171-D7Rat128</i>)/2Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd
5134687 WF.WKY-(<i>D7Rat51-D7Rat128</i>)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20110705 RGD compared to other Chr7 congenic strains
5134689 WF.WKY-(<i>D7Uwm25-D7Rat128</i>)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20110705 RGD compared to other Chr7 congenic strains
5134692 WF.WKY-(<i>D7Rat171-D7Rat45</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd
5134951 WF.COP-(<i>D7Rat39-D7Uwm12</i>)/1Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd
5134953 WF.COP-(<i>D7Rat39-D7Uwm12</i>)/2Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd
5135031 BN.MES-<i>Cyba</i>/Sna strain MP:0001656 focal hepatic necrosis IAGP N RGD:5134976|PMID:20660993 20110711 RGD
5135031 BN.MES-<i>Cyba</i>/Sna strain MP:0002941 increased circulating alanine transaminase level IAGP N RGD:5134976|PMID:20660993 20200708 RGD compared to BN/SsNSlc
5135031 BN.MES-<i>Cyba</i>/Sna strain MP:0005011 increased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20110711 RGD in bone marrow; compared to BN/SsNSlc
5135031 BN.MES-<i>Cyba</i>/Sna strain MP:0005012 decreased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20200708 RGD in blood; compared to MES/SLC
5135031 BN.MES-<i>Cyba</i>/Sna strain MP:0005343 increased circulating aspartate transaminase level IAGP N RGD:5134976|PMID:20660993 20200708 RGD compared to BN/SsNSlc
5135224 Leukc1 Leukocyte quantity QTL 1 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135221|PMID:16151696 20110713 RGD
5135226 Leukc2 Leukocyte quantity QTL 2 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135221|PMID:16151696 20110713 RGD
5135477 ACI.BN-(<I>D5Uwm70-D5Mgh15</I>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5135479 ACI.BN-(<I>D5Rat113-D5Rat36</I>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5135481 ACI.BN-(<I>D5Mgh17-D5Rat98</I>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5143964 Mstn<sup>em1Mcwi</sup> myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
5143964 Mstn<sup>em1Mcwi</sup> myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
5143964 Mstn<sup>em1Mcwi</sup> myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0003394 increased cardiac output IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004879 decreased systemic vascular resistance IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0011951 increased cardiac stroke volume IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11079199|PMID:25136115 20171102 RGD
5143979 Plekha7<sup>em4Mcwi</sup> pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type
5144089 Ncf2<sup>em1Mcwi</sup> neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
5144089 Ncf2<sup>em1Mcwi</sup> neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:9587793|PMID:22326221 20171101 RGD
5144089 Ncf2<sup>em1Mcwi</sup> neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
5144089 Ncf2<sup>em1Mcwi</sup> neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0020447 decreased NAD(P)H oxidase activity IMP N RGD:9587793|PMID:22326221 20171101 RGD
5144089 Ncf2<sup>em1Mcwi</sup> neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates
5144104 SS-<i>Ncf2<sup>em1Mcwi</sup></i> strain MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20171101 RGD compared to wild-type littermates
5144104 SS-<i>Ncf2<sup>em1Mcwi</sup></i> strain MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20171101 RGD compared to wild-type littermates
5144110 ACI.BN-(<i>D5Mgh17-D5Mgh15</i>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0000601 small liver IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-<i>Pkhd1<sup>pck</i></sup>/Crl
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0003675 kidney cyst MODEL: partially resistant IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-<i>Pkhd1<sup>pck</i></sup>/Crl
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0005553 increased circulating creatinine level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0005554 decreased circulating creatinine level IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-<i>Pkhd1<sup>pck</i></sup>/Crl
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-<i>Pkhd1<sup>pck</i></sup>/Crl
5147594 FHH.PCK-(<i>D9Rat35-D9Rat70</i>)/Mcwi strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-<i>Pkhd1<sup>pck</i></sup>/Crl
5508304 WUN-<i>Abcc2<sup>TR-</i></sup>/HsdRrrc strain MP:0004772 abnormal bile secretion IAGP N RGD:5508303|PMID:4018730 20190802 RGD
5508304 WUN-<i>Abcc2<sup>TR-</i></sup>/HsdRrrc strain MP:0004789 increased bile salt level IAGP N RGD:5508303|PMID:4018730 20190802 RGD
5508304 WUN-<i>Abcc2<sup>TR-</i></sup>/HsdRrrc strain MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD
5508304 WUN-<i>Abcc2<sup>TR-</i></sup>/HsdRrrc strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619
5508318 Agtr1a<sup>em5Mcwi</sup> angiotensin II receptor, type 1a; zinc finger nuclease induced mutant 5, Medical College of Wisconsin gene MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210715 RGD
5508324 Nppb<sup>em2Mcwi</sup> natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20201210 RGD
5508324 Nppb<sup>em2Mcwi</sup> natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20201210 RGD
5508324 Nppb<sup>em2Mcwi</sup> natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20201210 RGD
5508324 Nppb<sup>em2Mcwi</sup> natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20201210 RGD
5508365 SS-<i>Agtr1a<sup>em5Mcwi</sup></i> strain MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210708 RGD
5508397 HotHsd:SD Sprague Dawley strain MP:0008236 decreased susceptibility to neuronal excitotoxicity IAGP N RGD:13524860|PMID:17804792 20180502 RGD compared to Wistar rat
5508828 Leukc3 Leukocyte quantity QTL 3 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135222|PMID:17090969 20111025 RGD
5509086 ACI.BN-(<i>D5Rat72-D5Rat36</i>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5509087 ACI.BN-(<i>D5Rat113-D5Rat159</i>)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd
5509982 Sh2b3<sup>em2Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5509982 Sh2b3<sup>em2Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5509982 Sh2b3<sup>em2Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5509982 Sh2b3<sup>em2Mcwi</sup> SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:7204442|PMID:22868394 20200317 RGD compared to SS-Chr 12BN/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0002871 albuminuria IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0002953 thick ventricular wall IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:8693701|PMID:25001272 20140724 RGD 8% NaCl diet
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0005608 cardiac interstitial fibrosis IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi
5683890 SS-Chr 12<sup>BN</sup>.SS-(<i>D12Hmgc3-D12Hmgc6</i>)/Mcwi strain MP:0010724 thick interventricular septum IAGP N RGD:7204442|PMID:22868394 20121218 RGD as compared to SS-Chr 12<sup>BN</sup>/Mcwi
5684888 Pia42 Pristane induced arthritis QTL 42 qtl MP:0002933 joint inflammation IDA N RGD:1600250|PMID:17329308 20120104 RGD
5686318 SS-<i>Sh2b3<sup>em1Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em1Mcwi-</sup>/Sh2b3<sup>em1Mcwi-</sup></i> strain MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS
5686318 SS-<i>Sh2b3<sup>em1Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em1Mcwi-</sup>/Sh2b3<sup>em1Mcwi-</sup></i> strain MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS
5686318 SS-<i>Sh2b3<sup>em1Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em1Mcwi-</sup>/Sh2b3<sup>em1Mcwi-</sup></i> strain MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS
5686668 SS-<i>Cdh13<sup>em1Mcwi-/-</sup></i> SS-<i>Cdh13<sup>em1Mcwi-</sup>/Cdh13<sup>em1Mcwi-</sup></i> strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats
5686713 SS-<i>Mstn<sup>em1Mcwi-/-</sup></i> SS-<i>Mstn<sup>em1Mcwi-</sup>/Mstn<sup>em1Mcwi-</sup></i> strain MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type
5686713 SS-<i>Mstn<sup>em1Mcwi-/-</sup></i> SS-<i>Mstn<sup>em1Mcwi-</sup>/Mstn<sup>em1Mcwi-</sup></i> strain MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type
5686713 SS-<i>Mstn<sup>em1Mcwi-/-</sup></i> SS-<i>Mstn<sup>em1Mcwi-</sup>/Mstn<sup>em1Mcwi-</sup></i> strain MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type
5686730 SS-<i>Nppb<sup>em2Mcwi-/-</sup></i> SS-<i>Nppb<sup>em2Mcwi-</sup></i>/<i>Nppb<sup>em2Mcwi-</sup></i> strain MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20170609 RGD
5686730 SS-<i>Nppb<sup>em2Mcwi-/-</sup></i> SS-<i>Nppb<sup>em2Mcwi-</sup></i>/<i>Nppb<sup>em2Mcwi-</sup></i> strain MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20170609 RGD
5686730 SS-<i>Nppb<sup>em2Mcwi-/-</sup></i> SS-<i>Nppb<sup>em2Mcwi-</sup></i>/<i>Nppb<sup>em2Mcwi-</sup></i> strain MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20170609 RGD
5686730 SS-<i>Nppb<sup>em2Mcwi-/-</sup></i> SS-<i>Nppb<sup>em2Mcwi-</sup></i>/<i>Nppb<sup>em2Mcwi-</sup></i> strain MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20170609 RGD
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220131 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220131 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686758 SS-<i>Plekha7<sup>em4Mcwi-/-</sup></i> SS-<i>Plekha7<sup>em4Mcwi-</sup>/Plekha7<sup>em4Mcwi-</sup></i> strain MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type
5686766 SS-<i>Sh2b3<sup>em2Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em2Mcwi-</sup>/Sh2b3<sup>em2Mcwi-</sup></i> strain MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5686766 SS-<i>Sh2b3<sup>em2Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em2Mcwi-</sup>/Sh2b3<sup>em2Mcwi-</sup></i> strain MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5686766 SS-<i>Sh2b3<sup>em2Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em2Mcwi-</sup>/Sh2b3<sup>em2Mcwi-</sup></i> strain MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
5686766 SS-<i>Sh2b3<sup>em2Mcwi-/-</sup></i> SS-<i>Sh2b3<sup>em2Mcwi-</sup>/Sh2b3<sup>em2Mcwi-</sup></i> strain MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD
5686832 ACI.FHH-(<i>D1Mit18-D1Rat90</i>)(<i>D3Got102-D3Got149</i>)(<i>D14Mit11-D14Rat33</i>)(<i>D14Rat65-D14Rat90</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000113 N RGD:5684423|PMID:21127141 20120127 RGD compared to ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/EurMcwi, ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi
5686832 ACI.FHH-(<i>D1Mit18-D1Rat90</i>)(<i>D3Got102-D3Got149</i>)(<i>D14Mit11-D14Rat33</i>)(<i>D14Rat65-D14Rat90</i>)/Mcwi strain MP:0011402 renal cast induced IAGP XCO:0000113 N RGD:5684423|PMID:21127141 20120127 RGD
5686842 Rf59 Renal function QTL 59 qtl MP:0002962 increased urine protein level IDA N RGD:5684423|PMID:21127141 20120127 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687698 Adora2b<sup>em2Mcwi</sup> adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:13442481|PMID:24343121 20201210 RGD compared to wild-type
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:13442481|PMID:24343121 20201210 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
5687703 Cd247<sup>em1Mcwi</sup> Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD
5687705 Resp18<sup>em2Mcwi</sup> regulated endocrine-specific protein 18; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD
5687705 Resp18<sup>em2Mcwi</sup> regulated endocrine-specific protein 18; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD
5687721 Nr2f2<sup>em1Mcwi</sup> nuclear receptor subfamily 2, group F, member 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
5687721 Nr2f2<sup>em1Mcwi</sup> nuclear receptor subfamily 2, group F, member 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220301 RGD
5687981 SS-<i>Alms1<sup>em1Mcwi-/-</sup></i> SS-<i>Alms1<sup>em1Mcwi-</sup>/Alms1<sup>em1Mcwi-</sup></i> strain MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220301 RGD
5688010 SS-<i>Ets1<sup>em1Mcwi-/+</sup></i> SS-<i>Ets1<sup>em1Mcwi-</sup>/Ets1<sup>em1Mcwi+</sup></i> strain MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20210930 RGD compared to wild type littermate
5688010 SS-<i>Ets1<sup>em1Mcwi-/+</sup></i> SS-<i>Ets1<sup>em1Mcwi-</sup>/Ets1<sup>em1Mcwi+</sup></i> strain MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220624 RGD compared to wild type littermate
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231109 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS
5688030 SS-<i>Mmp2<sup>em1Mcwi-/-</sup></i> SS-<i>Mmp2<sup>em1Mcwi-</sup>/Mmp2<sup>em1Mcwi-</sup></i> strain MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
5688066 SS-<i>Ncf2<sup>em1Mcwi-/-</sup></i> SS-<i>Ncf2<sup>em1Mcwi-</sup>/Ncf2<sup>em1Mcwi-</sup></i> strain MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates
5688066 SS-<i>Ncf2<sup>em1Mcwi-/-</sup></i> SS-<i>Ncf2<sup>em1Mcwi-</sup>/Ncf2<sup>em1Mcwi-</sup></i> strain MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates
5688066 SS-<i>Ncf2<sup>em1Mcwi-/-</sup></i> SS-<i>Ncf2<sup>em1Mcwi-</sup>/Ncf2<sup>em1Mcwi-</sup></i> strain MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates
5688074 SS-<i>Nox4<sup>em2Mcwi-/-</sup></i> SS-<i>Nox4<sup>em2Mcwi-</sup>/Nox4<sup>em2Mcwi-</sup></i> strain MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi
5688074 SS-<i>Nox4<sup>em2Mcwi-/-</sup></i> SS-<i>Nox4<sup>em2Mcwi-</sup>/Nox4<sup>em2Mcwi-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20191122 RGD compared to SS/JrHsdMcwi
5688074 SS-<i>Nox4<sup>em2Mcwi-/-</sup></i> SS-<i>Nox4<sup>em2Mcwi-</sup>/Nox4<sup>em2Mcwi-</sup></i> strain MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi
5688074 SS-<i>Nox4<sup>em2Mcwi-/-</sup></i> SS-<i>Nox4<sup>em2Mcwi-</sup>/Nox4<sup>em2Mcwi-</sup></i> strain MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi
5688087 FHH.BN-(<i>D1Hmgc14-D1Hmgc15</i>)/Mcwi-<i>Rab38<sup>em1Mcwi-/-</sup></i> FHH.BN-(<i>D1Hmgc14-D1Hmgc15</i>)/Mcwi-<i>Rab38<sup>em1Mcwi-</sup>/Rab38<sup>em1Mcwi-</sup></i> strain MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20191212 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi
5688092 SS-<i>Rag1<sup>em1Mcwi-/-</sup></i> SS-<i>Rag1<sup>em1Mcwi-</sup>/Rag1<sup>em1Mcwi-</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20181011 RGD on 4% NaCl diet
5688092 SS-<i>Rag1<sup>em1Mcwi-/-</sup></i> SS-<i>Rag1<sup>em1Mcwi-</sup>/Rag1<sup>em1Mcwi-</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS
5688092 SS-<i>Rag1<sup>em1Mcwi-/-</sup></i> SS-<i>Rag1<sup>em1Mcwi-</sup>/Rag1<sup>em1Mcwi-</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS
5688096 SS-<i>Rag1<sup>em2Mcwi-/-</sup></i> SS-<i>Rag1<sup>em2Mcwi-</sup>/Rag1<sup>em2Mcwi-</sup></i> strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20181011 RGD on 4% NaCl diet
5688096 SS-<i>Rag1<sup>em2Mcwi-/-</sup></i> SS-<i>Rag1<sup>em2Mcwi-</sup>/Rag1<sup>em2Mcwi-</sup></i> strain MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS
5688096 SS-<i>Rag1<sup>em2Mcwi-/-</sup></i> SS-<i>Rag1<sup>em2Mcwi-</sup>/Rag1<sup>em2Mcwi-</sup></i> strain MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS-Rag1em1Mcwi on 4% NaCl diet
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220128 RGD
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688102 SS-<i>Ren<sup>em1Mcwi-/-</sup></i> SS-<i>Ren<sup>em1Mcwi-</sup>/Ren<sup>em1Mcwi-</sup></i> strain MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type
5688119 SS-<i>Tgfb1<sup>em3Mcwi+/-</sup></i> SS-<i>Tgfb1<sup>em3Mcwi+</sup>/Tgfb1<sup>em3Mcwi-</sup></i> strain MP:0002963 decreased urine protein level induces IMP N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+
5688119 SS-<i>Tgfb1<sup>em3Mcwi+/-</sup></i> SS-<i>Tgfb1<sup>em3Mcwi+</sup>/Tgfb1<sup>em3Mcwi-</sup></i> strain MP:0004154 renal tubular necrosis ameliorates IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+
5688119 SS-<i>Tgfb1<sup>em3Mcwi+/-</sup></i> SS-<i>Tgfb1<sup>em3Mcwi+</sup>/Tgfb1<sup>em3Mcwi-</sup></i> strain MP:0005540 decreased urine albumin level induces IMP N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+
5688119 SS-<i>Tgfb1<sup>em3Mcwi+/-</sup></i> SS-<i>Tgfb1<sup>em3Mcwi+</sup>/Tgfb1<sup>em3Mcwi-</sup></i> strain MP:0008838 decreased transforming growth factor beta level induces IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+
5688119 SS-<i>Tgfb1<sup>em3Mcwi+/-</sup></i> SS-<i>Tgfb1<sup>em3Mcwi+</sup>/Tgfb1<sup>em3Mcwi-</sup></i> strain MP:0020993 abnormal urine cytokine level induces IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0000790 abnormal stratification in cerebral cortex IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0000947 convulsive seizures IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0003232 abnormal forebrain development IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0008547 abnormal neocortex morphology IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0008840 abnormal spike wave discharge IAGP N RGD:407985868|PMID:32179177 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0011380 enlarged brain ventricles IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0011724 ectopic cortical neuron IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538479 SD-<i>Eml1<sup>tish</sup></i>/Scrb tish rat strain MP:0020581 abnormal neuron polarity IAGP N RGD:597538480|PMID:9236234 20250211 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0000790 abnormal stratification in cerebral cortex IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0000947 convulsive seizures IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0003232 abnormal forebrain development IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0008547 abnormal neocortex morphology IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0008840 abnormal spike wave discharge IAGP N RGD:407985868|PMID:32179177 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0011380 enlarged brain ventricles IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0011724 ectopic cortical neuron IAGP N RGD:597538480|PMID:9236234 20250213 RGD
597538481 Eml1<sup>tish</sup> EMAP like 1, tish mutant gene MP:0020581 abnormal neuron polarity IAGP N RGD:597538480|PMID:9236234 20250213 RGD
60990 LH/MavRrrc Lyon Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61057|PMID:7981757 19990101 RGD compared with LN/Mav
60993 FHH Fawn Hooded Hypertensive strain MP:0003025 increased vasoconstriction induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN and SD
60993 FHH Fawn Hooded Hypertensive strain MP:0031184 increased cerebral blood flow rate induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN and SD
60997 DA DA strain MP:0001845 abnormal inflammatory response IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0001846 increased inflammatory response IAGP N RGD:628543|PMID:12461526 20220531 RGD
60997 DA DA strain MP:0002499 chronic inflammation IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0002936 joint swelling IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0003186 abnormal redox activity IAGP N RGD:628543|PMID:12461526 20220531 RGD
60997 DA DA strain MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20220531 RGD
60997 DA DA strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0004799 increased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:61068|PMID:9692888 20200622 RGD compared to PAG.1AV1
60997 DA DA strain MP:0005515 uveitis penetrance IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain
60997 DA DA strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0008596 increased circulating interleukin-6 level IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD
60997 DA DA strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:61068|PMID:9692888 20200615 RGD compared to treated PVG.1AV1
60997 DA DA strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality penetrance IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain
60997 DA DA strain MP:0020445 abnormal NAD(P)H oxidase activity IAGP N RGD:628543|PMID:12461526 20220531 RGD
60999 LEW Lewis strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females
60999 LEW Lewis strain MP:0002644 decreased circulating triglyceride level sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females
60999 LEW Lewis strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females
60999 LEW Lewis strain MP:0005515 uveitis susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain
60999 LEW Lewis strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females
60999 LEW Lewis strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females
60999 LEW Lewis strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain
61000 SHR Spontaneously Hypertensive Rat strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
61000 SHR Spontaneously Hypertensive Rat strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
61000 SHR Spontaneously Hypertensive Rat strain MP:0003915 increased heart left ventricle weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to WKY
61000 SHR Spontaneously Hypertensive Rat strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to WKY
61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2316962|PMID:16928787 20191202 RGD compared with WKY
61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619655|PMID:9171954 20201201 RGD compared to WKY
61006 PVG PVG strain MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality severity IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to Lewis, AO, DA rat strains; HSV-1 McKrae virus strain
61006 PVG PVG strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm
61007 WF Wistar Furth strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000351 N RGD:61091|PMID:9563479 20200319 RGD tongue carcinoma, compared to treated DA/Slc
61007 WF Wistar Furth strain MP:0010271 decreased tongue tumor incidence induced IAGP XCO:0000351 N RGD:61091|PMID:9563479 20200319 RGD compared to treated DA/Slc
61008 WAG Wistar Albino Glaxo strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000159 N RGD:2306974|PMID:19089625 20090520 RGD
61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0002833 increased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY
61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0002834 decreased heart weight induced IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to untreated SHRSP
61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY
61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY
61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to untreated SHRSP
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001260 increased body weight IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001260 increased body weight IAGP N RGD:61072|PMID:9585427 20191105 RGD
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001262 decreased body weight IAGP N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001559 hyperglycemia IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001573 abnormal circulating alanine transaminase level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001777 abnormal body temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20070529 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001986 abnormal taste sensitivity IAGP N RGD:1625203|PMID:16081877 20070529 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0004893 decreased adiponectin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005293 impaired glucose tolerance IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005331 insulin resistance IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:619672|PMID:11853145 20191105 RGD
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011020 abnormal circadian temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20191107 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011939 increased food intake IAGP N RGD:1625200|PMID:16815799 20070529 RGD LETO
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011939 increased food intake IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:61072|PMID:9585427 20191105 RGD
61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0030968 decreased circulating adiponectin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone
61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0005282 decreased fatty acids level induced IAGP XCO:0000256 N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain
61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0006094 increased fat cell size IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain
61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain
61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0030017 decreased adipocyte glucose uptake induced IAGP XCO:0000245 N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain
61097 WKY/NCruk strain MP:0002608 increased hematocrit IAGP XCO:0000010 N RGD:69699|PMID:11157698 19990101 RGD compared to WKY/NCruk in normal air
61097 WKY/NCruk strain MP:0002833 increased heart weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd
61097 WKY/NCruk strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd
61097 WKY/NCruk strain MP:0003913 increased heart right ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd
61097 WKY/NCruk strain MP:0003915 increased heart left ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd
61097 WKY/NCruk strain MP:0004012 increased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:69699|PMID:11157698 19990101 RGD compared to WKY/NCruk in normal air and hypoxic F344/NHsd
61098 BXH/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20210121 RGD compared to SHR/OlaIpcv
61099 HXB/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20210121 RGD compared to SHR/OlaIpcv
61100 SHR/Ola strain MP:0002702 decreased circulating free fatty acids level IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to BN-Lx
61100 SHR/Ola strain MP:0004185 abnormal adipocyte glucose uptake susceptibility IAGP N RGD:619666|PMID:9916795 20201214 RGD compared to BN/Crl
61100 SHR/Ola strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub and SHR.BN-RT1n strains
61100 SHR/Ola strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:61079|PMID:8698878 19990101 RGD compared to BN-Lx
61100 SHR/Ola strain MP:0006094 increased fat cell size IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to BN-Lx
61100 SHR/Ola strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub strain
61100 SHR/Ola strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub strain
61100 SHR/Ola strain MP:0020870 decreased thigmotaxis IAGP N RGD:737695|PMID:14739700 20200219 RGD compared to BN-Lx/Cub strain
61100 SHR/Ola strain MP:0030017 decreased adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD compared to BN-Lx
61103 WKY strain MP:0002834 decreased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSP and SHRSR
61103 WKY strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSP and SHRSR
61104 LEW/NCrl strain MP:0001263 weight loss induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 20081126 RGD on 8% NaCl diet
61105 WKY/NHsd strain MP:0001364 decreased anxiety-related response IAGP N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd
61105 WKY/NHsd strain MP:0001382 abnormal nursing IAGP N RGD:1300040|PMID:15158425 20201106 RGD compared to F344/NHsd;
61105 WKY/NHsd strain MP:0001402 decreased locomotor activity induced IAGP XCO:0000157 N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd
61105 WKY/NHsd strain MP:0001442 decreased grooming behavior induced IAGP XCO:0000157 N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd
61105 WKY/NHsd strain MP:0001522 impaired swimming IAGP N RGD:4891104|PMID:14593430 20201216 RGD compared to F344, SD and Wi
61105 WKY/NHsd strain MP:0002665 decreased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598980|PMID:16895972 20080311 RGD compared to F344/NHsd males
61105 WKY/NHsd strain MP:0002757 decreased vertical activity IAGP N RGD:1578499|PMID:16490266 20061215 RGD
61105 WKY/NHsd strain MP:0002757 decreased vertical activity IAGP N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd
61105 WKY/NHsd strain MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD compared to F344/NHsd
61105 WKY/NHsd strain MP:0005293 impaired glucose tolerance IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131021 RGD
61105 WKY/NHsd strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316693|PMID:20068026 20200825 RGD compared to BN/SsN, BUF/N, F344/N
61105 WKY/NHsd strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20131021 RGD
61105 WKY/NHsd strain MP:0009327 abnormal maternal grooming IAGP N RGD:1300040|PMID:15158425 20201106 RGD compared to F344/NHsd;
61105 WKY/NHsd strain MP:0013308 decreased adrenal gland weight sexual_dimorphism IAGP N RGD:1598980|PMID:16895972 20080311 RGD compared to F344/NHsd males
61106 SHR.BN-(<i>D8Mit5-D8Mgh6</i>)/Ipcv strain MP:0002834 decreased heart weight IAGP N RGD:61054|PMID:9045857 20200122 RGD compared to SHR/Ola
61106 SHR.BN-(<i>D8Mit5-D8Mgh6</i>)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61054|PMID:9045857 19990101 RGD compared to SHR/Ola
61106 SHR.BN-(<i>D8Mit5-D8Mgh6</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61054|PMID:9045857 20200122 RGD compared to SHR/Ola
61107 BB/OK BioBreeding rat strain MP:0001552 increased circulating triglyceride level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol; sexual dimorphism
61107 BB/OK BioBreeding rat strain MP:0002963 decreased urine protein level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol
61107 BB/OK BioBreeding rat strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol
61107 BB/OK BioBreeding rat strain MP:0011467 decreased urine urea nitrogen level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol
61107 BB/OK BioBreeding rat strain MP:0011469 abnormal urine creatinine level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol; sexual dimorphism
61109 F344/NHsd F344/NHsd strain MP:0000635 pituitary gland hyperplasia IAGP N RGD:61074|PMID:9337394 19990101 RGD as compared to BN/SsNHsd
61109 F344/NHsd F344/NHsd strain MP:0001363 increased anxiety-related response IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd
61109 F344/NHsd F344/NHsd strain MP:0001399 hyperactivity IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd
61109 F344/NHsd F344/NHsd strain MP:0001441 increased grooming behavior IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd
61109 F344/NHsd F344/NHsd strain MP:0002608 increased hematocrit IAGP N RGD:69699|PMID:11157698 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0002834 decreased heart weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0002975 vascular smooth muscle hypertrophy IAGP N RGD:10401832|PMID:26258299 20151014 RGD
61109 F344/NHsd F344/NHsd strain MP:0003109 short femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to WKY/NHsd
61109 F344/NHsd F344/NHsd strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000210,XCO:0000442,XCO:0000206 N RGD:619598|PMID:10493520 20200225 RGD compared to BN/SsNHsd
61109 F344/NHsd F344/NHsd strain MP:0003914 decreased heart right ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0004013 decreased pulmonary artery pressure IAGP N RGD:69699|PMID:11157698 19990101 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0004013 decreased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:10401832|PMID:26258299 20200130 RGD as compared to WKY/Cruk
61109 F344/NHsd F344/NHsd strain MP:0004202 pulmonary hyperplasia IAGP N RGD:10401832|PMID:26258299 20151014 RGD
61109 F344/NHsd F344/NHsd strain MP:0004748 increased susceptibility to age-related hearing loss onset IAGP N RGD:2293526|PMID:18508213 20080603 RGD
61109 F344/NHsd F344/NHsd strain MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis resistance IAGP N RGD:2293749|PMID:18281616 20080612 RGD as compared to LEW/SsNHsd
61109 F344/NHsd F344/NHsd strain MP:0006325 impaired hearing onset IAGP N RGD:2293526|PMID:18508213 20080603 RGD
61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number IAGP N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw
61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw
61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D3Mgh13-D3Mgh7)/Dlw
61109 F344/NHsd F344/NHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl
61109 F344/NHsd F344/NHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw
61109 F344/NHsd F344/NHsd strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, BUF/NHsd, WKY/NHsd
61109 F344/NHsd F344/NHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw, in pituitary gland
61109 F344/NHsd F344/NHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd
61109 F344/NHsd F344/NHsd strain MP:0021066 increased tumor nonattached pericyte number induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd
61110 SHR/Mol strain MP:0000231 hypertension IAGP N RGD:619656|PMID:11414700 19990101 RGD
61110 SHR/Mol strain MP:0001262 decreased body weight IAGP N RGD:69701|PMID:9530625 20191206 RGD compared to strain BB/OK
61110 SHR/Mol strain MP:0002644 decreased circulating triglyceride level sexual_dimorphism IAGP N RGD:619656|PMID:11414700 20200103 RGD in males, compared to Wild/K strain
61110 SHR/Mol strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:619656|PMID:11414700 20200103 RGD in males, compared to Wild/K strain
61110 SHR/Mol strain MP:0005560 decreased circulating glucose level IAGP N RGD:619656|PMID:11414700 20200103 RGD compared to Wild/K strain
61110 SHR/Mol strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
61111 DA/Slc dark agouti strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD
61113 BN-<I>Lx</I> strain MP:0001548 hyperlipidemia IAGP N RGD:61079|PMID:8698878 19990101 RGD as compared to SHR/OlaIpcv
61113 BN-<I>Lx</I> strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61079|PMID:8698878 19990101 RGD as compared to SHR/OlaIpcv
61114 DA/Bkl strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000281 N RGD:61066|PMID:10857786 19990101 RGD compared to BN/SsN
61116 SHRSP/A3 strain MP:0001426 polydipsia IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0001916 intracerebral hemorrhage IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0002067 abnormal sensory capabilities/reflexes/nociception IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0002135 abnormal kidney morphology IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0002176 increased brain weight IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0002666 increased circulating aldosterone level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0002988 decreased urine osmolality IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0004119 hypokalemia IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:61092|PMID:10634822 19990101 RGD compared to male SHRSP/A3
61116 SHRSP/A3 strain MP:0005238 increased brain size IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0005610 increased circulating antidiuretic hormone level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0008688 decreased interleukin-2 secretion IAGP XCO:0000891,XCO:0000889 N RGD:149735373|PMID:32300198 20210910 RGD in T cells compared to SHR/Utx, SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0008997 increased blood osmolality IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0009763 increased susceptibility to induced morbidity/mortality IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx
61116 SHRSP/A3 strain MP:0011431 increased urine flow rate IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0011471 decreased urine creatinine level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2
61116 SHRSP/A3 strain MP:0020879 abnormal calcium level IAGP XCO:0000178,XCO:0000185 N RGD:149735373|PMID:32300198 20210910 RGD in PBMC compared to SHR/Utx, SHRSP.SHR-(rs106374972-rs106170276)/Utx
61117 BN-<i>Lx</i>/Cub Brown Norway with polydactyly-luxate strain MP:0001935 decreased litter size IAGP N RGD:631224|PMID:10615258 20200311 RGD compared to SHR/OlaIpcv
61117 BN-<i>Lx</i>/Cub Brown Norway with polydactyly-luxate strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246 N RGD:628911|PMID:2708818 20200121 RGD compared to SHR/Ola strain
61117 BN-<i>Lx</i>/Cub Brown Norway with polydactyly-luxate strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20240909 RGD compared to SHR/OlaIpcv strain
61276 Crhr1 corticotropin releasing hormone receptor 1 gene MP:0002797 increased thigmotaxis IDA N RGD:1626231|PMID:17550594 20070725 RGD in an induced arthritis pain model
61276 Crhr1 corticotropin releasing hormone receptor 1 gene MP:0003545 increased alcohol consumption IAGP N RGD:1626233|PMID:17015825 20070725 RGD DNA:polymorphism:promoter
61307 Ncf1 neutrophil cytosolic factor 1 gene MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20070315 RGD
61324 Eae5 Experimental allergic encephalomyelitis QTL 5 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61325 Aia5 Adjuvant induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61519 19990101 RGD
61326 Eae6 Experimental allergic encephalomyelitis QTL 6 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61327 Eae7 Experimental allergic encephalomyelitis QTL 7 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61328 Eae8 Experimental allergic encephalomyelitis QTL 8 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61329 Eae9 Experimental allergic encephalomyelitis QTL 9 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61330 Eau1 Experimental allergic uveoretinitis QTL 1 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
61330 Eau1 Experimental allergic uveoretinitis QTL 1 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD
61331 Eau2 Experimental allergic uveoretinitis QTL 2 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
61331 Eau2 Experimental allergic uveoretinitis QTL 2 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD
61332 Eau3 Experimental allergic uveoretinitis QTL 3 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD
61332 Eau3 Experimental allergic uveoretinitis QTL 3 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD
61333 Gluco16 Glucose level QTL 16 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD
61334 Gluco17 Glucose level QTL 17 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD
61335 Bp20 Blood pressure QTL 20 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61336 Bp21 Blood pressure QTL 21 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61337 Bp22 Blood pressure QTL 22 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61338 Bp23 Blood pressure QTL 23 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61339 Bp24 Blood pressure QTL 24 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61046|PMID:8567976 19990101 RGD
61340 Bp25 Blood pressure QTL 25 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD
61341 Bp26 Blood pressure QTL 26 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61048|PMID:9336384 19990101 RGD
61342 Bp27 Blood pressure QTL 27 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61049|PMID:8609235 19990101 RGD
61343 Bp28 Blood pressure QTL 28 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61050|PMID:8094726 19990101 RGD
61344 Bp29 Blood pressure QTL 29 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD
61345 Rf1 Renal disease susceptibility QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:61060|PMID:8528250 20120112 RGD
61345 Rf1 Renal disease susceptibility QTL 1 qtl MP:0005264 glomerulosclerosis QTM N RGD:61060|PMID:8528250 19990101 RGD
61346 Rf2 Renal disease susceptibility QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:61060|PMID:8528250 20120112 RGD
61346 Rf2 Renal disease susceptibility QTL 2 qtl MP:0005264 glomerulosclerosis QTM N RGD:61060|PMID:8528250 19990101 RGD
61347 Bp197 Blood pressure QTL 197 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61060|PMID:8528250 19990101 RGD
61348 Bp30 Blood pressure QTL 30 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61049|PMID:8609235 19990101 RGD
61349 Bp31 Blood pressure QTL 31 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD
61350 Bp32 Blood pressure QTL 32 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61044|PMID:7560090 19990101 RGD
61351 Bp33 Blood pressure QTL 33 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61044|PMID:7560090 19990101 RGD
61352 Bp34 Blood pressure QTL 34 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61053|PMID:9722941 19990101 RGD
61353 Bp35 Blood pressure QTL 35 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61054|PMID:9045857 19990101 RGD
61354 Pia10 Pristane induced arthritis QTL 10 qtl MP:0002936 joint swelling QTM N RGD:61519 19990101 RGD
61355 Bp36 Blood pressure QTL 36 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61356 Bp37 Blood pressure QTL 37 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61357 Bp38 Blood pressure QTL 38 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61358 Bp39 Blood pressure QTL 39 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61359 Eaex Experimental allergic encephalomyelitis QTL x qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61360 Eaey Experimental allergic encephalomyelitis QTL y qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61362 Oia2 Oil induced arthritis QTL 2 qtl MP:0002936 joint swelling IAGP N RGD:61087|PMID:9600974 19990101 RGD
61363 Oia3 Oil induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61087|PMID:9600974 19990101 RGD
61364 Iddm2 Insulin dependent diabetes mellitus QTL 2 qtl MP:0005559 increased circulating glucose level QTM N RGD:61075|PMID:1303251 19990101 RGD
61365 Iddm1 Insulin dependent diabetes mellitus QTL 1 qtl MP:0005015 increased T cell number IDA N RGD:61075|PMID:1303251 20120928 RGD
61365 Iddm1 Insulin dependent diabetes mellitus QTL 1 qtl MP:0005559 increased circulating glucose level QTM N RGD:61076|PMID:7026724 19990101 RGD
61366 Iddm3 Insulin dependent diabetes mellitus QTL 3 qtl MP:0001261 obese QTM N RGD:61075|PMID:1303251 19990101 RGD
61366 Iddm3 Insulin dependent diabetes mellitus QTL 3 qtl MP:0005559 increased circulating glucose level QTM N RGD:61075|PMID:1303251 19990101 RGD
61367 Iddm4 Insulin dependent diabetes mellitus QTL 4 qtl MP:0005559 increased circulating glucose level IAGP N RGD:61075|PMID:1303251 19990101 RGD
61368 Mcs1 Mammary carcinoma susceptibility QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61080|PMID:8168109 19990101 RGD
61369 Mcs2 Mammary carcinoma susceptibility QTL 2 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD
61370 Mcs3 Mammary carcinoma susceptibility QTL 3 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD
61371 Edpm1 Estrogen-dependent pituitary mass QTL 1 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:61074|PMID:9337394 19990101 RGD
61372 Bp40 Blood pressure QTL 40 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61373 Mcs4 Mammary carcinoma susceptibility QTL 4 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD
61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD
61375 Bp41 Blood pressure QTL 41 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD
61376 Bp42 Blood pressure QTL 42 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61377 Edpm3 Estrogen-dependent pituitary mass QTL 3 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD
61378 Bp43 Blood pressure QTL 43 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61379 Bp44 Blood pressure QTL 44 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61380 Edpm5 Estrogen-dependent pituitary mass QTL 5 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD
61381 Bp45 Blood pressure QTL 45 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61382 Bp46 Blood pressure QTL 46 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61383 Bp47 Blood pressure QTL 47 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61384 Bp48 Blood pressure QTL 48 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD
61385 Edpm9 Estrogen-dependent pituitary mass QTL 9 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD
61386 Bp49 Blood pressure QTL 49 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61056|PMID:9241273 19990101 RGD
61386 Bp49 Blood pressure QTL 49 qtl MP:0006060 increased cerebral infarct size IDA N RGD:61056|PMID:9241273 20070618 RGD
61387 Bp1 Blood pressure QTL 1 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61036|PMID:1655275 19990101 RGD
61388 Bp2 Blood pressure QTL 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61036|PMID:1655275 19990101 RGD
61389 Bp3 Blood pressure QTL 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61052|PMID:1656270 19990101 RGD
61390 Bp4 Blood pressure QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61052|PMID:1656270 19990101 RGD
61391 Bp5 Blood pressure QTL 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61057|PMID:7981757 19990101 RGD
61391 Bp5 Blood pressure QTL 5 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:61057|PMID:7981757 20121002 RGD
61392 Bp6 Blood pressure QTL 6 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61057|PMID:7981757 19990101 RGD
61392 Bp6 Blood pressure QTL 6 qtl MP:0006265 increased pulse pressure IDA N RGD:61057|PMID:7981757 20121002 RGD
61393 Bp7 Blood pressure QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61059|PMID:8201007 19990101 RGD
61394 Bp8 Blood pressure QTL 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61059|PMID:8201007 19990101 RGD
61395 Nka1 Natural killer alloreactivity QTL 1 qtl MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:61084|PMID:9521051 19990101 RGD
61396 Bp9 Blood pressure QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD
61397 Bw17 Body weight QTL 17 qtl MP:0001260 increased body weight QTM N RGD:61061|PMID:8528248 19990101 RGD
61398 Bp50 Blood pressure QTL 50 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61058|PMID:9329963 19990101 RGD
61399 Tcat1 Tongue tumor resistance QTL 1 qtl MP:0010271 decreased tongue tumor incidence QTM N RGD:61091|PMID:9563479 19990101 RGD
61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 qtl MP:0001260 increased body weight IDA N RGD:61082|PMID:8528247 19990101 RGD
61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 qtl MP:0005293 impaired glucose tolerance IDA N RGD:61082|PMID:8528247 19990101 RGD
61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61082|PMID:8528247 19990101 RGD
61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 qtl MP:0005559 increased circulating glucose level QTM N RGD:61082|PMID:8528247 19990101 RGD
61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 qtl MP:0005293 impaired glucose tolerance IDA N RGD:61082|PMID:8528247 19990101 RGD
61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 qtl MP:0005559 increased circulating glucose level IDA N RGD:61082|PMID:8528247 19990101 RGD
61403 Niddm4 Non-insulin dependent diabetes mellitus QTL 4 qtl MP:0001260 increased body weight QTM N RGD:61083|PMID:9169130 19990101 RGD
61403 Niddm4 Non-insulin dependent diabetes mellitus QTL 4 qtl MP:0005215 abnormal pancreatic islet morphology QTM N RGD:61083|PMID:9169130 19990101 RGD
61404 Bw120 Body weight QTL 120 qtl MP:0001260 increased body weight QTM N RGD:61083|PMID:9169130 19990101 RGD
61404 Bw120 Body weight QTL 120 qtl MP:0005559 increased circulating glucose level QTM N RGD:61083|PMID:9169130 19990101 RGD
61405 Niddm6 Non-insulin dependent diabetes mellitus QTL 6 qtl MP:0005559 increased circulating glucose level QTM N RGD:61083|PMID:9169130 19990101 RGD
61406 Scwia1 Streptococcal cell wall induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61064|PMID:10331011 19990101 RGD
61407 Scl12 Serum cholesterol level QTL 12 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD
61408 Scl23 Serum cholesterol level QTL 23 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD
61409 Scl13 Serum cholesterol level QTL 13 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD
61410 Bw19 Body weight QTL 19 qtl MP:0001260 increased body weight IDA N RGD:61082|PMID:8528247 19990101 RGD
61411 Pia1 Pristane induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61412 Pia2 Pristane induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61413 Eae10 Experimental allergic encephalomyelitis QTL 10 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61414 Pia3 Pristane induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61415 Eae11 Experimental allergic encephalomyelitis QTL 11 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61416 Pia4 Pristane induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61417 Cia10 Collagen induced arthritis QTL 10 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD
61417 Cia10 Collagen induced arthritis QTL 10 qtl MP:0002936 joint swelling QTM N RGD:61063|PMID:9870869 19990101 RGD
61418 Pia5 Pristane induced arthritis QTL 5 qtl MP:0002933 joint inflammation QTM N RGD:61089|PMID:9843218 19990101 RGD
61418 Pia5 Pristane induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61419 Cia11 Collagen induced arthritis QTL 11 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD
61420 Pia6 Pristane induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD
61421 Cia12 Collagen induced arthritis QTL 12 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD
61422 Cia13 Collagen induced arthritis QTL 13 qtl MP:0002933 joint inflammation QTM N RGD:61067|PMID:11001927 19990101 RGD
61422 Cia13 Collagen induced arthritis QTL 13 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61423 Cia14 Collagen induced arthritis QTL 14 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD
61424 Scl1 Serum cholesterol level QTL 1 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD
61425 Cia15 Collagen induced arthritis QTL 15 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61426 Scl2 Serum cholesterol level QTL 2 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD
61427 Cia16 Collagen induced arthritis QTL 16 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61428 Scl3 Serum cholesterol level QTL 3 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD
61429 Cia17 Collagen induced arthritis QTL 17 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61430 Cia18 Collagen induced arthritis QTL 18 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61431 Cia19 Collagen induced arthritis QTL 19 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61432 Cia1 Collagen induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD
61433 Cia2 Collagen induced arthritis QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD
61433 Cia2 Collagen induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD
61434 Cia3 Collagen induced arthritis QTL 3 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD
61434 Cia3 Collagen induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD
61435 Cia4 Collagen induced arthritis QTL 4 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD
61435 Cia4 Collagen induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61069|PMID:10398805 19990101 RGD
61436 Cia5 Collagen induced arthritis QTL 5 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD
61436 Cia5 Collagen induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD
61437 Cia6 Collagen induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61438 Cia7 Collagen induced arthritis QTL 7 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD
61438 Cia7 Collagen induced arthritis QTL 7 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD
61439 Cia8 Collagen induced arthritis QTL 8 qtl MP:0002936 joint swelling QTM N RGD:61069|PMID:10398805 19990101 RGD
61440 Cia9 Collagen induced arthritis QTL 9 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD
61440 Cia9 Collagen induced arthritis QTL 9 qtl MP:0002936 joint swelling QTM N RGD:61063|PMID:9870869 19990101 RGD
61441 Btemp1 Thermal response to stress QTL 1 qtl MP:0005533 increased body temperature QTM N RGD:61094|PMID:10679499 19990101 RGD
61441 Btemp1 Thermal response to stress QTL 1 qtl MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD
61442 Strs1 Sensitivity to stroke QTL 1 qtl MP:0006080 brain ischemia QTM N RGD:61093|PMID:8696337 19990101 RGD
61443 Btemp2 Thermal response to stress QTL 2 qtl MP:0005533 increased body temperature induced IAGP XCO:0000159, XCO:0000022 N RGD:61094|PMID:10679499 19990101 RGD
61443 Btemp2 Thermal response to stress QTL 2 qtl MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD
61444 Strs2 Sensitivity to stroke QTL 2 qtl MP:0006080 brain ischemia IAGP N RGD:61093|PMID:8696337 19990101 RGD
61445 Strs3 Sensitivity to stroke QTL 3 qtl MP:0006080 brain ischemia QTM N RGD:61093|PMID:8696337 19990101 RGD
61446 Coreg2 Compensatory renal growth QTL 2 qtl MP:0002955 increased compensatory renal growth QTM N RGD:61071|PMID:10864582 19990101 RGD
61447 Tcas1 Tongue tumor susceptibility QTL 1 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:61091|PMID:9563479 20111115 RGD
61448 Ciaa1 CIA Autoantibody QTL 1 qtl MP:0002493 increased IgG level QTM N RGD:61062|PMID:8782824 19990101 RGD
61448 Ciaa1 CIA Autoantibody QTL 1 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD
61449 Ciaa2 CIA Autoantibody QTL 2 qtl MP:0002493 increased IgG level QTM N RGD:61518 19990101 RGD
61449 Ciaa2 CIA Autoantibody QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD
61450 Ciaa3 CIA Autoantibody QTL 3 qtl MP:0002493 increased IgG level QTM N RGD:61066|PMID:10857786 19990101 RGD
61450 Ciaa3 CIA Autoantibody QTL 3 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD
61451 Ciaa4 CIA Autoantibody QTL 4 qtl MP:0002493 increased IgG level QTM N RGD:61067|PMID:11001927 19990101 RGD
61452 Ciaa5 CIA Autoantibody QTL 5 qtl MP:0002493 increased IgG level QTM N RGD:61067|PMID:11001927 19990101 RGD
61453 Pur1 Proteinuria QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:619599|PMID:9799838 20120112 RGD
61455 Niddm7 Non-insulin dependent diabetes mellitus QTL 7 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61061|PMID:8528248 19990101 RGD
61457 Niddm8 Non-insulin dependent diabetes mellitus QTL 8 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD
61458 Bp10 Blood pressure QTL 10 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619639|PMID:7768551 19990101 RGD
61460 Niddm9 Non-insulin dependent diabetes mellitus QTL 9 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD
61461 Bp11 Blood pressure QTL 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61037|PMID:1363813 19990101 RGD
61462 Niddm10 Non-insulin dependent diabetes mellitus QTL 10 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61061|PMID:8528248 19990101 RGD
61463 Bp12 Blood pressure QTL 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61037|PMID:1363813 19990101 RGD
61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD
61465 Bp13 Blood pressure QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD
61466 Niddm12 Non-insulin dependent diabetes mellitus QTL 12 qtl MP:0001260 increased body weight IDA N RGD:61061|PMID:8528248 19990101 RGD
61466 Niddm12 Non-insulin dependent diabetes mellitus QTL 12 qtl MP:0005559 increased circulating glucose level IDA N RGD:61061|PMID:8528248 19990101 RGD
61467 Bp14 Blood pressure QTL 14 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD
61468 Bp15 Blood pressure QTL 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD
61469 Bp16 Blood pressure QTL 16 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD
61471 Bp18 Blood pressure QTL 18 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61472 Aia1 Adjuvant induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD
61473 Bp19 Blood pressure QTL 19 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD
61474 Eae1 Experimental allergic encephalomyelitis QTL 1 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
61475 Aia2 Adjuvant induced arthritis QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61035|PMID:9780220 19990101 RGD
61475 Aia2 Adjuvant induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD
61476 Aia3 Adjuvant induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD
61477 Aia4 Adjuvant induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD
61498 BN/NHsdMcwi strain MP:0001262 decreased body weight IAGP N RGD:2290181|PMID:18285521 20200611 RGD comapred to LH/Mav
61498 BN/NHsdMcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to FHH and congenic
61498 BN/NHsdMcwi strain MP:0003022 increased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0003038 decreased myocardial infarct size IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 19990101 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0003039 increased time of peak ischemic contracture induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
61498 BN/NHsdMcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2290181|PMID:18285521 20200611 RGD comapred to LH/Mav
61498 BN/NHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:2290181|PMID:18285521 20200611 RGD
61498 BN/NHsdMcwi strain MP:0005318 decreased triglyceride level IAGP N RGD:2290181|PMID:18285521 20200611 RGD
61498 BN/NHsdMcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0005583 decreased renin activity induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to SS/JrHsdMcwi
61498 BN/NHsdMcwi strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated NBL/CrCrl, SHR/NHsd, LEW/NHsd, FHH/EurMcwiCrl, DA/OlaHsd
61499 SS/JrHsdMcwi strain MP:0001260 increased body weight induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
61499 SS/JrHsdMcwi strain MP:0001262 decreased body weight induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
61499 SS/JrHsdMcwi strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0001625 cardiac hypertrophy induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD
61499 SS/JrHsdMcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD
61499 SS/JrHsdMcwi strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD
61499 SS/JrHsdMcwi strain MP:0002871 albuminuria induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170407 RGD
61499 SS/JrHsdMcwi strain MP:0002959 increased urine microalbumin level induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated control
61499 SS/JrHsdMcwi strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
61499 SS/JrHsdMcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi
61499 SS/JrHsdMcwi strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
61499 SS/JrHsdMcwi strain MP:0003917 increased kidney weight induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170407 RGD
61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD
61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD
61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170407 RGD
61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension treatment IAGP XCO:0000022,XCO:0000032 N RGD:38500204|PMID:28931751 20200813 RGD compared to SS-Kcnj16em1Mcwi
61499 SS/JrHsdMcwi strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000645 N RGD:1626639|PMID:17589973 20070816 RGD compared to BN/NHsdMcwi, lower infusion of anesthetic propofol.
61499 SS/JrHsdMcwi strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0005264 glomerulosclerosis induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type vehicle-treated control
61499 SS/JrHsdMcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
61499 SS/JrHsdMcwi strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi
61499 SS/JrHsdMcwi strain MP:0005557 increased creatinine clearance induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi
61499 SS/JrHsdMcwi strain MP:0008140 podocyte foot process effacement induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to control and STZ treated SS-Trpc6em1Mcwi
61499 SS/JrHsdMcwi strain MP:0011296 decreased tubuloglomerular feedback response IAGP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS-Chr 2BN/Mcwi,SS-Shc1em1Mcwi, SS-Shc1em4Mcwi
61499 SS/JrHsdMcwi strain MP:0011402 renal cast IAGP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS-Kcnj16em1Mcwi
61499 SS/JrHsdMcwi strain MP:0011431 increased urine flow rate induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
61861 Gabra6 gamma-aminobutyric acid type A receptor subunit alpha6 gene MP:0001987 alcohol preference IAGP N RGD:1626511|PMID:14615016 20070810 RGD DNA:polymorphism:CDS:amino acid R100Q, Q allele higher in the alcohol preferring ANA line than the AA non-preferring line (P<0.0001)
61862 Gria2 glutamate ionotropic receptor AMPA type subunit 2 gene MP:0001454 abnormal cued conditioning behavior IMP N RGD:529195970|PMID:19160503 20241205 RGD
61862 Gria2 glutamate ionotropic receptor AMPA type subunit 2 gene MP:0003486 abnormal channel response intensity IMP N RGD:529195970|PMID:19160503 20241205 RGD
61862 Gria2 glutamate ionotropic receptor AMPA type subunit 2 gene MP:0020911 abnormal drug-induced reinstatement of an extinguished operant behavior for a drug reinforcer IMP N RGD:596933068|PMID:37190555 20241210 RGD
61903 Gpr182 G protein-coupled receptor 182 gene MP:0001613 abnormal vasodilation IDA N RGD:61533|PMID:7592696 19990101 RGD
61932 Fah fumarylacetoacetate hydrolase gene MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
61932 Fah fumarylacetoacetate hydrolase gene MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD
61932 Fah fumarylacetoacetate hydrolase gene MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD
61932 Fah fumarylacetoacetate hydrolase gene MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water
61958 S1pr1 sphingosine-1-phosphate receptor 1 gene MP:0001625 cardiac hypertrophy IMP N RGD:1357201|PMID:11549339 20061025 RGD
619613 Bp77 Blood pressure QTL 77 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD
619614 Bp78 Blood pressure QTL 78 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD
619615 Bp80 Blood pressure QTL 80 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD
619616 Bp79 Blood pressure QTL 79 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD
619617 Bp283 Blood pressure QTL 283 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70856|PMID:11053483 19990101 RGD
619618 Rf3 Renal disease susceptibility QTL 3 qtl MP:0002962 increased urine protein level IDA N RGD:70856|PMID:11053483 20120112 RGD
619618 Rf3 Renal disease susceptibility QTL 3 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD
619619 Rf4 Renal disease susceptibility QTL 4 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD
619620 Rf5 Renal disease susceptibility QTL 5 qtl MP:0002962 increased urine protein level IDA N RGD:70856|PMID:11053483 20120112 RGD
619620 Rf5 Renal disease susceptibility QTL 5 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD
619706 Ptprk protein tyrosine phosphatase, receptor type, K gene MP:0008076 abnormal CD4-positive T cell differentiation IAGP N RGD:15036800|PMID:17434290 20090211 RGD
619715 Sv2a synaptic vesicle glycoprotein 2a gene MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170317 RGD DNA:mutation:cds:p.L174Q(rat)
619715 Sv2a synaptic vesicle glycoprotein 2a gene MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170317 RGD DNA:mutation:cds:p.L174Q(rat)
619730 Tubb4a tubulin, beta 4A class IVa gene MP:0000745 tremors IAGP N RGD:150429639|PMID:28393430 20210910 RGD DNA:missense mutation:cds:p.Ala302Thr (rat)
619730 Tubb4a tubulin, beta 4A class IVa gene MP:0000921 demyelination IAGP N RGD:150429639|PMID:28393430 20210910 RGD DNA:missense mutation:cds:p.Ala302Thr (rat)
619745 Cdh13 cadherin 13 gene MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20200814 RGD knock-out compared to wild-type rats
619745 Cdh13 cadherin 13 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats
619769 Fmod fibromodulin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD
619769 Fmod fibromodulin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD
619777 L1cam L1 cell adhesion molecule gene MP:0000780 abnormal corpus callosum morphology IMP N RGD:14695001|PMID:30738385 20190725 RGD
619777 L1cam L1 cell adhesion molecule gene MP:0001732 postnatal growth retardation IMP N RGD:14695001|PMID:30738385 20190725 RGD
619777 L1cam L1 cell adhesion molecule gene MP:0008534 enlarged fourth ventricle IMP N RGD:14695001|PMID:30738385 20190725 RGD
619777 L1cam L1 cell adhesion molecule gene MP:0008535 enlarged lateral ventricles IMP N RGD:14695001|PMID:30738385 20190725 RGD
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated control
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type vehicle-treated control
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to STZ-treated wild type
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control
619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control
619790 Rag1 recombination activating 1 gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet
619790 Rag1 recombination activating 1 gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20201210 RGD as compared to SS
619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20170331 RGD
619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD
619790 Rag1 recombination activating 1 gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20170417 RGD
619790 Rag1 recombination activating 1 gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD
619790 Rag1 recombination activating 1 gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD
619816 Tnfsf4 TNF superfamily member 4 gene MP:0005671 abnormal response to transplant IDA N RGD:1580395|PMID:12626546 19990101 RGD
619830 Cd40 CD40 molecule gene MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD
619830 Cd40 CD40 molecule gene MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD
619830 Cd40 CD40 molecule gene MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD
619830 Cd40 CD40 molecule gene MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat
61986 Grk6 G protein-coupled receptor kinase 6 gene MP:0001392 abnormal locomotor behavior IMP N RGD:5684919|PMID:20410529 20171130 RGD associated with Parkinson Disease
61986 Grk6 G protein-coupled receptor kinase 6 gene MP:0003492 abnormal involuntary movement IMP N RGD:5684919|PMID:20410529 20171130 RGD associated with Parkinson Disease
619877 Nme2 NME/NM23 nucleoside diphosphate kinase 2 gene MP:0001273 decreased metastatic potential IMP N RGD:5132885|PMID:9854145 20110606 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0000599 enlarged liver IAGP N RGD:8657335|PMID:23569176 20140604 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0001260 increased body weight IAGP N RGD:8657335|PMID:23569176 20140604 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0003068 enlarged kidney IAGP N RGD:8657335|PMID:23569176 20140604 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD
619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210923 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723
61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220203 RGD
61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220203 RGD
61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220203 RGD
61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220203 RGD
61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220203 RGD
620006 Rin1 Ras and Rab interactor 1 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210429 RGD
620006 Rin1 Ras and Rab interactor 1 gene MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210429 RGD
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type and standard diet
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet and wild type
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet
620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0002871 albuminuria IMP N RGD:12910103|PMID:24722447 20170608 RGD
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210304 RGD
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0013219 abnormal substantia nigra pars compacta morphology IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to wild-type and untreated
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0013284 abnormal renal glomerular filtration IMP N RGD:12910103|PMID:24722447 20170608 RGD
620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0030585 enhanced behavioral response to amphetamine IMP N RGD:40924655|PMID:29530712 20210218 RGD compared to saline-treated
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in female
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006274 abnormal urine sodium level sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in male
62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type
620036 Ep300 E1A binding protein p300 gene MP:0001625 cardiac hypertrophy IDA N RGD:1298794|PMID:12477714 20061031 RGD
620062 Pon1 paraoxonase 1 gene MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD in peripheral blood, compared to SD
620062 Pon1 paraoxonase 1 gene MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620062 Pon1 paraoxonase 1 gene MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620062 Pon1 paraoxonase 1 gene MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620062 Pon1 paraoxonase 1 gene MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620062 Pon1 paraoxonase 1 gene MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in spleen, compared to SD
620062 Pon1 paraoxonase 1 gene MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620062 Pon1 paraoxonase 1 gene MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in bone marrow and peripheral blood, compared to SD
620062 Pon1 paraoxonase 1 gene MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD
620063 Ilk integrin-linked kinase gene MP:0003333 liver fibrosis IDA N RGD:2302063|PMID:16941698 20081117 RGD carbon tetrachloride-induced
620063 Ilk integrin-linked kinase gene MP:0008143 abnormal dendrite morphology IMP N RGD:2301736|PMID:18602949 20081030 RGD inhibition in the nucleus accumbens decreases dendrite density of medium spiny neurons
620100 Mgat5 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD
620112 Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 gene MP:0003789 increased osteosarcoma incidence IAGP N RGD:5147850|PMID:19825367 20190807 RGD DNA:deletion
620195 Mmp12 matrix metallopeptidase 12 gene MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20201210 RGD
620195 Mmp12 matrix metallopeptidase 12 gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20201210 RGD
620195 Mmp12 matrix metallopeptidase 12 gene MP:0012727 abnormal uterine spiral artery remodeling IMP N RGD:12910498|PMID:27807143 20170616 RGD
620226 Prelp proline and arginine rich end leucine rich repeat protein gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD
620226 Prelp proline and arginine rich end leucine rich repeat protein gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD
620268 Abcc6 ATP binding cassette subfamily C member 6 gene MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD
620287 Mybph myosin binding protein H gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
620287 Mybph myosin binding protein H gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
620298 Abcg5 ATP binding cassette subfamily G member 5 gene MP:0010077 increased phytosterol level IAGP N RGD:1598659|PMID:16026620 20061209 RGD DNA:missense mutation: p.G583C , 1757G>T (rat)
620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20201210 RGD
620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0001613 abnormal vasodilation IMP N RGD:11344212|PMID:26637559 20170913 RGD
620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20210610 RGD compared to SD
620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20201210 RGD
620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20201210 RGD
62037 Arc activity-regulated cytoskeleton-associated protein gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:11087075|PMID:25746394 20231212 RGD
620446 Shc1 SHC adaptor protein 1 gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD
620446 Shc1 SHC adaptor protein 1 gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD
620446 Shc1 SHC adaptor protein 1 gene MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD
620446 Shc1 SHC adaptor protein 1 gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD
620475 Npy2r neuropeptide Y receptor Y2 gene MP:0003545 increased alcohol consumption IDA N RGD:1642509|PMID:15670655 20070921 RGD
620505 Crh corticotropin releasing hormone gene MP:0001648 abnormal apoptosis IDA N RGD:704423|PMID:11908464 19990101 RGD
620505 Crh corticotropin releasing hormone gene MP:0005167 abnormal blood-brain barrier function IDA N RGD:704425|PMID:12663088 19990101 RGD
620505 Crh corticotropin releasing hormone gene MP:0005181 decreased circulating estradiol level IDA N RGD:704424|PMID:12450317 19990101 RGD
620505 Crh corticotropin releasing hormone gene MP:0005185 decreased circulating progesterone level IDA N RGD:704424|PMID:12450317 19990101 RGD
620563 Lpar1 lysophosphatidic acid receptor 1 gene MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20201012 RGD
620563 Lpar1 lysophosphatidic acid receptor 1 gene MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20181129 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0003290 intestinal hypoperistalsis IMP N RGD:12910748|PMID:7542218 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0004789 increased bile salt level IMP N RGD:12910748|PMID:7542218 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD
620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD
620573 Cyba cytochrome b-245 alpha chain gene MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction:
620573 Cyba cytochrome b-245 alpha chain gene MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction:
620593 Ccr3 C-C motif chemokine receptor 3 gene MP:0014114 abnormal cognition ameliorates IMP N RGD:407571672|PMID:39156650 20240925 RGD
620600 Nox4 NADPH oxidase 4 gene MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD
620600 Nox4 NADPH oxidase 4 gene MP:0004217 salt-sensitive hypertension severity IMP N RGD:11085830|PMID:26644237 20190103 RGD
620600 Nox4 NADPH oxidase 4 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
620600 Nox4 NADPH oxidase 4 gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
620600 Nox4 NADPH oxidase 4 gene MP:0005540 decreased urine albumin level IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
620600 Nox4 NADPH oxidase 4 gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
620600 Nox4 NADPH oxidase 4 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi
620600 Nox4 NADPH oxidase 4 gene MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD
620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0000580 deformed nails IMP N RGD:150520024|PMID:21325752 20211021 RGD
620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0001211 wrinkled skin IMP N RGD:150520024|PMID:21325752 20211021 RGD
620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0003815 hairless IMP N RGD:150520024|PMID:21325752 20211021 RGD
620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0010699 dilated hair follicle IMP N RGD:150520024|PMID:21325752 20211021 RGD
620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0030570 abnormal piliary canal morphology IMP N RGD:150520024|PMID:21325752 20211021 RGD
620640 Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 gene MP:0002066 abnormal motor capabilities/coordination/movement IAGP N RGD:1358549|PMID:12629505 20070423 RGD
620670 Dcx doublecortin gene MP:0000913 abnormal brain development IMP N RGD:1304461|PMID:14625554 19990101 RGD
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211104 RGD
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211104 RGD
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211104 RGD compared to untreated
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211104 RGD
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211104 RGD
620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211104 RGD
620711 Dhh desert hedgehog signaling molecule gene MP:0002780 decreased circulating testosterone level IMP N RGD:38548923|PMID:21062903 20200826 RGD
620711 Dhh desert hedgehog signaling molecule gene MP:0002789 male pseudohermaphroditism IMP N RGD:38548923|PMID:21062903 20200826 RGD
620711 Dhh desert hedgehog signaling molecule gene MP:0013603 abnormal fetal Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD
620711 Dhh desert hedgehog signaling molecule gene MP:0013604 abnormal adult Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD
620734 Ctnnd2 catenin delta 2 gene MP:0003651 abnormal axon extension IMP N RGD:407532699|PMID:32554807 20240911 RGD
620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type
620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type
620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type male
620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type female
620850 Nppc natriuretic peptide C gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620850 Nppc natriuretic peptide C gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type
620851 Npr2 natriuretic peptide receptor 2 gene MP:0001625 cardiac hypertrophy IAGP N RGD:1601488|PMID:16537417 20070423 RGD
620854 Dusp5 dual specificity phosphatase 5 gene MP:0003026 decreased vasoconstriction IMP N RGD:13446412|PMID:25397684 20201224 RGD compared to FHH.1BN
620874 Chi3l1 chitinase 3 like 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
620874 Chi3l1 chitinase 3 like 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0000218 increased leukocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0000219 increased neutrophil cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0005013 increased lymphocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0008993 abnormal portal triad morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0011353 expanded mesangial matrix IMP N RGD:2316657|PMID:19155635 20181120 RGD
62088 P2ry2 purinergic receptor P2Y2 gene MP:0013440 abnormal exorbital lacrimal gland morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
620979 Dnmt1 DNA methyltransferase 1 gene MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210518 RGD
620998 Nell1 neural EGFL like 1 gene MP:0002116 abnormal craniofacial bone morphology IMP N RGD:633405|PMID:12235118 19990101 RGD
621063 Csf1 colony stimulating factor 1 gene MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20210218 RGD
621063 Csf1 colony stimulating factor 1 gene MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20210218 RGD
621063 Csf1 colony stimulating factor 1 gene MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD
621063 Csf1 colony stimulating factor 1 gene MP:0003723 abnormal long bone morphology IAGP N RGD:628338|PMID:12379742 20170629 RGD
621063 Csf1 colony stimulating factor 1 gene MP:0030610 absent teeth IAGP N RGD:628338|PMID:12379742 20170629 RGD
621114 Ttn titin gene MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20170711 RGD
621114 Ttn titin gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD
621114 Ttn titin gene MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20170711 RGD
621114 Ttn titin gene MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20170711 RGD
621114 Ttn titin gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle
621119 Nlgn3 neuroligin 3 gene MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle
621119 Nlgn3 neuroligin 3 gene MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD
621119 Nlgn3 neuroligin 3 gene MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210423 RGD
621119 Nlgn3 neuroligin 3 gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD
621120 Cdk4 cyclin-dependent kinase 4 gene MP:0002006 neoplasm IDA N RGD:625485|PMID:12070150 19990101 RGD
621123 Ptprv protein tyrosine phosphatase, receptor type, V gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
621123 Ptprv protein tyrosine phosphatase, receptor type, V gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
621137 Rnpep arginyl aminopeptidase gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
621137 Rnpep arginyl aminopeptidase gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
621276 Trpc4 transient receptor potential cation channel, subfamily C, member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210506 RGD
621276 Trpc4 transient receptor potential cation channel, subfamily C, member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210506 RGD
621304 Atp2b3 ATPase plasma membrane Ca2+ transporting 3 gene MP:0000745 tremors IAGP N RGD:13825260|PMID:27013529 20181204 RGD
621316 Mmp2 matrix metallopeptidase 2 gene MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231116 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS
621316 Mmp2 matrix metallopeptidase 2 gene MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS
621320 Mmp9 matrix metallopeptidase 9 gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:597805897|PMID:37423509 20250220 RGD
621320 Mmp9 matrix metallopeptidase 9 gene MP:0005540 decreased urine albumin level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250220 RGD compared to wild type littermate
621320 Mmp9 matrix metallopeptidase 9 gene MP:0005554 decreased circulating creatinine level induces IMP XCO:0000795 N RGD:597805897|PMID:37423509 20250220 RGD compared to wild type littermate
621341 Nrg1 neuregulin 1 gene MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD
621341 Nrg1 neuregulin 1 gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to mutant male
621341 Nrg1 neuregulin 1 gene MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240425 RGD compared to female
621341 Nrg1 neuregulin 1 gene MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20151211 RGD DNA:transposon insertion
621341 Nrg1 neuregulin 1 gene MP:0008414 abnormal spatial reference memory IMP N RGD:10449010|PMID:23098760 20151211 RGD DNA:transposon insertion
621341 Nrg1 neuregulin 1 gene MP:0008428 abnormal spatial working memory IMP N RGD:10449010|PMID:23098760 20151211 RGD DNA:transposon insertion
621341 Nrg1 neuregulin 1 gene MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to wild type female
621341 Nrg1 neuregulin 1 gene MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD
621341 Nrg1 neuregulin 1 gene MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240425 RGD
621369 Uox urate oxidase gene MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211109 RGD
621369 Uox urate oxidase gene MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211109 RGD
621369 Uox urate oxidase gene MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211109 RGD
621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type
621397 Ghsr growth hormone secretagogue receptor gene MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0001258 decreased body length IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0001262 decreased body weight IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027
621397 Ghsr growth hormone secretagogue receptor gene MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027
621397 Ghsr growth hormone secretagogue receptor gene MP:0005668 decreased circulating leptin level IMP N RGD:12910109|PMID:19931319 20170609 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431)
621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027
621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:625699|PMID:12045256 20170613 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD
621397 Ghsr growth hormone secretagogue receptor gene MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD
621400 Nr1i3 nuclear receptor subfamily 1, group I, member 3 gene MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD male rats
621424 Lig1 DNA ligase 1 gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20200130 RGD
621446 Klf5 KLF transcription factor 5 gene MP:0008469 abnormal protein level IMP N RGD:45073134|PMID:32272873 20210716 RGD Syp, Gap43
621446 Klf5 KLF transcription factor 5 gene MP:0008948 decreased neuron number IMP N RGD:45073134|PMID:32272873 20210715 RGD in hippocampus
621446 Klf5 KLF transcription factor 5 gene MP:0020551 abnormal postsynaptic density morphology IMP N RGD:45073134|PMID:32272873 20210716 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000221 decreased leukocyte cell number IMP N RGD:2316325|PMID:20111598 20170327 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000694 spleen hypoplasia IMP N RGD:2316325|PMID:20111598 20170327 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0001823 thymus hypoplasia IMP N RGD:2316325|PMID:20111598 20170327 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001525 impaired balance IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001544 abnormal cardiovascular system physiology IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0005211 increased stomach mucosa thickness IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat)
621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat)
621541 Or2z2 olfactory receptor family 2 subfamily Z member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
621629 Or1n1 olfactory receptor family 1 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
621693 Aspa aspartoacylase gene MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD
621693 Aspa aspartoacylase gene MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD
621743 Ddx52 DExD-box helicase 52 gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1599269|PMID:17218081 20090212 RGD DNA:polymorphism
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model
621808 Park7 Parkinsonism associated deglycase gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD
621808 Park7 Parkinsonism associated deglycase gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
621820 Gja3 gap junction protein, alpha 3 gene MP:0001304 cataract NAS N RGD:1599824|PMID:16271086 20070216 RGD
621837 Lyst lysosomal trafficking regulator gene MP:0001186 pigmentation phenotype IAGP N RGD:1302441|PMID:12638234 20090206 RGD beige coat color; ACI/N or DA/Ham rat
621837 Lyst lysosomal trafficking regulator gene MP:0005606 increased bleeding time IAGP N RGD:1302441|PMID:12638234 20090206 RGD in beige mutant rats
625659 DRH/Seac strain MP:0010265 decreased hepatoma incidence induced IAGP XCO:0000207 N RGD:625382|PMID:11756240 20090216 RGD chemically-induced
628372 ACI.FHH-(<i>D1Mit34-D1Rat156</i>)/Eur strain MP:0002962 increased urine protein level induced IAGP XCO:0000112, XCO:0000121 N RGD:625641|PMID:11875190 20120112 RGD compared to ACI/Eur
628372 ACI.FHH-(<i>D1Mit34-D1Rat156</i>)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000112 N RGD:625641|PMID:11875190 20201202 RGD compared to ACI/Eur
628486 NER/Kyo Noda epileptic rat, GMS strain MP:0003997 tonic-clonic seizures penetrance IAGP N RGD:2313241|PMID:19713079 20200530 RGD
628486 NER/Kyo Noda epileptic rat, GMS strain MP:0003997 tonic-clonic seizures susceptibility IAGP N RGD:628480|PMID:9578020 20200530 RGD
628525 Ni/Hin strain MP:0000522 kidney cortex cyst IAGP N RGD:628433|PMID:11092972 19990101 RGD
628659 Nrxn1 neurexin 1 gene MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate
628659 Nrxn1 neurexin 1 gene MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210527 RGD
628659 Nrxn1 neurexin 1 gene MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate
628659 Nrxn1 neurexin 1 gene MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210527 RGD
628659 Nrxn1 neurexin 1 gene MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type male
628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20191105 RGD
628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)
628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)
628752 Rab38 RAB38, member RAS oncogene family gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:1300411|PMID:15112108 20070307 RGD DNA:point mutation:exon:p.M1I
628752 Rab38 RAB38, member RAS oncogene family gene MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20201210 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi
628752 Rab38 RAB38, member RAS oncogene family gene MP:0004722 abnormal platelet dense granule number IAGP N RGD:2324691|PMID:18983523 20100511 RGD
628752 Rab38 RAB38, member RAS oncogene family gene MP:0004780 abnormal surfactant secretion IAGP N RGD:2324690|PMID:19897744 20100511 RGD
628752 Rab38 RAB38, member RAS oncogene family gene MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD
628752 Rab38 RAB38, member RAS oncogene family gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13524861|PMID:28438206 20180501 RGD
628752 Rab38 RAB38, member RAS oncogene family gene MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD
628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210426 RGD
628830 Myo7a myosin VIIA gene MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
628830 Myo7a myosin VIIA gene MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
628830 Myo7a myosin VIIA gene MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
628830 Myo7a myosin VIIA gene MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
628830 Myo7a myosin VIIA gene MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds
628831 Nr1h4 nuclear receptor subfamily 1, group H, member 4 gene MP:0003333 liver fibrosis IDA N RGD:1625201|PMID:15980055 20070529 RGD
628831 Nr1h4 nuclear receptor subfamily 1, group H, member 4 gene MP:0003333 liver fibrosis treatment IMP N RGD:15042868|PMID:19418582 20191213 RGD mRNA:altered expression:liver (rat)
628835 Gpr37l1 G protein-coupled receptor 37-like 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD
628835 Gpr37l1 G protein-coupled receptor 37-like 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD
628871 Gimap5 GTPase, IMAP family member 5 gene MP:0005534 decreased body temperature IAGP N RGD:2303768|PMID:17705691 20090305 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0001304 cataract IAGP N RGD:629571|PMID:12356818 19990101 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD DNA:missense mutation:cds:p.L7Q(rat)
628890 Gja8 gap junction protein, alpha 8 gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20231005 RGD
628890 Gja8 gap junction protein, alpha 8 gene MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD
628907 SHR.BN-RT1<sup>n</sup> strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:628911|PMID:2708818 20200128 RGD compared to SHR/Ola
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0000530 abnormal kidney vasculature morphology IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0002962 increased urine protein level IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61048|PMID:9336384 20200505 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61048|PMID:9336384 19990101 RGD compared to SHR/Ola strain
628908 SHR.BN-(<i>D1Mit3-Igf2</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200506 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619652|PMID:9453331 19990101 RGD compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:61046|PMID:8567976 19990101 RGD males compared to SR/Jr males
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0010330 abnormal circulating lipoprotein level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD increased IDL compared to SHR/Ola
628909 SHR.BN-(<i>D13Arb5-Ren1</i>)/Ipcv strain MP:0010330 abnormal circulating lipoprotein level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200506 RGD increased IDL compared to SHR/Ola
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0000523 cortical renal glomerulopathies IAGP N RGD:628436|PMID:11135055 19990101 RGD compared to heterozygous +/fa rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001254 increased body height susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001254 increased body height treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001260 increased body weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001260 increased body weight treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001260 increased body weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001261 obese susceptibility IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated and control strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001552 increased circulating triglyceride level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001552 increased circulating triglyceride level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001554 increased circulating free fatty acids level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001554 increased circulating free fatty acids level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001745 increased circulating corticosterone level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0001745 increased circulating corticosterone level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0002079 increased circulating insulin level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0002871 albuminuria disease_progression IAGP N RGD:628436|PMID:11135055 20200430 RGD compared to heterozygous +/fa rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0002871 albuminuria treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0003215 renal interstitial fibrosis treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0003917 increased kidney weight susceptibility IAGP N RGD:628436|PMID:11135055 20200430 RGD compared to heterozygous +/fa rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0003917 increased kidney weight treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005178 increased circulating cholesterol level IAGP N RGD:628436|PMID:11135055 19990101 RGD compared to heterozygous +/fa rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005178 increased circulating cholesterol level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005178 increased circulating cholesterol level treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005178 increased circulating cholesterol level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005528 decreased renal glomerular filtration rate treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005557 increased creatinine clearance treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005559 increased circulating glucose level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005669 increased circulating leptin level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0005669 increased circulating leptin level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0008908 increased total fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0008908 increased total fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0009288 increased epididymal fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0009288 increased epididymal fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0009304 increased retroperitoneal fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0009304 increased retroperitoneal fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0011377 renal glomerulus fibrosis treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0011939 increased food intake susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0011939 increased food intake treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats
629459 ZUC-<i>Lepr<sup>faSteJrpz-/-</sup></i> strain MP:0011939 increased food intake treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001261 obese IAGP N RGD:628581|PMID:11500530 19990101 RGD compared to heterozygous controls +/fa
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 19990101 RGD compared to heterozygous controls +/fa
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201002 RGD compared to BN
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase
629462 ZUC-<I>Lepr</I><sup>faSte-/-</sup> strain MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats
629465 SHR/NCrlCrlj strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm
629465 SHR/NCrlCrlj strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm
629465 SHR/NCrlCrlj strain MP:0005560 decreased circulating glucose level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm
629465 SHR/NCrlCrlj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:629460|PMID:10391208 20201005 RGD compared to SHR/Izm
629482 WKY.SHR-(<i>D1Wox19-D1Mit2</i>)/Njs strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain
629482 WKY.SHR-(<i>D1Wox19-D1Mit2</i>)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to WKY
629482 WKY.SHR-(<i>D1Wox19-D1Mit2</i>)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain
629482 WKY.SHR-(<i>D1Wox19-D1Mit2</i>)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to WKY
629482 WKY.SHR-(<i>D1Wox19-D1Mit2</i>)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain
629484 LEW-<i>tl</i> strain MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD
629485 LE/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD
629486 PVG/OlaHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl
629487 SHR.WKY-(<i>D1Wox19-D1Wox34</i>)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain
629487 SHR.WKY-(<i>D1Wox19-D1Wox34</i>)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to SHR
629487 SHR.WKY-(<i>D1Wox19-D1Wox34</i>)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain
629487 SHR.WKY-(<i>D1Wox19-D1Wox34</i>)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61051|PMID:9774356 20191203 RGD compared to SHR
629487 SHR.WKY-(<i>D1Wox19-D1Wox34</i>)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain
629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0002075 abnormal coat/hair pigmentation IMP N RGD:628516|PMID:9739043 20171204 RGD
629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0003270 intestinal obstruction IAGP N RGD:628516|PMID:9739043 20171201 RGD
629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:13782267|PMID:11078344 20180830 RGD
629490 DA.F344-Aia1/1 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd
629491 DA.F344-Aia1/2 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd
629492 Sl strain MP:0000477 abnormal intestine morphology IMP N RGD:628516|PMID:9739043 19990101 RGD
629492 Sl strain MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628515|PMID:8570650 20061030 RGD
629492 Sl strain MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20061030 RGD
629492 Sl strain MP:0002926 aganglionic megacolon IAGP N RGD:628515|PMID:8570650 20061030 RGD
629492 Sl strain MP:0003270 intestinal obstruction IMP N RGD:628516|PMID:9739043 19990101 RGD
629493 DA.F344-Aia1/3 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd
629494 DA.F344-Aia1/4 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd
629501 SD-Tg(Ren2)27 strain MP:0003353 decreased circulating renin level IMP N RGD:628589|PMID:2181319 20200211 RGD
629501 SD-Tg(Ren2)27 strain MP:0003915 increased heart left ventricle weight IMP N RGD:13513906|PMID:16882881 20200214 RGD compared to non-transgenic littermate SD-Tg(Ren2)27-/-
629501 SD-Tg(Ren2)27 strain MP:0005583 decreased renin activity IMP N RGD:628589|PMID:2181319 20200211 RGD in plasma, kidney
629501 SD-Tg(Ren2)27 strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:13513906|PMID:16882881 20191202 RGD compared with SD-Tg(Ren2)27-/-
629501 SD-Tg(Ren2)27 strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:628589|PMID:2181319 19990101 RGD compared to wild-type littermate
629501 SD-Tg(Ren2)27 strain MP:0011540 increased urine aldosterone level IMP N RGD:628589|PMID:2181319 20200211 RGD in male
629502 SHR.BN-(<i>Il6-Npy</i>) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:2300254|PMID:18587397 20080910 RGD as compared to SHR progenitor
629502 SHR.BN-(<i>Il6-Npy</i>) strain MP:0030016 increased adipocyte glucose uptake IAGP N RGD:619666|PMID:9916795 20201214 RGD compared to SHR
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 19990101 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:619647|PMID:9931113 19990101 RGD compared to SHR/Ola
629503 SHR.BN-(<i>D19Rat57-D19Mit7</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:619647|PMID:9931113 20200122 RGD compared to SHR/Ola
629504 WKY.SHR-(<i>D1Mit3-D1Rat57</i>)/Iwai strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:628906|PMID:9774355 19990101 RGD compared to WKY
629509 FHH/EurMcwi strain MP:0000249 abnormal blood vessel physiology IAGP N RGD:61023|PMID:10070148 20191206 RGD compared to FHL/EurMcwi
629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to BN/NHsdMcwi
629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN
629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20191212 RGD compared to FHL/EurMcwi
629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHL/EurMcw, ACI/SegHsd
629509 FHH/EurMcwi strain MP:0003071 decreased vascular permeability induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD Associated with hypertension, compared to FHH-Tg(CAG-Add3)McwiRoman
629509 FHH/EurMcwi strain MP:0003985 renal fibrosis induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman
629509 FHH/EurMcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHL/EurMcwi
629509 FHH/EurMcwi strain MP:0005325 abnormal renal glomerulus morphology induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman
629509 FHH/EurMcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi
629509 FHH/EurMcwi strain MP:0008874 decreased physiological sensitivity to xenobiotic IAGP N RGD:61023|PMID:10070148 20191206 RGD compared to FHL/EurMcwi
629509 FHH/EurMcwi strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman
629509 FHH/EurMcwi strain MP:0011402 renal cast induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman
629509 FHH/EurMcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN
629509 FHH/EurMcwi strain MP:0020849 abnormal actin cytoskeleton morphology IMP N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman
629510 SS.BN-(<i>D12Arb13-D12Rat79</i>)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS.BN-(D12Arb13-D12Rat79)/Mcwi
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0003009 abnormal cytokine secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD increased GM-CSF secretion compared to SS/Hsd;
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 2BN/Mcwi��
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0005264 glomerulosclerosis ameliorates IAGP N RGD:12792230|PMID:27270176 20210409 RGD compared to SS/JrHsdMcwi
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level IAGP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS-Chr 2BN/Mcwi��
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0008560 increased tumor necrosis factor secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS/Hsd;
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0008660 increased interleukin-10 secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS/Hsd;
629511 SS-Chr 2<sup>BN</sup>/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi
629513 SS-Chr 4<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS-Chr 4BN/Mcwi��
629514 SS-Chr 6<sup>BN</sup>/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD
629514 SS-Chr 6<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male and female SS/JrHsdMcwi�
629514 SS-Chr 6<sup>BN</sup>/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
629514 SS-Chr 6<sup>BN</sup>/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
629515 SS-Chr 7<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629515 SS-Chr 7<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi on 8% NaCl diet
629515 SS-Chr 7<sup>BN</sup>/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi
629516 SS-Chr 8<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629516 SS-Chr 8<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
629517 SS-Chr Y<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629518 SS-Chr 9<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 9BN/Mcwi, female SS/JrHsdMCWi
629518 SS-Chr 9<sup>BN</sup>/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
629520 FHH-Chr 1<sup>BN</sup>/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
629520 FHH-Chr 1<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi
629520 FHH-Chr 1<sup>BN</sup>/Mcwi strain MP:0031183 decreased cerebral blood flow rate induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN
629521 SS-Chr 11<sup>BN</sup>/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD
629521 SS-Chr 11<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
629522 SS-Chr 20<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629522 SS-Chr 20<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD compared to female SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0003352 increased circulating renin level IAGP N RGD:2289092|PMID:18198281 20080515 RGD compared to SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2289092|PMID:18198281 20191213 RGD compared to male SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000645 N RGD:1626639|PMID:17589973 20070816 RGD compared to SS/JrHsdMcwi, higher infusion of anesthetic propofol
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
629523 SS-Chr 13<sup>BN</sup>/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD compared to SS/JrHsdMcwi
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0005330 cardiomyopathy IAGP N RGD:1598977|PMID:17204904 20070117 RGD
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD compared to SS/JrHsdMcwi
629524 SS-Chr 16<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female
629525 SS-Chr 18<sup>BN</sup>/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi
629525 SS-Chr 18<sup>BN</sup>/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi
629525 SS-Chr 18<sup>BN</sup>/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi
629578 SS.LEW-(<i>D5Rat130-D5Mco10</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
631158 DXE1/Ztm strain MP:0002993 autoimmune arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd
631158 DXE1/Ztm strain MP:0003724 increased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd
631160 DXE2/Ztm strain MP:0003561 rheumatoid arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd
631160 DXE2/Ztm strain MP:0003724 increased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd
631161 DXE3/Ztm strain MP:0003436 decreased susceptibility to induced arthritis resistance IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to induced strain DA/Ztm
631182 DA/BklArbN strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD
631182 DA/BklArbN strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263|XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
631198 Cm22 Cardiac mass QTL 22 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD
631199 Cm23 Cardiac mass QTL 23 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD
631200 Cm25 Cardiac mass QTL 25 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:69706|PMID:10205229 19990101 RGD
631201 Panci1 Pancreas inflammation QTL 1 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD
631201 Panci1 Pancreas inflammation QTL 1 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD
631202 Gluco13 Glucose level QTL 13 qtl MP:0001260 increased body weight QTM N RGD:631173|PMID:12705906 19990101 RGD
631202 Gluco13 Glucose level QTL 13 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD
631203 Gluco14 Glucose level QTL 14 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD
631204 Gluco15 Glucose level QTL 15 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD
631205 Bp196 Blood pressure QTL 196 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61484|PMID:9495256 19990101 RGD
631206 Niddm40 Non-insulin dependent diabetes mellitus QTL 40 qtl MP:0005293 impaired glucose tolerance IDA N RGD:619671|PMID:10902185 19990101 RGD
631207 Niddm41 Non-insulin dependent diabetes mellitus QTL 41 qtl MP:0005293 impaired glucose tolerance IDA N RGD:619671|PMID:10902185 19990101 RGD
631208 Bw1 Body weight QTL1 qtl MP:0000010 abnormal abdominal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631209 Bw2 Body weight QTL2 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631210 Bw3 Body weight QTL3 qtl MP:0000010 abnormal abdominal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631211 Bw4 Body weight QTL4 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631212 Bw5 Body weight QTL5 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631213 Bw60 Body weight QTL60 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD
631214 Bw61 Body weight QTL61 qtl MP:0000013 abnormal adipose tissue distribution QTM N RGD:619672|PMID:11853145 19990101 RGD
631215 Stl8 Serum triglyceride level QTL 8 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:70852|PMID:10644432 19990101 RGD
631216 Stl9 Serum triglyceride level QTL 9 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:70852|PMID:10644432 19990101 RGD
631217 Activ1 Activity QTL 1 qtl MP:0001399 hyperactivity QTM N RGD:631170|PMID:8944030 19990101 RGD
631217 Activ1 Activity QTL 1 qtl MP:0001415 increased exploration in new environment QTM N RGD:631228|PMID:12660808 19990101 RGD
631219 SDT/Jcl strain MP:0000187 abnormal triglyceride level IAGP N RGD:628479|PMID:11469401 20180125 RGD
631219 SDT/Jcl strain MP:0001262 decreased body weight IAGP N RGD:2298688|PMID:18612083 20200130 RGD
631219 SDT/Jcl strain MP:0001262 decreased body weight IAGP N RGD:628479|PMID:11469401 19990101 RGD compared to Crj:CD(SD) controls, sexual dimorphism
631219 SDT/Jcl strain MP:0001304 cataract IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0001426 polydipsia IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus
631219 SDT/Jcl strain MP:0001433 polyphagia IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus
631219 SDT/Jcl strain MP:0001559 hyperglycemia IAGP N RGD:2298688|PMID:18612083 20180404 RGD
631219 SDT/Jcl strain MP:0001559 hyperglycemia IAGP N RGD:631173|PMID:12705906 19990101 RGD
631219 SDT/Jcl strain MP:0001759 increased urine glucose level IAGP N RGD:628479|PMID:11469401 20180125 RGD
631219 SDT/Jcl strain MP:0001762 polyuria IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus
631219 SDT/Jcl strain MP:0001869 pancreas inflammation IAGP N RGD:2298688|PMID:18612083 20200130 RGD
631219 SDT/Jcl strain MP:0001944 abnormal pancreas morphology IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0002727 decreased circulating insulin level IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0002840 abnormal lens fiber morphology IAGP N RGD:628479|PMID:11469401 20200130 RGD
631219 SDT/Jcl strain MP:0002901 increased urine phosphate level induced IAGP XCO:0000018, XCO:0000547 N RGD:12914778|PMID:28674323 20170712 RGD
631219 SDT/Jcl strain MP:0002904 increased circulating parathyroid hormone level induced IAGP XCO:0000018,XCO:0000547 N RGD:12914778|PMID:28674323 20201006 RGD
631219 SDT/Jcl strain MP:0003334 pancreas fibrosis IAGP N RGD:2298688|PMID:18612083 20200130 RGD
631219 SDT/Jcl strain MP:0003334 pancreas fibrosis IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:2298688|PMID:18612083 20200130 RGD
631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:631173|PMID:12705906 20200130 RGD
631219 SDT/Jcl strain MP:0005441 increased urine calcium level induced IAGP XCO:0000018, XCO:0000547 N RGD:12914778|PMID:28674323 20170712 RGD
631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to Sprague Dawley rats
631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:628479|PMID:11469401 19990101 RGD
631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:631173|PMID:12705906 19990101 RGD
631219 SDT/Jcl strain MP:0009168 decreased pancreatic islet number IAGP N RGD:628479|PMID:11469401 20081208 RGD
631260 Tcas2 Tongue tumor susceptibility QTL 2 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD
631261 Tcas3 Tongue tumor susceptibility QTL 3 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD
631262 Tcas4 Tongue tumor susceptibility QTL 4 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD
631263 Cm24 Cardiac mass QTL 24 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:619659|PMID:11157676 19990101 RGD
631264 Scl22 Serum cholesterol level QTL 22 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:61055|PMID:9199194 19990101 RGD
631265 Iresp1 Immunoglobin response QTL1 qtl MP:0005613 increased susceptibility to type II hypersensitivity reaction QTM N RGD:619646|PMID:10898507 19990101 RGD
631266 Bp132 Blood pressure QTL 132 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619621|PMID:10406815 19990101 RGD
631266 Bp132 Blood pressure QTL 132 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD
631267 Cia20 Collagen induced arthritis QTL 20 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD
631268 Cia21 Collagen induced arthritis QTL 21 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD
631269 Cia22 Collagen induced arthritis QTL 22 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD
631270 Cia23 Collagen induced arthritis QTL 23 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD
631271 Lecl1 Lens clarity QTL 1 qtl MP:0001314 cornea opacity QTM N RGD:68701|PMID:11252169 19990101 RGD
631272 Lanf1 Left ventricular atrial natriuretic factor QTL 1 qtl MP:0005522 increased circulating atrial natriuretic factor QTM N RGD:619659|PMID:11157676 19990101 RGD
631273 Lecl2 Lens clarity QTL 2 qtl MP:0001314 cornea opacity QTM N RGD:68701|PMID:11252169 19990101 RGD
631274 Sprol1 Serum protein level QTL 1 qtl MP:0005568 increased circulating total protein level QTM N RGD:61055|PMID:9199194 19990101 RGD
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD compared to SHRSP/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD as compared to parental SHRSP/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD at normal salt and 1% salt diet
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD at normal salt and 1% salt diet
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc
631278 SHRSP.WKY-(<I>D2Rat13-D2Rat157</I>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
631279 SHRSP.WKY-(<I>D2Rat13-D2Mit5</I>)/Gcrc strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc
631279 SHRSP.WKY-(<I>D2Rat13-D2Mit5</I>)/Gcrc strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD
631279 SHRSP.WKY-(<I>D2Rat13-D2Mit5</I>)/Gcrc strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
631279 SHRSP.WKY-(<I>D2Rat13-D2Mit5</I>)/Gcrc strain MP:0012045 increased susceptibility to hypertension sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD
631279 SHRSP.WKY-(<I>D2Rat13-D2Mit5</I>)/Gcrc strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
631280 WKY.SHRSP-(<I>D2Mit5-D2Mgh12</I>)/Gcrc strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD
631280 WKY.SHRSP-(<I>D2Mit5-D2Mgh12</I>)/Gcrc strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 20201027 RGD
631280 WKY.SHRSP-(<I>D2Mit5-D2Mgh12</I>)/Gcrc strain MP:0004216 salt-resistant hypertension IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
631280 WKY.SHRSP-(<I>D2Mit5-D2Mgh12</I>)/Gcrc strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
631280 WKY.SHRSP-(<I>D2Mit5-D2Mgh12</I>)/Gcrc strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
631281 WKY.SHRSP-(<I>Fst-Pklr</I>)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD
631281 WKY.SHRSP-(<I>Fst-Pklr</I>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
631282 DA.F344-(<I>D10Arb20-D10Arb22</I>)/Arb strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD
631282 DA.F344-(<I>D10Arb20-D10Arb22</I>)/Arb strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD
631282 DA.F344-(<I>D10Arb20-D10Arb22</I>)/Arb strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD
631282 DA.F344-(<I>D10Arb20-D10Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD
631282 DA.F344-(<I>D10Arb20-D10Arb22</I>)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD
631283 DA.F344-(<I>D10Arb21-D10Arb22</I>)/Arb strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD
631286 WKY/Izm Wistar-Kyoto strain MP:0004052 decreased renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:61092|PMID:10634822 19990101 RGD compared to male WKY/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0005293 impaired glucose tolerance IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, MMO:0000326
631286 WKY/Izm Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery
631286 WKY/Izm Wistar-Kyoto strain MP:0030769 decreased urine dopamine level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0030771 decreased urine adrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm
631286 WKY/Izm Wistar-Kyoto strain MP:0030773 decreased urine noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0001260 increased body weight IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:619677|PMID:10580437 20180129 RGD compared to F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0002078 abnormal glucose homeostasis IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0002727 decreased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0005293 impaired glucose tolerance IAGP N RGD:1599587|PMID:16951059 20070226 RGD compared to F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20070226 RGD compared to F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe
631294 F344.GK-(<I>D1Arb42a-D1Rat90</I>)/Swe strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe
631332 Tph2 tryptophan hydroxylase 2 gene MP:0002833 increased heart weight IMP N RGD:597830145|PMID:32909922 20250306 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:597830153|PMID:36169206 20250307 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:597830145|PMID:32909922 20250306 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0005333 decreased heart rate IMP N RGD:597830156|PMID:28775068 20250307 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0005630 increased lung weight IMP N RGD:597830145|PMID:32909922 20250306 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0005655 increased aggression IMP N RGD:126925967|PMID:31078489 20250228 RGD
631332 Tph2 tryptophan hydroxylase 2 gene MP:0008770 decreased survivor rate IMP N RGD:597830071|PMID:34228894 20250228 RGD
631338 Rcan1 regulator of calcineurin 1 gene MP:0001625 cardiac hypertrophy IDA N RGD:1581475|PMID:15899894 20061017 RGD
631345 Abcg2 ATP binding cassette subfamily G member 2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD
631375 Egln1 egl-9 family hypoxia-inducible factor 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11251783|PMID:20231529 20160622 RGD DNA:duplication
631494 Bp95 Blood pressure QTL 95 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD
631495 Bp96 Blood pressure QTL 96 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD
631496 Bp97 Blood pressure QTL 97 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD
631497 Bp98 Blood pressure QTL 98 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD
631498 Bp100 Blood pressure QTL 100 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619655|PMID:9171954 19990101 RGD
631499 Stl1 Serum triglyceride level QTL 1 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631500 Bp99 Blood pressure QTL 99 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619650|PMID:7852741 19990101 RGD
631501 Bp101 Blood pressure QTL 101 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631502 Cm26 Cardiac mass QTL 26 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 19990101 RGD
631503 Bp102 Blood pressure QTL 102 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631504 Cm27 Cardiac mass QTL 27 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 19990101 RGD
631504 Cm27 Cardiac mass QTL 27 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 19990101 RGD
631505 Bp103 Blood pressure QTL 103 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631506 Bp104 Blood pressure QTL 104 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631507 Bp105 Blood pressure QTL 105 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:619651|PMID:11403354 19990101 RGD
631507 Bp105 Blood pressure QTL 105 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD
631508 Sald1 Serum aldosterone level QTL 1 qtl MP:0002666 increased circulating aldosterone level QTM N RGD:629577|PMID:12482837 19990101 RGD
631509 Sald2 Serum aldosterone level QTL 2 qtl MP:0002666 increased circulating aldosterone level QTM N RGD:629577|PMID:12482837 19990101 RGD
631510 Spl2 Serum phospholipid level QTL 2 qtl MP:0001548 hyperlipidemia QTM N RGD:629577|PMID:12482837 19990101 RGD
631511 Pia7 Pristane induced arthritis QTL 7 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD
631512 Scl6 Serum cholesterol level QTL 6 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD
631513 Scl7 Serum cholesterol level QTL 7 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD
631514 Scl8 Serum cholesterol level QTL8 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD
631515 Bw10 Body weight QTL 10 qtl MP:0001260 increased body weight IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631516 Gluco31 Glucose level QTL 31 qtl MP:0005559 increased circulating glucose level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631517 Scl9 Serum cholesterol level QTL 9 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD
631518 Bw11 Body weight QTL 11 qtl MP:0001260 increased body weight IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631519 Pia11 Pristane induced arthritis QTL 11 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD
631520 Bp73 Blood pressure QTL 73 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631320|PMID:12661916 19990101 RGD
631520 Bp73 Blood pressure QTL 73 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70380|PMID:11773968 19990101 RGD
631521 Pia12 Pristane induced arthritis QTL 12 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD
631522 Bp74 Blood pressure QTL 74 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70380|PMID:11773968 19990101 RGD
631523 Pia13 Pristane induced arthritis QTL 13 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD
631524 Bp75 Blood pressure QTL 75 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70460|PMID:11919686 19990101 RGD
631525 Pia14 Pristane induced arthritis QTL 14 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD
631526 Bp76 Blood pressure QTL 76 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:619625|PMID:9607182 19990101 RGD
631526 Bp76 Blood pressure QTL 76 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:619626|PMID:9096100 19990101 RGD
631527 Tls1 T-lymphoma susceptibility QTL 1 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD
631528 Scl11 Serum cholesterol level QTL 11 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain
631529 Tls2 T-lymphoma susceptibility QTL 2 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD
631530 Tls3 T-lymphoma susceptibility QTL 3 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD
631531 Iresp2 Immunoglobin response QTL2 qtl MP:0002497 increased IgE level QTM N RGD:619646|PMID:10898507 19990101 RGD
631532 Cm50 Cardiac mass QTL 50 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD
631533 Iresp3 Immunoglobin response QTL3 qtl MP:0002497 increased IgE level QTM N RGD:619646|PMID:10898507 19990101 RGD
631534 Lnnr1 Liver neoplastic nodule remodeling QTL 1 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:629574|PMID:12672032 20111107 RGD
631535 Cm51 Cardiac mass QTL 51 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD
631536 Lnnr2 Liver neoplastic nodule remodeling QTL 2 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:629574|PMID:12672032 20111107 RGD
631537 Oia4 Oil induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD
631538 Oia5 Oil induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD
631539 Oia6 Oil induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD
631540 Bw9 Body weight QTL 9 qtl MP:0001260 increased body weight QTM N RGD:619631|PMID:10051321 19990101 RGD
631541 Bp81 Blood pressure QTL 81 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD
631541 Bp81 Blood pressure QTL 81 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD
631542 Bp82 Blood pressure QTL 82 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD
631542 Bp82 Blood pressure QTL 82 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD
631543 Bp83 Blood pressure QTL 83 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD
631544 Bp84 Blood pressure QTL 84 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619634|PMID:10604486 19990101 RGD
631544 Bp84 Blood pressure QTL 84 qtl MP:0004184 abnormal baroreceptor physiology TAS N RGD:2302408|PMID:19047583 20081217 RGD
631545 Bp85 Blood pressure QTL 85 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD
631546 Bp86 Blood pressure QTL 86 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD
631547 Bp87 Blood pressure QTL 87 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD
631548 Bp88 Blood pressure QTL 88 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD
631549 Bp89 Blood pressure QTL 89 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619635|PMID:10779121 19990101 RGD
631550 Bw7 Body weight QTL 7 qtl MP:0001260 increased body weight QTM N RGD:629577|PMID:12482837 19990101 RGD
631551 Vetf1 Vascular elastic tissue fragility QTL 1 qtl MP:0005340 abnormal susceptibility to atherosclerosis QTM N RGD:619605|PMID:11526202 19990101 RGD
631552 Vetf2 Vascular elastic tissue fragility QTL 2 qtl MP:0005340 abnormal susceptibility to atherosclerosis QTM N RGD:619605|PMID:11526202 19990101 RGD
631554 Bp133 Blood pressure QTL 133 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619633|PMID:7568016 19990101 RGD
631555 Bp134 Blood pressure QTL 134 qtl MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD
631556 Bp135 Blood pressure QTL 135 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631181|PMID:8476428 19990101 RGD
631557 Bp136 Blood pressure QTL 136 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:628510|PMID:11641286 19990101 RGD
631558 Bp137 Blood pressure QTL 137 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:628510|PMID:11641286 19990101 RGD
631559 Hcuc1 Hepatic copper content QTL 1 qtl MP:0003066 increased liver copper level QTM N RGD:619607|PMID:11741328 19990101 RGD
631560 Apr1 Acute phase response QTL 1 qtl MP:0010211 abnormal acute phase protein level IAGP N RGD:629561|PMID:11817600 19990101 RGD
631561 Hcuc2 Hepatic copper content QTL 2 qtl MP:0003066 increased liver copper level QTM N RGD:619607|PMID:11741328 19990101 RGD
631562 Apr2 Acute phase response QTL 2 qtl MP:0010211 abnormal acute phase protein level QTM N RGD:629561|PMID:11817600 19990101 RGD
631563 Hcuc3 Hepatic copper content QTL 3 qtl MP:0003066 increased liver copper level QTM N RGD:629572|PMID:12094018 19990101 RGD
631564 Apr3 Acute phase response QTL 3 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD
631565 Hcuc4 Hepatic copper content QTL 4 qtl MP:0003066 increased liver copper level QTM N RGD:629572|PMID:12094018 19990101 RGD
631566 Bp90 Blood pressure QTL 90 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619640|PMID:9541488 19990101 RGD
631567 Bp91 Blood pressure QTL 91 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619640|PMID:9541488 19990101 RGD
631568 Bp92 Blood pressure QTL 92 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD
631569 Bp93 Blood pressure QTL 93 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD
631570 Bp94 Blood pressure QTL 94 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD
631571 SS.LEW-(<i>D1Uia8-D1Mco38</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
631572 SBH/Ygl Sabra hypertension prone strain MP:0002743 glomerulonephritis IAGP N RGD:629619|PMID:12045297 20200813 RGD compared to SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0002743 glomerulonephritis severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to uninephrectomized SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to SBH/Ygl control
631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:4889613|PMID:20876844 20101209 RGD in males, compared to SBH/Ygl control, salt-loaded SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level severity IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD in females, compared to SBH/Ygl control
631572 SBH/Ygl Sabra hypertension prone strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:629619|PMID:12045297 20101208 RGD in males, compared to SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0005553 increased circulating creatinine level sexual_dimorphism IAGP N RGD:629619|PMID:12045297 20101208 RGD in males, compared to SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0005553 increased circulating creatinine level sexual_dimorphism IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD in males, compared to SBH/Ygl control, uninephrectomized SBN/Ygl
631572 SBH/Ygl Sabra hypertension prone strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:629619|PMID:12045297 20200410 RGD in males, compared to SBH/Ygl control, salt-loaded SBN/Ygl
631573 SBN/Ygl Sabra hypertension resistant strain MP:0002743 glomerulonephritis sexual_dimorphism IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD in males, compared to SBN/Ygl control
631573 SBN/Ygl Sabra hypertension resistant strain MP:0002962 increased urine protein level IAGP N RGD:629619|PMID:12045297 20101208 RGD
631573 SBN/Ygl Sabra hypertension resistant strain MP:0002962 increased urine protein level severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to SBN/Ygl control
631576 LEW/CrlCrlj strain MP:0001260 increased body weight IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm
631576 LEW/CrlCrlj strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm
631576 LEW/CrlCrlj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm
631577 SHR/Izm strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 20200108 RGD compared to LEW/CrlCrlj strain
631577 SHR/Izm strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 19990101 RGD compared to LEW/CrlCrlj strain
631577 SHR/Izm strain MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:40902813|PMID:541053 20080627 RGD compared to WKY
631577 SHR/Izm strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:40902813|PMID:541053 20201210 RGD compared to WKY
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0001260 increased body weight IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0002834 decreased heart weight IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0005289 increased oxygen consumption IAGP N RGD:150429949|PMID:29261326 20211013 RGD compared to SHR/OlaIpcv strain
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain
631578 SHR.BN-(<I>D2Rat171-D2Arb24</I>)/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20240906 RGD compared to SHR/OlaIpcv strain
631579 LEW/OlaHsd strain MP:0001260 increased body weight IAGP N RGD:629577|PMID:12482837 20200408 RGD compared to BC/CpbU
631579 LEW/OlaHsd strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:629577|PMID:12482837 20200408 RGD compared to LEW/OlaHsd females
631579 LEW/OlaHsd strain MP:0003980 increased circulating phospholipid level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 20200408 RGD compared to treated BC/CpbU
631579 LEW/OlaHsd strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to LEW/OlaHds, treated BC/CpbU
631581 LEW.1F strain MP:0001846 increased inflammatory response IAGP N RGD:631225|PMID:12111642 19990101 RGD
631581 LEW.1F strain MP:0002933 joint inflammation induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0002936 joint swelling induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0003201 extremity edema induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0008596 increased circulating interleukin-6 level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0010211 abnormal acute phase protein level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631581 LEW.1F strain MP:0030805 abnormal limb joint morphology induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631585 SS.LEW-(<I>D16Mit2-D16Rat12</I>)/Ayd strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
631586 SS.MNS-(<I>D10Mco14-D10Mit11</I>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 20070607 RGD compared to SS/Jr
631586 SS.MNS-(<I>D10Mco14-D10Mit11</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 19990101 RGD compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr
631587 SS.MNS-(<i>D10M11Mit119-D10Mit11</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
631588 SS.MNS-(<i>D10Mit11-Vamp2</i>)/Mco strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:619625|PMID:9607182 19990101 RGD compared to SS/JrMco
631589 SHR.WKY-(<i>D1Wox34-D1Rat164</i>)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to SHR/NCruk strain
631589 SHR.WKY-(<i>D1Wox34-D1Rat164</i>)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain
631590 SHR.WKY-(<i>D1Wox34-Sah</i>)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain
631590 SHR.WKY-(<i>D1Wox34-Sah</i>)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain
631591 WKY.SHR-(<i>D1Rat56-D1M7Mit206</i>)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200129 RGD compared to WKY/NCruk strain
631591 WKY.SHR-(<i>D1Rat56-D1M7Mit206</i>)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to WKY/NCruk strain
631592 WKY.SHR-(<i>D1Rat236-D1M7Mit206</i>)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200129 RGD compared to WKY/NCruk strain
631592 WKY.SHR-(<i>D1Rat236-D1M7Mit206</i>)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to WKY/NCruk strain
631594 BN/Rj strain MP:0002493 increased IgG level induced IAGP XCO:0000369 N RGD:619646|PMID:10898507 19990101 RGD compared to LEW/Rj
631594 BN/Rj strain MP:0002497 increased IgE level induced IAGP XCO:0000369 N RGD:619646|PMID:10898507 19990101 RGD compared to LEW/Rj
631594 BN/Rj strain MP:0003139 patent ductus arteriosus IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb
631594 BN/Rj strain MP:0003279 aneurysm IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb
631594 BN/Rj strain MP:0003907 decreased aorta elastin content IAGP N RGD:8662443|PMID:17356016 20140624 RGD compared to LOU.MBbb
631594 BN/Rj strain MP:0004194 abnormal kidney pelvis morphology IAGP N RGD:2293631|PMID:18523158 20080616 RGD
631594 BN/Rj strain MP:0009870 abnormal abdominal aorta morphology IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb
631594 BN/Rj strain MP:0010468 abnormal thoracic aorta morphology IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb
631595 LEW.1AV1.DA-(<i>D10Rat92-D10Rat135</i>)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000265 N RGD:61087|PMID:9600974 19990101 RGD compared to LEW.1AV1/Kini
631596 LEW.1AV1.DA-(<i>D10Rat92-D10Wox17</i>)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631596 LEW.1AV1.DA-(<i>D10Rat92-D10Wox17</i>)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1
631596 LEW.1AV1.DA-(<i>D10Rat92-D10Wox17</i>)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631597 LEW.1AV1.DA-(<i>D10Wox17-D10Rat135</i>)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631597 LEW.1AV1.DA-(<i>D10Wox17-D10Rat135</i>)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1
631597 LEW.1AV1.DA-(<i>D10Wox17-D10Rat135</i>)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631598 LEW.1AV1.DA-(<i>D10Got154-D10Rat135</i>)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631598 LEW.1AV1.DA-(<i>D10Got154-D10Rat135</i>)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1
631598 LEW.1AV1.DA-(<i>D10Got154-D10Rat135</i>)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1
631599 SHRSP/Izm strain MP:0000231 hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0001262 decreased body weight induced IAGP XCO:0000010 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0001762 polyuria induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery
631599 SHRSP/Izm strain MP:0002608 increased hematocrit induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200203 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619634|PMID:10604486 19990101 RGD
631599 SHRSP/Izm strain MP:0002871 albuminuria susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP.WKY/Izm congenics
631599 SHRSP/Izm strain MP:0003076 increased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0003076 increased susceptibility to ischemic brain injury severity IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age
631599 SHRSP/Izm strain MP:0003918 decreased kidney weight induced IAGP XCO:0000010 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0004051 increased renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0004484 abnormal response of heart to induced stress induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure severity IAGP N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age
631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0005525 increased renal plasma flow rate induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD
631599 SHRSP/Izm strain MP:0005526 decreased renal plasma flow rate induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0005530 decreased renal vascular resistance IAGP N RGD:2296062|PMID:18565192 20080627 RGD after renal denervation
631599 SHRSP/Izm strain MP:0005531 increased renal vascular resistance induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0006060 increased cerebral infarct size severity IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age
631599 SHRSP/Izm strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm, greater in male, increased with aging
631599 SHRSP/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery.
631599 SHRSP/Izm strain MP:0010109 abnormal renal sodium reabsorption susceptibility IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm and WKY.SHRSP-(D1Wox29-D1Arb21)/Izm
631599 SHRSP/Izm strain MP:0010697 abnormal systemic arterial blood pressure regulation susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0011295 abnormal tubuloglomerular feedback response induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200203 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery
631599 SHRSP/Izm strain MP:0011296 decreased tubuloglomerular feedback response induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm
631599 SHRSP/Izm strain MP:0012045 increased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm, greater in male, increased with aging
631599 SHRSP/Izm strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm
631599 SHRSP/Izm strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery
631599 SHRSP/Izm strain MP:0030768 increased urine dopamine level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
631599 SHRSP/Izm strain MP:0030770 increased urine adrenaline level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
631599 SHRSP/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm
631600 WKY.SHRSP-(<i>Mt1pa-D1Rat200</i>)/Bbb strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb
631600 WKY.SHRSP-(<i>Mt1pa-D1Rat200</i>)/Bbb strain MP:0004216 salt-resistant hypertension IAGP N RGD:619643|PMID:10523340 19990101 RGD
631600 WKY.SHRSP-(<i>Mt1pa-D1Rat200</i>)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb
631600 WKY.SHRSP-(<i>Mt1pa-D1Rat200</i>)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD compared to WKY/Bbb
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:619633|PMID:7568016 20200114 RGD compared to WKY/Bbb
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP XCO:0000022 N RGD:619633|PMID:7568016 20200107 RGD compared to WKY/Bbb
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619633|PMID:7568016 20200114 RGD compared to WKY/Bbb
631601 WKY.SHRSP-(<i>Asgr1-Vamp2</i>)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD compared to WKY/Bbb
631602 BN/Elh strain MP:0003211 abnormal aorta elastic fiber morphology severity IAGP N RGD:619605|PMID:11526202 20191125 RGD
631602 BN/Elh strain MP:0020099 increased susceptibility to diet-induced aortic fatty streak lesions IAGP N RGD:619605|PMID:11526202 20191125 RGD
631604 SHR/Snk strain MP:0002833 increased heart weight IAGP N RGD:1599588|PMID:17261463 20200120 RGD compared to F344/Snk control strain
631604 SHR/Snk strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631181|PMID:8476428 19990101 RGD
631604 SHR/Snk strain MP:0004866 increased platelet calcium level IAGP XCO:0000317,XCO:0000177|XCO:0000178 N RGD:1599588|PMID:17261463 20200129 RGD also with thrombin alone; compared to F344/Snk control strain
631604 SHR/Snk strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1599588|PMID:17261463 20200120 RGD compared to F344/Snk control strain
631604 SHR/Snk strain MP:0009586 increased platelet aggregation IAGP XCO:0000317 N RGD:1599588|PMID:17261463 20200129 RGD compared to F344/Snk control strain
631605 SS.LEW-(<i>D10Arb9-D10Got101</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr
631605 SS.LEW-(<i>D10Arb9-D10Got101</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 19990101 RGD compared to SS/Jr
631606 SS.MNS-(<i>D10Rat13-D10Mit11</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr
631606 SS.MNS-(<i>D10Rat13-D10Mit11</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr
631607 SS.WKY-(<i>D2N35-Mme</i>)/Mco strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
631607 SS.WKY-(<i>D2N35-Mme</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr
631642 Stl2 Serum triglyceride level QTL 2 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619667|PMID:9633608 19990101 RGD
631643 Bp120 Blood pressure QTL 120 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631645 Bp121 Blood pressure QTL 121 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631646 Stl4 Serum triglyceride level QTL 4 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD
631646 Stl4 Serum triglyceride level QTL 4 qtl MP:0002079 increased circulating insulin level QTM N RGD:631174|PMID:12687333 19990101 RGD
631647 Bp122 Blood pressure QTL 122 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631648 Stl5 Serum triglyceride level QTL 5 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD
631649 Bp123 Blood pressure QTL 123 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631650 Stl6 Serum triglyceride level QTL 6 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD
631651 Bp124 Blood pressure QTL 124 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631652 Bp106 Blood pressure QTL 106 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629620|PMID:12566390 19990101 RGD
631653 Bp125 Blood pressure QTL 125 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631654 Bp107 Blood pressure QTL 107 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629620|PMID:12566390 19990101 RGD
631655 Bp126 Blood pressure QTL 126 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631656 Bp108 Blood pressure QTL 108 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629621|PMID:12775577 19990101 RGD
631658 Cm7 Cardiac mass QTL 7 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD
631660 Hcar1 Hepatocarcinoma resistance QTL 1 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD
631662 Hcar2 Hepatocarcinoma resistance QTL 2 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD
631663 Bw6 Body weight QTL 6 qtl MP:0001260 increased body weight QTM N RGD:629577|PMID:12482837 19990101 RGD
631664 Hcar3 Hepatocarcinoma resistance QTL 3 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD
631665 Bw8 Body weight QTL 8 qtl MP:0001260 increased body weight IAGP N RGD:619631|PMID:10051321 19990101 RGD
631666 Iddm5 Insulin dependent diabetes mellitus QTL 5 qtl MP:0005559 increased circulating glucose level IDA N RGD:625443|PMID:8586150 19990101 RGD
631667 Iddm6 Insulin dependent diabetes mellitus QTL 6 qtl MP:0005559 increased circulating glucose level IDA N RGD:625443|PMID:8586150 19990101 RGD
631668 Iddm7 Insulin dependent diabetes mellitus QTL 7 qtl MP:0005559 increased circulating glucose level IAGP N RGD:631165|PMID:9080298 19990101 RGD
631669 Iddm9 Insulin dependent diabetes mellitus QTL 9 qtl MP:0005559 increased circulating glucose level IAGP N RGD:6903877|PMID:9858659 19990101 RGD
631670 Iddm10 Insulin dependent diabetes mellitus QTL 10 qtl MP:0005559 increased circulating glucose level QTM N RGD:6903877|PMID:9858659 19990101 RGD
631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0001869 pancreas inflammation QTM N RGD:61480|PMID:9892222 19990101 RGD
631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0004031 insulitis IDA N RGD:61480|PMID:9892222 20120918 RGD
631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD
631672 Iddm12 Insulin dependent diabetes mellitus QTL 12 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD
631673 Iddm13 Insulin dependent diabetes mellitus QTL 13 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD
631674 Iddm14 Insulin dependent diabetes mellitus QTL 14 qtl MP:0005559 increased circulating glucose level QTM N RGD:61479|PMID:10535446 19990101 RGD
631675 Iddm15 Insulin dependent diabetes mellitus QTL 15 qtl MP:0003870 decreased urine glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD
631675 Iddm15 Insulin dependent diabetes mellitus QTL 15 qtl MP:0005560 decreased circulating glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD
631676 Cm8 Cardiac mass QTL 8 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD
631678 Cm9 Cardiac mass QTL 9 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD
631679 Cm10 Cardiac mass QTL 10 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD
631680 Cm11 Cardiac mass QTL 11 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD
631681 Cm12 Cardiac mass QTL 12 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD
631682 Bp115 Blood pressure QTL 115 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629622|PMID:12473864 19990101 RGD
631683 Bp116 Blood pressure QTL 116 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629622|PMID:12473864 19990101 RGD
631684 Bp117 Blood pressure QTL 117 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631685 Bp118 Blood pressure QTL 118 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631686 Bp119 Blood pressure QTL 119 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD
631687 Hcas1 Hepatocarcinoma susceptibility QTL 1 qtl MP:0003331 increased hepatocellular carcinoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD
631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 qtl MP:0003331 increased hepatocellular carcinoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD
631689 Scl4 Serum cholesterol level QTL 4 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619667|PMID:9633608 19990101 RGD
631690 Scl5 Serum cholesterol level QTL 5 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619667|PMID:9633608 19990101 RGD
631694 WKY.SHRSP-(<I>D1Rat200-D1Rat216</I>)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015
631695 SS/JrRkb strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629621|PMID:12775577 19990101 RGD compared to SHR/FubRkb on 4% NaCl diet
631695 SS/JrRkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:629621|PMID:12775577 19990101 RGD compared to SHR/FubRkb on 4% NaCl diet
631695 SS/JrRkb strain MP:0005608 cardiac interstitial fibrosis IAGP N RGD:629621|PMID:12775577 20201117 RGD on 4% NaCl diet
631695 SS/JrRkb strain MP:0011749 perivascular fibrosis IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS-Chr 19SHR/Rkb
631695 SS/JrRkb strain MP:0031200 increased aortic weight IAGP N RGD:629621|PMID:12775577 20201117 RGD compared to SHR/FubRkb on 4% NaCl diet
631696 SHR/FubRkb strain MP:0000231 hypertension IAGP N RGD:25314252|PMID:23868088 20210311 RGD compared to MWF and WKY
631696 SHR/FubRkb strain MP:0002833 increased heart weight IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female MWF/FubRkb, female MWF-Chr 6SHR/Rkb
631696 SHR/FubRkb strain MP:0005554 decreased circulating creatinine level IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female MWF/FubRkb, female MWF-Chr 6SHR/Rkb
631696 SHR/FubRkb strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to female MWF/Rkb
631696 SHR/FubRkb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1642911|PMID:17953514 20080311 RGD compared to MWF/FubRkb, females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb
631696 SHR/FubRkb strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to male SHR/FubRkb
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0000221 decreased leukocyte cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism
631700 BB.SHR-(<i>Gnal-D18Mit9</i>)/K strain MP:0005559 increased circulating glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD
631703 SS.LEW-(<i>D10Rat207-D10Mgh1</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:69734|PMID:11471055 19990101 RGD
631827 Alc4 Alcohol consumption QTL 4 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD
631828 Alc5 Alcohol consumption QTL 5 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD
631829 Alc6 Alcohol consumption QTL 6 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD
631830 Alc7 Alcohol consumption QTL 7 qtl MP:0001987 alcohol preference QTM N RGD:724636|PMID:12960747 19990101 RGD
631831 Alc8 Alcohol consumption QTL 8 qtl MP:0001987 alcohol preference QTM N RGD:631229|PMID:11958543 19990101 RGD
631832 Sach1 Saccharin preference QTL 1 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD
631832 Sach1 Saccharin preference QTL 1 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD
631833 Sach2 Saccharin preference QTL 2 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD
631833 Sach2 Saccharin preference QTL 2 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD
631834 Sach3 Saccharin preference QTL 3 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD
631834 Sach3 Saccharin preference QTL 3 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD
631835 Scl67 Serum cholesterol level QTL 67 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619669|PMID:11071303 19990101 RGD
631835 Scl67 Serum cholesterol level QTL 67 qtl MP:0010024 increased total body fat amount IDA N RGD:619669|PMID:11071303 20111107 RGD
631836 Stl31 Serum triglyceride level QTL 31 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619669|PMID:11071303 19990101 RGD
631837 Niddm35 Non-insulin dependent diabetes mellitus QTL 35 qtl MP:0003059 decreased insulin secretion QTM N RGD:619688|PMID:11723056 19990101 RGD
631838 Niddm36 Non-insulin dependent diabetes mellitus QTL 36 qtl MP:0003059 decreased insulin secretion QTM N RGD:619688|PMID:11723056 19990101 RGD
631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD
631840 Niddm38 Non-insulin dependent diabetes mellitus QTL 38 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD
631841 Niddm39 Non-insulin dependent diabetes mellitus QTL 39 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD
631842 Inf1 Infertility severity QTL 1 qtl MP:0001157 small seminal vesicle IAGP N RGD:631224|PMID:10615258 19990101 RGD
631842 Inf1 Infertility severity QTL 1 qtl MP:0001922 reduced male fertility IAGP N RGD:631224|PMID:10615258 19990101 RGD
631842 Inf1 Infertility severity QTL 1 qtl MP:0001935 decreased litter size IAGP N RGD:631224|PMID:10615258 19990101 RGD
631843 Bw116 Body weight QTL 116 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
631843 Bw116 Body weight QTL 116 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619669|PMID:11071303 19990101 RGD
631844 Iusm:HAD1 high-alcohol-drinking strain MP:0001262 decreased body weight onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months; compared to Iusm:LAD1
631844 Iusm:HAD1 high-alcohol-drinking strain MP:0002764 short tibia onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1
631844 Iusm:HAD1 high-alcohol-drinking strain MP:0003109 short femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1
631844 Iusm:HAD1 high-alcohol-drinking strain MP:0004351 short humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1
631844 Iusm:HAD1 high-alcohol-drinking strain MP:0004359 short ulna onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1
631847 F344.GK-(<i>D1Mit7-D1Mgh25</i>)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl rats
631847 F344.GK-(<i>D1Mit7-D1Mgh25</i>)/Swe strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl
631847 F344.GK-(<i>D1Mit7-D1Mgh25</i>)/Swe strain MP:0030017 decreased adipocyte glucose uptake induced IAGP XCO:0000245 N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl rats
631848 SHR/OlaIpcv strain MP:0001552 increased circulating triglyceride level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0002079 increased circulating insulin level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to PD/Cub, BN/Cub
631848 SHR/OlaIpcv strain MP:0002981 increased liver weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0003917 increased kidney weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0005559 increased circulating glucose level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
631848 SHR/OlaIpcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD
631848 SHR/OlaIpcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD
631848 SHR/OlaIpcv strain MP:0010955 abnormal respiratory electron transport chain IAGP N RGD:150429949|PMID:29261326 20211013 RGD compared to SHR-2
634305 Mamtr1 Mammary tumor resistance QTL 1 qtl MP:0010269 decreased mammary gland tumor incidence IAGP N RGD:631852|PMID:12844486 20111107 RGD
634306 Bp140 Blood pressure QTL 140 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631322|PMID:11924719 19990101 RGD
634307 Bp141 Blood pressure QTL 141 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631324|PMID:10523818 19990101 RGD
634308 Sach6 Saccharin preference QTL 6 qtl MP:0002805 abnormal conditioned taste aversion behavior QTM N RGD:631221|PMID:11958542 19990101 RGD
634310 Bp142 Blood pressure QTL 142 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631324|PMID:10523818 19990101 RGD
634311 Sach7 Saccharin preference QTL 7 qtl MP:0002805 abnormal conditioned taste aversion behavior QTM N RGD:631221|PMID:11958542 19990101 RGD
634312 Bp143 Blood pressure QTL 143 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631325|PMID:11984003 19990101 RGD
634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 qtl MP:0002727 decreased circulating insulin level QTM N RGD:619688|PMID:11723056 19990101 RGD
634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619688|PMID:11723056 19990101 RGD
634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 qtl MP:0002727 decreased circulating insulin level QTM N RGD:619688|PMID:11723056 19990101 RGD
634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619688|PMID:11723056 19990101 RGD
634315 Niddm45 Non-insulin dependent diabetes mellitus QTL 45 qtl MP:0005457 abnormal percent body fat/body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
634315 Niddm45 Non-insulin dependent diabetes mellitus QTL 45 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD
634317 Bw117 Body weight QTL 117 qtl MP:0010024 increased total body fat amount IDA N RGD:619678|PMID:10373320 20111107 RGD
634318 Bw118 Body weight QTL 118 qtl MP:0001262 decreased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
634318 Bw118 Body weight QTL 118 qtl MP:0005560 decreased circulating glucose level IAGP N RGD:619678|PMID:10373320 19990101 RGD
634318 Bw118 Body weight QTL 118 qtl MP:0010025 decreased total body fat amount IDA N RGD:619678|PMID:10373320 20111104 RGD
634319 Bw119 Body weight QTL 119 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619678|PMID:10373320 19990101 RGD
634319 Bw119 Body weight QTL 119 qtl MP:0010025 decreased total body fat amount IDA N RGD:619678|PMID:10373320 20111104 RGD
634320 Niddm49 Non-insulin dependent diabetes mellitus QTL 49 qtl MP:0005560 decreased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD
634321 Hc1 Hypercalciuria QTL 1 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD
634322 Bw12 Body weight QTL 12 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD
634323 Hc2 Hypercalciuria QTL 2 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD
634325 Bw13 Body weight QTL 13 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD
634325 Bw13 Body weight QTL 13 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD
634325 Bw13 Body weight QTL 13 qtl MP:0002079 increased circulating insulin level QTM N RGD:619682|PMID:11414764 19990101 RGD
634326 Hc3 Hypercalciuria QTL 3 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD
634327 Hc4 Hypercalciuria QTL 4 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD
634328 Hc5 Hypercalciuria QTL 5 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD
634329 Pia15 Pristane induced arthritis QTL 15 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD
634330 Pia16 Pristane induced arthritis QTL 16 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD
634331 Pia17 Pristane induced arthritis QTL 17 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD
634332 Pia18 Pristane induced arthritis QTL 18 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD
634333 Pia19 Pristane induced arthritis QTL 19 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD
634334 Xhs3 X-ray hypersensitivity QTL 3 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:631318|PMID:11381618 19990101 RGD
634335 Anxrr16 Anxiety related response QTL 16 qtl MP:0001363 increased anxiety-related response IAGP N RGD:631324|PMID:10523818 19990101 RGD
634336 Anxrr17 Anxiety related response QTL 17 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:631324|PMID:10523818 19990101 RGD
634338 Hcar4 Hepatocarcinoma resistance QTL 4 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD
634339 Niddm50 Non-insulin dependent diabetes mellitus QTL 50 qtl MP:0005457 abnormal percent body fat/body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
634339 Niddm50 Non-insulin dependent diabetes mellitus QTL 50 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD
634340 Hcar5 Hepatocarcinoma resistance QTL 5 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD
634341 Bw121 Body weight QTL 121 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
634341 Bw121 Body weight QTL 121 qtl MP:0010024 increased total body fat amount IDA N RGD:619678|PMID:10373320 20111107 RGD
634342 Cia24 Collagen induced arthritis QTL 24 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD
634343 Hcar6 Hepatocarcinoma resistance QTL 6 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD
634344 Hcar7 Hepatocarcinoma resistance QTL 7 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD
634346 Insul4 Insulin level QTL 4 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD
634346 Insul4 Insulin level QTL 4 qtl MP:0002079 increased circulating insulin level QTM N RGD:619682|PMID:11414764 19990101 RGD
634346 Insul4 Insulin level QTL 4 qtl MP:0002833 increased heart weight QTM N RGD:619682|PMID:11414764 19990101 RGD
634347 Hcar8 Hepatocarcinoma resistance QTL 8 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD
634348 Bp138 Blood pressure QTL 138 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631321|PMID:12358148 19990101 RGD
634349 Bp139 Blood pressure QTL 139 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631851|PMID:12790759 19990101 RGD
634350 Apr4 Acute phase response QTL 4 qtl MP:0010211 abnormal acute phase protein level QTM N RGD:629561|PMID:11817600 19990101 RGD
634351 Apr5 Acute phase response QTL 5 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD
634352 Apr6 Acute phase response QTL 6 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD
634353 Rends2 Renal damage susceptibility QTL 2 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD
634354 Rends3 Renal damage susceptibility QTL 3 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD
634355 Rends4 Renal damage susceptibility QTL 4 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD
634359 WF.WKY-(<i>D5Pas1-D5Uwm37</i>)/Uwm strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF/NHsd
634359 WF.WKY-(<i>D5Pas1-D5Uwm37</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF/NHsd
634363 LEW/NIcoCrlf strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20070119 RGD
634363 LEW/NIcoCrlf strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598975|PMID:17052845 20200511 RGD females compared to males
634363 LEW/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20200511 RGD
634363 LEW/NIcoCrlf strain MP:0003546 decreased alcohol consumption IAGP N RGD:1598390|PMID:16923148 20061121 RGD
634363 LEW/NIcoCrlf strain MP:0012347 low sweet preference IAGP N RGD:1598390|PMID:16923148 20061121 RGD compared to SHR/NIcoCrlf strain
634364 SHR/NIcoCrlf strain MP:0001364 decreased anxiety-related response IAGP N RGD:1598390|PMID:16923148 20061121 RGD compared to LEW/NlcoCrlf strain
634364 SHR/NIcoCrlf strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:1598390|PMID:16923148 20200508 RGD females compared to LEW/NIcoCrlf females
634364 SHR/NIcoCrlf strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to LEW/NIcoCrlf strain
634364 SHR/NIcoCrlf strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20070119 RGD
634364 SHR/NIcoCrlf strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598975|PMID:17052845 20200511 RGD females compared to males
634364 SHR/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold IAGP N RGD:1598975|PMID:17052845 20200511 RGD compared to LEW/NIcoCrlf strain
634364 SHR/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20200511 RGD
634364 SHR/NIcoCrlf strain MP:0001987 alcohol preference IAGP N RGD:1598390|PMID:16923148 20200508 RGD compared to LEW/NlcoCrlf strain at lower alcohol concentrations
634364 SHR/NIcoCrlf strain MP:0001987 alcohol preference sexual_dimorphism IAGP N RGD:1598390|PMID:16923148 20061121 RGD females compared to LEW/NlcoCrlf females at higher alcohol concentrations
634364 SHR/NIcoCrlf strain MP:0002065 abnormal fear/anxiety-related behavior IAGP N RGD:631324|PMID:10523818 19990101 RGD compared to LEW/NIcoCrlf strain
634364 SHR/NIcoCrlf strain MP:0002065 abnormal fear/anxiety-related behavior sexual_dimorphism IAGP N RGD:631324|PMID:10523818 19990101 RGD compared to males
634364 SHR/NIcoCrlf strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to females
634364 SHR/NIcoCrlf strain MP:0020870 decreased thigmotaxis IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to LEW/NIcoCrlf strain
634365 SS/Hsd strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd
634365 SS/Hsd strain MP:0001261 obese IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd
634365 SS/Hsd strain MP:0001552 increased circulating triglyceride level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd
634365 SS/Hsd strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd
634365 SS/Hsd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to BN/Crl
634365 SS/Hsd strain MP:0011640 abnormal aorta collagen fibril morphology IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS-Chr 2BN/Mcwi, BN/Crl
634366 SR/Hsd strain MP:0010182 decreased susceptibility to weight gain IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SS/Hsd
634370 F344.GK-(<i>D1Mgh10-D1Rat119</i>)/Swe strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:619677|PMID:10580437 20180129 RGD compared to F344/DuCrlSwe
634372 GHS strain MP:0003639 abnormal response to vitamins IAGP N RGD:13432078|PMID:9593778 20170918 RGD
634373 DA/ZtmRhd strain MP:0002933 joint inflammation induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0002936 joint swelling induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:2302026|PMID:14674011 20081117 RGD compared to E3/ZtmRhd
634373 DA/ZtmRhd strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0004622 sacral vertebral fusion induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0008596 increased circulating interleukin-6 level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0010211 abnormal acute phase protein level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634373 DA/ZtmRhd strain MP:0030805 abnormal limb joint morphology induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3
634374 E3/ZtmRhd strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:2302026|PMID:14674011 20081117 RGD compared to DA/ZtmRhd
634376 LEA/Ncu strain MP:0003992 increased mortality induced by ionizing radiation IAGP N RGD:631318|PMID:11381618 19990101 RGD compared to BN/Sea
634377 BN/Sea BN/Sea strain MP:0003010 decreased mortality induced by ionizing radiation IAGP N RGD:69702|PMID:11003700 20201029 RGD compared to LEC/Ncu
634380 iP/Iusm inbred alcohol-preferring strain MP:0001987 alcohol preference IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N
634380 iP/Iusm inbred alcohol-preferring strain MP:0003545 increased alcohol consumption IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N
634382 SHR.BN-(<i>D5Wox12-D5Wox20</i>)/Ipcv strain MP:0001260 increased body weight IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain
634382 SHR.BN-(<i>D5Wox12-D5Wox20</i>)/Ipcv strain MP:0003918 decreased kidney weight IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain
634382 SHR.BN-(<i>D5Wox12-D5Wox20</i>)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain
6478680 Anxrr29 Anxiety related response QTL 29 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478684 Anxrr30 Anxiety related response QTL 30 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478686 Anxrr31 Anxiety related response QTL 31 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478693 Anxrr32 Anxiety related response QTL 32 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478700 Anxrr33 Anxiety related response QTL 33 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478718 Anxrr34 Anxiety related response QTL 34 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478720 Alc23 Alcohol consumption QTL 23 qtl MP:0003545 increased alcohol consumption IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478724 Anxrr35 Anxiety related response QTL 35 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478728 Anxrr36 Anxiety related response QTL 36 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478733 Anxrr37 Anxiety related response QTL 37 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478737 Anxrr38 Anxiety related response QTL 38 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478740 Anxrr39 Anxiety related response QTL 39 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478743 Anxrr40 Anxiety related response QTL 40 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478745 Anxrr41 Anxiety related response QTL 41 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478748 Anxrr42 Anxiety related response QTL 42 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478754 Anxrr43 Anxiety related response QTL 43 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478757 Anxrr44 Anxiety related response QTL 44 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478760 Anxrr45 Anxiety related response QTL 45 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478763 Anxrr46 Anxiety related response QTL 46 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478766 Anxrr47 Anxiety related response QTL 47 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478769 Anxrr48 Anxiety related response QTL 48 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478772 Anxrr49 Anxiety related response QTL 49 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478775 Anxrr50 Anxiety related response QTL 50 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478778 Anxrr51 Anxiety related response QTL 51 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478782 Anxrr52 Anxiety related response QTL 52 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478785 Anxrr53 Anxiety related response QTL 53 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD
6478788 STOCK-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc p53 knockout rat strain MP:0002036 increased rhabdomyosarcoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD
6478788 STOCK-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc p53 knockout rat strain MP:0003667 increased hemangiosarcoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD
6478788 STOCK-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc p53 knockout rat strain MP:0004499 increased incidence of tumors by chemical induction IAGP N RGD:12792958|PMID:22791818 20170316 RGD
6478788 STOCK-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc p53 knockout rat strain MP:0010273 increased classified tumor incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD
6478788 STOCK-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc p53 knockout rat strain MP:0012431 increased lymphoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD
6480190 NAft:HS Heterogeneous stock strain MP:0001260 increased body weight IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of ACI/N, BN/SsNHsd, F344/NHsd
6480190 NAft:HS Heterogeneous stock strain MP:0001363 increased anxiety-related response IAGP N RGD:6480191|PMID:19447285 20120314 RGD compared to RHA/N-di
6480190 NAft:HS Heterogeneous stock strain MP:0001364 decreased anxiety-related response sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20120315 RGD compared to males
6480190 NAft:HS Heterogeneous stock strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20201216 RGD compared to males
6480190 NAft:HS Heterogeneous stock strain MP:0003460 decreased fear-related response sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20120315 RGD compared to males
6480190 NAft:HS Heterogeneous stock strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, WKY/NHsd
6480190 NAft:HS Heterogeneous stock strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female BUF/NHsd
6480190 NAft:HS Heterogeneous stock strain MP:0012293 impaired active avoidance behavior IAGP N RGD:6480191|PMID:19447285 20120314 RGD compared to RHA/N-di
6480190 NAft:HS Heterogeneous stock strain MP:0013618 decreased areal bone mineral density IAGP N RGD:6480192|PMID:21334473 20200414 RGD female
6480190 NAft:HS Heterogeneous stock strain MP:0030788 abnormal femur head morphology IAGP N RGD:6480192|PMID:21334473 20120314 RGD compared to female WKY/NHsd
6480190 NAft:HS Heterogeneous stock strain MP:0030789 abnormal femur neck morphology IAGP N RGD:6480192|PMID:21334473 20200414 RGD narrower femur neck width
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0002871 albuminuria induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0002871 albuminuria induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb, treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb
6480210 SHR-Chr 8<sup>MWF</sup>/Rkb strain MP:0011405 tubulointerstitial nephritis induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200427 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb, treated SHR/FubRkb
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20171206 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD
6480218 AR-<i>Ednrb<sup>sl</i></sup>/Hkv Aganglionosis rat strain MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD
6480220 LEH/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480220 LEH/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480220 LEH/Hkv Aganglionosis rat strain MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480223 F344.AR-<i>Ednrb<sup>sl</sup></i>/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon penetrance IAGP N RGD:6480215|PMID:22132166 20120315 RGD
6480223 F344.AR-<i>Ednrb<sup>sl</sup></i>/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480223 F344.AR-<i>Ednrb<sup>sl</sup></i>/Hkv Aganglionosis rat strain MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20120315 RGD
6480225 Gdil1 Gastrointestinal dilation QTL 1 qtl MP:0002926 aganglionic megacolon IDA N RGD:6480217|PMID:21915282 20120316 RGD
6480773 Gluco64 Glucose level QTL 64 qtl MP:0005293 impaired glucose tolerance IDA N RGD:6893578|PMID:22947656 20131022 RGD
6480777 Insul17 Insulin level QTL 17 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD
6480780 Insul18 Insulin level QTL 18 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD
6480783 Insul19 Insulin level QTL 19 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD
6480866 BN-Chr 13<sup>LH</sup>/MavRrrc strain MP:0005527 increased renal glomerular filtration rate induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
6480866 BN-Chr 13<sup>LH</sup>/MavRrrc strain MP:0006316 increased urine sodium level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
6480866 BN-Chr 13<sup>LH</sup>/MavRrrc strain MP:0006316 increased urine sodium level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi
6482243 WI-<i>Cit<sup>fhJjlo</sup></i>/Rrrc flathead rat strain MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD
6482243 WI-<i>Cit<sup>fhJjlo</sup></i>/Rrrc flathead rat strain MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD
6482243 WI-<i>Cit<sup>fhJjlo</sup></i>/Rrrc flathead rat strain MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20170721 RGD
6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0001661 extended life span IMP N RGD:2292511|PMID:9739044 20201104 RGD
6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd
6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0005166 decreased susceptibility to injury induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd
6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd
6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd
6482247 FDIO/Rrrc strain MP:0001260 increased body weight susceptibility IAGP N RGD:6482246|PMID:12855420 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0002079 increased circulating insulin level IAGP XCO:0000015,XCO:0000025 N RGD:24922212|PMID:15879056 20200330 RGD compared to standard diet fed rats and F344 control strain
6482247 FDIO/Rrrc strain MP:0002079 increased circulating insulin level susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats
6482247 FDIO/Rrrc strain MP:0002981 increased liver weight susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats
6482247 FDIO/Rrrc strain MP:0003926 decreased cellular glucose uptake susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0005291 abnormal glucose tolerance susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0005291 abnormal glucose tolerance susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats
6482247 FDIO/Rrrc strain MP:0005331 insulin resistance susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0005455 increased susceptibility to weight gain IAGP N RGD:6482246|PMID:12855420 20120420 RGD diet, sexual dimorphism
6482247 FDIO/Rrrc strain MP:0005669 increased circulating leptin level IAGP XCO:0000015,XCO:0000025 N RGD:24922212|PMID:15879056 20200330 RGD compared to standard diet fed rats
6482247 FDIO/Rrrc strain MP:0005669 increased circulating leptin level susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats
6482247 FDIO/Rrrc strain MP:0008908 increased total fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0009288 increased epididymal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0009292 increased inguinal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0009298 increased mesenteric fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0009304 increased retroperitoneal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0011939 increased food intake susceptibility IAGP N RGD:6482246|PMID:12855420 20200330 RGD compared to F344
6482247 FDIO/Rrrc strain MP:0014142 increased body fat mass susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats
6482247 FDIO/Rrrc strain MP:0020102 increased hepatic glucose production susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344
6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD
6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0005528 decreased renal glomerular filtration rate treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD
6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD
6482674 HIS/NdkRrrc High-Saccharin-Consuming (HiS) Rat strain MP:0001988 cocaine preference induced IAGP XCO:0000367, XCO:0000163 N RGD:6482649|PMID:16596398 20120425 RGD compared to LOS/NdkRrrc
6482674 HIS/NdkRrrc High-Saccharin-Consuming (HiS) Rat strain MP:0002850 saccharin preference induced IAGP XCO:0000298, XCO:0000483, XCO:0000367 N RGD:6482648|PMID:8976546 20120425 RGD compared to HIS/NdkRrrc
6482676 LOS/NdkRrrc Low-Saccharin-Consuming (HiS) Rat strain MP:0002849 abnormal saccharin consumption induced IAGP XCO:0000298, XCO:0000483, XCO:0000367 N RGD:6482648|PMID:8976546 20120425 RGD compared to HIS/NdkRrrc
6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010269 decreased mammary gland tumor incidence induced IMP XCO:0000201 N RGD:6482679|PMID:12150826 20200310 RGD in males
6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010299 increased mammary gland tumor incidence induced IMP XCO:0000094,CHEBI:16330 N RGD:6482679|PMID:12150826 20200310 RGD in females
6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010299 increased mammary gland tumor incidence sexual_dimorphism IMP N RGD:6482679|PMID:12150826 20200310 RGD compared to females
6484581 SS-<i>Resp18<sup>em2Mcwi</sup></i> strain MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD
6484581 SS-<i>Resp18<sup>em2Mcwi</sup></i> strain MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD
6484582 SS-<i>Cd247<sup>em1Mcwi</sup></i> strain MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD
6484583 SS-<i>Nr2f2<sup>em1Mcwi</sup></i> strain MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
6484583 SS-<i>Nr2f2<sup>em1Mcwi</sup></i> strain MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD compared to SS/JrHsdMcwi
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20200702 RGD compared to SS/JrHsdMcwi
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005331 insulin resistance IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20170707 RGD
6484701 Lepr<sup>em2Mcwi</sup> leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484715 SS-<i>Adora2b<sup>em2Mcwi</sup></i> strain MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20191216 RGD
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20191216 RGD
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20170707 RGD
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20200702 RGD
6484719 SS-<i>Lepr<sup>em2Mcwi</sup></i> strain MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi
67935 WOKW strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0000188 abnormal circulating glucose level IAGP N RGD:1357168|PMID:11374884 20191216 RGD compared to DA/K
67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:1624313|PMID:17473932 20200316 RGD compared to DA/K
67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0002079 increased circulating insulin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0002079 increased circulating insulin level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0002962 increased urine protein level IAGP N RGD:1624313|PMID:17473932 20200316 RGD compared to DA/K
67935 WOKW strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0005293 impaired glucose tolerance IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0005293 impaired glucose tolerance IAGP N RGD:619689|PMID:10720472 19990101 RGD compared to DA/K
67935 WOKW strain MP:0005559 increased circulating glucose level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
67935 WOKW strain MP:0005669 increased circulating leptin level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K
67935 WOKW strain MP:0006087 increased body mass index IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0000275 heart hyperplasia IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0001560 abnormal circulating insulin level IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0001759 increased urine glucose level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1354689|PMID:14643580 19990101 RGD compared to WKY and CD
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002962 increased urine protein level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0003674 oxidative stress IAGP N RGD:1354689|PMID:14643580 19990101 RGD compared to WKY, SHR, and CD strains
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005293 impaired glucose tolerance severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005328 abnormal circulating creatinine level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005558 decreased creatinine clearance severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005559 increased circulating glucose level IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0009644 uremia severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0010951 abnormal lipid oxidation IAGP N RGD:1354689|PMID:14643580 20200129 RGD compared to WKY, SHR, and CD strains
68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0010953 abnormal fatty acid oxidation IAGP N RGD:1354689|PMID:14643580 20200129 RGD compared to WKY, SHR, and CD strains
68036 FH strain MP:0004725 decreased platelet serotonin level IAGP N RGD:724730|PMID:1169825 20111109 RGD
68036 FH strain MP:0005178 increased circulating cholesterol level IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W
68036 FH strain MP:0005560 decreased circulating glucose level IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W
68036 FH strain MP:0012359 increased partial thromboplastin time IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W
68036 FH strain MP:0012619 increased circulating factor X level IAGP N RGD:724730|PMID:1169825 20210111 RGD compared to W
68036 FH strain MP:0020985 increased circulating factor XI level IAGP N RGD:724730|PMID:1169825 20210121 RGD compared to W
68047 HMT strain MP:0001661 extended life span sexual_dimorphism IAGP N RGD:724737|PMID:7370169 20200810 RGD compared to male
68047 HMT strain MP:0002038 increased carcinoma incidence IAGP N RGD:724737|PMID:7370169 20111114 RGD
68073 LETL strain MP:0001426 polydipsia IAGP N RGD:724731|PMID:1682194 19990101 RGD
68073 LETL strain MP:0001759 increased urine glucose level IAGP N RGD:724731|PMID:1682194 19990101 RGD
68073 LETL strain MP:0001762 polyuria IAGP N RGD:724731|PMID:1682194 20201222 RGD
68073 LETL strain MP:0005559 increased circulating glucose level IAGP N RGD:724731|PMID:1682194 19990101 RGD
68079 LOU strain MP:0001262 decreased body weight IAGP N RGD:1342467|PMID:15471977 19990101 RGD
68099 MWF strain MP:0000231 hypertension treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY and untreated
68099 MWF strain MP:0002847 abnormal renal glomerular filtration rate ameliorates IAGP XCO:0000677 N RGD:25314266|PMID:25680709 20210708 RGD compared to untreated
68099 MWF strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY and untreated
68099 MWF strain MP:0005325 abnormal renal glomerulus morphology onset IAGP N RGD:25314266|PMID:25680709 20210708 RGD
68099 MWF strain MP:0011753 decreased podocyte number treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY, MWF 40 weeks and untreated
68104 NIG-III/Hok strain MP:0005172 decreased eye pigmentation IAGP N RGD:1579834|PMID:16245028 20210224 RGD
68114 OXYS/Nov strain MP:0000921 demyelination IAGP N RGD:13503332|PMID:24047616 20180111 RGD
68114 OXYS/Nov strain MP:0003329 amyloid beta deposits IAGP N RGD:13503332|PMID:24047616 20180111 RGD
68114 OXYS/Nov strain MP:0005548 retina pigment epithelium atrophy IAGP N RGD:13503349|PMID:22683466 20180115 RGD
68114 OXYS/Nov strain MP:0008535 enlarged lateral ventricles IAGP N RGD:13503332|PMID:24047616 20180111 RGD
68114 OXYS/Nov strain MP:0020038 retina macular degeneration sexual_dimorphism IAGP N RGD:7794750|PMID:22300709 20200416 RGD compared to female
68137 SHHF strain MP:0000231 hypertension IAGP N RGD:628511|PMID:12384454 20231206 RGD
68137 SHHF strain MP:0002079 increased circulating insulin level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprfa/cp/Crl
68137 SHHF strain MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0002833 increased heart weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR and WKY controls
68137 SHHF strain MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
68137 SHHF strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
68137 SHHF strain MP:0003821 decreased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR controls
68137 SHHF strain MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls
68137 SHHF strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0005264 glomerulosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68137 SHHF strain MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR
68145 TF strain MP:0002780 decreased circulating testosterone level IMP N RGD:38548923|PMID:21062903 20200826 RGD
68145 TF strain MP:0002789 male pseudohermaphroditism IMP N RGD:38548923|PMID:21062903 20200826 RGD
68145 TF strain MP:0013603 abnormal fetal Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD
68145 TF strain MP:0013604 abnormal adult Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD
68149 TM Tester Moriyama rat strain MP:0005606 increased bleeding time IAGP N RGD:1302447|PMID:9250486 19990101 RGD
68164 UChA strain MP:0012042 low alcohol preference IAGP N RGD:625612|PMID:6683362 19990101 RGD compared to UChB
68165 UChB strain MP:0001987 alcohol preference IAGP N RGD:625612|PMID:6683362 19990101 RGD compared to UChA
68186 WKHA/N strain MP:0001399 hyperactivity IAGP N RGD:631170|PMID:8944030 19990101 RGD
68189 HTX/Hcj strain MP:0001891 hydrocephaly IAGP N RGD:1559414|PMID:7257730 19990101 RGD
68337 Htt huntingtin gene MP:0001524 impaired limb coordination IMP N RGD:13452381|PMID:12620967 20171117 RGD
68337 Htt huntingtin gene MP:0002229 neurodegeneration IMP N RGD:13452380|PMID:25162006 20171117 RGD
68337 Htt huntingtin gene MP:0005643 decreased dopamine level IMP N RGD:13452381|PMID:12620967 20171117 RGD
68337 Htt huntingtin gene MP:0014115 cognitive inflexibility IMP N RGD:13452381|PMID:12620967 20171117 RGD
68384 Ccnd1 cyclin D1 gene MP:0000351 increased cell proliferation IDA N RGD:704417|PMID:12668975 19990101 RGD
68384 Ccnd1 cyclin D1 gene MP:0002658 abnormal liver regeneration IDA N RGD:704417|PMID:12668975 19990101 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD
68411 Sh2b3 SH2B adaptor protein 3 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210520 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210520 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210520 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210520 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210520 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD
68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:14349028|PMID:25704616 20190206 RGD
6893332 Cm74 Cardiac mass QTL 74 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893336 Cm75 Cardiac mass QTL 75 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893338 Cm76 Cardiac mass QTL 76 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893340 Cm77 Cardiac mass QTL 77 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893342 Cm78 Cardiac mass QTL 78 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893344 Cm79 Cardiac mass QTL 79 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893347 Bw98 Body weight QTL 98 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893350 Bw99 Body weight QTL 99 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893352 Bw100 Body weight QTL 100 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893355 Bw101 Body weight QTL 101 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893357 Bw102 Body weight QTL 102 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893359 Bw103 Body weight QTL 103 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893361 Bw104 Body weight QTL 104 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893363 Bw105 Body weight QTL 105 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893366 Bw106 Body weight QTL 106 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893368 Bw107 Body weight QTL 107 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD
6893419 Hvcn1<sup>em2Mcwi</sup> hydrogen voltage-gated channel 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20201210 RGD
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi
6893423 Kcnj16<sup>em1Mcwi</sup> potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi
6893434 SS-<i>Kcnj16<sup>em1Mcwi-/-</sup></i> strain MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi
6893439 SS-<i>Hvcn1<sup>em2Mcwi-/-</sup></i> strain MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20191107 RGD
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0001260 increased body weight IAGP N RGD:6893459|PMID:19996157 20120905 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0001261 obese IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0001869 pancreas inflammation IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0002079 increased circulating insulin level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw, in females
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005178 increased circulating cholesterol level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005491 pancreatic islet hyperplasia IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005559 increased circulating glucose level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw, in males
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0005669 increased circulating leptin level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0009285 increased gonadal fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893530 BBDR.LA-(<i>D5Rat98-D5Rat233</i>)/Rhw strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0001261 obese IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0001869 pancreas inflammation IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0002079 increased circulating insulin level IAGP N RGD:6893459|PMID:19996157 20120905 RGD
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0005178 increased circulating cholesterol level IAGP N RGD:6893459|PMID:19996157 20120905 RGD in females
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0005491 pancreatic islet hyperplasia IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0005669 increased circulating leptin level IAGP N RGD:6893459|PMID:19996157 20120905 RGD
6893535 BBDR.LA-(<i>D5Rat98-D5Rat233</i>), BBDP-(<i>D4Mit6-D4Mit7</i>)/Rhw strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
6893678 Bw108 Body weight QTL 108 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD
6893681 Bw109 Body weight QTL 109 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD
6893683 Bw110 Body weight QTL 110 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD
6893685 Bw111 Body weight QTL 111 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210805 RGD
68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD
6902893 BB.SHR-(<i>Acsm3-Igf2</i>)/K strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:69701|PMID:9530625 20120919 RGD only males; as compared to BB/OK males
6903294 Stl30 Serum triglyceride level QTL 30 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903300 Scl33 Serum cholesterol QTL 33 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903303 Scl34 Serum cholesterol QTL 34 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903306 Scl35 Serum cholesterol QTL 35 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903308 Scl36 Serum cholesterol QTL 36 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903312 Bw112 Body weight QTL 112 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903316 Bw113 Body weight QTL 113 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903319 Bw114 Body weight QTL 114 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD
6903345 Bp349 Blood pressure QTL 349 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903345 Bp349 Blood pressure QTL 349 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903347 Bp350 Blood pressure QTL 350 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903347 Bp350 Blood pressure QTL 350 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903349 Bp351 Blood pressure QTL 351 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903349 Bp351 Blood pressure QTL 351 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903351 Bp352 Blood pressure QTL 352 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903351 Bp352 Blood pressure QTL 352 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903353 Bp353 Blood pressure QTL 353 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903353 Bp353 Blood pressure QTL 353 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903356 Bp354 Blood pressure QTL 354 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903356 Bp354 Blood pressure QTL 354 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903359 Bp355 Blood pressure QTL 355 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD
6903359 Bp355 Blood pressure QTL 355 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD
6903917 SS.SHR-(<i>D9Mco72-D9Mco109</i>)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903920 SS.SHR-(<i>D9Mco72-D9Uia4</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903920 SS.SHR-(<i>D9Mco72-D9Uia4</i>)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903920 SS.SHR-(<i>D9Mco72-D9Uia4</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903922 SS.SHR-(<i>D9Mco72-D9Mco106</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903922 SS.SHR-(<i>D9Mco72-D9Mco106</i>)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903922 SS.SHR-(<i>D9Mco72-D9Mco106</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903925 SS.SHR-(<i>D9Mco72-D9Mco105</i>)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903925 SS.SHR-(<i>D9Mco72-D9Mco105</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903925 SS.SHR-(<i>D9Mco72-D9Mco105</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903928 SS.SHR-(<i>D9Rat7-D9Got111</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903936 SS.SHR-(<i>D9Rat7-D9Rat84</i>)/Mco strain MP:0002833 increased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903936 SS.SHR-(<i>D9Rat7-D9Rat84</i>)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903936 SS.SHR-(<i>D9Rat7-D9Rat84</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903936 SS.SHR-(<i>D9Rat7-D9Rat84</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr
6903937 Bp356 Blood pressure QTL 356 qtl MP:0006263 decreased systemic arterial diastolic blood pressure IDA N RGD:6903249|PMID:21814219 20121008 RGD
6903937 Bp356 Blood pressure QTL 356 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:6903249|PMID:21814219 20121008 RGD
6903941 Pur31 Proteinuria QTL 31 qtl MP:0002963 decreased urine protein level IDA N RGD:6903249|PMID:21814219 20121008 RGD
69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD
69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0005319 abnormal enzyme/coenzyme level IMP N RGD:127285625|PMID:27856527 20210701 RGD Por
69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0020169 increased thyroid gland weight IMP N RGD:38549342|PMID:29548889 20210701 RGD
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20201210 RGD
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20201210 RGD
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD
69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD
69063 Atrn attractin gene MP:0000745 tremors IAGP N RGD:1299186|PMID:12379762 20070731 RGD DNA:deletion:exon
69063 Atrn attractin gene MP:0000745 tremors IAGP N RGD:67998|PMID:11209055 20201214 RGD DNA:deletion
69063 Atrn attractin gene MP:0005409 darkened coat color IAGP N RGD:67998|PMID:11209055 20070731 RGD DNA:deletion
69063 Atrn attractin gene MP:0008025 brain vacuoles IAGP N RGD:67998|PMID:11209055 20201214 RGD DNA:deletion
6907054 WF.WKY-(<i>D5Uwm67-D5Uwm98</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907057 WF.WKY-(<i>D5Uwm76-D5Uwm61</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907059 WF.WKY-(<i>D5Uwm76-D5Uwm98</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907063 WF.WKY-(<i>D5Uwm76-D5Got18</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907076 WF.WKY-(<i>D5Uwm78-D5Uwm98</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907080 WF.WKY-(<i>D5Uwm67-D5Uwm81</i>)/Uwm strain MP:0010299 increased mammary gland tumor incidence induced IAGP N RGD:5684388|PMID:21205740 20121030 RGD DMBA induced; as compared to WKY/NHsd
6907084 WF.WKY-(<i>D5Uwm76-D5Uwm92</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090|XCO:0000675 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907090 WF.WKY-(<i>D5Uwm78-D5Uwm93</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907096 WF.WKY-(<i>D5Uwm85-D5Uwm92</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907098 WF.WKY-(<i>D5Uwm82-D5Uwm92</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907100 WF.WKY-(<i>D5Uwm82-D5Uwm91</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907104 WF.WKY-(<i>D5Uwm77-D5Uwm91</i>)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd
6907110 Mcs28 Mammary carcinoma susceptibility QTL 28 qtl MP:0010269 decreased mammary gland tumor incidence IAGP N RGD:5684388|PMID:21205740 20121030 RGD
6907115 Mcs29 Mammary carcinoma susceptibility QTL 29 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:5684388|PMID:21205740 20121030 RGD
6907363 Bp357 Blood pressure QTL 357 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:61058|PMID:9329963 20121031 RGD
6909122 Insul22 Insulin level QTL 22 qtl MP:0002727 decreased circulating insulin level IAGP N RGD:1626640|PMID:17213368 20121107 RGD
6909128 Pancm4 Pancreatic morphology QTL 4 qtl MP:0009109 decreased pancreas weight IAGP N RGD:1626640|PMID:17213368 20121107 RGD
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210325 RGD
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to untreated
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0010769 abnormal survival IMP N RGD:32716373|PMID:32231239 20210325 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats
69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated
69219 Aldh2 aldehyde dehydrogenase 2 family member gene MP:0001987 alcohol preference IAGP N RGD:2306341|PMID:15900217 20090409 RGD DNA:polymorphism
69219 Aldh2 aldehyde dehydrogenase 2 family member gene MP:0002570 alcohol aversion IMP N RGD:15036815|PMID:11535626 20191120 RGD
69283 Mertk MER proto-oncogene, tyrosine kinase gene MP:0008515 thin retina outer nuclear layer IAGP N RGD:69668|PMID:11592982 20190802 RGD
69300 Slco1b2 solute carrier organic anion transporter family member 1B2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211109 RGD
69305 Nr2f2 nuclear receptor subfamily 2, group F, member 2 gene MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
69305 Nr2f2 nuclear receptor subfamily 2, group F, member 2 gene MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw
69309 Fabp4 fatty acid binding protein 4 gene MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD
69364 Scn1a sodium voltage-gated channel alpha subunit 1 gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20210218 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211007 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD
69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211007 RGD
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004770 abnormal synaptic vesicle recycling IMP N RGD:41408338|PMID:31074746 20210210 RGD
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004792 abnormal synaptic vesicle number IMP N RGD:41408338|PMID:31074746 20210210 RGD
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat
69418 Ubd ubiquitin D gene MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction
69418 Ubd ubiquitin D gene MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction
69418 Ubd ubiquitin D gene MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction
69418 Ubd ubiquitin D gene MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction
69423 Srebf1 sterol regulatory element binding transcription factor 1 gene MP:0003983 decreased cholesterol level IAGP N RGD:1643359|PMID:18071061 20090609 RGD
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0001556 increased circulating HDL cholesterol level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002628 hepatic steatosis induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002644 decreased circulating triglyceride level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0003907 decreased aorta elastin content IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0003907 decreased aorta elastin content induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0006042 increased apoptosis induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008577 increased circulating interferon-gamma level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008577 increased circulating interferon-gamma level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008594 decreased circulating interleukin-10 level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008594 decreased circulating interleukin-10 level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008603 decreased circulating interleukin-4 level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008603 decreased circulating interleukin-4 level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008642 decreased circulating interleukin-1 beta level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008642 decreased circulating interleukin-1 beta level MODEL: induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN
70153 Bp59 Blood pressure QTL 59 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD
70154 Insul2 Insulin level QTL 2 qtl MP:0002727 decreased circulating insulin level QTM N RGD:69703|PMID:9819774 19990101 RGD
70155 Gcs1 Gastric cancer susceptibility QTL1 qtl MP:0002021 increased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD
70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70157 Niddm32 Non-insulin dependent diabetes mellitus QTL 32 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70158 Bp60 Blood pressure QTL 60 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD
70159 Bp61 Blood pressure QTL 61 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69711|PMID:11247666 19990101 RGD
70160 Bw18 Body weight QTL 18 qtl MP:0001261 obese IAGP N RGD:69701|PMID:9530625 19990101 RGD
70161 Bp62 Blood pressure QTL 62 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD
70162 Bp63 Blood pressure QTL 63 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD
70163 Bw20 Body weight QTL 20 qtl MP:0001261 obese IAGP N RGD:69701|PMID:9530625 19990101 RGD
70164 Bw21 Body weight QTL 21 qtl MP:0001261 obese QTM N RGD:69691|PMID:9824537 19990101 RGD
70165 Bp64 Blood pressure QTL 64 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD
70166 Bp65 Blood pressure QTL 65 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD
70167 Bw22 Body weight QTL 22 qtl MP:0001261 obese QTM N RGD:69707|PMID:9530522 19990101 RGD
70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD
70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD
70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD
70169 Eae13 Experimental allergic encephalomyelitis QTL 13 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD
70169 Eae13 Experimental allergic encephalomyelitis QTL 13 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD
70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD
70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD
70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD
70171 Cari1 Carrageenan-induced inflammation QTL 1 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69693|PMID:10087293 19990101 RGD
70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD
70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD
70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0001846 increased inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD
70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69691|PMID:9824537 19990101 RGD
70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70174 BpQTLCluster2 Blood pressure QTL cluster 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70175 BpQTLCluster3 Blood pressure QTL cluster 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70176 Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD
70177 Xhs1 X-ray hypersensitivity QTL 1 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:69702|PMID:11003700 19990101 RGD
70178 Eaez Experimental allergic encephalomyelitis QTL z qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD
70178 Eaez Experimental allergic encephalomyelitis QTL z qtl MP:0001845 abnormal inflammatory response QTM N RGD:61031|PMID:10640775 19990101 RGD
70179 Xhs2 X-ray hypersensitivity QTL 2 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:69702|PMID:11003700 19990101 RGD
70180 BpQTLcluster10 Blood pressure QTL cluster 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70181 BpQTLcluster11 Blood pressure QTL cluster 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70182 BpQTLcluster12 Blood pressure QTL cluster 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70183 BpQTLcluster13 Blood pressure QTL cluster 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70184 BpQTLcluster14 Blood pressure QTL cluster 14 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70185 BpQTLcluster15 Blood pressure QTL cluster 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70186 Niddm26 Non-insulin dependent diabetes mellitus QTL 26 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70187 Pancm5 Pancreatic morphology QTL 5 qtl MP:0005520 impaired pancreas regeneration QTM N RGD:69697|PMID:9745032 19990101 RGD
70188 BpQTLcluster1 Blood pressure QTL cluster 1 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70189 Mcs5 Mammary carcinoma susceptibility QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD
70190 Mcs6 Mammary carcinoma susceptibility QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD
70191 BpQTLcluster4 Blood pressure QTL cluster 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70192 BpQTLcluster5 Blood pressure QTL cluster 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70193 Mcs7 Mammary carcinoma susceptibility QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD
70194 BpQTLcluster6 Blood pressure QTL cluster 6 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70195 Mcs8 Mammary carcinoma susceptibility QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD
70196 BpQTLcluster7 Blood pressure QTL cluster 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70197 BpQTLcluster8 Blood pressure QTL cluster 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70198 BpQTLcluster9 Blood pressure QTL cluster 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD
70199 Coreg1 Compensatory renal growth QTL 1 qtl MP:0002955 increased compensatory renal growth QTM N RGD:69708|PMID:10732705 19990101 RGD
70200 Alc18 Alcohol consumption QTL 18 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD
70201 Gcr1 Gastric cancer resistance QTL 1 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD
70202 Alc19 Alcohol consumption QTL 19 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD
70203 Gcr2 Gastric cancer resistance QTL 2 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD
70204 Niddm20 Non-insulin dependent diabetes mellitus QTL 20 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69691|PMID:9824537 19990101 RGD
70204 Niddm20 Non-insulin dependent diabetes mellitus QTL 20 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69696|PMID:10594234 19990101 RGD
70205 Gcr3 Gastric cancer resistance QTL 3 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD
70206 Alc20 Alcohol consumption QTL 20 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD
70207 Niddm31 Non-insulin dependent diabetes mellitus QTL 31 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70208 Niddm22 Non-insulin dependent diabetes mellitus QTL 22 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69691|PMID:9824537 19990101 RGD
70208 Niddm22 Non-insulin dependent diabetes mellitus QTL 22 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70209 Niddm23 Non-insulin dependent diabetes mellitus QTL 23 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70210 Cm15 Cardiac mass QTL 15 qtl MP:0000276 heart right ventricle hypertrophy QTM N RGD:69699|PMID:11157698 19990101 RGD
70210 Cm15 Cardiac mass QTL 15 qtl MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:10401832|PMID:26258299 20151014 RGD
70210 Cm15 Cardiac mass QTL 15 qtl MP:0004202 pulmonary hyperplasia IDA N RGD:10401832|PMID:26258299 20151014 RGD
70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69696|PMID:10594234 19990101 RGD
70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70214 Niddm28 Non-insulin dependent diabetes mellitus QTL 28 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70215 Niddm29 Non-insulin dependent diabetes mellitus QTL 29 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD
70216 Cm14 Cardiac mass QTL 14 qtl MP:0000274 enlarged heart IAGP N RGD:69705|PMID:9922389 19990101 RGD
70216 Cm14 Cardiac mass QTL 14 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70067 19990101 RGD
70218 Cm28 Cardiac mass QTL 28 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD
70220 Bp55 Blood pressure QTL 55 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD
70221 Bp56 Blood pressure QTL 56 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD
70222 Eae2 Experimental allergic encephalomyelitis QTL 2 qtl MP:0000754 paresis QTM N RGD:69694|PMID:9973459 19990101 RGD
70222 Eae2 Experimental allergic encephalomyelitis QTL 2 qtl MP:0001846 increased inflammatory response QTM N RGD:69694|PMID:9973459 19990101 RGD
70223 Bp57 Blood pressure QTL 57 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD
70224 Eae3 Experimental allergic encephalomyelitis QTL 3 qtl MP:0000754 paresis IDA N RGD:69694|PMID:9973459 20100217 RGD
70224 Eae3 Experimental allergic encephalomyelitis QTL 3 qtl MP:0001846 increased inflammatory response IDA N RGD:69694|PMID:9973459 20100217 RGD
70225 Bp58 Blood pressure QTL 58 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD
70226 Eae4 Experimental allergic encephalomyelitis QTL 4 qtl MP:0000754 paresis QTM N RGD:69712|PMID:10072499 19990101 RGD
70226 Eae4 Experimental allergic encephalomyelitis QTL 4 qtl MP:0001846 increased inflammatory response QTM N RGD:69712|PMID:10072499 19990101 RGD
70363 Bp71 Blood pressure QTL 71 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:69734|PMID:11471055 19990101 RGD
70364 Bp72 Blood pressure QTL 72 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:69734|PMID:11471055 19990101 RGD
70410 AA Alko, Alcohol strain MP:0001987 alcohol preference IAGP N RGD:70283|PMID:17795073 20201103 RGD
70411 ANA Alko, Non-Alcohol strain MP:0012042 low alcohol preference IAGP N RGD:70283|PMID:17795073 19990101 RGD
70429 AO strain MP:0005515 uveitis susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain
70429 AO strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain
70454 WKY/N strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
70454 WKY/N strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
70454 WKY/N strain MP:0002626 increased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
70454 WKY/N strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0000187 abnormal triglyceride level treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD decreased muscle triglyceride level
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0001559 hyperglycemia IAGP N RGD:68929|PMID:11334402 20200205 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0002727 decreased circulating insulin level IAGP N RGD:68929|PMID:11334402 20200205 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0003564 abnormal insulin secretion IAGP N RGD:68929|PMID:11334402 20200205 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005292 improved glucose tolerance treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005293 impaired glucose tolerance IAGP N RGD:68929|PMID:11334402 20200205 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005559 increased circulating glucose level IAGP N RGD:68929|PMID:11334402 20200205 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0008853 decreased abdominal adipose tissue amount treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0009425 increased soleus weight treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD
70459 ZDF Vancouver diabetic fatty Zucker strain MP:0031001 increased glycogen synthesis treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD in adipose tissue and skeletal muscle
70495 Map2k1 mitogen activated protein kinase kinase 1 gene MP:0000740 impaired smooth muscle contractility IDA N RGD:2293329|PMID:10198244 20080527 RGD inhibition decreases both calcium-stimulated and unstimulated myogenic tone in middle cerebral arteries (p<0.001)
70508 SD Sprague-Dawley strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:68927|PMID:11246877 19990101 RGD compared to control
70509 F344/NRrrc strain MP:0003331 increased hepatocellular carcinoma incidence induced IAGP XCO:0000210,XCO:0000442,XCO:0000206 N RGD:619598|PMID:10493520 19990101 RGD compared to BN/SsNHsd
70547 Crhr2 corticotropin releasing hormone receptor 2 gene MP:0001987 alcohol preference IAGP N RGD:8662401|PMID:24611993 20210714 RGD DNA:polymorphism, missense mutation:promoter, cds
708419 Brinp2 BMP/retinoic acid inducible neural specific 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD
708419 Brinp2 BMP/retinoic acid inducible neural specific 2 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD
708422 Or1f45 olfactory receptor family 1 subfamily F member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
708429 Golgb1 golgin B1 gene MP:0001785 edema IAGP N RGD:40902994|PMID:21851869 20210121 RGD
708429 Golgb1 golgin B1 gene MP:0002082 postnatal lethality IAGP N RGD:40902994|PMID:21851869 20210121 RGD
708429 Golgb1 golgin B1 gene MP:0014101 decreased chondrocyte proliferation IAGP N RGD:40902994|PMID:21851869 20210121 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD
708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD
708465 Otos otospiralin gene MP:0005191 head tilt IMP N RGD:1302368|PMID:11880501 19990101 RGD
708584 Spon2 spondin 2 gene MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230803 RGD
70878 Cit citron rho-interacting serine/threonine kinase gene MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD
70878 Cit citron rho-interacting serine/threonine kinase gene MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD
70878 Cit citron rho-interacting serine/threonine kinase gene MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20180501 RGD
70944 Cplx1 complexin 1 gene MP:0001262 decreased body weight IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001363 increased anxiety-related response IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001406 abnormal gait IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001407 short stride length IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001415 increased exploration in new environment IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001442 decreased grooming behavior IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0001524 impaired limb coordination IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0002083 premature death IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0002733 abnormal thermal nociception IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0002757 decreased vertical activity IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0003449 abnormal intestinal goblet cell morphology IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0005210 disorganized stomach mucosa IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0014219 decreased intestinal mucosa thickness IMP N RGD:127285808|PMID:31875236 20210701 RGD
70944 Cplx1 complexin 1 gene MP:0020336 abnormal motor neuron dendrite morphology IMP N RGD:127285808|PMID:31875236 20210701 RGD
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD
70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type
70982 Gsk3b glycogen synthase kinase 3 beta gene MP:0002229 neurodegeneration IDA N RGD:1358648|PMID:15073173 19990101 RGD
71009 Adcy3 adenylate cyclase 3 gene MP:0001984 abnormal olfaction IDA N RGD:70798|PMID:2255909 19990101 RGD
71009 Adcy3 adenylate cyclase 3 gene MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200824 RGD DNA:missense mutation:cds:p.L121P (rat, WKY/N)
71024 Actr3 actin related protein 3 gene MP:0002962 increased urine protein level IAGP N RGD:2292230|PMID:18064521 20161221 RGD DNA:missense mutation:cds:p.L111F
71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD
71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male
71037 Prlhr prolactin releasing hormone receptor gene MP:0001261 obese IAGP N RGD:1641829|PMID:15854142 20070823 RGD
71037 Prlhr prolactin releasing hormone receptor gene MP:0001433 polyphagia IAGP N RGD:1641829|PMID:15854142 20070823 RGD
71037 Prlhr prolactin releasing hormone receptor gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200824 RGD DNA, protein:misense mutation,deletion:cds:p.1-64 (rat, WKY/N, BUF/N,MR/N, )
71082 Bmpr2 bone morphogenetic protein receptor type 2 gene MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD
71112 Bw115 Body weight QTL 115 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD
71112 Bw115 Body weight QTL 115 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD
71112 Bw115 Body weight QTL 115 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD
71113 Cari2 Carrageenan-induced inflammation QTL 2 qtl MP:0001845 abnormal inflammatory response QTM N RGD:70860|PMID:11306811 19990101 RGD
71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD
71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD
71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD
71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61072|PMID:9585427 19990101 RGD
71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD
71116 Niddm16 Non-insulin dependent diabetes mellitus QTL 16 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD
71117 Niddm17 Non-insulin dependent diabetes mellitus QTL 17 qtl MP:0005293 impaired glucose tolerance QTM N RGD:70861|PMID:8702404 19990101 RGD
71118 Thym1 Thymus enlargement QTL 1 qtl MP:0000708 thymus hyperplasia QTM N RGD:70859|PMID:10792781 19990101 RGD
71119 Thym2 Thymus enlargement QTL 2 qtl MP:0000708 thymus hyperplasia QTM N RGD:70859|PMID:10792781 19990101 RGD
71120 Niddm21 Non-insulin dependent diabetes mellitus QTL 21 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61021|PMID:10051320 19990101 RGD
71120 Niddm21 Non-insulin dependent diabetes mellitus QTL 21 qtl MP:0005559 increased circulating glucose level contributes_to IDA N RGD:2300331|PMID:18421176 20080912 RGD heterozygous genotype at the Niddm21 locus
7204132 Rag1<sup>em1Ztm</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20180508 RGD
7204132 Rag1<sup>em1Ztm</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20180508 RGD
7204132 Rag1<sup>em1Ztm</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20180508 RGD
7204133 LEW-<i>Rag1<sup>em1Ztm</sup></i> strain MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20121217 RGD
7204133 LEW-<i>Rag1<sup>em1Ztm</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20121217 RGD
7204133 LEW-<i>Rag1<sup>em1Ztm</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20121217 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20180507 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20180507 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20180507 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20180507 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20180507 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204135 Rag1<sup>em1Ang</sup> recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20121217 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20121217 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20121217 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20121217 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20121217 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204136 SD-<i>Rag1<sup>em1Ang</sup></i> strain MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD
7204484 Bp358 Blood pressure QTL 358 qtl MP:0002962 increased urine protein level IAGP N RGD:7204442|PMID:22868394 20121219 RGD
7204484 Bp358 Blood pressure QTL 358 qtl MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7204442|PMID:22868394 20121219 RGD
7207885 Glom27 Glomerulus QTL 27 qtl MP:0002743 glomerulonephritis IAGP N RGD:7207870|PMID:22445570 20130212 RGD
7240514 DA.PVG.1AV1-(<i>D4Kiru12-D4Kiru55</i>)/Kiru strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000265 N RGD:1642519|PMID:17665455 20130213 RGD compared to DA/ZtmKini
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241042 Park7<sup>em1Sage</sup> parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20190103 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241045 Lrrk2<sup>em1Sage</sup> leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20190103 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20201210 RGD
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
7241046 Pink1<sup>em1Sage</sup> PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH
7241049 LE-<i>Pink1<sup>em1Sage-/-</sup></i> strain MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241055 LE-<i>Park7<sup>em1Sage-/-</sup></i> strain MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20180824 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20190103 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD
7241056 LE-<i>Lrrk2<sup>em1Sage-/-</sup></i> strain MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20190103 RGD
7241240 DA.BN-(<i>D9Mit6-D9Rat29</i>)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini
7241243 DA.BN-(<i>D9Wox24-D9Rat20</i>)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini
7241244 DA.BN-(<i>D9Wox24-D9Wox18</i>)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini
7241245 DA.BN-(<i>D9Wox24-D9Rat139</i>)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini
7241246 DA.BN-(<i>D9Wox24-D9Rat44</i>)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini
7241248 LEW.BN-(<i>D9Wox24-D9Got22</i>)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000688 N RGD:7241236|PMID:20368159 20200505 RGD compared to LEW/Rj
7241265 SHR-Chr Y<sup>WKY</sup>/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7241263|PMID:8505094 20130307 RGD for males as compared to the SHR/NHsd males
7241265 SHR-Chr Y<sup>WKY</sup>/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000203 N RGD:7241263|PMID:8505094 20130307 RGD compared to sham control
7241265 SHR-Chr Y<sup>WKY</sup>/Akr strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR
7241267 WKY-Chr Y<sup>SHR</sup>/Akr strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7241263|PMID:8505094 20130307 RGD for males as compared to WKY/NHsd males
7241267 WKY-Chr Y<sup>SHR</sup>/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000203 N RGD:7241263|PMID:8505094 20130307 RGD compared to shame control
7241271 SHR.BN-(<i>D10Mit4-D10Wox11</i>)/Cub strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR
7241593 Rbm20<i><sup>m1Mlgw</sup></i> RNA binding motif protein 20; mutation 1, Marion Greaser gene MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210520 RGD
7241594 (SDxF344)F1-<i>Rbm20<sup>m1Mlgw</i></sup> strain MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210518 RGD
7241811 BBDP.WF-(<i>D8Rat73-D8Sunn1467</i>)(<i>D13Rat124-D13Mgh5</i>)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD
7243862 Mcs30 Mammary carcinoma susceptibility QTL 30 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7327193|PMID:24023717 20130918 RGD
7243965 DA.F344-(<i>D4Arb21-D4Arb4</i>)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD compared to BklArbNsi
7243966 DA.F344-(<i>D4Arb5-D4Arb4</i>)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000281|XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD compared to BklArbNsi
724513 Uae14 Urinary albumin excretion QTL 14 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724514 Uae15 Urinary albumin excretion QTL 15 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724515 Uae16 Urinary albumin excretion QTL 16 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724516 Uae17 Urinary albumin excretion QTL 17 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724517 Uae18 Urinary albumin excretion QTL 18 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724518 Uae19 Urinary albumin excretion QTL 19 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724519 Bp144 Blood pressure QTL 144 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619638|PMID:8938440 19990101 RGD
724520 Bp145 Blood pressure QTL 145 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD
724521 Uae1 Urinary albumin excretion QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD
724522 Bp146 Blood pressure QTL 146 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD
724523 Tsu1 Thymus enlargement suppressive QTL 1 qtl MP:0000706 small thymus QTM N RGD:634729|PMID:9234381 19990101 RGD
724524 Uae2 Urinary albumin excretion QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD
724525 Bp147 Blood pressure QTL 147 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD
724526 Uae3 Urinary albumin excretion QTL 3 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD
724527 Bp148 Blood pressure QTL 148 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD
724528 Uae4 Urinary albumin excretion QTL 4 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD
724529 Cm16 Cardiac mass QTL 16 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724529 Cm16 Cardiac mass QTL 16 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634617|PMID:12707388 19990101 RGD
724530 Bp149 Blood pressure QTL 149 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD
724531 Uae5 Urinary albumin excretion QTL 5 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724531 Uae5 Urinary albumin excretion QTL 5 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724532 Cm17 Cardiac mass QTL 17 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724533 Rf51 Renal function QTL 51 qtl MP:0005526 decreased renal plasma flow rate QTM N RGD:619628|PMID:10545438 19990101 RGD
724533 Rf51 Renal function QTL 51 qtl MP:0005528 decreased renal glomerular filtration rate QTM N RGD:619628|PMID:10545438 19990101 RGD
724533 Rf51 Renal function QTL 51 qtl MP:0005531 increased renal vascular resistance QTM N RGD:619628|PMID:10545438 19990101 RGD
724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0005264 glomerulosclerosis QTM N RGD:634617|PMID:12707388 19990101 RGD
724535 Cm18 Cardiac mass QTL 18 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724536 Uae7 Urinary albumin excretion QTL 7 qtl MP:0002871 albuminuria IDA N RGD:634617|PMID:12707388 19990101 RGD
724536 Uae7 Urinary albumin excretion QTL 7 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724537 Niddm52 Non-insulin dependent diabetes mellitus QTL 52 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD
724538 Kidm1 Kidney mass QTL 1 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD
724539 Cm19 Cardiac mass QTL 19 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724540 Uae8 Urinary albumin excretion QTL 8 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724540 Uae8 Urinary albumin excretion QTL 8 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724541 Niddm53 Non-insulin dependent diabetes mellitus QTL 53 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD
724542 Kidm2 Kidney mass QTL 2 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD
724543 Cm20 Cardiac mass QTL 20 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724544 Uae9 Urinary albumin excretion QTL 9 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724545 Niddm54 Non-insulin dependent diabetes mellitus QTL 54 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD
724546 Kidm3 Kidney mass QTL 3 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD
724547 Cm21 Cardiac mass QTL 21 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD
724548 Niddm55 Non-insulin dependent diabetes mellitus QTL 55 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD
724549 Niddm56 Non-insulin dependent diabetes mellitus QTL 56 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD
724550 Thym3 Thymus enlargement QTL 3 qtl MP:0000709 enlarged thymus QTM N RGD:70859|PMID:10792781 19990101 RGD
724551 Glom1 Glomerulus QTL 1 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD
724552 Glom2 Glomerulus QTL 2 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD
7245527 WKHA/Edh strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female
7245527 WKHA/Edh strain MP:0001262 decreased body weight IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N
7245527 WKHA/Edh strain MP:0001399 hyperactivity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N
7245527 WKHA/Edh strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female
7245527 WKHA/Edh strain MP:0005333 decreased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
7245527 WKHA/Edh strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female
7245527 WKHA/Edh strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
7245527 WKHA/Edh strain MP:0008772 increased heart ventricle size IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N
724553 Glom3 Glomerulus QTL 3 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD
724554 Iddm17 Insulin dependent diabetes mellitus QTL 17 qtl MP:0001869 pancreas inflammation QTM N RGD:634732|PMID:9329965 19990101 RGD
724555 Bp150 Blood pressure QTL 150 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD
7245556 WKHT/Edh strain MP:0000279 ventricular hypoplasia IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to male WKHA/Edh
7245556 WKHT/Edh strain MP:0001260 increased body weight IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh
7245556 WKHT/Edh strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female
7245556 WKHT/Edh strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N female
7245556 WKHT/Edh strain MP:0001402 decreased locomotor activity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh, SHR/N
7245556 WKHT/Edh strain MP:0002626 increased heart rate IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to SHR/N
7245556 WKHT/Edh strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh
724556 Pur2 Proteinuria QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724557 Plsm1 Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD
724558 Plsm2 Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD
724559 Pancm1 Pancreatic morphology QTL 1 qtl MP:0005215 abnormal pancreatic islet morphology QTM N RGD:61083|PMID:9169130 19990101 RGD
724560 Plsm3 Polydactyly-luxate syndrome (PLS) morphotypes QTL 3 qtl MP:0002764 short tibia IDA N RGD:632346|PMID:8997636 19990101 RGD
724561 Plsm4 Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD
724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0000530 abnormal kidney vasculature morphology IAGP N RGD:632218|PMID:10454439 19990101 RGD
724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0002962 increased urine protein level IAGP N RGD:632218|PMID:10454439 20120112 RGD
724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:632218|PMID:10454439 19990101 RGD
724563 Uae10 Urinary albumin excretion QTL 10 qtl MP:0002871 albuminuria IDA N RGD:634617|PMID:12707388 19990101 RGD
724563 Uae10 Urinary albumin excretion QTL 10 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD
724564 Uae11 Urinary albumin excretion QTL 11 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724565 Tcas5 Tongue tumor susceptibility QTL 5 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD
724566 Uae12 Urinary albumin excretion QTL 12 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD
724567 Tcas6 Tongue tumor susceptibility QTL 6 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD
724568 Uae13 Urinary albumin excretion QTL 13 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0001260 increased body weight IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002834 decreased heart weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:2292240|PMID:18199599 20210712 RGD compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to SHR/FubRkb, SHR-Chr 6MWF/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx, WU-Nx-ACEI, and MWF-Sham
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD males compared to SHR/FubRkb, female MWF/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx-ACEI
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003821 decreased left ventricle diastolic pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight IAGP N RGD:25314272|PMID:16915036 20210709 RGD compared to Wi
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD compared to SHR/FubRkb strain
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0004505 decreased renal glomerulus number IAGP N RGD:15023481|PMID:30900988 20210819 RGD compared to SHR, MWF-6SHR, MWF.SHR-(D6Rat1-D6Mgh4)
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0004505 decreased renal glomerulus number IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, WU-Nx, MWF-Nx-ACEI and MWF-Sham-Nx-ACEI
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to female MWF/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx-ACEI
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005522 increased circulating atrial natriuretic factor induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005522 increased circulating atrial natriuretic factor treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to male MWF/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:2292240|PMID:18199599 20210712 RGD compared to male SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005557 increased creatinine clearance treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005558 decreased creatinine clearance induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Sham
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005598 decreased heart ventricle muscle contractility induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-sham and WU-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005600 increased heart ventricle muscle contractility treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005608 cardiac interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Sham
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005608 cardiac interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314272|PMID:16915036 20210709 RGD compared to Wi
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:634618|PMID:12397040 19990101 RGD compared to LEW/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312602|PMID:18647879 20191220 RGD compared to SHR/FubRkb strain
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0010064 increased circulating creatine level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0011760 abnormal ureteric bud tip morphology IAGP N RGD:25314259|PMID:22871889 20210709 RGD compared to SHR and MWF-Chr 6SHR/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020312 increased hydroxymethylbilane synthase activity IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020418 increased cardiac muscle relaxation treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx
724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020419 decreased cardiac muscle relaxation induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-sham and WU-Nx
724572 SS.LEW-(<i>D10Wox51-D10Rat27</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0003016 increased circulating bicarbonate level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0003917 increased kidney weight IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005627 increased circulating potassium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005633 increased circulating sodium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco
724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0011377 renal glomerulus fibrosis severity IAGP N RGD:1625111|PMID:17504948 20191126 RGD
724574 SHR/NHsd strain MP:0001262 decreased body weight IAGP N RGD:61516|PMID:11015598 19990101 RGD compared to SS/Jr
724574 SHR/NHsd strain MP:0003025 increased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to BN/SsNHsd
724574 SHR/NHsd strain MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to BN-Lx
724575 SS.LEW-(<i>D10Rat17-D10Mgh1</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS
724577 SS.LEW-(<i>D10Rat27-Igfbp4</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD
7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0000753 paralysis IMP N RGD:9685710|PMID:21408206 20190726 RGD
7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0003224 neuron degeneration IMP N RGD:9685710|PMID:21408206 20190726 RGD
7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0008143 abnormal dendrite morphology IMP N RGD:7247277|PMID:22833456 20190726 RGD
7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0008414 abnormal spatial reference memory IMP N RGD:7247277|PMID:22833456 20190726 RGD
7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0011743 abnormal Golgi apparatus morphology IMP N RGD:7247277|PMID:22833456 20190726 RGD
7247286 F344-Tg(APP)21Besey strain MP:0003329 amyloid beta deposits IMP N RGD:7247288|PMID:22017494 20190726 RGD induced by human Alzheimer brain extracts containing aggregated Abeta
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0000218 increased leukocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0000219 increased neutrophil cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0005013 increased lymphocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0005325 abnormal renal glomerulus morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0008993 abnormal portal triad morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0011353 expanded mesangial matrix IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0013440 abnormal exorbital lacrimal gland morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD
7247442 Uae39 Urinary albumin excretion QTL 39 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0002871 albuminuria IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:8693701|PMID:25001272 20140724 RGD
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:8693701|PMID:25001272 20140724 RGD 8% NaCl diet
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0005264 glomerulosclerosis IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0011402 renal cast IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
7248453 SS.BN-(<i>D12Hmgc3-AU047911</i>)/Mcwi strain MP:0011405 tubulointerstitial nephritis IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN
7257661 Tlr4<sup>em1Geh</sup> toll-like receptor 4; mutation 1, Gregg E. Homanics gene MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD
7257663 WI-<i>Tlr4<sup>em1Geh</i></sup> strain MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD
727792 Isca1 iron-sulfur cluster assembly 1 gene MP:0010955 abnormal respiratory electron transport chain IMP N RGD:39131292|PMID:31016283 20201001 RGD
727792 Isca1 iron-sulfur cluster assembly 1 gene MP:0011092 embryonic lethality, complete penetrance IMP N RGD:39131292|PMID:31016283 20201001 RGD
727799 Astn1 astrotactin 1 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD
727799 Astn1 astrotactin 1 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD
727845 F8 coagulation factor VIII gene MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
727845 F8 coagulation factor VIII gene MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley
727845 F8 coagulation factor VIII gene MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20201210 RGD
727845 F8 coagulation factor VIII gene MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
727845 F8 coagulation factor VIII gene MP:0002875 decreased erythrocyte cell number IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat)
727845 F8 coagulation factor VIII gene MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley
727845 F8 coagulation factor VIII gene MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley
727845 F8 coagulation factor VIII gene MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley
727845 F8 coagulation factor VIII gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD
727845 F8 coagulation factor VIII gene MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley
727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20170815 RGD
727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0003378 early sexual maturation IDA N RGD:2292180|PMID:15486019 20080411 RGD via chronic central administration of kisspeptin-10 to immature females
727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20170815 RGD
727865 Or7a38c olfactory receptor family 7 subfamily A member 38C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
727916 Rffl ring finger and FYVE-like domain containing E3 ubiquitin protein ligase gene MP:0003900 shortened QT interval IAGP N RGD:13442502|PMID:21357277 20171106 RGD as compared to SS/Jr
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0004686 decreased length of long bones IAGP N RGD:40924666|PMID:27727328 20210224 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220203 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0006281 abnormal tail development IAGP N RGD:40924666|PMID:27727328 20210224 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009431 decreased fetal weight IAGP N RGD:40924666|PMID:27727328 20210224 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20210416 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv;
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0011102 embryonic lethality, incomplete penetrance IAGP N RGD:40924666|PMID:27727328 20210224 RGD
727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0011722 abnormal ossification involved in bone maturation IAGP N RGD:40924666|PMID:27727328 20210224 RGD
728134 SS.LEW-(<I>D1Rat35-D1Rat49</I>)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728134 SS.LEW-(<I>D1Rat35-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728134 SS.LEW-(<I>D1Rat35-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
728135 SS.LEW-(<I>D5Uwm14-D5Uwm31</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD
728137 SS.LEW-(<I>D10Rat141-D10Mgh1</I>)/Ayd strain MP:0002834 decreased heart weight IMP N RGD:625380|PMID:11791025 19990101 RGD compared to SS/Jr
728137 SS.LEW-(<I>D10Rat141-D10Mgh1</I>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625380|PMID:11791025 20201112 RGD compared to SS/Jr
728138 SS.MNS-(<I>Mme-Gca</I>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625376|PMID:11773603 20201112 RGD compared to SS/Jr
728139 WKY.SHRSP-(<I>D1Rat200-D1Rat216</I>)(<I>Shbg-Atp1b2</I>)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015
728139 WKY.SHRSP-(<I>D1Rat200-D1Rat216</I>)(<I>Shbg-Atp1b2</I>)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015
728139 WKY.SHRSP-(<I>D1Rat200-D1Rat216</I>)(<I>Shbg-Atp1b2</I>)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015
728142 BN.SHR-(<i>Il6-Cd36</i>)/Cub strain MP:0002981 increased liver weight IAGP N RGD:632347|PMID:12118727 20200313 RGD
728142 BN.SHR-(<i>Il6-Cd36</i>)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub
728142 BN.SHR-(<i>Il6-Cd36</i>)/Cub strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:632347|PMID:12118727 20200313 RGD
728143 SS.LEW-(<I>D1Mco38-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728144 BN.PD-(<I>D8Rat39-D8Rat35</I>)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub
728145 SS.LEW-(<I>D5Rat130-D5Rat108</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0020330 increased capillary density IAGP N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw, diethylstilbestrol treated F344/NHsd
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0021058 increased tumor perivascular space size IAGP N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0021058 increased tumor perivascular space size induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to diethylstilbestrol treated F344/NHsd
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0021066 increased tumor nonattached pericyte number IAGP N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd
728146 F344.BN-(<I>D3Mgh13-D3Mgh7</I>)/Dlw strain MP:0021066 increased tumor nonattached pericyte number induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to diethylstilbestrol treated F344/NHsd
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0001552 increased circulating triglyceride level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:632347|PMID:12118727 20200313 RGD
728147 BN.PD-(<I>D8Rat39-D8Rat35</I>),SHR-(<I>D4Mgh2-Cd36</I>),SHR-(<I>D20Wox3-D20Mgh5</I>)/Cub strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728148 SS.LEW-(<I>D16Uia2-D16Rat12</I>)/Ayd strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
728153 SS.LEW-(<I>D1Rat196-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728155 BBDR.BBDP-(<I>D4Mit6-D4Mit7</I>)/1Rhw strain MP:0001869 pancreas inflammation susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
728155 BBDR.BBDP-(<I>D4Mit6-D4Mit7</I>)/1Rhw strain MP:0004129 abnormal respiratory quotient IAGP N RGD:2293508|PMID:18465680 20080611 RGD compared to DR.lyp/+
728155 BBDR.BBDP-(<I>D4Mit6-D4Mit7</I>)/1Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:2293508|PMID:18465680 20080611 RGD compared to DR.lyp/+
728155 BBDR.BBDP-(<I>D4Mit6-D4Mit7</I>)/1Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
728155 BBDR.BBDP-(<I>D4Mit6-D4Mit7</I>)/1Rhw strain MP:0005215 abnormal pancreatic islet morphology susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw
728156 SS.LEW-(<I>D5Mco34-D5Mco10</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
728157 SS.LEW-(<I>D5Rat130-D5Mit19</I>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
728158 SS.LEW-(<I>D5Uia4-D5Mco10</I>)/Jr strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr
728158 SS.LEW-(<I>D5Uia4-D5Mco10</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 20200109 RGD compared to SS/Jr
728159 SS.LEW-(<I>D1Mco36-D1Rat49</I>)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 20080514 RGD compared to SS/Jr
728159 SS.LEW-(<I>D1Mco36-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728159 SS.LEW-(<I>D1Mco36-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
728161 PD/Cub polydactylous strain MP:0001260 increased body weight IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to SHR/OlaIpcv, BN/Cub
728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0002644 decreased circulating triglyceride level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD
728161 PD/Cub polydactylous strain MP:0002702 decreased circulating free fatty acids level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD
728161 PD/Cub polydactylous strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0002981 increased liver weight IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0002981 increased liver weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0003443 increased circulating glycerol level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0003917 increased kidney weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0003918 decreased kidney weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to SHR/Ola, BN/Cub
728161 PD/Cub polydactylous strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD
728161 PD/Cub polydactylous strain MP:0005179 decreased circulating cholesterol level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD
728161 PD/Cub polydactylous strain MP:0005293 impaired glucose tolerance IAGP N RGD:1580750|PMID:15007394 20200416 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0005559 increased circulating glucose level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0005559 increased circulating glucose level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1580750|PMID:15007394 20200416 RGD compared to BN/Cub
728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to SHR/OlaIpcv, BN/Cub
728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200416 RGD
728162 SS.LEW-(<I>D1Mco87-D1Rat71</I>)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr
728162 SS.LEW-(<I>D1Mco87-D1Rat71</I>)/Jr strain MP:0002833 increased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728162 SS.LEW-(<I>D1Mco87-D1Rat71</I>)/Jr strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191205 RGD compared to SS/Jr
728162 SS.LEW-(<I>D1Mco87-D1Rat71</I>)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD
728163 SS.LEW-(<I>D1Uia2-D1Rat49</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728165 SS.LEW-(<I>D1Rat196-D1Mco36</I>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr
728170 SS.MNS-(<I>Mme-D2Mit14</I>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625376|PMID:11773603 20201112 RGD compared to SS/Jr
728183 WF/N strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm
728184 SHRSP/A3N strain MP:0001262 decreased body weight susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl
728184 SHRSP/A3N strain MP:0001262 decreased body weight susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0001625 cardiac hypertrophy susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0002962 increased urine protein level IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0003215 renal interstitial fibrosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0003215 renal interstitial fibrosis IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0003393 decreased cardiac output susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl
728184 SHRSP/A3N strain MP:0003393 decreased cardiac output susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0003985 renal fibrosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0005264 glomerulosclerosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0005264 glomerulosclerosis IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl
728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0008770 decreased survivor rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0011402 renal cast IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0011402 renal cast IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0011442 abnormal renal sodium ion transport susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0011758 renal ischemia IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N
728184 SHRSP/A3N strain MP:0011952 decreased cardiac stroke volume susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N
728184 SHRSP/A3N strain MP:0011978 abnormal potassium ion homeostasis susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N
728194 SHR/N strain MP:0001260 increased body weight IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain
728194 SHR/N strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
728194 SHR/N strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
728194 SHR/N strain MP:0001399 hyperactivity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N
728194 SHR/N strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
728194 SHR/N strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD compared to DRY control strain
728194 SHR/N strain MP:0002626 increased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
728194 SHR/N strain MP:0003915 increased heart left ventricle weight IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain
728194 SHR/N strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:61484|PMID:9495256 19990101 RGD compared to DRY control strain
728194 SHR/N strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:731210|PMID:14678232 19990101 RGD compared to WKY/N control strain
728194 SHR/N strain MP:0005333 decreased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
728194 SHR/N strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain
728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N
728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain
728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N
728194 SHR/N strain MP:0008772 increased heart ventricle size IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210429 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210429 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210429 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210429 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0003205 testicular atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210429 RGD
728326 Brca2<i><sup>m1Uwm</sup></i> BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210429 RGD
728328 Srebf1_v2 sterol regulatory element binding factor 1, variant 2 gene MP:0003983 decreased cholesterol level IAGP N RGD:1643359|PMID:18071061 20090609 RGD
728383 UPL/Cas Upjohn Pharmaceuticals Limited strain MP:0001304 cataract IAGP N RGD:727242|PMID:8282038 19990101 RGD
728384 SS.LEW-(<i>D10Rat24-Igfbp4</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD
728384 SS.LEW-(<i>D10Rat24-Igfbp4</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
728386 SS.LEW-(<i>D10Rat119-D10Rat133</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD
728386 SS.LEW-(<i>D10Rat119-D10Rat133</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
728388 SS.LEW-(<i>D10Rat119-D10Mgh1</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS
728392 RHA/N-<I>di</I> Roman high avoidance-<i>di</i> mutation strain MP:0001263 weight loss induced IAGP XCO:0000297 N RGD:2314670|PMID:3736782 20200709 RGD compared to induced RHA/N
728392 RHA/N-<I>di</I> Roman high avoidance-<i>di</i> mutation strain MP:0001426 polydipsia IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N
728392 RHA/N-<I>di</I> Roman high avoidance-<i>di</i> mutation strain MP:0002988 decreased urine osmolality IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N
728392 RHA/N-<I>di</I> Roman high avoidance-<i>di</i> mutation strain MP:0005611 decreased circulating antidiuretic hormone level IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N
728392 RHA/N-<I>di</I> Roman high avoidance-<i>di</i> mutation strain MP:0008997 increased blood osmolality IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N
728393 SS.LEW-(<i>D10Got125-D10Rat120</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
728394 SS.LEW-(<i>D10Rat55-D10Rat13</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD
728394 SS.LEW-(<i>D10Rat55-D10Rat13</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
728395 SS.LEW-(<i>D10Rat55-D10Rat120</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
728396 SS.LEW-(<i>D10Mco15-D10Mgh1</i>)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD
731164 Uae25 Urinary albumin excretion QTL 25 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731165 Uae21 Urinary albumin excretion QTL 21 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731166 Mamtr2 Mammary tumor resistance QTL 2 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD
731167 Glom4 Glomerulus QTL 4 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD
731168 Bp154 Blood pressure QTL 154 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:730283|PMID:14623828 19990101 RGD
731169 Bp153 Blood pressure QTL 153 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:728381|PMID:14597851 19990101 RGD
731170 Pur3 Proteinuria QTL 3 qtl MP:0002962 increased urine protein level IAGP N RGD:730279|PMID:14638907 20120112 RGD
731171 Glom6 Glomerulus QTL 6 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD
731172 Bp151 Blood pressure QTL 151 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:724791|PMID:14517349 19990101 RGD
731173 Uae22 Urinary albumin excretion QTL 22 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731174 Uae23 Urinary albumin excretion QTL 23 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731175 Uae20 Urinary albumin excretion QTL 20 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731176 Glom5 Glomerulus QTL 5 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD
731177 Uae26 Urinary albumin excretion QTL 26 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731178 Oia7 Oil induced arthritis QTL 7 qtl MP:0002936 joint swelling IAGP N RGD:730281|PMID:12915467 19990101 RGD
731179 Mamtr3 Mammary tumor resistance QTL 3 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD
731180 Bp152 Blood pressure QTL 152 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:724791|PMID:14517349 19990101 RGD
731181 Uae27 Urinary albumin excretion QTL 27 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731182 Uae24 Urinary albumin excretion QTL 24 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD
731183 Pia20 Pristane induced arthritis QTL 20 qtl MP:0002936 joint swelling QTM N RGD:730280|PMID:14624754 19990101 RGD
731184 Mamtr4 Mammary tumor resistance QTL 4 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD
731185 MWF/Fub Munich Wistar Fromter strain MP:0001260 increased body weight induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female and Lew
731185 MWF/Fub Munich Wistar Fromter strain MP:0001262 decreased body weight IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi
731185 MWF/Fub Munich Wistar Fromter strain MP:0001262 decreased body weight IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain
731185 MWF/Fub Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain
731185 MWF/Fub Munich Wistar Fromter strain MP:0003917 increased kidney weight induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female and Lew
731185 MWF/Fub Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi
731185 MWF/Fub Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain
731185 MWF/Fub Munich Wistar Fromter strain MP:0004217 salt-sensitive hypertension induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to standard diet and LEW
731185 MWF/Fub Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:25314287|PMID:23241663 20210708 RGD compared to Wi
731185 MWF/Fub Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD compared to SHR/Fub strain
731185 MWF/Fub Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi
731185 MWF/Fub Munich Wistar Fromter strain MP:0006316 increased urine sodium level induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to Lew
731187 Iusm:HAD2 high-alcohol-drinking strain MP:0000482 long fibula onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2
731187 Iusm:HAD2 high-alcohol-drinking strain MP:0001260 increased body weight IAGP N RGD:155883170|PMID:16269906 20230313 RGD compared to Iusm:LAD2
731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004348 long femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2
731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004350 long humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2
731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004370 long ulna onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:730283|PMID:14623828 19990101 RGD
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0001262 decreased body weight IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in male
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0002834 decreased heart weight IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in female
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0005293 impaired glucose tolerance IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, MMO:0000326
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0005559 increased circulating glucose level IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in female
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm
731189 SHRSP.WKY-(<i>Klk1-D1Rat116</i>)/Izm strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm
731191 SHRSP.WKY-(<i>D2Rat14-D2Mgh12</i>)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
731191 SHRSP.WKY-(<i>D2Rat14-D2Mgh12</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
731192 SS.LEW-(<i>D3Rat52-D3Rat130</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr
731192 SS.LEW-(<i>D3Rat52-D3Rat130</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
731192 SS.LEW-(<i>D3Rat52-D3Rat130</i>)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr
731192 SS.LEW-(<i>D3Rat52-D3Rat130</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr
731194 SS.LEW-(<i>D3Chm64-D3Rat17</i>)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr
731194 SS.LEW-(<i>D3Chm64-D3Rat17</i>)/Ayd strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD
731194 SS.LEW-(<i>D3Chm64-D3Rat17</i>)/Ayd strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD
731195 DA.E3-(<i>D14Wox8-D14Rat64</i>)/Rhd strain MP:0002993 autoimmune arthritis IAGP N RGD:730280|PMID:14624754 19990101 RGD
734471 SS.LEW-(<i>D1Mgh7-D1Mco41</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734472 SS.LEW-(<i>D1Mco2-D1Wox6</i>)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734472 SS.LEW-(<i>D1Mco2-D1Wox6</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734474 SS.LEW-(<i>D5Mit9-D5Mco10</i>)/Jr strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734474 SS.LEW-(<i>D5Mit9-D5Mco10</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734474 SS.LEW-(<i>D5Mit9-D5Mco10</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734475 DA/OlaHsd strain MP:0001262 decreased body weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0002626 increased heart rate induced IAGP XCO:0000296 N RGD:731241|PMID:11015562 20200629 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0002833 increased heart weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0003022 increased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
734475 DA/OlaHsd strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
734475 DA/OlaHsd strain MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0003402 decreased liver weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
734475 DA/OlaHsd strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
734475 DA/OlaHsd strain MP:0003915 increased heart left ventricle weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734475 DA/OlaHsd strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd
734476 Crl:CD(SD) strain MP:0002079 increased circulating insulin level induces IAGP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD
734478 F344/DuCrl strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to SHRSP
734478 F344/DuCrl strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to SHRSP
734478 F344/DuCrl strain MP:0020088 decreased susceptibility to non-insulin-dependent diabetes IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to GK/KyoSwe
734479 SS.LEW-(<i>D1Mco2-D1Rat49</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 20201102 RGD compared to SS/Jr
734479 SS.LEW-(<i>D1Mco2-D1Rat49</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 20201102 RGD compared to SS/Jr
734480 SS.LEW-(<i>D10Mit10-D10Mgh1</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734480 SS.LEW-(<i>D10Mit10-D10Mgh1</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200205 RGD compared to SS/Jr
734480 SS.LEW-(<i>D10Mit10-D10Mgh1</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr
734480 SS.LEW-(<i>D10Mit10-D10Mgh1</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734481 SS.LEW-(<i>D1Mco2-D1Mco35</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734481 SS.LEW-(<i>D1Mco2-D1Mco35</i>)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734481 SS.LEW-(<i>D1Mco2-D1Mco35</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734481 SS.LEW-(<i>D1Mco2-D1Mco35</i>)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr
734483 SS.LEW-(<i>D1Rat42-D1Wox10</i>)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734483 SS.LEW-(<i>D1Rat42-D1Wox10</i>)/Jr strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0001559 hyperglycemia IAGP N RGD:619690|PMID:11087657 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj
734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:619690|PMID:11087657 20191106 RGD compared to F344/DuCrlCrlj
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0001258 decreased body length IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0001262 decreased body weight IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0002176 increased brain weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0003402 decreased liver weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000103 N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0006086 decreased body mass index IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0006352 decreased glycosylated hemoglobin level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0009287 decreased abdominal fat pad weight IAGP N RGD:734465|PMID:12190994 20111104 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0009299 decreased mesenteric fat pad weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734531 OLETF.F344-(<i>D1Rat306-D1Rat461</i>)/Got strain MP:0011940 decreased food intake IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD MMO:0000015
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0002962 increased urine protein level IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension severity IAGP XCO:0000164 N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc; more severe in males
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc; sexual dimorphism
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004875 increased mean systemic arterial blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004875 increased mean systemic arterial blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006265 increased pulse pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0008552 abnormal circulating tumor necrosis factor level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0010212 abnormal circulating C-reactive protein level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0010213 abnormal circulating fibrinogen level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics
734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0003918 decreased kidney weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc
734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 qtl MP:0001260 increased body weight QTM N RGD:619679|PMID:11355573 19990101 RGD
734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619679|PMID:11355573 19990101 RGD
734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0001262 decreased body weight IDA N RGD:734465|PMID:12190994 19990101 RGD
734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0005179 decreased circulating cholesterol level IDA N RGD:734465|PMID:12190994 19990101 RGD
734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0005318 decreased triglyceride level IDA N RGD:734465|PMID:12190994 19990101 RGD
734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0010025 decreased total body fat amount IDA N RGD:734465|PMID:12190994 20111104 RGD
734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0001262 decreased body weight IDA N RGD:619683|PMID:11153534 19990101 RGD
734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0002644 decreased circulating triglyceride level IDA N RGD:619683|PMID:11153534 19990101 RGD
734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0002727 decreased circulating insulin level IAGP N RGD:619683|PMID:11153534 19990101 RGD
734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0005292 improved glucose tolerance IAGP N RGD:619683|PMID:11153534 19990101 RGD
734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0010025 decreased total body fat amount IDA N RGD:619683|PMID:11153534 20111104 RGD
7349321 LEXF2D/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
7349322 LEXF8B/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD
735015 Dsg4 desmoglein 4 gene MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211111 RGD
735015 Dsg4 desmoglein 4 gene MP:0000416 sparse hair IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat)
735015 Dsg4 desmoglein 4 gene MP:0001211 wrinkled skin IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat)
735015 Dsg4 desmoglein 4 gene MP:0001242 hyperkeratosis IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat)
735015 Dsg4 desmoglein 4 gene MP:0001278 kinked vibrissae IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat)
735015 Dsg4 desmoglein 4 gene MP:0001283 sparse vibrissae IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat)
735025 Or2y13 olfactory receptor family 2 subfamily Y member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
735088 Flcn folliculin gene MP:0002080 prenatal lethality IAGP N RGD:1302869|PMID:14769940 20070105 RGD
735088 Flcn folliculin gene MP:0008762 embryonic lethality treatment IMP N RGD:13605606|PMID:16369488 20180606 RGD
735109 Unc5c unc-5 netrin receptor C gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD
735190 Or10al7 olfactory receptor family 10 subfamily AL member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD
7364940 F344-<i>Tp53<sup>tm1(EGFP-Pac)Qly</sup></i>/Rrrc strain MP:0002083 premature death IMP N RGD:12738450|PMID:27528400 20210428 RGD
7365043 SS.SR-(<i>rs65785750-rs106808193</i>)/Opaz strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd
7365043 SS.SR-(<i>rs65785750-rs106808193</i>)/Opaz strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd
7365043 SS.SR-(<i>rs65785750-rs106808193</i>)/Opaz strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd
7365049 Bp359 Blood pressure QTL 359 qtl MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD
737658 PVG.1AV1 Piebald-Virol-Glaxo strain MP:0010539 decreased level of surface class II molecules IAGP N RGD:1358146|PMID:15821736 20170825 RGD compared to DA strain
737688 Pax6<sup>Sey</sup> paired box gene 6, small eye mutation gene MP:0002233 abnormal nose morphology IAGP N RGD:1601213|PMID:7981749 20070410 RGD
737688 Pax6<sup>Sey</sup> paired box gene 6, small eye mutation gene MP:0005253 abnormal eye physiology IAGP N RGD:1601213|PMID:7981749 20070410 RGD
737691 BN/Crli strain MP:0008019 increased liver tumor incidence induced IAGP XCO:0000206 N RGD:1599590|PMID:17079458 20070314 RGD compared to F344/Crli ;
737818 Hcar12 Hepatocarcinoma resistance QTL 12 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD
737819 Hcas4 Hepatocarcinoma susceptibility QTL 4 qtl MP:0010264 increased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111108 RGD
737820 Alc9 Alcohol consumption QTL 9 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD
737821 Hcar9 Hepatocarcinoma resistance QTL 9 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD
737822 Alc10 Alcohol consumption QTL 10 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD
737823 Alc12 Alcohol consumption QTL 12 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD
737824 Hcar10 Hepatocarcinoma resistance QTL 10 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD
737825 Alc13 Alcohol consumption QTL 13 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD
737826 Alc11 Alcohol consumption QTL 11 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD
737827 Hcar11 Hepatocarcinoma resistance QTL 11 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD
737828 Hcas3 Hepatocarcinoma susceptibility QTL 3 qtl MP:0010264 increased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111108 RGD
737856 Edpm10 Estrogen-dependent pituitary mass QTL 10 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD
737857 DA.PVG.1AV1-(<i>D4Rat155-D4Rat84</i>) strain MP:0001263 weight loss IAGP XCO:0000266|XCO:0000280 N RGD:629560|PMID:12571866 20200815 RGD compared to PVG.1AV1/Kini
737857 DA.PVG.1AV1-(<i>D4Rat155-D4Rat84</i>) strain MP:0002933 joint inflammation penetrance IAGP XCO:0000280|XCO:0000263|XCO:0000266|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 19990101 RGD compared to DA/ZtmKini
737858 DA.PVG.1AV1-(<i>D4Rat155-Spr</i>) strain MP:0001263 weight loss IAGP XCO:0000281,XCO:0000265|XCO:0000263 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini
737858 DA.PVG.1AV1-(<i>D4Rat155-Spr</i>) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 19990101 RGD compared to PVG.1AV1/Kini
737859 DA.PVG.1AV1-(<i>D4Mgh17-D4Rat56</i>) strain MP:0001263 weight loss sexual_dimorphism IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD in males, compared to DA/ZtmKini
737859 DA.PVG.1AV1-(<i>D4Mgh17-D4Rat56</i>) strain MP:0002933 joint inflammation sexual_dimorphism IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD in males, compared to DA/ZtmKini
737859 DA.PVG.1AV1-(<i>D4Mgh17-D4Rat56</i>) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini
737861 DA.PVG.1AV1-(<i>D4Rat63-D4Rat203</i>) strain MP:0001263 weight loss severity IAGP XCO:0000265,XCO:0000281 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
737861 DA.PVG.1AV1-(<i>D4Rat63-D4Rat203</i>) strain MP:0002933 joint inflammation severity IAGP XCO:0000280|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
737861 DA.PVG.1AV1-(<i>D4Rat63-D4Rat203</i>) strain MP:0002933 joint inflammation susceptibility IAGP XCO:0000263 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini
737861 DA.PVG.1AV1-(<i>D4Rat63-D4Rat203</i>) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000281,XCO:0000265|XCO:0000263|XCO:0000280 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini
737861 DA.PVG.1AV1-(<i>D4Rat63-D4Rat203</i>) strain MP:0008501 increased IgG2b level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini
737862 SHRSP.WKY-(<i>D2Rat14-D2Mit5</i>)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
737862 SHRSP.WKY-(<i>D2Rat14-D2Mit5</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015
737863 SHRSP.WKY-(<i>D2Wox9-D2Mgh12</i>)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc
737864 SS.SR-(<i>D13Mit9-D13Mit1</i>)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61047|PMID:9271663 19990101 RGD compared to SS/Jr
737866 WKY.SHRSP-(<I>D2Rat14-D2Mit5</I>) strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 20201027 RGD
737870 DA.E3-(<i>D20Wox3-D20Mgh4</i>)/Rhd strain MP:0005092 decreased double-positive T cell number severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd
737871 DA.E3-(<i>D12Got46-D12Rat26</i>)/Rhd strain MP:0001876 decreased inflammatory response IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain
737871 DA.E3-(<i>D12Got46-D12Rat26</i>)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain
737871 DA.E3-(<i>D12Got46-D12Rat26</i>)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd
737871 DA.E3-(<i>D12Got46-D12Rat26</i>)/Rhd strain MP:0021039 decreased circulating orosomucoid 1 protein level IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain
737872 DA.E3-(<i>D4Mit16-D4Mgh11</i>)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:631850|PMID:12817024 19990101 RGD compared to treated DA/ZtmRhd
737872 DA.E3-(<i>D4Mit16-D4Mgh11</i>)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd
737873 DA.E3-(<i>D6Wox5-D6Rat90</i>)/Rhd strain MP:0002993 autoimmune arthritis IAGP N RGD:728382|PMID:14611807 19990101 RGD
737891 Crl:SD strain MP:0002963 decreased urine protein level ameliorates IAGP XCO:0000588 N RGD:25314278|PMID:1580281 20210708 RGD compared with untreated
737891 Crl:SD strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000548 N RGD:68697|PMID:11208766 20200211 RGD compared to untreated
737891 Crl:SD strain MP:0004876 decreased mean systemic arterial blood pressure induces IMP XCO:0000897 N RGD:13792700|PMID:27335281 20210929 RGD
737891 Crl:SD strain MP:0005333 decreased heart rate induces IDA N RGD:13792700|PMID:27335281 20211112 RGD Compared to untreated
737891 Crl:SD strain MP:0005333 decreased heart rate induces IMP XCO:0000897 N RGD:13792700|PMID:27335281 20210929 RGD
737891 Crl:SD strain MP:0005633 increased circulating sodium level induces IDA N RGD:13792700|PMID:27335281 20211112 RGD compared to 0 min
737891 Crl:SD strain MP:0006264 decreased systemic arterial systolic blood pressure ameliorates IAGP N RGD:25314278|PMID:1580281 20210723 RGD compared with untreated
737891 Crl:SD strain MP:0008997 increased blood osmolality induces IDA N RGD:13792700|PMID:27335281 20211112 RGD compared to 0 min
737892 ACI/SegHsd strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000092 N RGD:1642522|PMID:16885383 20070927 RGD compared to treated BN/SsNHsd
737892 ACI/SegHsd strain MP:0002044 increased colon adenoma incidence induced IAGP XCO:0000393 N RGD:1625309|PMID:17510081 20200316 RGD compared to treated WF/CrCrli
737892 ACI/SegHsd strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl
737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to ACI/SegHsd
737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl
737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD compared to ACI/SegHsd and treated COP/CrCrl
737892 ACI/SegHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD compared to BN/HsdMcwiCrl
737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to ACI/SegHsd
737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared with ACI/SedHsd, treated BN/SsNHsd
737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl
737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD
737892 ACI/SegHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000092 N RGD:1358956|PMID:11713205 20200310 RGD compared to COP/OlaHsd
737892 ACI/SegHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI.COP-(D6Rat80-D6Rat146)/Shul��
737892 ACI/SegHsd strain MP:0010308 decreased tumor latency MODEL: induced IAGP XCO:0000092 N RGD:1642522|PMID:16885383 20200317 RGD compared to treated BN/SsNHsd
737895 WKY/Ztm strain MP:0004502 decreased incidence of tumors by chemical induction MODEL: control IAGP XCO:0000090 N RGD:1599317|PMID:16596452 20200316 RGD compared to 7,12-dimethyltetraphene treated SPRD/Ztm
737899 BN/Cub strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub
737899 BN/Cub strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub
737899 BN/Cub strain MP:0013278 decreased fasting circulating glucose level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub
737903 Hsd:SD Sprague Dawley strain MP:0001859 kidney inflammation induced IAGP XCO:0000599,XCO:0000367,XCO:0000790 N RGD:6903837|PMID:12675855 20121003 RGD
737903 Hsd:SD Sprague Dawley strain MP:0002498 abnormal acute inflammation induced IAGP XCO:0000599,XCO:0000367,XCO:0000790 N RGD:6903837|PMID:12675855 20121003 RGD
737903 Hsd:SD Sprague Dawley strain MP:0002981 increased liver weight induced IAGP XCO:0000600 N RGD:13204753|PMID:23859880 20210630 RGD
737903 Hsd:SD Sprague Dawley strain MP:0002981 increased liver weight induced IAGP XCO:0000844 N RGD:38549342|PMID:29548889 20210629 RGD
737903 Hsd:SD Sprague Dawley strain MP:0004956 decreased thymus weight induced IAGP XCO:0000600 N RGD:13204753|PMID:23859880 20210630 RGD
737903 Hsd:SD Sprague Dawley strain MP:0005584 abnormal enzyme/coenzyme activity induced IAGP XCO:0000844|XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD increased EROD, PROD
737903 Hsd:SD Sprague Dawley strain MP:0020169 increased thyroid gland weight induced IAGP XCO:0000845|XCO:0000844 N RGD:38549342|PMID:29548889 20210629 RGD
737903 Hsd:SD Sprague Dawley strain MP:0021085 increased DNA replication induced IAGP XCO:0000844|XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD
737905 LEW/Maas strain MP:0010451 kidney microaneurysm induced IAGP XCO:0000282 N RGD:2312422|PMID:18682577 20090812 RGD compared to LEW/Mol
737906 MWF/Hsd Munich Wistar Fromter strain MP:0000208 decreased hematocrit induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0000221 decreased leukocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0000276 heart right ventricle hypertrophy induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0001262 decreased body weight induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0001544 abnormal cardiovascular system physiology induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0001552 increased circulating triglyceride level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
737906 MWF/Hsd Munich Wistar Fromter strain MP:0002875 decreased erythrocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0003822 decreased left ventricle systolic pressure induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0004876 decreased mean systemic arterial blood pressure induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control
737906 MWF/Hsd Munich Wistar Fromter strain MP:0005178 increased circulating cholesterol level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
737906 MWF/Hsd Munich Wistar Fromter strain MP:0005264 glomerulosclerosis IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH
737906 MWF/Hsd Munich Wistar Fromter strain MP:0009814 increased prostaglandin level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH
737906 MWF/Hsd Munich Wistar Fromter strain MP:0011431 increased urine flow rate IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW
737906 MWF/Hsd Munich Wistar Fromter strain MP:0020110 increased thromboxane level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH
737906 MWF/Hsd Munich Wistar Fromter strain MP:0020419 decreased cardiac muscle relaxation induced IAGP XCO:0000143 N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH
737906 MWF/Hsd Munich Wistar Fromter strain MP:0030661 increased circulating arginine level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to FHH
737907 SS.SR-<i>Inha</i>/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61053|PMID:9722941 19990101 RGD compared to SS/Jr
737907 SS.SR-<i>Inha</i>/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61053|PMID:9722941 19990101 RGD compared to SS/Jr
737908 WF/NHsd strain MP:0000208 decreased hematocrit IAGP N RGD:11531111|PMID:3285908 20200623 RGD compared to LE
737908 WF/NHsd strain MP:0000218 increased leukocyte cell number IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD
737908 WF/NHsd strain MP:0001262 decreased body weight IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD
737908 WF/NHsd strain MP:0002599 increased mean platelet volume IAGP N RGD:11531111|PMID:3285908 20160826 RGD compared to LE
737908 WF/NHsd strain MP:0002599 increased mean platelet volume IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD
737908 WF/NHsd strain MP:0003179 thrombocytopenia IAGP N RGD:11531111|PMID:3285908 20160826 RGD compared to LE
737908 WF/NHsd strain MP:0003179 thrombocytopenia IAGP N RGD:11531112|PMID:3414775 20160826 RGD compared to SD
737908 WF/NHsd strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF.WKY-(D5Wox7-D5Uwm37)/Uwm
737908 WF/NHsd strain MP:0005505 thrombocytosis induced IAGP XCO:0000727 N RGD:11531111|PMID:3285908 20200626 RGD compared to untreated WF/Nhsd
737908 WF/NHsd strain MP:0005606 increased bleeding time IAGP N RGD:11531110|PMID:9473225 20160826 RGD compared to Hsd:WI
737908 WF/NHsd strain MP:0008255 decreased megakaryocyte cell number IAGP N RGD:11531112|PMID:3414775 20160826 RGD compared to SD
737908 WF/NHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF.WKY-(D5Wox7-D5Uwm37)/Uwm
737908 WF/NHsd strain MP:0014060 abnormal platelet alpha-granule morphology IAGP N RGD:11531117|PMID:2040691 20160829 RGD compared to Hsd:WI
737908 WF/NHsd strain MP:0020399 enhanced megakaryocyte emperipolesis IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD
737921 BDIV/lfz strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain
737921 BDIV/lfz strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain
737922 LEW/SsNHsd strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
737922 LEW/SsNHsd strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
737922 LEW/SsNHsd strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
737922 LEW/SsNHsd strain MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis induced IAGP XCO:0000288 N RGD:2296064|PMID:18453595 20080630 RGD compared to F344/NHsd
737922 LEW/SsNHsd strain MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IAGP N RGD:2293749|PMID:18281616 20080612 RGD
737922 LEW/SsNHsd strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
737922 LEW/SsNHsd strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated DA/OlaHsd
737926 F344/NCrl strain MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240419 RGD compared to female
737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000304 N RGD:127285625|PMID:27856527 20210623 RGD Por
737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000372,XCO:0000880 N RGD:127285625|PMID:27856527 20210720 RGD Arnt, Por
737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000879 N RGD:127285625|PMID:27856527 20210720 RGD Arnt
737929 Crl:WI Wistar rats strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:68697|PMID:11208766 20200211 RGD compared to no sodium content diet
737930 LEW/Ztm LEW/Ztm strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000263 N RGD:1299867|PMID:15081107 20200720 RGD
737932 LEW/Crl Lewis strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
737932 LEW/Crl Lewis strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20080513 RGD compared to female LEW-Tg(Ren2)27/Jmul
737932 LEW/Crl Lewis strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737932 LEW/Crl Lewis strain MP:0003916 decreased heart left ventricle weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
737932 LEW/Crl Lewis strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737932 LEW/Crl Lewis strain MP:0003918 decreased kidney weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
737932 LEW/Crl Lewis strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737932 LEW/Crl Lewis strain MP:0005425 increased macrophage cell number induces IAGP XCO:0000861,XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to mAb OX8 and 341 treated
737932 LEW/Crl Lewis strain MP:0005583 decreased renin activity sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl in kidney
737932 LEW/Crl Lewis strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737932 LEW/Crl Lewis strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737932 LEW/Crl Lewis strain MP:0008074 increased CD4-positive, alpha-beta T cell number induces IAGP XCO:0000861,XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to mAb OX8,341 treated and CB8KO rat
737932 LEW/Crl Lewis strain MP:0010212 abnormal circulating C-reactive protein level sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl
737932 LEW/Crl Lewis strain MP:0011079 decreased macrophage cytokine production IAGP N RGD:2293336|PMID:18443593 20210107 RGD compared to WKY/NCrl
737932 LEW/Crl Lewis strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr
737950 DA/Ztm strain MP:0000753 paralysis induced IAGP N RGD:1302437|PMID:15240732 20080702 RGD
737950 DA/Ztm strain MP:0003724 increased susceptibility to induced arthritis penetrance IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266| N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1
737957 WOKW/K strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000798 N RGD:1642517|PMID:17875345 20070925 RGD compared to DA/K
737957 WOKW/K strain MP:0011939 increased food intake IAGP N RGD:1642517|PMID:17875345 20070925 RGD compared to DA/K
737960 Hsd:WI Wistar strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
737960 Hsd:WI Wistar strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
737960 Hsd:WI Wistar strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD
737960 Hsd:WI Wistar strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi
737962 SPRD/Ztm strain MP:0004499 increased incidence of tumors by chemical induction MODEL: induced IAGP XCO:0000090 N RGD:1599317|PMID:16596452 20200316 RGD compared to 7,12-dimethyltetraphene treated WKY/Ztm
737962 SPRD/Ztm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20200708 RGD compared to WKY
737972 BN/Crl strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female BN/Crl
737972 BN/Crl strain MP:0004702 increased circulating insulin-like growth factor I level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD male compared to female
737972 BN/Crl strain MP:0005137 increased growth hormone level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD female compared to male BN/Crl
737972 BN/Crl strain MP:0005139 increased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to male BN/Crl
737973 Pia21 Pristane induced arthritis QTL 21 qtl MP:0003079 decreased susceptibility to induced joint inflammation IDA N RGD:631850|PMID:12817024 19990101 RGD
737974 Bp161 Blood pressure QTL 161 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD
737975 Bw122 Body weight QTL 122 qtl MP:0001260 increased body weight QTM N RGD:737696|PMID:14756694 19990101 RGD
737976 Pia24 Pristane induced arthritis QTL 24 qtl MP:0002936 joint swelling IAGP N RGD:728382|PMID:14611807 19990101 RGD
737977 Bp160 Blood pressure QTL 160 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD
737977 Bp160 Blood pressure QTL 160 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD
737978 Pia23 Pristane induced arthritis QTL 23 qtl MP:0002936 joint swelling IAGP N RGD:631850|PMID:12817024 19990101 RGD
737979 Pia22 Pristane induced arthritis QTL 22 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD
738005 Anxrr11 Anxiety related response QTL 11 qtl MP:0001399 hyperactivity IAGP N RGD:737695|PMID:14739700 19990101 RGD
738006 Anxrr14 Anxiety related response QTL 14 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD
738007 Anxrr7 Anxiety related response QTL 7 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738007 Anxrr7 Anxiety related response QTL 7 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD
738008 Hcar14 Hepatocarcinoma resistance QTL 14 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738009 Sach4 Saccharine consumption QTL 4 qtl MP:0002850 saccharin preference IDA N RGD:731213|PMID:12972953 20111114 RGD
738009 Sach4 Saccharine consumption QTL 4 qtl MP:0002850 saccharin preference QTM N RGD:731213|PMID:12972953 19990101 RGD
738010 Lnnr3 Liver neoplastic nodule remodeling QTL 3 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738011 Anxrr9 Anxiety related response QTL 9 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738011 Anxrr9 Anxiety related response QTL 9 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD
738012 Anxrr3 Anxiety related response QTL 3 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738013 Alc15 Alcohol consumption QTL 15 qtl MP:0001425 abnormal alcohol consumption QTM N RGD:731213|PMID:12972953 19990101 RGD
738014 Anxrr15 Anxiety related response QTL 15 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD
738015 Pia9 Pristane induced arthritis QTL 9 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD
738016 Alc16 Alcohol consumption QTL 16 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD
738017 Hcas7 Hepatocarcinoma susceptibility QTL 7 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD
738018 Anxrr4 Anxiety related response QTL 4 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738019 Anxrr10 Anxiety related response QTL 10 qtl MP:0001399 hyperactivity IAGP N RGD:737695|PMID:14739700 19990101 RGD
738020 Pia8 Pristane induced arthritis QTL 8 qtl MP:0002936 joint swelling IAGP N RGD:629570|PMID:11090241 19990101 RGD
738021 Hcar13 Hepatocarcinoma resistance QTL 13 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738022 Anxrr13 Anxiety related response QTL 13 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD
738023 Alc17 Alcohol consumption QTL 17 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD
738024 Sach5 Saccharine consumption QTL 5 qtl MP:0002850 saccharin preference IDA N RGD:731213|PMID:12972953 20111114 RGD
738024 Sach5 Saccharine consumption QTL 5 qtl MP:0002850 saccharin preference QTM N RGD:731213|PMID:12972953 19990101 RGD
738025 Stresp3 Stress response QTL 3 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD
738025 Stresp3 Stress response QTL 3 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD
738026 Lnnr5 Liver neoplastic nodule remodeling QTL 5 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738027 Lnnr6 Liver neoplastic nodule remodeling QTL 6 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738028 Anxrr12 Anxiety related response QTL 12 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD
738029 Stresp2 Stress response QTL 2 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD
738029 Stresp2 Stress response QTL 2 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD
738030 Anxrr8 Anxiety related response QTL 8 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738030 Anxrr8 Anxiety related response QTL 8 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD
738031 Alc14 Alcohol consumption QTL 14 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD
738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD
738033 Anxrr6 Anxiety related response QTL 6 qtl MP:0001362 abnormal anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738034 Anxrr5 Anxiety related response QTL 5 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD
738035 Stresp1 Stress response QTL 1 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD
738035 Stresp1 Stress response QTL 1 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD
738036 Lnnr4 Liver neoplastic nodule remodeling QTL 4 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD
738037 Hcas6 Hepatocarcinoma susceptibility QTL 6 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD
738038 HEP high ethanol preferring strain MP:0001399 hyperactivity IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY
738038 HEP high ethanol preferring strain MP:0001987 alcohol preference IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY
738038 HEP high ethanol preferring strain MP:0002850 saccharin preference IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY
738038 HEP high ethanol preferring strain MP:0003545 increased alcohol consumption IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY
738120 LEW-Tg(HLA-B*2705m1,B2M)133-1Trg<sup>Tg/Tg</sup> strain MP:0001875 testis inflammation IAGP N RGD:731214|PMID:10450519 19990101 RGD
738120 LEW-Tg(HLA-B*2705m1,B2M)133-1Trg<sup>Tg/Tg</sup> strain MP:0002816 colitis IAGP N RGD:731214|PMID:10450519 19990101 RGD
738120 LEW-Tg(HLA-B*2705m1,B2M)133-1Trg<sup>Tg/Tg</sup> strain MP:0002993 autoimmune arthritis IAGP N RGD:731214|PMID:10450519 19990101 RGD
7387227 Uae40 Urinary albumin excretion QTL 40 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387235 Uae41 Urinary albumin excretion QTL 41 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387267 Uae42 Urinary albumin excretion QTL 42 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387280 Uae43 Urinary albumin excretion QTL 43 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387283 Uae44 Urinary albumin excretion QTL 44 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387289 Uae45 Urinary albumin excretion QTL 45 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387292 Kidm42 Kidney mass QTL 42 qtl MP:0003917 increased kidney weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387306 Bw124 Body weight QTL 124 qtl MP:0001260 increased body weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387312 Bw125 Body weight QTL 125 qtl MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7387318 Stl32 Serum triglyceride level QTL 32 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:7365117|PMID:20159938 20131029 RGD
7394701 Uae46 Urinary albumin excretion QTL 46 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131030 RGD
7394708 Emca11 Estrogen-induced mammary cancer QTL 11 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD
7394710 Emca12 Estrogen-induced mammary cancer QTL 12 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD
7394712 Emca13 Estrogen-induced mammary cancer QTL 13 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD
7394818 P.NP-(<i>D4Mgh16-D4Rat173</i>)/Iusm strain MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD
7394826 Bw126 Body weight QTL 126 qtl MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD
7394837 Memor18 Memory QTL 18 qtl MP:0001463 abnormal spatial learning IDA N RGD:7394833|PMID:23469157 20131107 RGD
7401203 SS.SR-(<i>rs105019230-D17Rat44</i>)/Opaz strain MP:0001463 abnormal spatial learning IAGP N RGD:7394833|PMID:23469157 20131107 RGD compared to Dahl S
7411542 Bw127 Body weight QTL 127 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411545 Bw128 Body weight QTL 128 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411547 Bw129 Body weight QTL 129 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411549 Bw130 Body weight QTL 130 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411551 Bw131 Body weight QTL 131 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411555 Bw132 Body weight QTL 132 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411558 Bw133 Body weight QTL 133 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411561 Bw134 Body weight QTL 134 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411564 Bw135 Body weight QTL 135 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411566 Bw136 Body weight QTL 136 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411569 Bw137 Body weight QTL 137 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411571 Bw138 Body weight QTL 138 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411573 Bw139 Body weight QTL 139 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411575 Bw140 Body weight QTL 140 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411577 Bw141 Body weight QTL 141 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411579 Bw142 Body weight QTL 142 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411582 Foco3 Food consumption QTL 3 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20160108 RGD
7411582 Foco3 Food consumption QTL 3 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20160108 RGD
7411584 Foco4 Food consumption QTL 4 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411584 Foco4 Food consumption QTL 4 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411586 Foco5 Food consumption QTL 5 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411586 Foco5 Food consumption QTL 5 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411588 Foco6 Food consumption QTL 6 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411588 Foco6 Food consumption QTL 6 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411590 Foco7 Food consumption QTL 7 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411590 Foco7 Food consumption QTL 7 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411592 Foco8 Food consumption QTL 8 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411592 Foco8 Food consumption QTL 8 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411595 Foco9 Food consumption QTL 9 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411595 Foco9 Food consumption QTL 9 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411597 Foco10 Food consumption QTL 10 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411597 Foco10 Food consumption QTL 10 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411599 Foco11 Food consumption QTL 11 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411599 Foco11 Food consumption QTL 11 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411601 Foco12 Food consumption QTL 12 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411601 Foco12 Food consumption QTL 12 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411603 Foco13 Food consumption QTL 13 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411603 Foco13 Food consumption QTL 13 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411605 Foco14 Food consumption QTL 14 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411605 Foco14 Food consumption QTL 14 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411607 Foco15 Food consumption QTL 15 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411607 Foco15 Food consumption QTL 15 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411609 Foco16 Food consumption QTL 16 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411609 Foco16 Food consumption QTL 16 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411611 Foco17 Food consumption QTL 17 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411611 Foco17 Food consumption QTL 17 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411614 Foco18 Food consumption QTL 18 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411614 Foco18 Food consumption QTL 18 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411641 Foco19 Food consumption QTL 19 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411641 Foco19 Food consumption QTL 19 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411643 Foco20 Food consumption QTL 20 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411643 Foco20 Food consumption QTL 20 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411646 Foco21 Food consumption QTL 21 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411646 Foco21 Food consumption QTL 21 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411648 Foco22 Food consumption QTL 22 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411648 Foco22 Food consumption QTL 22 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411650 Foco23 Food consumption QTL 23 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411650 Foco23 Food consumption QTL 23 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411652 Foco24 Food consumption QTL 24 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411652 Foco24 Food consumption QTL 24 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411654 Foco25 Food consumption QTL 25 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411654 Foco25 Food consumption QTL 25 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411656 Foco26 Food consumption QTL 26 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411656 Foco26 Food consumption QTL 26 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411658 Foco27 Food consumption QTL 27 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411658 Foco27 Food consumption QTL 27 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411660 Foco28 Food consumption QTL 28 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411660 Foco28 Food consumption QTL 28 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411662 Foco29 Food consumption QTL 29 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411662 Foco29 Food consumption QTL 29 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411664 Foco30 Food consumption QTL 30 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411664 Foco30 Food consumption QTL 30 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411666 Foco31 Food consumption QTL 31 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411666 Foco31 Food consumption QTL 31 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411668 Foco32 Food consumption QTL 32 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411668 Foco32 Food consumption QTL 32 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0002135 abnormal kidney morphology IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to WKY/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0003918 decreased kidney weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc
7411676 SHRSP.WKY-(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc
7411679 SHRSP.WKY-(<i>D2Rat13-D2Rat157</i>)(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0002135 abnormal kidney morphology IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to WKY/Gcrc
7411679 SHRSP.WKY-(<i>D2Rat13-D2Rat157</i>)(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to SHRSP/Gcrc
7411679 SHRSP.WKY-(<i>D2Rat13-D2Rat157</i>)(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc
7411679 SHRSP.WKY-(<i>D2Rat13-D2Rat157</i>)(<i>D3Mgh16-D3Rat114</i>)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc
7411705 SHR.SHRSP-(<i>D1Rat93-D1Rat269</i>)(<i>D18Rat73-D18Rat11</i>)/Izm strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7411685|PMID:23690346 20131119 RGD compared to SHR and baseline
7411707 SHRSP.SHR-(<i>D1Mgh5-D1Got87</i>)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm
7411709 SHRSP.SHR-(<i>D1Mit30-D1Rat269</i>)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm
7411712 Strs4 Sensitivity to stroke QTL 4 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD
7411719 Strs5 Sensitivity to stroke QTL 5 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD
7411722 Strs6 Sensitivity to stroke QTL 6 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD
7411725 Strs7 Sensitivity to stroke QTL 7 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:7411685|PMID:23690346 20131119 RGD
7411725 Strs7 Sensitivity to stroke QTL 7 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD
7421599 SS.LEW-(<i>D1Chm64-D1Rat19</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421603 SS.LEW-(<i>D1Rat320-D1Mgh32</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421606 SS.LEW-(<i>D1Uia4-D1Rat320</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421610 SS.LEW-(<i>D5Mit5-D5M4Mit14</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD
7421612 SS.LEW-(<i>D16Chm48-D16Chm60</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
7421612 SS.LEW-(<i>D16Chm48-D16Chm60</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421612 SS.LEW-(<i>D16Chm48-D16Chm60</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
7421617 SS.LEW-(<i>D17Chm14-D17Rat65</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD
7421619 SS.LEW-(<i>D17Chm85-D17Chm71</i>)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD
7421621 SS.LEW-(<i>D17Chm131-D17Chm93</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
7421621 SS.LEW-(<i>D17Chm131-D17Chm93</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421621 SS.LEW-(<i>D17Chm131-D17Chm93</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
7421623 SS.LEW-(<i>D17Rat84-D17Chm17</i>)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr
7421626 Bp360 Blood pressure QTL 360 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced
7421628 Bp361 Blood pressure QTL 361 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced
7421630 Bp362 Blood pressure QTL 362 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced
7421634 SS.MNS-(<i>D2Got93-D2Rat222</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421636 SS.MNS-(<i>D2Chm90-D2Rat38</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20201215 RGD compared to C2S.M21
7421638 SS.MNS-(<i>D2Chm381-D2Chm225</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421640 SS.MNS-(<i>D2Rat155-D2Chm161</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421640 SS.MNS-(<i>D2Rat155-D2Chm161</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
7421643 SS.MNS-(<i>D2Chm254-D2Chm161</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421643 SS.MNS-(<i>D2Chm254-D2Chm161</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
7421645 SS.MNS-(<i>D2Rat155-D2Chm419</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421647 SS.MNS-(<i>D2Chm161-D2Chm410</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421649 SS.MNS-(<i>D2Chm153-D2Chm410</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421654 SS.MNS-(<i>D2Chm366-D2Rat52</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr
7421654 SS.MNS-(<i>D2Chm366-D2Rat52</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
7488904 Bp363 Blood pressure QTL 363 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488925 Bp364 Blood pressure QTL 364 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488927 Bp365 Blood pressure QTL 365 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488929 Bp366 Blood pressure QTL 366 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488931 Bp367 Blood pressure QTL 367 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488933 Bp368 Blood pressure QTL 368 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr
7488963 Bp369 Blood pressure QTL 369 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced
7488966 Bp370 Blood pressure QTL 370 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced
7771589 SS.SR-(<i>D2Rat352-rs63922710</i>)/Opaz strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd
7771589 SS.SR-(<i>D2Rat352-rs63922710</i>)/Opaz strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd
7771589 SS.SR-(<i>D2Rat352-rs63922710</i>)/Opaz strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd
7771589 SS.SR-(<i>D2Rat352-rs63922710</i>)/Opaz strain MP:0006266 decreased pulse pressure IAGP N RGD:7495755|PMID:23861781 20201005 RGD compared to SS/JrHsd
7771589 SS.SR-(<i>D2Rat352-rs63922710</i>)/Opaz strain MP:0012307 impaired spatial learning sexual_dimorphism IAGP N RGD:7495755|PMID:23861781 20131220 RGD in males compared to SS/JrHsd
7771603 Bp371 Blood pressure QTL 371 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD
7771603 Bp371 Blood pressure QTL 371 qtl MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD
7771603 Bp371 Blood pressure QTL 371 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD
7771605 Memor19 Memory QTL 19 qtl MP:0012307 impaired spatial learning IAGP N RGD:7495755|PMID:23861781 20131220 RGD
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0001260 increased body weight IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0001260 increased body weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20131220 RGD compared to F344/DuCrl
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20131220 RGD compared to SHRSP
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to F344
7771610 SHRSP-Chr 1<sup>F344</sup>/Rkb strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl
7771612 Cm80 Cardiac mass QTL 80 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:7771608|PMID:23901062 20131220 RGD
7771612 Cm80 Cardiac mass QTL 80 qtl MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20131220 RGD
7794706 SS.LEW-(<i>D5Mco39-D5Mco41</i>)(<i>D5Mco42-D5Mco47</i>)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco
7794706 SS.LEW-(<i>D5Mco39-D5Mco41</i>)(<i>D5Mco42-D5Mco47</i>)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco
7794706 SS.LEW-(<i>D5Mco39-D5Mco41</i>)(<i>D5Mco42-D5Mco47</i>)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco
7794706 SS.LEW-(<i>D5Mco39-D5Mco41</i>)(<i>D5Mco42-D5Mco47</i>)/Mco strain MP:0006266 decreased pulse pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco
7794739 Bp372 Blood pressure QTL 372 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD
7794743 Bp373 Blood pressure QTL 373 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD
7794784 Mcs31 Mammary carcinoma susceptibility QTL 31 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD
7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD
7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD
7794793 Mcs34 Mammary carcinoma susceptibility QTL 34 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD
7800671 F344-<i>Sv2a<sup>m1Kyo</sup></i> strain MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170317 RGD
7800671 F344-<i>Sv2a<sup>m1Kyo</sup></i> strain MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170317 RGD
8142383 SHRSP/BbbUtx strain MP:0002494 increased IgM level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx renal anti-dsDNA antibodies
8142383 SHRSP/BbbUtx strain MP:0002871 albuminuria IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0004974 decreased regulatory T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney
8142383 SHRSP/BbbUtx strain MP:0005014 increased B cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney
8142383 SHRSP/BbbUtx strain MP:0005015 increased T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney
8142383 SHRSP/BbbUtx strain MP:0005095 decreased T cell proliferation IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0006414 decreased T cell apoptosis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx
8142383 SHRSP/BbbUtx strain MP:0008074 increased CD4-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney
8142383 SHRSP/BbbUtx strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney
8142383 SHRSP/BbbUtx strain MP:0008567 decreased interferon-gamma secretion IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx T cells
8142383 SHRSP/BbbUtx strain MP:0008688 decreased interleukin-2 secretion IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx T cells
8142383 SHRSP/BbbUtx strain MP:0011405 tubulointerstitial nephritis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0011854 cerebral edema IAGP XCO:0000795 N RGD:150429755|PMID:31608789 20210927 RGD compared to SHRSP.SHR-(rs198233821-rs198932221)/Utx
8142383 SHRSP/BbbUtx strain MP:0020879 abnormal calcium level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx CD4+ T cells
8142383 SHRSP/BbbUtx strain MP:0020989 increased urine lipocalin 2 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0020992 increased urine HAVCR1 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142383 SHRSP/BbbUtx strain MP:0020996 increased urine osteopontin level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx
8142385 SHR/Utx strain MP:0020988 decreased urine lipocalin 2 level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males
8142385 SHR/Utx strain MP:0020991 decreased urine HAVCR1 level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males
8142385 SHR/Utx strain MP:0020995 decreased urine osteopontin level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males
8549776 F344-<i>Lep<sup>m1Kyo</sup></i> F344 OB rat strain MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD
8549776 F344-<i>Lep<sup>m1Kyo</sup></i> F344 OB rat strain MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170317 RGD
8549776 F344-<i>Lep<sup>m1Kyo</sup></i> F344 OB rat strain MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD
8551785 SS.LEW-(<i>D18Wox7-D18Rat67</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr
8551787 SS.LEW-(<i>D18Rat55-D18Mgh2</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr
8551787 SS.LEW-(<i>D18Rat55-D18Mgh2</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
8551789 SS.LEW-(<i>D18Chm59-D18Rat1</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr
8552275 F344-<i>Lgi1<sup>m1Kyo</sup></i> strain MP:0001496 audiogenic seizures IMP XCO:0000048 N RGD:14995940|PMID:30813600 20191105 RGD compared to F344/NSlc
8552275 F344-<i>Lgi1<sup>m1Kyo</sup></i> strain MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)(Lgi1)
8552275 F344-<i>Lgi1<sup>m1Kyo</sup></i> strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)(Lgi1)
8552298 DA-<i>Tyr<sup>em1Kyo</i></sup> strain MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170317 RGD DNA:deletion:cds:
8552341 DA.PVG.1AV1-(<i>D10Got6-D10Rat184</i>)/Kini strain MP:0010539 decreased level of surface class II molecules IAGP N RGD:7242893|PMID:18292553 20170825 RGD
8552782 Vie1 Viral induced encephalitis QTL 1 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552791 Vie2 Viral induced encephalitis QTL 2 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552796 Vie3 Viral induced encephalitis QTL 3 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552801 Bw143 Body weight QTL 143 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552803 Bw144 Body weight QTL 144 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552805 Bw145 Body weight QTL 145 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552807 Vie4 Viral induced encephalitis QTL 4 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552809 Vie5 Viral induced encephalitis QTL 5 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD
8552891 Epfw5 Epididymal fat weight QTL 5 qtl MP:0009289 decreased epididymal fat pad weight IDA N RGD:8552892|PMID:24099777 20140430 RGD
8552900 Pigfal1 Plasma insulin-like growth factor 1 level QTL 1 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552903 Pigfal2 Plasma insulin-like growth factor 1 level QTL 2 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552906 Pigfal3 Plasma insulin-like growth factor 1 level QTL 3 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552910 Pigfal5 Plasma insulin-like growth factor 1 level QTL 5 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552920 Pigfal8 Plasma insulin-like growth factor 1 level QTL 8 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552928 Pigfal9 Plasma insulin-like growth factor 1 level QTL 9 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552935 Pigfal10 Plasma insulin-like growth factor 1 level QTL 10 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552948 Pigfal11 Plasma insulin-like growth factor 1 level QTL 11 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552950 Pigfal12 Plasma insulin-like growth factor 1 level QTL 12 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552952 Pigfal13 Plasma insulin-like growth factor 1 level QTL 13 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552954 Pigfal14 Plasma insulin-like growth factor 1 level QTL 14 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552962 Pigfal16 Plasma insulin-like growth factor 1 level QTL 16 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552966 Pigfal18 Plasma insulin-like growth factor 1 level QTL 18 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8552968 Pigfal19 Plasma insulin-like growth factor 1 level QTL 19 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD
8553187 FHH.BN(<i>D14Rat98-D14Hmgc4</i>)/Mcwi strain MP:0008139 fused podocyte foot processes ameliorates IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to FHH
8553187 FHH.BN(<i>D14Rat98-D14Hmgc4</i>)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to BN
8553187 FHH.BN(<i>D14Rat98-D14Hmgc4</i>)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function ameliorates IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to FHH
8655649 Arrd1 Age-related retinal degeneration QTL 1 qtl MP:0003727 abnormal retina layer morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD
8655655 Arrd2 Age-related retinal degeneration QTL 2 qtl MP:0003727 abnormal retina layer morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD
8655855 Arrd3 Age-related retinal degeneration QTL 3 qtl MP:0001303 abnormal lens morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD
8655906 Rf60 Renal function QTL 60 qtl MP:0005528 decreased renal glomerular filtration rate IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655945 Rf61 Renal function QTL 61 qtl MP:0005528 decreased renal glomerular filtration rate IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655949 Rf62 Renal function QTL 62 qtl MP:0005565 increased blood urea nitrogen level IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655951 Rf63 Renal function QTL 63 qtl MP:0005565 increased blood urea nitrogen level IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655959 Pur32 Proteinuria QTL 32 qtl MP:0002962 increased urine protein level IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655961 Kidm43 Kidney mass QTL 43 qtl MP:0003917 increased kidney weight IDA N RGD:8552897|PMID:24192394 20140523 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0001260 increased body weight IAGP N RGD:8655976|PMID:19369235 20140527 RGD compared to W-Lepr+/+/Nin
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0001262 decreased body weight induced IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0001326 retina degeneration IAGP N RGD:8655976|PMID:19369235 20140527 RGD compared to W-Lepr+/+/Nin
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0001327 decreased retina photoreceptor cell number IAGP N RGD:8655976|PMID:19369235 20190729 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0003674 oxidative stress IAGP N RGD:21408553|PMID:24709042 20200312 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0003729 abnormal photoreceptor outer segment morphology treatment IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0005559 increased circulating glucose level IAGP N RGD:8657053|PMID:23036575 20200313 RGD compared to W-Lepr+/+/Nin
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:8655976|PMID:19369235 20190729 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0008515 thin retina outer nuclear layer treatment IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0008519 thin retina outer plexiform layer IAGP N RGD:8655976|PMID:19369235 20190729 RGD
8655992 W-<i>Lepr</i><sup>faNin</sup> strain MP:0011234 abnormal retinol level IAGP N RGD:8657053|PMID:23036575 20200313 RGD compared to W-Lepr+/+/Nin
8657050 Bw146 Body weight QTL 146 qtl MP:0001260 increased body weight IDA N RGD:8657042|PMID:24204914 20140528 RGD
8657079 SS.LEW-(<i>D18Chm124-D18Chm126</i>)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr
8657135 SS.LEW-(<i>D10Chm280-D10Chm216</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
8657135 SS.LEW-(<i>D10Chm280-D10Chm216</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd
8657348 SS.LEW-(<i>D17Chm131-D17Chm93</i>),MNS-(<i>D2Rat155-D2Chm161</i>),LEW-(<i>D18Chm41-D18Rat92</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
8657348 SS.LEW-(<i>D17Chm131-D17Chm93</i>),MNS-(<i>D2Rat155-D2Chm161</i>),LEW-(<i>D18Chm41-D18Rat92</i>)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140605 RGD
8657348 SS.LEW-(<i>D17Chm131-D17Chm93</i>),MNS-(<i>D2Rat155-D2Chm161</i>),LEW-(<i>D18Chm41-D18Rat92</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140605 RGD
8657351 SS.MNS-(<i>D2Chm366-D2Rat52</i>),LEW-(<i>D18Rat61-D18Rat45</i>),LEW-(<i>D10Chm128-D10Chm121</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
8657351 SS.MNS-(<i>D2Chm366-D2Rat52</i>),LEW-(<i>D18Rat61-D18Rat45</i>),LEW-(<i>D10Chm128-D10Chm121</i>)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD
8657351 SS.MNS-(<i>D2Chm366-D2Rat52</i>),LEW-(<i>D18Rat61-D18Rat45</i>),LEW-(<i>D10Chm128-D10Chm121</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD compared to SS/JrHsd
8657361 SS.MNS-(<i>D2Chm254-D2Chm161</i>),LEW-(<i>D10Chm246-D10Chm257</i>),LEW-(<i>D16Chm48-D16Chm60</i>),LEW-(<i>D18Rat55-D18Mgh2</i>)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis
8657361 SS.MNS-(<i>D2Chm254-D2Chm161</i>),LEW-(<i>D10Chm246-D10Chm257</i>),LEW-(<i>D16Chm48-D16Chm60</i>),LEW-(<i>D18Rat55-D18Mgh2</i>)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD
8657361 SS.MNS-(<i>D2Chm254-D2Chm161</i>),LEW-(<i>D10Chm246-D10Chm257</i>),LEW-(<i>D16Chm48-D16Chm60</i>),LEW-(<i>D18Rat55-D18Mgh2</i>)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD compared to SS/JrHsd
8657410 Bp374 Blood pressure QTL 374 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:8657382|PMID:23773896 20151130 RGD
8662350 Eae35 Experimental allergic encephalomyelitis QTL 35 qtl MP:0006082 CNS inflammation IDA N RGD:8662331|PMID:20505148 20140620 RGD
8662454 Vetf3 Vascular elastic tissue fragility QTL 3 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662816 Vetf4 Vascular elastic tissue fragility QTL 4 qtl MP:0011317 abnormal renal artery morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662823 Vetf5 Vascular elastic tissue fragility QTL 5 qtl MP:0003139 patent ductus arteriosus IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662828 Vetf6 Vascular elastic tissue fragility QTL 6 qtl MP:0003139 patent ductus arteriosus IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662832 Vetf7 Vascular elastic tissue fragility QTL 7 qtl MP:0003905 abnormal aorta elastin content IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662836 Vetf8 Vascular elastic tissue fragility QTL 8 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662843 Vetf9 Vascular elastic tissue fragility QTL 9 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662860 Vetf10 Vascular elastic tissue fragility QTL 10 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD
8662861 LOU.BN-(<i>D5Rat59-D5Rat133</i>)/Bbb strain MP:0003279 aneurysm IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb and BN/Rj
8693608 Alc24 Alcohol consumption QTL 24 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693618 Alc25 Alcohol consumption QTL 25 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693622 Alc26 Alcohol consumption QTL 26 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693632 Alc27 Alcohol consumption QTL 27 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693635 Alc28 Alcohol consumption QTL 28 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693637 Alc29 Alcohol consumption QTL 29 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693641 Alc30 Alcohol consumption QTL 30 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693645 Alc31 Alcohol consumption QTL 31 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693654 Alc32 Alcohol consumption QTL 32 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693658 Alc33 Alcohol consumption QTL 33 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693661 Alc34 Alcohol consumption QTL 34 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693690 Alc35 Alcohol consumption QTL 35 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693697 Alc36 Alcohol consumption QTL 36 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8693699 Alc37 Alcohol consumption QTL 37 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD
8694166 Bw147 Body weight QTL 147 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694169 Bw148 Body weight QTL 148 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694173 Bw149 Body weight QTL 149 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694179 Bw150 Body weight QTL 150 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694181 Bw151 Body weight QTL 151 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694186 Bw152 Body weight QTL 152 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694189 Bw153 Body weight QTL 153 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD
8694194 Abfw1 Abdominal fat weight QTL 1 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694196 Abfw2 Abdominal fat weight QTL 2 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694198 Abfw3 Abdominal fat weight QTL 3 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694200 Abfw4 Abdominal fat weight QTL 4 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694359 Abfw5 Abdominal fat weight QTL 5 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694361 Abfw6 Abdominal fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694364 Abfw7 Abdominal fat weight QTL 7 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694366 Abfw8 Abdominal fat weight QTL 8 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
8694370 Bw154 Body weight QTL 154 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694374 Bw155 Body weight QTL 155 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694376 Bw156 Body weight QTL 156 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694378 Bw157 Body weight QTL 157 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694383 Bw158 Body weight QTL 158 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694386 Bw159 Body weight QTL 159 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694389 Bw160 Body weight QTL 160 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694392 Bw161 Body weight QTL 161 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694424 Bw162 Body weight QTL 162 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694427 Bw163 Body weight QTL 163 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694429 Bw164 Body weight QTL 164 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694432 Bw165 Body weight QTL 165 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694435 Bw166 Body weight QTL 166 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694437 Bw167 Body weight QTL 167 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694439 Bw168 Body weight QTL 168 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694441 Bw169 Body weight QTL 169 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694446 Bw170 Body weight QTL 170 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694450 Bw171 Body weight QTL 171 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
8694453 Bw172 Body weight QTL 172 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD
9587428 Epfw6 Epididymal fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9588537 Ndufc2<sup>em1Mcwi</sup> NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage
9588541 Ndufc2<sup>em2Mcwi</sup> NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage
9588541 Ndufc2<sup>em2Mcwi</sup> NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:11040458|PMID:26888427 20160816 RGD
9588544 SHR-<i>Ndufc2<sup>em1Mcwi</sup></i> strain MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD no homozygous knockout embryos found at implantation stage
9588546 SHR-<i>Ndufc2<sup>em2Mcwi</sup></i> strain MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD no homozygous knockout embryos found at implantation stage
9588549 Nfe2l2<sup>em1Mcwi</sup> nuclear factor, erythroid 2-like 2; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0001613 abnormal vasodilation IMP N RGD:11344212|PMID:26637559 20170913 RGD
9588549 Nfe2l2<sup>em1Mcwi</sup> nuclear factor, erythroid 2-like 2; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20210610 RGD compared to SD
9589025 Epfw7 Epididymal fat weight QTL 7 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589028 Epfw8 Epididymal fat weight QTL 8 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589030 Epfw9 Epididymal fat weight QTL 9 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589032 Epfw10 Epididymal fat weight QTL 10 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589034 Epfw11 Epididymal fat weight QTL 11 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589041 Epfw12 Epididymal fat weight QTL 12 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589044 Scfw1 Subcutaneous fat weight QTL 1 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589046 Scfw2 Subcutaneous fat weight QTL 2 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589048 Scfw3 Subcutaneous fat weight QTL 3 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589051 Scfw4 Subcutaneous fat weight QTL 4 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589055 Scfw5 Subcutaneous fat weight QTL 5 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589057 Scfw6 Subcutaneous fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589093 Slep10 Serum leptin concentration QTL 10 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589097 Slep11 Serum leptin concentration QTL 11 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589100 Slep12 Serum leptin concentration QTL 12 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589102 Slep13 Serum leptin concentration QTL 13 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589106 Insul23 Insulin level QTL 23 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589129 Insul24 Insulin level QTL 24 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589131 Insul25 Insulin level QTL 25 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589133 Insul26 Insulin level QTL 26 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589136 Insul27 Insulin level QTL 27 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589141 Insul28 Insulin level QTL 28 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589149 Insul29 Insulin level QTL 29 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589151 Insul30 Insulin level QTL 30 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9589153 Insul31 Insulin level QTL 31 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9589155 Insul32 Insulin level QTL 32 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9589158 Gluco65 Glucose level QTL 65 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589164 Gluco66 Glucose level QTL 66 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589814 Gluco67 Glucose level QTL 67 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589816 Gluco68 Glucose level QTL 68 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD
9589820 Insglur3 Insulin/glucose ratio QTL 3 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590080 Insglur4 Insulin/glucose ratio QTL 4 qtl MP:0005331 insulin resistance IAGP N RGD:8694157|PMID:25003539 20141125 RGD
9590084 Insglur5 Insulin/glucose ratio QTL 5 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590086 Insglur6 Insulin/glucose ratio QTL 6 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590088 Insglur7 Insulin/glucose ratio QTL 7 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590090 Insglur8 Insulin/glucose ratio QTL 8 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590092 Insglur9 Insulin/glucose ratio QTL 9 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD
9590095 Sffal3 Serum free fatty acids level QTL 3 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590100 Sffal4 Serum free fatty acids level QTL 4 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590102 Sffal5 Serum free fatty acids level QTL 5 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590104 Sffal6 Serum free fatty acids level QTL 6 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590107 Sffal7 Serum free fatty acids level QTL 7 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590109 Sffal8 Serum free fatty acids level QTL 8 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590136 Scort3 Serum corticosterone level QTL 3 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590140 Scort4 Serum corticosterone level QTL 4 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590142 Scort5 Serum corticosterone level QTL 5 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590144 Scort6 Serum corticosterone level QTL 6 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590147 Scort7 Serum corticosterone level QTL 7 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590151 Scort8 Serum corticosterone level QTL 8 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590154 Scort9 Serum corticosterone level QTL 9 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590248 Scort10 Serum corticosterone level QTL 10 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590250 Scort11 Serum corticosterone level QTL 11 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590252 Scort12 Serum corticosterone level QTL 12 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590268 Scort13 Serum corticosterone level QTL 13 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590272 Scort14 Serum corticosterone level QTL 14 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590275 Scort15 Serum corticosterone level QTL 15 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590284 SS-Tg(ApoC3-CETP)25Opaz strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2290427|PMID:10581080 20200320 RGD compared to SS/JrHsd
9590284 SS-Tg(ApoC3-CETP)25Opaz strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2290427|PMID:10581080 20200320 RGD compared to SS/JrHsd
9590286 Uminl1 Urine mineral level QTL 1 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD
9590290 Uminl2 Urine mineral level QTL 2 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD
9590292 Uminl3 Urine mineral level QTL 3 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD
9590294 Uminl4 Urine mineral level QTL 4 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD
9590298 Uminl5 Urine mineral level QTL 5 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD
9590300 Scort16 Serum corticosterone level QTL 16 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590304 Scort17 Serum corticosterone level QTL 17 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590306 Scort18 Serum corticosterone level QTL 18 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590310 Scort19 Serum corticosterone level QTL 19 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590313 Scort20 Serum corticosterone level QTL 20 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590316 Scort21 Serum corticosterone level QTL 21 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9590318 Scort22 Serum corticosterone level QTL 22 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD
9685065 Swd6 Spike wave discharge measurement QTL 6 qtl MP:0001499 abnormal kindling response IDA N RGD:7794751|PMID:23903052 20141216 RGD
9685068 Swd7 Spike wave discharge measurement QTL 7 qtl MP:0001499 abnormal kindling response IDA N RGD:7794751|PMID:23903052 20141216 RGD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20170223 RGD compared to SD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20170223 RGD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20170223 RGD compared to SD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD
9685623 SD-<i>Pax6<sup>Sey2</sup></i>/Mce strain MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD
9685791 SS.LEW-(<i>D1Mco36-D1Mco61</i>)/Bj strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685793 SS.LEW-(<i>D1Rat200-D1Mco136</i>)/Bj strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685793 SS.LEW-(<i>D1Rat200-D1Mco136</i>)/Bj strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685793 SS.LEW-(<i>D1Rat200-D1Mco136</i>)/Bj strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685793 SS.LEW-(<i>D1Rat200-D1Mco136</i>)/Bj strain MP:0006265 increased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685795 SS.LEW-(<i>D1Mco55-D1Wox6</i>)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685795 SS.LEW-(<i>D1Mco55-D1Wox6</i>)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685795 SS.LEW-(<i>D1Mco55-D1Wox6</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685795 SS.LEW-(<i>D1Mco55-D1Wox6</i>)/Bj strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to parental SS/Jr
9685797 SS.LEW-(<i>D1Mco134-D1Wox6</i>)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685797 SS.LEW-(<i>D1Mco134-D1Wox6</i>)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685797 SS.LEW-(<i>D1Mco134-D1Wox6</i>)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685797 SS.LEW-(<i>D1Mco134-D1Wox6</i>)/Bj strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr
9685799 Bp375 Blood pressure QTL 375 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:9685377|PMID:25231251 20150306 RGD as compared to parental SS
9685802 Bp376 Blood pressure QTL 376 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:9685377|PMID:25231251 20150306 RGD as compared to parental SS
9831158 Y59/Zgd strain MP:0000063 decreased bone mineral density induced IAGP XCO:0000469 N RGD:9831160|PMID:24271527 20150227 RGD
9831158 Y59/Zgd strain MP:0020879 abnormal calcium level induced IAGP XCO:0000469 N RGD:629460|PMID:10391208 20201005 RGD decreased in femur
9831158 Y59/Zgd strain MP:0020885 abnormal phosphate level induced IAGP XCO:0000469 N RGD:629460|PMID:10391208 20201005 RGD decreased in femur